,drug_name,disease_name,protein_name
0,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
1,imatinib,systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
2,imatinib,systemic mastocytosis,platelet derived growth factor receptor alpha
3,paracetamol,pain,prostaglandin-endoperoxide synthase 1
4,paracetamol,pain,prostaglandin-endoperoxide synthase 2
5,paracetamol,pain,prostaglandin e synthase 3
6,aspirin,pain,prostaglandin-endoperoxide synthase 1
7,aspirin,pain,prostaglandin-endoperoxide synthase 2
8,aspirin,thrombotic disease,prostaglandin-endoperoxide synthase 1
9,naproxen,pain,prostaglandin-endoperoxide synthase 2
10,cortisone,keratitis,nuclear receptor subfamily 3 group c member 1
11,dexamethasone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
12,pinacidil,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
13,antazoline,vasomotor rhinitis,histamine receptor h1
14,levofloxacin,pyelonephritis,dna topoisomerase ii alpha
15,meloxicam,pain,prostaglandin-endoperoxide synthase 2
16,fluticasone,bronchitis,nuclear receptor subfamily 3 group c member 1
17,fluphenazine,schizophrenia,dopamine receptor d2
18,fluphenazine,schizophrenia,dopamine receptor d1
19,terfenadine,allergic contact dermatitis,histamine receptor h1
20,norethisterone,menorrhagia,progesterone receptor
21,ziprasidone,schizophrenia,dopamine receptor d2
22,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 2a
23,carbinoxamine,atopic conjunctivitis,histamine receptor h1
24,fsh,primary ovarian failure,follicle stimulating hormone receptor
25,warfarin,pulmonary embolism,vitamin k epoxide reductase complex subunit 1
26,loratadine,allergic rhinitis,histamine receptor h1
27,oxymetazoline,nasal congestion,adrenoceptor alpha 1a
28,duloxetine,major depressive disorder,solute carrier family 6 member 4
29,doxylamine,allergic rhinitis,histamine receptor h1
30,minoxidil,alopecia,potassium inwardly rectifying channel subfamily j member 1
31,minoxidil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 1
32,sildenafil,erectile dysfunction,phosphodiesterase 5a
33,betamethasone,crohn disease,nuclear receptor subfamily 3 group c member 1
34,triamcinolone,crohn disease,nuclear receptor subfamily 3 group c member 1
35,gabapentin,restless legs syndrome,calcium voltage-gated channel auxiliary subunit alpha2delta 1
36,prednisolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
37,pimozide,tourette syndrome,dopamine receptor d2
38,levonorgestrel,menorrhagia,progesterone receptor
39,dimethyl fumarate,multiple sclerosis,kelch like ech associated protein 1
40,protriptyline,major depressive disorder,solute carrier family 6 member 2
41,terguride,pulmonary hypertension,5-hydroxytryptamine receptor 2b
42,lafutidine,gastroesophageal reflux disease,histamine receptor h2
43,ospemifene,psychologic dyspareunia,estrogen receptor 1
44,glipizide,hyperglycemia,atp binding cassette subfamily c member 8
45,landiolol,tachycardia,adrenoceptor beta 1
46,levocabastine,atopic conjunctivitis,histamine receptor h1
47,acenocoumarol,pulmonary embolism,vitamin k epoxide reductase complex subunit 1
48,dexamethasone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
49,mosapramine,schizophrenia,dopamine receptor d2
50,thyrotropin alfa,thyroid tumor,thyroid stimulating hormone receptor
51,metolazone,hypertensive disorder,solute carrier family 12 member 3
52,gepirone,major depressive disorder,5-hydroxytryptamine receptor 1a
53,tramadol,pain,opioid receptor mu 1
54,trimethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
55,apalutamide,prostate cancer,androgen receptor
56,aminoglutethimide,breast neoplasm,cytochrome p450 family 19 subfamily a member 1
57,anastrozole,breast neoplasm,cytochrome p450 family 19 subfamily a member 1
58,etizolam,anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha1
59,sulfasalazine,ulcerative colitis,arachidonate 5-lipoxygenase
60,vinpocetine,dementia,phosphodiesterase 1a
61,glutethimide,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
62,fomepizole,acidosis disorder,"alcohol dehydrogenase 1a (class i), alpha polypeptide"
63,afamelanotide,erythropoietic protoporphyria,melanocortin 1 receptor
64,voclosporin,uveitis,"protein phosphatase 3 regulatory subunit b, alpha"
65,cobicistat,hiv infectious disease,cytochrome p450 family 3 subfamily a member 43
66,medrysone,uveitis,nuclear receptor subfamily 3 group c member 1
67,medrysone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
68,medrysone,iritis,nuclear receptor subfamily 3 group c member 1
69,medrysone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
70,diflunisal,osteoarthritis,prostaglandin-endoperoxide synthase 1
71,diflunisal,osteoarthritis,prostaglandin-endoperoxide synthase 2
72,diflunisal,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
73,diflunisal,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
74,diflunisal,pain,prostaglandin-endoperoxide synthase 1
75,diflunisal,pain,prostaglandin-endoperoxide synthase 2
76,diflunisal,chronic pain,prostaglandin-endoperoxide synthase 1
77,diflunisal,chronic pain,prostaglandin-endoperoxide synthase 2
78,polythiazide,hypertensive disorder,solute carrier family 12 member 3
79,mepyramine,atopic conjunctivitis,histamine receptor h1
80,mepyramine,seasonal allergic rhinitis,histamine receptor h1
81,mepyramine,sneeze,histamine receptor h1
82,mepyramine,allergic rhinitis,histamine receptor h1
83,mepyramine,dysmenorrhea,histamine receptor h1
84,mepyramine,vasomotor rhinitis,histamine receptor h1
85,mepyramine,urticaria,histamine receptor h1
86,mepyramine,pruritus,histamine receptor h1
87,azilsartan medoxomil,hypertensive disorder,angiotensin ii receptor type 1
88,teriflunomide,multiple sclerosis,dihydroorotate dehydrogenase (quinone)
89,hydroxocobalamin,vitamin b12 deficiency,5-methyltetrahydrofolate-homocysteine methyltransferase
90,hydroxocobalamin,vitamin b12 deficiency,methylmalonyl-coa mutase
91,hydroxocobalamin,vitamin deficiency disorder,5-methyltetrahydrofolate-homocysteine methyltransferase
92,hydroxocobalamin,vitamin deficiency disorder,methylmalonyl-coa mutase
93,hydroxocobalamin,pernicious anemia,5-methyltetrahydrofolate-homocysteine methyltransferase
94,formoterol,pulmonary emphysema,adrenoceptor beta 2
95,bromocriptine,acromegaly,dopamine receptor d2
96,bromocriptine,acromegaly,dopamine receptor d3
97,bromocriptine,postencephalitic parkinson disease,dopamine receptor d2
98,bromocriptine,postencephalitic parkinson disease,dopamine receptor d3
99,bromocriptine,parkinson disease,dopamine receptor d2
100,bromocriptine,parkinson disease,dopamine receptor d3
101,bromocriptine,hyperprolactinemia,dopamine receptor d2
102,bromocriptine,hyperprolactinemia,dopamine receptor d3
103,pramipexole,parkinson disease,dopamine receptor d2
104,pramipexole,parkinson disease,dopamine receptor d3
105,pramipexole,parkinson disease,dopamine receptor d4
106,pramipexole,restless legs syndrome,dopamine receptor d2
107,pramipexole,restless legs syndrome,dopamine receptor d3
108,pramipexole,restless legs syndrome,dopamine receptor d4
109,spironolactone,hyperaldosteronism,nuclear receptor subfamily 3 group c member 2
110,spironolactone,edema,nuclear receptor subfamily 3 group c member 2
111,spironolactone,ascites,nuclear receptor subfamily 3 group c member 2
112,spironolactone,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
113,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
114,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
115,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
116,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
117,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
118,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
119,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
120,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
121,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
122,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
123,saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
124,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1d
125,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1b
126,eletriptan,migraine disorder,5-hydroxytryptamine receptor 2a
127,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1a
128,terbutaline,pulmonary emphysema,adrenoceptor beta 2
129,terbutaline,pulmonary emphysema,adrenoceptor beta 3
130,terbutaline,pruritus,adrenoceptor beta 2
131,terbutaline,pruritus,adrenoceptor beta 3
132,terbutaline,asthma,adrenoceptor beta 2
133,terbutaline,asthma,adrenoceptor beta 3
134,terbutaline,bronchitis,adrenoceptor beta 2
135,terbutaline,bronchitis,adrenoceptor beta 3
136,belotecan,non-small cell lung carcinoma,dna topoisomerase i
137,belotecan,ovarian cancer,dna topoisomerase i
138,amphetamine,obesity disorder,solute carrier family 18 member a2
139,amphetamine,obesity disorder,trace amine associated receptor 1
140,amphetamine,obesity disorder,cart prepropeptide
141,amphetamine,narcolepsy,solute carrier family 18 member a2
142,amphetamine,narcolepsy,trace amine associated receptor 1
143,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
144,amphetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
145,cinnarizine,nausea,histamine receptor h1
146,cinnarizine,central nervous system origin vertigo,histamine receptor h1
147,cinnarizine,motion sickness,histamine receptor h1
148,carmofur,colonic neoplasm,n-acylsphingosine amidohydrolase 1
149,topiroxostat,hyperuricemia,xanthine dehydrogenase
150,topiroxostat,hyperuricemia,atp binding cassette subfamily g member 2 (jr blood group)
151,topiroxostat,gout,xanthine dehydrogenase
152,topiroxostat,gout,atp binding cassette subfamily g member 2 (jr blood group)
153,leuprolide,endometriosis,gonadotropin releasing hormone receptor
154,leuprolide,precocious puberty,gonadotropin releasing hormone receptor
155,glimepiride,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
156,glimepiride,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
157,loxapine,schizophrenia,dopamine receptor d2
158,loxapine,schizophrenia,5-hydroxytryptamine receptor 2a
159,loxapine,bipolar disorder,dopamine receptor d2
160,loxapine,bipolar disorder,5-hydroxytryptamine receptor 2a
161,oxaprozin,osteoarthritis,prostaglandin-endoperoxide synthase 1
162,oxaprozin,osteoarthritis,prostaglandin-endoperoxide synthase 2
163,oxaprozin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
164,oxaprozin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
165,oxaprozin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
166,oxaprozin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
167,pimozide,tourette syndrome,dopamine receptor d3
168,dehydroepiandrosterone,psychologic dyspareunia,estrogen receptor 1
169,dehydroepiandrosterone,psychologic dyspareunia,estrogen receptor 2
170,dehydroepiandrosterone,psychologic dyspareunia,androgen receptor
171,dehydroepiandrosterone,systemic lupus erythematosus,androgen receptor
172,omacetaxine mepesuccinate,"chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein l3
173,anagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
174,clemastine,urticaria,histamine receptor h1
175,clemastine,pruritus,histamine receptor h1
176,clemastine,sneeze,histamine receptor h1
177,clemastine,vasomotor rhinitis,histamine receptor h1
178,clemastine,allergic rhinitis,histamine receptor h1
179,clemastine,atopic conjunctivitis,histamine receptor h1
180,sapropterin,phenylketonuria,phenylalanine hydroxylase
181,insulin detemir,diabetes mellitus,insulin receptor
182,benzbromarone,hyperuricemia,solute carrier family 22 member 12
183,benzbromarone,gout,solute carrier family 22 member 12
184,phendimetrazine,obesity disorder,adrenoceptor alpha 1a
185,phendimetrazine,obesity disorder,adrenoceptor alpha 1b
186,phendimetrazine,obesity disorder,solute carrier family 6 member 2
187,valproic acid,absence epilepsy,aldehyde dehydrogenase 5 family member a1
188,valproic acid,absence epilepsy,histone deacetylase 9
189,valproic acid,bipolar disorder,myristoylated alanine rich protein kinase c substrate
190,valproic acid,epilepsy,histone deacetylase 9
191,valproic acid,migraine disorder,solute carrier family 27 member 2
192,levomethadyl acetate,opiate dependence,opioid receptor mu 1
193,bunolol,open-angle glaucoma,adrenoceptor beta 1
194,bunolol,open-angle glaucoma,adrenoceptor beta 2
195,bunolol,ocular hypertension,adrenoceptor beta 1
196,bunolol,ocular hypertension,adrenoceptor beta 2
197,clopidogrel,acute coronary syndrome,purinergic receptor p2y12
198,clopidogrel,intracranial embolism,purinergic receptor p2y12
199,carbetocin,post-partum hemorrhage,oxytocin receptor
200,brompheniramine,seasonal allergic rhinitis,histamine receptor h1
201,brompheniramine,urticaria,histamine receptor h1
202,brompheniramine,pruritus,histamine receptor h1
203,brompheniramine,atopic conjunctivitis,histamine receptor h1
204,brompheniramine,vasomotor rhinitis,histamine receptor h1
205,brompheniramine,allergic rhinitis,histamine receptor h1
206,belotecan,ovarian cancer,thymidylate synthetase
207,belotecan,ovarian cancer,cytidine/uridine monophosphate kinase 1
208,belotecan,ovarian cancer,ribonucleotide reductase catalytic subunit m1
209,belotecan,non-small cell lung carcinoma,thymidylate synthetase
210,belotecan,non-small cell lung carcinoma,cytidine/uridine monophosphate kinase 1
211,belotecan,non-small cell lung carcinoma,ribonucleotide reductase catalytic subunit m1
212,fentanyl,pain,opioid receptor mu 1
213,fentanyl,pain,opioid receptor delta 1
214,bitolterol,bronchitis,adrenoceptor beta 2
215,bitolterol,bronchiectasis,adrenoceptor beta 2
216,bitolterol,asthma,adrenoceptor beta 2
217,bitolterol,pulmonary emphysema,adrenoceptor beta 2
218,diazoxide,pancreatic insulinoma,potassium inwardly rectifying channel subfamily j member 11
219,diazoxide,hyperinsulinism,potassium inwardly rectifying channel subfamily j member 11
220,diazoxide,islet cell adenomatosis,potassium inwardly rectifying channel subfamily j member 11
221,floctafenine,acute pain,prostaglandin-endoperoxide synthase 1
222,floctafenine,acute pain,prostaglandin-endoperoxide synthase 2
223,umeclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 2
224,umeclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
225,acrivastine,vasomotor rhinitis,histamine receptor h1
226,acrivastine,atopic conjunctivitis,histamine receptor h1
227,acrivastine,seasonal allergic rhinitis,histamine receptor h1
228,acrivastine,sneeze,histamine receptor h1
229,acrivastine,common cold,histamine receptor h1
230,acrivastine,allergic rhinitis,histamine receptor h1
231,oxytocin,post-partum hemorrhage,oxytocin receptor
232,ribavirin,chronic hepatitis c virus infection,inosine monophosphate dehydrogenase 1
233,ribavirin,respiratory syncytial virus infectious disease,inosine monophosphate dehydrogenase 1
234,butenafine,tinea pedis,squalene epoxidase
235,butenafine,pityriasis versicolor,squalene epoxidase
236,regorafenib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
237,regorafenib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
238,regorafenib,hepatocellular carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
239,regorafenib,hepatocellular carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
240,regorafenib,hepatocellular carcinoma,platelet derived growth factor receptor alpha
241,regorafenib,hepatocellular carcinoma,fibroblast growth factor receptor 1
242,regorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 1
243,regorafenib,hepatocellular carcinoma,kinase insert domain receptor
244,selexipag,pulmonary arterial hypertension,prostaglandin i2 receptor
245,mizolastine,allergic rhinitis,histamine receptor h1
246,carbenoxolone,peptic ulcer disease,hydroxysteroid 11-beta dehydrogenase 1
247,carbenoxolone,peptic ulcer disease,15-hydroxyprostaglandin dehydrogenase
248,mizolastine,perennial allergic rhinitis,histamine receptor h1
249,abiraterone acetate,prostate cancer,cytochrome p450 family 17 subfamily a member 1
250,abiraterone acetate,prostate cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
251,abiraterone acetate,prostate cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
252,abiraterone acetate,prostate cancer,cytochrome p450 family 11 subfamily b member 1
253,abiraterone acetate,prostate cancer,cytochrome p450 family 21 subfamily a member 2
254,abiraterone acetate,prostate cancer,cytochrome p450 family 1 subfamily a member 2
255,abiraterone acetate,prostate cancer,cytochrome p450 family 2 subfamily c member 9
256,abiraterone acetate,prostate cancer,cytochrome p450 family 3 subfamily a member 4
257,abiraterone acetate,prostate cancer,androgen receptor
258,venlafaxine,panic disorder,solute carrier family 6 member 4
259,venlafaxine,panic disorder,solute carrier family 6 member 2
260,venlafaxine,social phobia,solute carrier family 6 member 4
261,venlafaxine,social phobia,solute carrier family 6 member 2
262,venlafaxine,social phobia,solute carrier family 6 member 3
263,venlafaxine,major depressive disorder,solute carrier family 6 member 4
264,venlafaxine,major depressive disorder,solute carrier family 6 member 2
265,venlafaxine,major depressive disorder,solute carrier family 6 member 3
266,amoxapine,depressive disorder,solute carrier family 6 member 4
267,venlafaxine,depressive disorder,solute carrier family 6 member 2
268,amoxapine,depressive disorder,dopamine receptor d1
269,tulobuterol,asthma,adrenoceptor beta 2
270,tulobuterol,pulmonary emphysema,adrenoceptor beta 2
271,rupatadine,allergic rhinitis,histamine receptor h1
272,rupatadine,allergic rhinitis,platelet activating factor receptor
273,rupatadine,urticaria,histamine receptor h1
274,rupatadine,urticaria,platelet activating factor receptor
275,clobetasone,atopic eczema,nuclear receptor subfamily 3 group c member 1
276,clobetasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
277,defibrotide,hepatic veno-occlusive disease,"plasminogen activator, tissue type"
278,defibrotide,hepatic veno-occlusive disease,serpin family e member 1
279,celiprolol,hypertensive disorder,adrenoceptor beta 1
280,celiprolol,hypertensive disorder,adrenoceptor beta 2
281,celiprolol,angina pectoris,adrenoceptor beta 1
282,celiprolol,angina pectoris,adrenoceptor beta 2
283,physostigmine,open-angle glaucoma,acetylcholinesterase (yt blood group)
284,vigabatrin,west syndrome,4-aminobutyrate aminotransferase
285,linagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
286,oxyphencyclimine,peptic ulcer disease,cholinergic receptor muscarinic 3
287,propylthiouracil,hyperthyroidism,thyroid peroxidase
288,propylthiouracil,thyroid crisis,thyroid peroxidase
289,butorphanol,pain,opioid receptor kappa 1
290,butorphanol,pain,opioid receptor delta 1
291,butorphanol,pain,opioid receptor mu 1
292,butorphanol,labor pain,opioid receptor kappa 1
293,butorphanol,labor pain,opioid receptor delta 1
294,butorphanol,labor pain,opioid receptor mu 1
295,dextropropoxyphene,pain,opioid receptor mu 1
296,dextropropoxyphene,pain,opioid receptor delta 1
297,cilazapril,hypertensive disorder,angiotensin i converting enzyme
298,icatibant,hereditary angioedema,bradykinin receptor b2
299,limaprost,thromboangiitis obliterans,prostaglandin e receptor 2
300,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha1
301,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha2
302,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha3
303,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha4
304,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha5
305,riluzole,amyotrophic lateral sclerosis,sodium voltage-gated channel alpha subunit 5
306,hydrochlorothiazide,edema,solute carrier family 12 member 3
307,hydrochlorothiazide,hypertensive disorder,solute carrier family 12 member 3
308,irbesartan,hypertensive disorder,angiotensin ii receptor type 1
309,irbesartan,diabetic kidney disease,angiotensin ii receptor type 1
310,estrone sulphate,postmenopausal atrophic vaginitis,estrogen receptor 1
311,entacapone,parkinson disease,catechol-o-methyltransferase
312,"1,25-dihydroxyvitamin d3",hypophosphatemia,vitamin d receptor
313,"1,25-dihydroxyvitamin d3",hypocalcemia,vitamin d receptor
314,"1,25-dihydroxyvitamin d3",hypoparathyroidism,vitamin d receptor
315,"1,25-dihydroxyvitamin d3",renal osteodystrophy,vitamin d receptor
316,carbachol,open-angle glaucoma,cholinergic receptor nicotinic alpha 2 subunit
317,tazarotene,acne,retinoic acid receptor alpha
318,tazarotene,acne,retinoid x receptor beta
319,tazarotene,acne,retinoic acid receptor gamma
320,tazarotene,acne,retinoic acid receptor beta
321,tazarotene,psoriasis,retinoic acid receptor alpha
322,tazarotene,psoriasis,retinoid x receptor beta
323,tazarotene,psoriasis,retinoic acid receptor gamma
324,tazarotene,psoriasis,retinoic acid receptor beta
325,avanafil,erectile dysfunction,phosphodiesterase 5a
326,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4a
327,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4b
328,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4c
329,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4d
330,dyphylline,chronic bronchitis,phosphodiesterase 4a
331,dyphylline,chronic bronchitis,phosphodiesterase 4b
332,dyphylline,chronic bronchitis,phosphodiesterase 4c
333,dyphylline,chronic bronchitis,phosphodiesterase 4d
334,dyphylline,bronchial disorder,phosphodiesterase 4a
335,dyphylline,bronchial disorder,phosphodiesterase 4b
336,dyphylline,bronchial disorder,phosphodiesterase 4c
337,dyphylline,bronchial disorder,phosphodiesterase 4d
338,dyphylline,pulmonary emphysema,phosphodiesterase 4a
339,dyphylline,pulmonary emphysema,phosphodiesterase 4b
340,dyphylline,pulmonary emphysema,phosphodiesterase 4c
341,dyphylline,pulmonary emphysema,phosphodiesterase 4d
342,dyphylline,asthma,phosphodiesterase 4a
343,dyphylline,asthma,phosphodiesterase 4b
344,dyphylline,asthma,phosphodiesterase 4c
345,dyphylline,asthma,phosphodiesterase 4d
346,lenvatinib,thyroid gland papillary carcinoma,platelet derived growth factor receptor alpha
347,lenvatinib,thyroid gland papillary carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
348,lenvatinib,thyroid gland papillary carcinoma,ret proto-oncogene
349,lenvatinib,thyroid gland follicular carcinoma,platelet derived growth factor receptor alpha
350,lenvatinib,thyroid gland follicular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
351,lenvatinib,thyroid gland follicular carcinoma,ret proto-oncogene
352,lenvatinib,renal cell carcinoma,platelet derived growth factor receptor alpha
353,lenvatinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
354,lenvatinib,renal cell carcinoma,ret proto-oncogene
355,liraglutide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
356,crizotinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
357,crizotinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
358,triflupromazine,psychotic disorder,dopamine receptor d1
359,triflupromazine,psychotic disorder,dopamine receptor d2
360,triflupromazine,psychotic disorder,cholinergic receptor muscarinic 1
361,triflupromazine,psychotic disorder,cholinergic receptor muscarinic 2
362,triflupromazine,psychotic disorder,5-hydroxytryptamine receptor 2b
363,triflupromazine,vomiting,dopamine receptor d2
364,triflupromazine,nausea,dopamine receptor d2
365,buprenorphine,chronic pain,opioid receptor mu 1
366,buprenorphine,chronic pain,opioid receptor kappa 1
367,buprenorphine,opiate dependence,opioid receptor mu 1
368,buprenorphine,opiate dependence,opioid receptor kappa 1
369,nebivolol,hypertensive disorder,adrenoceptor beta 1
370,papaverine,peripheral vascular disease,phosphodiesterase 4b
371,pioglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
372,sotalol,atrial fibrillation,adrenoceptor beta 1
373,sotalol,atrial fibrillation,adrenoceptor beta 2
374,sotalol,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
375,sufentanil,post-operative pain,opioid receptor mu 1
376,tirofiban,acute coronary syndrome,integrin subunit alpha 2b
377,tirofiban,acute coronary syndrome,integrin subunit beta 3
378,valrubicin,urinary bladder neoplasm,dna topoisomerase ii alpha
379,cabergoline,hyperprolactinemia,dopamine receptor d2
380,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
381,estradiol valerate,premenstrual dysphoric disorder,estrogen receptor 1
382,estradiol valerate,premenstrual dysphoric disorder,estrogen receptor 2
383,estradiol valerate,hot flashes,estrogen receptor 1
384,estradiol valerate,hot flashes,estrogen receptor 2
385,estradiol valerate,postmenopausal osteoporosis,estrogen receptor 1
386,estradiol valerate,postmenopausal osteoporosis,estrogen receptor 2
387,estradiol valerate,postmenopausal atrophic vaginitis,estrogen receptor 1
388,estradiol valerate,postmenopausal atrophic vaginitis,estrogen receptor 2
389,estradiol valerate,acne,estrogen receptor 1
390,estradiol valerate,acne,estrogen receptor 2
391,metformin,type 2 diabetes mellitus,electron transfer flavoprotein dehydrogenase
392,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
393,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
394,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase b
395,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase a
396,mebendazole,trichuriasis,tubulin alpha 1a
397,mebendazole,trichuriasis,tubulin beta 4b class ivb
398,mebendazole,ascariasis,tubulin alpha 1a
399,mebendazole,ascariasis,tubulin beta 4b class ivb
400,mebendazole,enterobiasis,tubulin alpha 1a
401,mebendazole,enterobiasis,tubulin beta 4b class ivb
402,prednicarbate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
403,prednicarbate,pruritus ani,nuclear receptor subfamily 3 group c member 1
404,prednicarbate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
405,prednicarbate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
406,prednicarbate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
407,prednicarbate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
408,prednicarbate,exanthem,nuclear receptor subfamily 3 group c member 1
409,prednicarbate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
410,prednicarbate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
411,metoclopramide,gastroesophageal reflux disease,dopamine receptor d2
412,metoclopramide,gastroesophageal reflux disease,cholinergic receptor muscarinic 1
413,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 4
414,fesoterodine,urge incontinence,cholinergic receptor muscarinic 3
415,chlorthalidone,hypertensive disorder,solute carrier family 12 member 1
416,chlorthalidone,edema,solute carrier family 12 member 1
417,nicardipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
418,nicardipine,angina pectoris,calcium voltage-gated channel auxiliary subunit beta 2
419,nicardipine,angina pectoris,calcium voltage-gated channel auxiliary subunit alpha2delta 1
420,nicardipine,angina pectoris,calcium voltage-gated channel subunit alpha1 d
421,nicardipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
422,nicardipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
423,nicardipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
424,nicardipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
425,benzphetamine,obesity disorder,adrenoceptor alpha 1a
426,anakinra,rheumatoid arthritis,interleukin 1 receptor type 1
427,anakinra,cryopyrin-associated periodic syndrome,interleukin 1 receptor type 1
428,darifenacin,urge incontinence,cholinergic receptor muscarinic 3
429,desoximetasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
430,desoximetasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
431,desoximetasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
432,desoximetasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
433,desoximetasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
434,desoximetasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
435,desoximetasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
436,desoximetasone,exanthem,nuclear receptor subfamily 3 group c member 1
437,desoximetasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
438,almotriptan,migraine disorder,5-hydroxytryptamine receptor 1b
439,almotriptan,migraine disorder,5-hydroxytryptamine receptor 1d
440,acebutolol,premature ventricular contraction,adrenoceptor beta 1
441,apraclonidine,open-angle glaucoma,adrenoceptor alpha 2a
442,eplerenone,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
443,febuxostat,hyperuricemia,xanthine dehydrogenase
444,cilastatin,bacterial endocarditis,dipeptidase 1
445,cilastatin,abdominal abscess,dipeptidase 1
446,cilastatin,abdominal infection,dipeptidase 1
447,cilastatin,streptococcal pneumonia,dipeptidase 1
448,cilastatin,bacterial pneumonia,dipeptidase 1
449,cilastatin,endometritis,dipeptidase 1
450,clonidine,hypertensive disorder,adrenoceptor alpha 2a
451,clonidine,hypertensive disorder,adrenoceptor alpha 2b
452,clonidine,hypertensive disorder,adrenoceptor alpha 2c
453,clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
454,clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
455,clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
456,clonidine,open-angle glaucoma,adrenoceptor alpha 2a
457,clonidine,open-angle glaucoma,adrenoceptor alpha 2b
458,clonidine,open-angle glaucoma,adrenoceptor alpha 2c
459,tranexamic acid,endometriosis,plasminogen
460,tranexamic acid,menorrhagia,plasminogen
461,trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 g
462,trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 h
463,trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 i
464,(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 2a
465,(-)-adrenaline,anaphylaxis,adrenoceptor alpha 1a
466,(-)-adrenaline,anaphylaxis,adrenoceptor alpha 1b
467,(-)-adrenaline,anaphylaxis,adrenoceptor alpha 1d
468,(-)-adrenaline,anaphylaxis,adrenoceptor beta 2
469,(-)-adrenaline,hypotensive disorder,adrenoceptor beta 1
470,crisaborole,"dermatitis, atopic",phosphodiesterase 4a
471,crisaborole,"dermatitis, atopic",phosphodiesterase 4b
472,crisaborole,"dermatitis, atopic",phosphodiesterase 4c
473,crisaborole,"dermatitis, atopic",phosphodiesterase 4d
474,ibrutinib,waldenstrom macroglobulinemia,bruton tyrosine kinase
475,ibrutinib,mantle cell lymphoma,bruton tyrosine kinase
476,selegiline,parkinson disease,monoamine oxidase b
477,selegiline,parkinson disease,monoamine oxidase a
478,selegiline,major depressive disorder,monoamine oxidase b
479,selegiline,major depressive disorder,monoamine oxidase a
480,sitagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
481,beraprost,pulmonary arterial hypertension,prostaglandin i2 receptor
482,valbenazine,tardive dyskinesia,solute carrier family 18 member a2
483,radotinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
484,bepridil,angina pectoris,"troponin c1, slow skeletal and cardiac type"
485,ethinylestradiol,premenstrual dysphoric disorder,estrogen receptor 1
486,ethinylestradiol,hot flashes,estrogen receptor 1
487,ethinylestradiol,acne,estrogen receptor 1
488,ethinylestradiol,postmenopausal atrophic vaginitis,estrogen receptor 1
489,ethinylestradiol,postmenopausal osteoporosis,estrogen receptor 1
490,sildenafil,pulmonary arterial hypertension,phosphodiesterase 5a
491,miglitol,type 2 diabetes mellitus,maltase-glucoamylase
492,miglitol,type 2 diabetes mellitus,alpha glucosidase
493,miglitol,type 2 diabetes mellitus,glucosidase ii alpha subunit
494,miglitol,type 2 diabetes mellitus,"glucosidase alpha, neutral c"
495,isoprenaline,cardiac arrest,adrenoceptor beta 1
496,isoprenaline,cardiac arrest,adrenoceptor beta 2
497,isoprenaline,cardiac arrest,adrenoceptor beta 3
498,isoprenaline,atrioventricular block,adrenoceptor beta 1
499,isoprenaline,atrioventricular block,adrenoceptor beta 2
500,isoprenaline,atrioventricular block,adrenoceptor beta 3
501,isoprenaline,decreased cardiac output,adrenoceptor beta 1
502,isoprenaline,decreased cardiac output,adrenoceptor beta 2
503,isoprenaline,decreased cardiac output,adrenoceptor beta 3
504,isoprenaline,common cold,adrenoceptor beta 1
505,isoprenaline,common cold,adrenoceptor beta 2
506,isoprenaline,common cold,adrenoceptor beta 3
507,isoprenaline,shock,adrenoceptor beta 1
508,isoprenaline,shock,adrenoceptor beta 2
509,isoprenaline,shock,adrenoceptor beta 3
510,talinolol,hypertensive disorder,adrenoceptor beta 1
511,cyproheptadine,atopic conjunctivitis,histamine receptor h1
512,cyproheptadine,pruritus,histamine receptor h1
513,cyproheptadine,urticaria,histamine receptor h1
514,cyproheptadine,sneeze,histamine receptor h1
515,cyproheptadine,allergic rhinitis,histamine receptor h1
516,pindolol,hypertensive disorder,adrenoceptor beta 1
517,pindolol,hypertensive disorder,adrenoceptor beta 2
518,bortezomib,mantle cell lymphoma,proteasome 20s subunit beta 5
519,bortezomib,mantle cell lymphoma,proteasome 20s subunit beta 1
520,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 5
521,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 1
522,sufinpyrazone,hyperuricemia,solute carrier family 22 member 12
523,magnesium salicylate,back pain,prostaglandin-endoperoxide synthase 1
524,magnesium salicylate,back pain,prostaglandin-endoperoxide synthase 2
525,magnesium salicylate,bursitis,prostaglandin-endoperoxide synthase 1
526,magnesium salicylate,bursitis,prostaglandin-endoperoxide synthase 2
527,magnesium salicylate,arthralgia,prostaglandin-endoperoxide synthase 1
528,magnesium salicylate,arthralgia,prostaglandin-endoperoxide synthase 2
529,magnesium salicylate,synovitis,prostaglandin-endoperoxide synthase 1
530,magnesium salicylate,synovitis,prostaglandin-endoperoxide synthase 2
531,magnesium salicylate,dysmenorrhea,prostaglandin-endoperoxide synthase 1
532,magnesium salicylate,dysmenorrhea,prostaglandin-endoperoxide synthase 2
533,magnesium salicylate,osteoarthritis,prostaglandin-endoperoxide synthase 1
534,magnesium salicylate,osteoarthritis,prostaglandin-endoperoxide synthase 2
535,magnesium salicylate,pain,prostaglandin-endoperoxide synthase 1
536,magnesium salicylate,pain,prostaglandin-endoperoxide synthase 2
537,magnesium salicylate,fever,prostaglandin-endoperoxide synthase 1
538,magnesium salicylate,fever,prostaglandin-endoperoxide synthase 2
539,magnesium salicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
540,magnesium salicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
541,magnesium salicylate,headache disorder,prostaglandin-endoperoxide synthase 1
542,magnesium salicylate,headache disorder,prostaglandin-endoperoxide synthase 2
543,baricitinib,rheumatoid arthritis,janus kinase 1
544,baricitinib,rheumatoid arthritis,janus kinase 2
545,baricitinib,rheumatoid arthritis,janus kinase 3
546,baricitinib,rheumatoid arthritis,tyrosine kinase 2
547,budesonide,crohn disease,nuclear receptor subfamily 3 group c member 1
548,budesonide,asthma,nuclear receptor subfamily 3 group c member 1
549,budesonide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
550,citalopram,depressive disorder,solute carrier family 6 member 4
551,citalopram,major depressive disorder,solute carrier family 6 member 4
552,nisoldipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
553,nisoldipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
554,vilazodone,major depressive disorder,solute carrier family 6 member 4
555,vilazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
556,etelcalcetide,secondary hyperparathyroidism,calcium sensing receptor
557,cilostazol,intermittent vascular claudication,phosphodiesterase 3a
558,diclofenamide,open-angle glaucoma,carbonic anhydrase 1
559,diclofenamide,open-angle glaucoma,carbonic anhydrase 2
560,diclofenamide,open-angle glaucoma,carbonic anhydrase 4
561,diclofenamide,open-angle glaucoma,carbonic anhydrase 7
562,diclofenamide,open-angle glaucoma,carbonic anhydrase 12
563,ethacrynic acid,edema,solute carrier family 12 member 1
564,oprelvekin,thrombocytopenia,interleukin 11 receptor subunit alpha
565,tolazoline,vascular disorder,adrenoceptor alpha 1a
566,tolazoline,vascular disorder,adrenoceptor alpha 2a
567,tolazoline,vascular disorder,adrenoceptor alpha 2b
568,tolazoline,vascular disorder,adrenoceptor alpha 2c
569,tolazoline,vascular disorder,histamine receptor h1
570,tolazoline,vascular disorder,histamine receptor h2
571,tolazoline,cerebrovascular disorder,histamine receptor h1
572,tolazoline,cerebrovascular disorder,histamine receptor h2
573,tolazoline,cerebrovascular disorder,adrenoceptor alpha 1a
574,tolazoline,cerebrovascular disorder,adrenoceptor alpha 2a
575,tolazoline,cerebrovascular disorder,adrenoceptor alpha 2b
576,tolazoline,cerebrovascular disorder,adrenoceptor alpha 2c
577,tolazoline,persistent fetal circulation syndrome,histamine receptor h1
578,tolazoline,persistent fetal circulation syndrome,histamine receptor h2
579,tolazoline,persistent fetal circulation syndrome,adrenoceptor alpha 1a
580,tolazoline,persistent fetal circulation syndrome,adrenoceptor alpha 2a
581,diclofenamide,angle-closure glaucoma,carbonic anhydrase 1
582,diclofenamide,angle-closure glaucoma,carbonic anhydrase 2
583,diclofenamide,angle-closure glaucoma,carbonic anhydrase 4
584,diclofenamide,angle-closure glaucoma,carbonic anhydrase 7
585,diclofenamide,angle-closure glaucoma,carbonic anhydrase 12
586,venetoclax,b-cell chronic lymphocytic leukemia,bcl2 apoptosis regulator
587,ketoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
588,ketoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
589,ketoprofen,rheumatoid arthritis,c-x-c motif chemokine receptor 1
590,ketoprofen,pain,prostaglandin-endoperoxide synthase 1
591,ketoprofen,pain,prostaglandin-endoperoxide synthase 2
592,ketoprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
593,ketoprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
594,clotrimazole,acne,toll like receptor 2
595,lusutrombopag,thrombocytopenia,"mpl proto-oncogene, thrombopoietin receptor"
596,levocabastine,atopic conjunctivitis,neurotensin receptor 2
597,ethosuximide,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
598,empagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
599,cimetidine,duodenal ulcer,histamine receptor h2
600,cimetidine,gastric ulcer,histamine receptor h2
601,cimetidine,zollinger-ellison syndrome,histamine receptor h2
602,cimetidine,multiple endocrine neoplasia,histamine receptor h2
603,cimetidine,dyspepsia,histamine receptor h2
604,cimetidine,gastroesophageal reflux disease,histamine receptor h2
605,cimetidine,systemic mastocytosis,histamine receptor h2
606,naloxone,opiate dependence,opioid receptor mu 1
607,naloxone,opiate dependence,opioid receptor delta 1
608,naloxone,opiate dependence,opioid receptor kappa 1
609,naloxone,pain,opioid receptor mu 1
610,naloxone,pain,opioid receptor delta 1
611,naloxone,pain,opioid receptor kappa 1
612,benzatropine,postencephalitic parkinson disease,solute carrier family 6 member 3
613,benzatropine,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
614,benzatropine,parkinsonian disorder,solute carrier family 6 member 3
615,benzatropine,parkinsonian disorder,cholinergic receptor muscarinic 1
616,benzatropine,basal ganglia disorder,solute carrier family 6 member 3
617,benzatropine,basal ganglia disorder,cholinergic receptor muscarinic 1
618,benzatropine,parkinson disease,solute carrier family 6 member 3
619,benzatropine,parkinson disease,cholinergic receptor muscarinic 1
620,imipramine,depressive disorder,solute carrier family 6 member 2
621,imipramine,depressive disorder,solute carrier family 6 member 4
622,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
623,nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
624,nifedipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
625,dantrolene,spasticity,ryanodine receptor 1
626,dantrolene,"malignant hyperthermia, susceptibility to, 1",ryanodine receptor 1
627,alimemazine,urticaria,histamine receptor h1
628,alimemazine,sneeze,histamine receptor h1
629,alimemazine,angioedema,histamine receptor h1
630,alimemazine,atopic conjunctivitis,histamine receptor h1
631,alimemazine,pruritus,histamine receptor h1
632,alimemazine,allergic rhinitis,histamine receptor h1
633,dapoxetine,premature ejaculation,solute carrier family 6 member 4
634,histrelin,precocious puberty,gonadotropin releasing hormone receptor
635,befunolol,open-angle glaucoma,adrenoceptor beta 1
636,befunolol,open-angle glaucoma,adrenoceptor beta 2
637,befunolol,ocular hypertension,adrenoceptor beta 1
638,befunolol,ocular hypertension,adrenoceptor beta 2
639,indapamide,edema,solute carrier family 12 member 3
640,indapamide,hypertensive disorder,solute carrier family 12 member 3
641,meclofenamic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
642,meclofenamic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
643,meclofenamic acid,menorrhagia,prostaglandin-endoperoxide synthase 1
644,meclofenamic acid,menorrhagia,prostaglandin-endoperoxide synthase 2
645,meclofenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 1
646,meclofenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 2
647,meclofenamic acid,pain,prostaglandin-endoperoxide synthase 1
648,meclofenamic acid,pain,prostaglandin-endoperoxide synthase 2
649,meclofenamic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
650,meclofenamic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
651,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
652,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
653,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1f
654,methyltestosterone,eunuchism,androgen receptor
655,methyltestosterone,delayed puberty,androgen receptor
656,perphenazine,schizophrenia,dopamine receptor d2
657,choline magnesium trisalicylate,fever,prostaglandin-endoperoxide synthase 1
658,choline magnesium trisalicylate,fever,prostaglandin-endoperoxide synthase 2
659,choline magnesium trisalicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
660,choline magnesium trisalicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
661,choline magnesium trisalicylate,osteoarthritis,prostaglandin-endoperoxide synthase 1
662,choline magnesium trisalicylate,osteoarthritis,prostaglandin-endoperoxide synthase 2
663,choline magnesium trisalicylate,pain,prostaglandin-endoperoxide synthase 1
664,choline magnesium trisalicylate,pain,prostaglandin-endoperoxide synthase 2
665,dexlansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
666,dexlansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
667,dexlansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
668,dexlansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
669,capsaicin,postherpetic neuralgia,transient receptor potential cation channel subfamily v member 1
670,capsaicin,neuralgia,transient receptor potential cation channel subfamily v member 1
671,capsaicin,back pain,transient receptor potential cation channel subfamily v member 1
672,(-)-adrenaline,bronchiectasis,adrenoceptor alpha 1a
673,(-)-adrenaline,bronchiectasis,adrenoceptor alpha 1b
674,(-)-adrenaline,bronchiectasis,adrenoceptor alpha 1d
675,(-)-adrenaline,bronchiectasis,adrenoceptor alpha 2a
676,(-)-adrenaline,bronchiectasis,adrenoceptor alpha 2b
677,(-)-adrenaline,bronchiectasis,adrenoceptor beta 1
678,(-)-adrenaline,bronchiectasis,adrenoceptor beta 2
679,(-)-adrenaline,bronchitis,adrenoceptor alpha 1a
680,(-)-adrenaline,bronchitis,adrenoceptor alpha 1b
681,(-)-adrenaline,bronchitis,adrenoceptor alpha 1d
682,(-)-adrenaline,bronchitis,adrenoceptor alpha 2a
683,(-)-adrenaline,bronchitis,adrenoceptor alpha 2b
684,(-)-adrenaline,bronchitis,adrenoceptor beta 1
685,(-)-adrenaline,bronchitis,adrenoceptor beta 2
686,(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 1a
687,(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 1b
688,(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 1d
689,(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 2a
690,(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 2b
691,(-)-adrenaline,pulmonary emphysema,adrenoceptor beta 1
692,(-)-adrenaline,pulmonary emphysema,adrenoceptor beta 2
693,(-)-adrenaline,respiratory sounds,adrenoceptor alpha 1a
694,(-)-adrenaline,respiratory sounds,adrenoceptor alpha 1b
695,(-)-adrenaline,respiratory sounds,adrenoceptor alpha 1d
696,(-)-adrenaline,respiratory sounds,adrenoceptor alpha 2a
697,(-)-adrenaline,respiratory sounds,adrenoceptor alpha 2b
698,(-)-adrenaline,respiratory sounds,adrenoceptor beta 1
699,(-)-adrenaline,respiratory sounds,adrenoceptor beta 2
700,(-)-adrenaline,dyspnea,adrenoceptor alpha 1a
701,(-)-adrenaline,dyspnea,adrenoceptor alpha 1b
702,(-)-adrenaline,dyspnea,adrenoceptor alpha 1d
703,(-)-adrenaline,dyspnea,adrenoceptor alpha 2a
704,(-)-adrenaline,dyspnea,adrenoceptor alpha 2b
705,(-)-adrenaline,dyspnea,adrenoceptor beta 1
706,(-)-adrenaline,dyspnea,adrenoceptor beta 2
707,ibrutinib,b-cell chronic lymphocytic leukemia,bruton tyrosine kinase
708,rufinamide,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
709,vindesine,melanoma,tubulin beta 1 class vi
710,vindesine,lung neoplasm,tubulin beta 1 class vi
711,vindesine,"chronic myelogenous leukemia, bcr-abl1 positive",tubulin beta 1 class vi
712,treprostinil,pulmonary arterial hypertension,prostaglandin i2 receptor
713,estramustine,prostate cancer,microtubule associated protein 2
714,estramustine,prostate cancer,microtubule associated protein 1a
715,testosterone propionate,cryptorchidism,androgen receptor
716,testosterone propionate,delayed puberty,androgen receptor
717,testosterone propionate,eunuchism,androgen receptor
718,testosterone propionate,klinefelter syndrome,androgen receptor
719,canagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
720,idelalisib,follicular lymphoma,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"
721,idelalisib,b-cell chronic lymphocytic leukemia,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"
722,olaparib,ovarian cancer,poly(adp-ribose) polymerase 1
723,olaparib,ovarian cancer,poly(adp-ribose) polymerase 2
724,olaparib,ovarian cancer,poly(adp-ribose) polymerase family member 3
725,dexbrompheniramine,seasonal allergic rhinitis,histamine receptor h1
726,dexbrompheniramine,urticaria,histamine receptor h1
727,dexbrompheniramine,pruritus,histamine receptor h1
728,dexbrompheniramine,vasomotor rhinitis,histamine receptor h1
729,dexbrompheniramine,atopic conjunctivitis,histamine receptor h1
730,epinastine,atopic conjunctivitis,histamine receptor h1
731,epinastine,atopic conjunctivitis,histamine receptor h2
732,amantadine,basal ganglia disorder,dopamine receptor d2
733,amantadine,parkinson disease,dopamine receptor d2
734,amantadine,parkinsonian disorder,dopamine receptor d2
735,amantadine,postencephalitic parkinson disease,dopamine receptor d2
736,emedastine,urticaria,histamine receptor h1
737,emedastine,pruritus,histamine receptor h1
738,emedastine,atopic conjunctivitis,histamine receptor h1
739,tetracosactide,adrenocortical insufficiency,melanocortin 2 receptor
740,mepenzolic acid,peptic ulcer disease,cholinergic receptor muscarinic 3
741,mepenzolic acid,peptic ulcer disease,cholinergic receptor muscarinic 1
742,mepenzolic acid,gastric ulcer,cholinergic receptor muscarinic 3
743,mepenzolic acid,gastric ulcer,cholinergic receptor muscarinic 1
744,bepotastine,atopic conjunctivitis,histamine receptor h1
745,brexpiprazole,major depressive disorder,5-hydroxytryptamine receptor 2a
746,brexpiprazole,schizophrenia,5-hydroxytryptamine receptor 2a
747,enalaprilat,hypertensive disorder,angiotensin i converting enzyme
748,enalaprilat,heart failure,angiotensin i converting enzyme
749,chlorothiazide,edema,solute carrier family 12 member 3
750,imiquimod,common wart,toll like receptor 7
751,imiquimod,anogenital human papillomavirus infection,toll like receptor 7
752,imiquimod,actinic keratosis,toll like receptor 7
753,teriparatide,postmenopausal osteoporosis,parathyroid hormone 1 receptor
754,vorapaxar,stroke disorder,coagulation factor ii thrombin receptor
755,mirodenafil,erectile dysfunction,phosphodiesterase 5a
756,luseogliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
757,luseogliflozin,type 2 diabetes mellitus,solute carrier family 5 member 11
758,cromoglicic acid,allergic rhinitis,s100 calcium binding protein p
759,cromoglicic acid,systemic mastocytosis,s100 calcium binding protein p
760,cromoglicic acid,asthma,s100 calcium binding protein p
761,gabapentin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
762,bretylium,ventricular fibrillation,atpase na+/k+ transporting subunit alpha 1
763,tramadol,pain,solute carrier family 6 member 2
764,tramadol,pain,solute carrier family 6 member 4
765,tramadol,osteoarthritis,opioid receptor mu 1
766,tramadol,osteoarthritis,solute carrier family 6 member 2
767,tramadol,osteoarthritis,solute carrier family 6 member 4
768,tramadol,chronic pain,opioid receptor mu 1
769,tramadol,chronic pain,solute carrier family 6 member 2
770,tramadol,chronic pain,solute carrier family 6 member 4
771,isradipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
772,montelukast,allergic rhinitis,cysteinyl leukotriene receptor 1
773,chlophedianol,allergic rhinitis,histamine receptor h1
774,chlophedianol,rhinitis,histamine receptor h1
775,chlophedianol,vasomotor rhinitis,histamine receptor h1
776,donepezil,alzheimer disease,acetylcholinesterase (yt blood group)
777,salmeterol,pulmonary emphysema,adrenoceptor beta 2
778,azelastine,vasomotor rhinitis,histamine receptor h1
779,azelastine,vasomotor rhinitis,histamine receptor h2
780,azelastine,vasomotor rhinitis,phospholipase a2 group ib
781,azelastine,vasomotor rhinitis,leukotriene c4 synthase
782,azelastine,seasonal allergic rhinitis,histamine receptor h1
783,azelastine,seasonal allergic rhinitis,histamine receptor h2
784,azelastine,seasonal allergic rhinitis,phospholipase a2 group ib
785,azelastine,seasonal allergic rhinitis,leukotriene c4 synthase
786,azelastine,allergic rhinitis,histamine receptor h1
787,azelastine,allergic rhinitis,histamine receptor h2
788,azelastine,allergic rhinitis,phospholipase a2 group ib
789,azelastine,allergic rhinitis,leukotriene c4 synthase
790,azelastine,atopic conjunctivitis,histamine receptor h1
791,azelastine,atopic conjunctivitis,histamine receptor h2
792,azelastine,atopic conjunctivitis,phospholipase a2 group ib
793,azelastine,atopic conjunctivitis,leukotriene c4 synthase
794,ergometrine,post-partum hemorrhage,adrenoceptor alpha 1a
795,almitrine,chronic obstructive pulmonary disease,atpase na+/k+ transporting subunit alpha 1
796,acetylmethadol,opiate dependence,opioid receptor mu 1
797,pargyline,hypertensive disorder,monoamine oxidase b
798,teduglutide,short bowel syndrome,glucagon like peptide 2 receptor
799,chlorcyclizine,atopic conjunctivitis,histamine receptor h1
800,chlorcyclizine,allergic rhinitis,histamine receptor h1
801,chlorcyclizine,seasonal allergic rhinitis,histamine receptor h1
802,chlorcyclizine,sneeze,histamine receptor h1
803,chlorcyclizine,cough,histamine receptor h1
804,chlorcyclizine,vasomotor rhinitis,histamine receptor h1
805,chlorcyclizine,common cold,histamine receptor h1
806,stanozolol,pheochromocytoma,adrenoceptor alpha 1a
807,stanozolol,pheochromocytoma,adrenoceptor alpha 2a
808,stanozolol,pheochromocytoma,adrenoceptor alpha 2c
809,stanozolol,pheochromocytoma,adrenoceptor alpha 1d
810,stanozolol,pheochromocytoma,adrenoceptor alpha 1b
811,stanozolol,pheochromocytoma,adrenoceptor alpha 2b
812,nedocromil,atopic conjunctivitis,cysteinyl leukotriene receptor 2
813,nedocromil,atopic conjunctivitis,cysteinyl leukotriene receptor 1
814,nedocromil,asthma,cysteinyl leukotriene receptor 2
815,nedocromil,asthma,cysteinyl leukotriene receptor 1
816,fexofenadine,atopic conjunctivitis,histamine receptor h1
817,fexofenadine,urticaria,histamine receptor h1
818,fexofenadine,seasonal allergic rhinitis,histamine receptor h1
819,fexofenadine,sneeze,histamine receptor h1
820,fexofenadine,allergic rhinitis,histamine receptor h1
821,phenacemide,epilepsy,sodium voltage-gated channel alpha subunit 1
822,carvedilol,hypertensive disorder,adrenoceptor beta 1
823,carvedilol,hypertensive disorder,adrenoceptor alpha 1a
824,trabectedin,ovarian cancer,atp binding cassette subfamily b member 1
825,trabectedin,leiomyosarcoma,atp binding cassette subfamily b member 1
826,trabectedin,liposarcoma,atp binding cassette subfamily b member 1
827,trilostane,adrenal gland hyperfunction,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
828,trilostane,adrenal gland hyperfunction,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
829,axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 1
830,axitinib,renal cell carcinoma,kinase insert domain receptor
831,axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 4
832,trifluoperazine,schizophrenia,dopamine receptor d2
833,trifluoperazine,schizophrenia,dopamine receptor d1
834,trifluoperazine,anxiety,dopamine receptor d2
835,trifluoperazine,anxiety,dopamine receptor d1
836,glymidine,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
837,gonadorelin,amenorrhea,gonadotropin releasing hormone receptor
838,icosapent,hypertriglyceridemia,diacylglycerol o-acyltransferase 1
839,icosapent,hypertriglyceridemia,lipoprotein lipase
840,nicotinic acid,hypertriglyceridemia,diacylglycerol o-acyltransferase 1
841,nicotinic acid,hypertriglyceridemia,apolipoprotein b
842,nicotinic acid,hypertriglyceridemia,lipoprotein lipase
843,nicotinic acid,"hyperlipidemia, familial combined, lpl related",diacylglycerol o-acyltransferase 1
844,nicotinic acid,"hyperlipidemia, familial combined, lpl related",apolipoprotein b
845,nicotinic acid,"hyperlipidemia, familial combined, lpl related",apolipoprotein a1
846,nicotinic acid,hypercholesterolemia,cholesteryl ester transfer protein
847,nicotinic acid,hypercholesterolemia,apolipoprotein a1
848,nicotinic acid,hyperlipidemia,diacylglycerol o-acyltransferase 1
849,nicotinic acid,hyperlipidemia,apolipoprotein b
850,nicotinic acid,hyperlipidemia,apolipoprotein a1
851,brimonidine (uk14304),rosacea,adrenoceptor alpha 2a
852,brimonidine (uk14304),rosacea,adrenoceptor alpha 2b
853,brimonidine (uk14304),rosacea,adrenoceptor alpha 2c
854,esomeprazole,peptic esophagitis,atpase h+/k+ transporting subunit alpha
855,esomeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
856,esomeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
857,tolvaptan,hyponatremia,arginine vasopressin receptor 2
858,tolvaptan,inappropriate adh syndrome,arginine vasopressin receptor 2
859,tolvaptan,autosomal dominant polycystic kidney disease,arginine vasopressin receptor 2
860,biperiden,parkinson disease,cholinergic receptor muscarinic 1
861,biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
862,biperiden,parkinsonian disorder,cholinergic receptor muscarinic 1
863,biperiden,basal ganglia disorder,cholinergic receptor muscarinic 1
864,brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 2a
865,brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 2b
866,brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 2c
867,brimonidine (uk14304),ocular hypertension,adrenoceptor alpha 2a
868,brimonidine (uk14304),ocular hypertension,adrenoceptor alpha 2b
869,brimonidine (uk14304),ocular hypertension,adrenoceptor alpha 2c
870,triiodothyronine,myxedema,thyroid hormone receptor alpha
871,triiodothyronine,myxedema,thyroid hormone receptor beta
872,triiodothyronine,hypothyroidism,thyroid hormone receptor alpha
873,triiodothyronine,hypothyroidism,thyroid hormone receptor beta
874,triiodothyronine,goiter,thyroid hormone receptor alpha
875,triiodothyronine,goiter,thyroid hormone receptor beta
876,triiodothyronine,congenital hypothyroidism,thyroid hormone receptor alpha
877,triiodothyronine,congenital hypothyroidism,thyroid hormone receptor beta
878,triiodothyronine,endemic goiter,thyroid hormone receptor alpha
879,triiodothyronine,endemic goiter,thyroid hormone receptor beta
880,travoprost,ocular hypertension,prostaglandin f receptor
881,travoprost,open-angle glaucoma,prostaglandin f receptor
882,eflornithine,human african trypanosomiasis,ornithine decarboxylase 1
883,plerixafor,plasma cell myeloma,c-x-c motif chemokine receptor 4
884,chlorpromazine,psychotic disorder,dopamine receptor d2
885,chlorpromazine,acute intermittent porphyria,dopamine receptor d2
886,chlorpromazine,schizophrenia,dopamine receptor d2
887,chlorpromazine,oppositional defiant disorder,dopamine receptor d2
888,etoposide,testicular cancer,dna topoisomerase ii alpha
889,etoposide,small cell lung carcinoma,dna topoisomerase ii alpha
890,desloratadine,seasonal allergic rhinitis,histamine receptor h1
891,desloratadine,common cold,histamine receptor h1
892,desloratadine,vasomotor rhinitis,histamine receptor h1
893,desloratadine,chronic urticaria,histamine receptor h1
894,desloratadine,allergic rhinitis,histamine receptor h1
895,desloratadine,sneeze,histamine receptor h1
896,desloratadine,atopic conjunctivitis,histamine receptor h1
897,pasireotide,adrenal gland hyperfunction,somatostatin receptor 1
898,pasireotide,adrenal gland hyperfunction,somatostatin receptor 2
899,pasireotide,adrenal gland hyperfunction,somatostatin receptor 3
900,pasireotide,adrenal gland hyperfunction,somatostatin receptor 5
901,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 5
902,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 8
903,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 1
904,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 9
905,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 2
906,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 10
907,enzalutamide,prostate cancer,androgen receptor
908,aspirin,myocardial infarction,prostaglandin-endoperoxide synthase 1
909,aspirin,myocardial infarction,prostaglandin-endoperoxide synthase 2
910,aspirin,common cold,prostaglandin-endoperoxide synthase 1
911,aspirin,common cold,prostaglandin-endoperoxide synthase 2
912,aspirin,toothache,prostaglandin-endoperoxide synthase 1
913,aspirin,toothache,prostaglandin-endoperoxide synthase 2
914,aspirin,headache disorder,prostaglandin-endoperoxide synthase 1
915,aspirin,headache disorder,prostaglandin-endoperoxide synthase 2
916,aspirin,migraine disorder,prostaglandin-endoperoxide synthase 1
917,aspirin,migraine disorder,prostaglandin-endoperoxide synthase 2
918,aspirin,back pain,prostaglandin-endoperoxide synthase 1
919,aspirin,back pain,prostaglandin-endoperoxide synthase 2
920,aspirin,osteoarthritis,prostaglandin-endoperoxide synthase 1
921,aspirin,osteoarthritis,prostaglandin-endoperoxide synthase 2
922,aspirin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
923,aspirin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
924,aspirin,arthralgia,prostaglandin-endoperoxide synthase 1
925,aspirin,arthralgia,prostaglandin-endoperoxide synthase 2
926,metaraminol,hypotensive disorder,adrenoceptor alpha 1a
927,ibandronic acid,postmenopausal osteoporosis,farnesyl diphosphate synthase
928,ibandronic acid,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
929,ibandronic acid,hypercalcemia disease,farnesyl diphosphate synthase
930,ibandronic acid,hypercalcemia disease,geranylgeranyl diphosphate synthase 1
931,lixisenatide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
932,perospirone,schizophrenia,5-hydroxytryptamine receptor 1a
933,perospirone,schizophrenia,dopamine receptor d2
934,perospirone,schizophrenia,5-hydroxytryptamine receptor 2a
935,flunisolide,asthma,nuclear receptor subfamily 3 group c member 1
936,flunisolide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
937,ropinirole,parkinson disease,dopamine receptor d2
938,ropinirole,parkinson disease,dopamine receptor d3
939,latanoprost (isopropyl ester),ocular hypertension,prostaglandin f receptor
940,latanoprost (isopropyl ester),open-angle glaucoma,prostaglandin f receptor
941,apomorphine,parkinson disease,dopamine receptor d2
942,apomorphine,parkinson disease,dopamine receptor d3
943,apomorphine,parkinson disease,dopamine receptor d4
944,modafinil,narcolepsy,solute carrier family 6 member 3
945,salicylamide,arthralgia,prostaglandin-endoperoxide synthase 1
946,salicylamide,arthralgia,prostaglandin-endoperoxide synthase 2
947,salicylamide,headache disorder,prostaglandin-endoperoxide synthase 1
948,salicylamide,headache disorder,prostaglandin-endoperoxide synthase 2
949,salicylamide,pain,prostaglandin-endoperoxide synthase 1
950,salicylamide,pain,prostaglandin-endoperoxide synthase 2
951,salicylamide,back pain,prostaglandin-endoperoxide synthase 1
952,salicylamide,back pain,prostaglandin-endoperoxide synthase 2
953,salicylamide,fever,prostaglandin-endoperoxide synthase 1
954,salicylamide,fever,prostaglandin-endoperoxide synthase 2
955,mesalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 1
956,mesalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 2
957,mesalazine,ulcerative colitis,arachidonate 5-lipoxygenase
958,mesalazine,ulcerative colitis,peroxisome proliferator activated receptor gamma
959,pimecrolimus,"dermatitis, atopic",protein phosphatase 3 catalytic subunit alpha
960,phytomenadione,hypocalcemia,bone gamma-carboxyglutamate protein
961,phytomenadione,postmenopausal osteoporosis,bone gamma-carboxyglutamate protein
962,phytomenadione,osteoporosis,bone gamma-carboxyglutamate protein
963,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 2d
964,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 1
965,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 3b
966,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 3a
967,asenapine,schizophrenia,5-hydroxytryptamine receptor 2a
968,asenapine,schizophrenia,dopamine receptor d2
969,ubidecarenone,heart failure,nadh:ubiquinone oxidoreductase subunit v3
970,ubidecarenone,heart failure,succinate dehydrogenase complex flavoprotein subunit a
971,quetiapine,schizophrenia,dopamine receptor d2
972,quetiapine,schizophrenia,5-hydroxytryptamine receptor 2a
973,imatinib,chronic eosinophilic leukemia,platelet derived growth factor receptor alpha
974,imatinib,hypereosinophilic syndrome,platelet derived growth factor receptor alpha
975,imatinib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
976,imatinib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
977,imatinib,dermatofibrosarcoma protuberans,platelet derived growth factor receptor alpha
978,dosulepin,major depressive disorder,solute carrier family 6 member 4
979,dosulepin,major depressive disorder,solute carrier family 6 member 2
980,quetiapine,bipolar disorder,solute carrier family 6 member 2
981,losartan,diabetic kidney disease,angiotensin ii receptor type 1
982,losartan,hypertensive disorder,angiotensin ii receptor type 1
983,bethanechol,urinary retention,cholinergic receptor muscarinic 2
984,mercaptopurine,acute promyelocytic leukemia,hypoxanthine phosphoribosyltransferase 1
985,mercaptopurine,acute promyelocytic leukemia,phosphoribosyl pyrophosphate amidotransferase
986,mercaptopurine,acute promyelocytic leukemia,inosine monophosphate dehydrogenase 1
987,mercaptopurine,acute promyelocytic leukemia,inosine monophosphate dehydrogenase 2
988,diamicron,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
989,pilsicainide,tachycardia,sodium voltage-gated channel alpha subunit 5
990,tropicamide,mydriasis,cholinergic receptor muscarinic 3
991,tenoxicam,arthritic joint disease,prostaglandin-endoperoxide synthase 1
992,tenoxicam,arthritic joint disease,prostaglandin-endoperoxide synthase 2
993,rotigotine,parkinson disease,dopamine receptor d3
994,rotigotine,parkinson disease,dopamine receptor d4
995,rotigotine,parkinson disease,dopamine receptor d2
996,rotigotine,parkinson disease,dopamine receptor d5
997,rotigotine,parkinson disease,dopamine receptor d1
998,rotigotine,restless legs syndrome,dopamine receptor d3
999,rotigotine,restless legs syndrome,dopamine receptor d4
1000,rotigotine,restless legs syndrome,dopamine receptor d2
1001,rotigotine,restless legs syndrome,dopamine receptor d5
1002,rotigotine,restless legs syndrome,dopamine receptor d1
1003,prasugrel,acute coronary syndrome,purinergic receptor p2y12
1004,dutasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 2
1005,dutasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 1
1006,calcium citrate,hypocalcemia,calcium sensing receptor
1007,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,histone deacetylase 2
1008,theophylline,asthma,histone deacetylase 2
1009,theophylline,bronchitis,histone deacetylase 2
1010,theophylline,pulmonary emphysema,histone deacetylase 2
1011,theophylline,bronchial disorder,histone deacetylase 2
1012,dofetilide,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
1013,dofetilide,atrial fibrillation,potassium two pore domain channel subfamily k member 2
1014,dofetilide,atrial fibrillation,potassium inwardly rectifying channel subfamily j member 12
1015,clidinium,enterocolitis,cholinergic receptor muscarinic 1
1016,clidinium,irritable bowel syndrome,cholinergic receptor muscarinic 1
1017,cycrimine,parkinson disease,cholinergic receptor muscarinic 1
1018,insulin lispro,type 1 diabetes mellitus,insulin receptor
1019,insulin lispro,type 2 diabetes mellitus,insulin receptor
1020,calcium citrate,postmenopausal osteoporosis,calcium sensing receptor
1021,lasofoxifene,postmenopausal osteoporosis,estrogen receptor 1
1022,lasofoxifene,postmenopausal osteoporosis,estrogen receptor 2
1023,brigatinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
1024,brigatinib,non-small cell lung carcinoma,epidermal growth factor receptor
1025,benzquinamide,postoperative nausea and vomiting,dopamine receptor d2
1026,insulin glulisine,diabetes mellitus,insulin receptor
1027,olodaterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
1028,ripasudil,ocular hypertension,rho associated coiled-coil containing protein kinase 1
1029,ripasudil,ocular hypertension,rho associated coiled-coil containing protein kinase 2
1030,ripasudil,glaucoma,rho associated coiled-coil containing protein kinase 1
1031,ripasudil,glaucoma,rho associated coiled-coil containing protein kinase 2
1032,amcinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1033,amcinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
1034,amcinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1035,amcinonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1036,amcinonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1037,amcinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1038,amcinonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1039,naltrexone,chronic pain,toll like receptor 4
1040,naltrexone,alcohol abuse,opioid receptor kappa 1
1041,naltrexone,alcohol abuse,opioid receptor delta 1
1042,naltrexone,alcohol abuse,opioid receptor mu 1
1043,piribedil,parkinsonian disorder,dopamine receptor d2
1044,piribedil,parkinsonian disorder,dopamine receptor d3
1045,dexibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1046,dexibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1047,dexibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1048,dexibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1049,dexibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
1050,dexibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
1051,dexibuprofen,fever,prostaglandin-endoperoxide synthase 1
1052,dexibuprofen,fever,prostaglandin-endoperoxide synthase 2
1053,dexibuprofen,pain,prostaglandin-endoperoxide synthase 1
1054,dexibuprofen,pain,prostaglandin-endoperoxide synthase 2
1055,dexibuprofen,headache,prostaglandin-endoperoxide synthase 1
1056,dexibuprofen,headache,prostaglandin-endoperoxide synthase 2
1057,dexibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
1058,dexibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1059,linaclotide,irritable bowel syndrome,guanylate cyclase 2c
1060,prucalopride,constipation disorder,5-hydroxytryptamine receptor 4
1061,bazedoxifene,postmenopausal osteoporosis,estrogen receptor 1
1062,bazedoxifene,postmenopausal osteoporosis,estrogen receptor 2
1063,echothiophate,esotropia,acetylcholinesterase (yt blood group)
1064,echothiophate,esotropia,butyrylcholinesterase
1065,echothiophate,open-angle glaucoma,acetylcholinesterase (yt blood group)
1066,echothiophate,open-angle glaucoma,butyrylcholinesterase
1067,echothiophate,glaucoma,acetylcholinesterase (yt blood group)
1068,echothiophate,glaucoma,butyrylcholinesterase
1069,echothiophate,stargardt disease,acetylcholinesterase (yt blood group)
1070,echothiophate,stargardt disease,butyrylcholinesterase
1071,colecalciferol,osteoporosis,vitamin d receptor
1072,colecalciferol,postmenopausal osteoporosis,vitamin d receptor
1073,colecalciferol,hypoparathyroidism,vitamin d receptor
1074,colecalciferol,vitamin d deficiency,vitamin d receptor
1075,colecalciferol,rickets,vitamin d receptor
1076,colecalciferol,hypocalcemia,vitamin d receptor
1077,pge1,pulmonary valve atresia,prostaglandin e receptor 2
1078,pge1,pulmonary artery stenosis,prostaglandin e receptor 2
1079,pge1,tricuspid atresia,prostaglandin e receptor 2
1080,pge1,aorta coarctation,prostaglandin e receptor 2
1081,pge1,erectile dysfunction,prostaglandin e receptor 2
1082,pge1,tetralogy of fallot,prostaglandin e receptor 2
1083,guanfacine,hypertensive disorder,adrenoceptor alpha 2a
1084,oxybutynin,urge incontinence,cholinergic receptor muscarinic 3
1085,oxybutynin,urge incontinence,cholinergic receptor muscarinic 2
1086,oxybutynin,urge incontinence,cholinergic receptor muscarinic 1
1087,oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 3
1088,oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 2
1089,oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 1
1090,(r)-cetirizine,seasonal allergic rhinitis,histamine receptor h1
1091,(r)-cetirizine,allergic rhinitis,histamine receptor h1
1092,(r)-cetirizine,chronic urticaria,histamine receptor h1
1093,diphenylpyraline,sneeze,histamine receptor h1
1094,diphenylpyraline,pruritus,histamine receptor h1
1095,diphenylpyraline,allergic rhinitis,histamine receptor h1
1096,diphenylpyraline,atopic conjunctivitis,histamine receptor h1
1097,diphenylpyraline,vasomotor rhinitis,histamine receptor h1
1098,diphenylpyraline,urticaria,histamine receptor h1
1099,alcaftadine,atopic conjunctivitis,histamine receptor h1
1100,omarigliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
1101,azelnidipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 1
1102,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1d
1103,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1b
1104,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1f
1105,bisoprolol,hypertensive disorder,adrenoceptor beta 1
1106,dextrothyroxine,hyperlipidemia,thyroid hormone receptor alpha
1107,dextrothyroxine,hyperlipidemia,thyroid hormone receptor beta
1108,betaxolol,ocular hypertension,adrenoceptor beta 1
1109,betaxolol,open-angle glaucoma,adrenoceptor beta 1
1110,betaxolol,hypertensive disorder,adrenoceptor beta 1
1111,ketotifen,atopic conjunctivitis,histamine receptor h1
1112,ephedrine,vasomotor rhinitis,adrenoceptor alpha 1a
1113,ephedrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
1114,ephedrine,allergic rhinitis,adrenoceptor alpha 1a
1115,ephedrine,atopic conjunctivitis,adrenoceptor alpha 1a
1116,ephedrine,sneeze,adrenoceptor alpha 1a
1117,ephedrine,headache disorder,adrenoceptor alpha 1a
1118,ephedrine,bronchitis,adrenoceptor beta 2
1119,ephedrine,common cold,adrenoceptor alpha 1a
1120,ephedrine,bronchial disorder,adrenoceptor beta 2
1121,viloxazine,narcolepsy,solute carrier family 6 member 2
1122,hydroxyzine,atopic conjunctivitis,histamine receptor h1
1123,hydroxyzine,allergic rhinitis,histamine receptor h1
1124,hydroxyzine,"dermatitis, atopic",histamine receptor h1
1125,hydroxyzine,urticaria,histamine receptor h1
1126,hydroxyzine,pruritus,histamine receptor h1
1127,levorphanol,pain,opioid receptor mu 1
1128,gemfibrozil,hypertriglyceridemia,peroxisome proliferator activated receptor alpha
1129,pitavastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
1130,pitavastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
1131,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
1132,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 i
1133,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
1134,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
1135,amlodipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
1136,amlodipine,angina pectoris,calcium voltage-gated channel subunit alpha1 i
1137,amlodipine,stroke disorder,calcium voltage-gated channel subunit alpha1 c
1138,amlodipine,stroke disorder,calcium voltage-gated channel subunit alpha1 i
1139,cyclopentolate,mydriasis,cholinergic receptor muscarinic 1
1140,flecainide,atrial fibrillation,sodium voltage-gated channel alpha subunit 4
1141,flecainide,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
1142,insulin glargine,type 1 diabetes mellitus,insulin receptor
1143,insulin glargine,type 2 diabetes mellitus,insulin receptor
1144,olanzapine,schizophrenia,dopamine receptor d2
1145,olanzapine,major depressive disorder,dopamine receptor d2
1146,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2a
1147,olanzapine,bipolar disorder,dopamine receptor d2
1148,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 2a
1149,propranolol,hypertrophic cardiomyopathy,adrenoceptor beta 1
1150,propranolol,hypertrophic cardiomyopathy,adrenoceptor beta 2
1151,propranolol,angina pectoris,adrenoceptor beta 1
1152,propranolol,angina pectoris,adrenoceptor beta 2
1153,propranolol,hypertensive disorder,adrenoceptor beta 1
1154,propranolol,hypertensive disorder,adrenoceptor beta 2
1155,propranolol,hemangioma,vascular endothelial growth factor a
1156,propranolol,atrial fibrillation,adrenoceptor beta 1
1157,propranolol,atrial fibrillation,adrenoceptor beta 2
1158,propranolol,supraventricular tachycardia,adrenoceptor beta 1
1159,propranolol,supraventricular tachycardia,adrenoceptor beta 2
1160,bosentan,localized scleroderma,endothelin receptor type a
1161,bosentan,localized scleroderma,endothelin receptor type b
1162,bosentan,pulmonary hypertension,endothelin receptor type a
1163,bosentan,pulmonary hypertension,endothelin receptor type b
1164,bosentan,pulmonary arterial hypertension,endothelin receptor type a
1165,bosentan,pulmonary arterial hypertension,endothelin receptor type b
1166,testosterone propionate,hot flashes,androgen receptor
1167,diethylcarbamazine,pulmonary eosinophilia,arachidonate 5-lipoxygenase
1168,diethylcarbamazine,pulmonary eosinophilia,prostaglandin-endoperoxide synthase 1
1169,drospirenone,postmenopausal atrophic vaginitis,progesterone receptor
1170,etidronic acid,humoral hypercalcemia of malignancy,atpase h+ transporting v1 subunit a
1171,etidronic acid,bone paget disease,atpase h+ transporting v1 subunit a
1172,reboxetine,major depressive disorder,solute carrier family 6 member 2
1173,flibanserin,psychosexual disorder,5-hydroxytryptamine receptor 1a
1174,flibanserin,psychosexual disorder,5-hydroxytryptamine receptor 2a
1175,erlotinib,non-small cell lung carcinoma,epidermal growth factor receptor
1176,doxapram,respiratory failure,potassium two pore domain channel subfamily k member 3
1177,doxapram,respiratory failure,potassium two pore domain channel subfamily k member 9
1178,etodolac,pain,prostaglandin-endoperoxide synthase 2
1179,etodolac,pain,prostaglandin-endoperoxide synthase 1
1180,etodolac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1181,etodolac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1182,etodolac,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1183,etodolac,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1184,etodolac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1185,etodolac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1186,levosalbutamol,bronchial disorder,adrenoceptor beta 2
1187,tripelennamine,sneeze,histamine receptor h1
1188,tripelennamine,pruritus,histamine receptor h1
1189,tripelennamine,atopic conjunctivitis,histamine receptor h1
1190,tripelennamine,allergic rhinitis,histamine receptor h1
1191,tripelennamine,urticaria,histamine receptor h1
1192,tripelennamine,vasomotor rhinitis,histamine receptor h1
1193,nortriptyline,depressive disorder,solute carrier family 6 member 2
1194,nortriptyline,depressive disorder,solute carrier family 6 member 4
1195,triprolidine,pruritus,histamine receptor h1
1196,triprolidine,urticaria,histamine receptor h1
1197,triprolidine,allergic rhinitis,histamine receptor h1
1198,triprolidine,atopic conjunctivitis,histamine receptor h1
1199,triprolidine,common cold,histamine receptor h1
1200,triprolidine,vasomotor rhinitis,histamine receptor h1
1201,triprolidine,seasonal allergic rhinitis,histamine receptor h1
1202,(-)-noradrenaline,bronchiectasis,adrenoceptor beta 2
1203,(-)-noradrenaline,bronchitis,adrenoceptor beta 2
1204,(-)-noradrenaline,asthma,adrenoceptor beta 2
1205,(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 1a
1206,(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 1b
1207,(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 1d
1208,(-)-noradrenaline,pulmonary emphysema,adrenoceptor beta 2
1209,pregabalin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
1210,pregabalin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
1211,glycopyrrolate,peptic ulcer disease,cholinergic receptor muscarinic 3
1212,glycopyrrolate,peptic ulcer disease,cholinergic receptor muscarinic 1
1213,glycopyrrolate,drooling,cholinergic receptor muscarinic 3
1214,glycopyrrolate,drooling,cholinergic receptor muscarinic 1
1215,glycopyrrolate,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
1216,vonoprazan,gastric ulcer,atpase h+/k+ transporting subunit alpha
1217,vonoprazan,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1218,diflorasone diacetate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1219,diflorasone diacetate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1220,diflorasone diacetate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1221,diflorasone diacetate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1222,diflorasone diacetate,exanthem,nuclear receptor subfamily 3 group c member 1
1223,diflorasone diacetate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1224,diflorasone diacetate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1225,diflorasone diacetate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1226,carmustine,diffuse large b-cell lymphoma,glutathione-disulfide reductase
1227,carmustine,plasma cell myeloma,glutathione-disulfide reductase
1228,carmustine,glioma,glutathione-disulfide reductase
1229,carmustine,classic hodgkin lymphoma,glutathione-disulfide reductase
1230,carmustine,brain cancer,glutathione-disulfide reductase
1231,carmustine,non-hodgkin lymphoma,glutathione-disulfide reductase
1232,dibucaine,pruritus,sodium voltage-gated channel alpha subunit 10
1233,dibucaine,pruritus,sodium voltage-gated channel alpha subunit 5
1234,doxazosin,hypertensive disorder,adrenoceptor alpha 1a
1235,doxazosin,hypertensive disorder,adrenoceptor alpha 1d
1236,doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1237,doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1238,loteprednol etabonate,iritis,nuclear receptor subfamily 3 group c member 1
1239,loteprednol etabonate,uveitis,nuclear receptor subfamily 3 group c member 1
1240,loteprednol etabonate,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
1241,loteprednol etabonate,iridocyclitis,nuclear receptor subfamily 3 group c member 1
1242,loteprednol etabonate,anterior uveitis,nuclear receptor subfamily 3 group c member 1
1243,apremilast,psoriatic arthritis,phosphodiesterase 4a
1244,apremilast,psoriatic arthritis,phosphodiesterase 4b
1245,apremilast,psoriatic arthritis,phosphodiesterase 4c
1246,apremilast,psoriatic arthritis,phosphodiesterase 4d
1247,levobetaxolol,open-angle glaucoma,adrenoceptor beta 1
1248,levobetaxolol,ocular hypertension,adrenoceptor beta 1
1249,nafarelin,endometriosis,gonadotropin releasing hormone receptor
1250,nafarelin,precocious puberty,gonadotropin releasing hormone receptor
1251,pethidine,labor pain,opioid receptor kappa 1
1252,pethidine,labor pain,opioid receptor mu 1
1253,pethidine,pain,opioid receptor kappa 1
1254,pethidine,pain,opioid receptor mu 1
1255,brinzolamide,ocular hypertension,carbonic anhydrase 2
1256,brinzolamide,open-angle glaucoma,carbonic anhydrase 2
1257,ezetimibe,sitosterolemia,npc1 like intracellular cholesterol transporter 1
1258,ezetimibe,hyperlipidemia,npc1 like intracellular cholesterol transporter 1
1259,ezetimibe,"hyperlipidemia, familial combined, lpl related",npc1 like intracellular cholesterol transporter 1
1260,ezetimibe,hypercholesterolemia,npc1 like intracellular cholesterol transporter 1
1261,lisinopril,myocardial infarction,angiotensin i converting enzyme
1262,lisinopril,hypertensive disorder,angiotensin i converting enzyme
1263,eptifibatide,acute coronary syndrome,integrin subunit beta 3
1264,eptifibatide,acute coronary syndrome,integrin subunit alpha 2b
1265,pantoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
1266,pantoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
1267,pantoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1268,pantoprazole,multiple endocrine neoplasia,atpase h+/k+ transporting subunit alpha
1269,gefitinib,non-small cell lung carcinoma,epidermal growth factor receptor
1270,lisuride,amenorrhea,dopamine receptor d2
1271,lisuride,acromegaly,dopamine receptor d2
1272,eprosartan,hypertensive disorder,angiotensin ii receptor type 1
1273,pemetrexed,non-small cell lung carcinoma,thymidylate synthetase
1274,pemetrexed,non-small cell lung carcinoma,dihydrofolate reductase
1275,pemetrexed,non-small cell lung carcinoma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
1276,pemetrexed,non-small cell lung carcinoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1277,tocilizumab,castleman disease,interleukin 6 receptor
1278,tocilizumab,temporal arteritis,interleukin 6 receptor
1279,tocilizumab,rheumatoid arthritis,interleukin 6 receptor
1280,tocilizumab,juvenile idiopathic arthritis,interleukin 6 receptor
1281,safinamide,parkinson disease,monoamine oxidase b
1282,opipramol,depressive disorder,sigma non-opioid intracellular receptor 1
1283,acetophenazine,psychotic disorder,dopamine receptor d2
1284,goserelin,endometriosis,gonadotropin releasing hormone receptor
1285,dromostanolone propionate,breast neoplasm,androgen receptor
1286,tetrabenazine,huntington disease,solute carrier family 18 member a2
1287,tranilast,asthma,histamine receptor h1
1288,tranilast,allergic rhinitis,histamine receptor h1
1289,tranilast,allergic rhinitis,prostaglandin-endoperoxide synthase 2
1290,tranilast,"dermatitis, atopic",histamine receptor h1
1291,tranilast,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
1292,tranilast,keloid,histamine receptor h1
1293,tranilast,"cicatrix, hypertrophic",histamine receptor h1
1294,loperamide,diarrheal disease,opioid receptor mu 1
1295,levodopa,parkinsonian disorder,dopamine receptor d1
1296,levodopa,parkinsonian disorder,dopamine receptor d5
1297,levodopa,parkinsonian disorder,dopamine receptor d2
1298,levodopa,parkinsonian disorder,dopamine receptor d3
1299,levodopa,parkinsonian disorder,dopamine receptor d4
1300,formoterol,chronic bronchitis,adrenoceptor beta 2
1301,formoterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
1302,mesuximide,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
1303,mesuximide,epilepsy,calcium voltage-gated channel subunit alpha1 g
1304,tofacitinib,rheumatoid arthritis,janus kinase 1
1305,tofacitinib,rheumatoid arthritis,janus kinase 3
1306,isoxsuprine,vascular disorder,adrenoceptor beta 2
1307,isoxsuprine,raynaud disease,adrenoceptor beta 2
1308,tenofovir alafenamide,depressive disorder,monoamine oxidase a
1309,pamidronic acid,bone paget disease,farnesyl diphosphate synthase
1310,pamidronic acid,bone paget disease,geranylgeranyl diphosphate synthase 1
1311,pamidronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
1312,pamidronic acid,humoral hypercalcemia of malignancy,geranylgeranyl diphosphate synthase 1
1313,rofecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1314,rofecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
1315,rofecoxib,migraine disorder,prostaglandin-endoperoxide synthase 2
1316,rofecoxib,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1317,rofecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1318,rofecoxib,pain,prostaglandin-endoperoxide synthase 2
1319,flumethasone pivalate,exanthem,nuclear receptor subfamily 3 group c member 1
1320,flumethasone pivalate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1321,flumethasone pivalate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1322,flumethasone pivalate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1323,flumethasone pivalate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1324,flumethasone pivalate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1325,flumethasone pivalate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1326,flumethasone pivalate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1327,flumethasone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1328,dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 3
1329,sulpiride,schizophrenia,dopamine receptor d2
1330,sulpiride,schizophrenia,dopamine receptor d3
1331,lercanidipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
1332,cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 4
1333,cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3a
1334,cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 2a
1335,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 1
1336,promethazine,atopic conjunctivitis,histamine receptor h1
1337,promethazine,seasonal allergic rhinitis,histamine receptor h1
1338,promethazine,vasomotor rhinitis,histamine receptor h1
1339,promethazine,urticaria,histamine receptor h1
1340,sertraline,depressive disorder,solute carrier family 6 member 4
1341,sertraline,social phobia,solute carrier family 6 member 4
1342,sertraline,premenstrual dysphoric disorder,solute carrier family 6 member 4
1343,sertraline,obsessive-compulsive disorder,solute carrier family 6 member 4
1344,sertraline,post-traumatic stress disorder,solute carrier family 6 member 4
1345,sertraline,panic disorder,solute carrier family 6 member 4
1346,penbutolol,hypertensive disorder,adrenoceptor beta 1
1347,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
1348,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
1349,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 3
1350,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 6
1351,nilotinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
1352,lobeglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
1353,phentermine,hypotensive disorder,solute carrier family 6 member 2
1354,phentermine,obesity disorder,solute carrier family 6 member 2
1355,phentermine,obesity disorder,neuropeptide y
1356,methoxamine,hypotensive disorder,adrenoceptor alpha 1a
1357,methoxamine,hypotensive disorder,adrenoceptor alpha 1b
1358,pomalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
1359,pomalidomide,plasma cell myeloma,tumor necrosis factor
1360,aliskiren,hypertensive disorder,renin
1361,flurbiprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
1362,flurbiprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
1363,flurbiprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1364,flurbiprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1365,eldecalcitol,osteoporosis,vitamin d receptor
1366,camphor,back pain,transient receptor potential cation channel subfamily a member 1
1367,desvenlafaxine,major depressive disorder,solute carrier family 6 member 4
1368,desvenlafaxine,major depressive disorder,solute carrier family 6 member 2
1369,desvenlafaxine,major depressive disorder,solute carrier family 6 member 3
1370,nalbuphine,pain,opioid receptor kappa 1
1371,nalbuphine,labor pain,opioid receptor kappa 1
1372,diphenhydramine,vasomotor rhinitis,histamine receptor h1
1373,diphenhydramine,seasonal allergic rhinitis,histamine receptor h1
1374,diphenhydramine,atopic conjunctivitis,histamine receptor h1
1375,paclitaxel,ovarian cancer,tubulin beta 1 class vi
1376,paclitaxel,ovarian cancer,bcl2 apoptosis regulator
1377,paclitaxel,non-small cell lung carcinoma,tubulin beta 1 class vi
1378,paclitaxel,non-small cell lung carcinoma,bcl2 apoptosis regulator
1379,paclitaxel,breast neoplasm,tubulin beta 1 class vi
1380,paclitaxel,breast neoplasm,bcl2 apoptosis regulator
1381,paclitaxel,kaposi's sarcoma,tubulin beta 1 class vi
1382,paclitaxel,kaposi's sarcoma,bcl2 apoptosis regulator
1383,felbinac,pain,prostaglandin-endoperoxide synthase 2
1384,felbinac,pain,prostaglandin-endoperoxide synthase 1
1385,felbinac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1386,felbinac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1387,vilanterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
1388,vilanterol,pulmonary emphysema,adrenoceptor beta 2
1389,vilanterol,chronic bronchitis,adrenoceptor beta 2
1390,vilanterol,asthma,adrenoceptor beta 2
1391,tranylcypromine,major depressive disorder,monoamine oxidase b
1392,tranylcypromine,major depressive disorder,monoamine oxidase a
1393,propantheline,peptic ulcer disease,cholinergic receptor muscarinic 3
1394,tacrolimus,"dermatitis, atopic",fkbp prolyl isomerase 1a
1395,(+)-chlorpheniramine,pruritus,histamine receptor h1
1396,(+)-chlorpheniramine,atopic conjunctivitis,histamine receptor h1
1397,(+)-chlorpheniramine,allergic rhinitis,histamine receptor h1
1398,(+)-chlorpheniramine,vasomotor rhinitis,histamine receptor h1
1399,(+)-chlorpheniramine,urticaria,histamine receptor h1
1400,(+)-chlorpheniramine,seasonal allergic rhinitis,histamine receptor h1
1401,methyclothiazide,edema,solute carrier family 12 member 3
1402,tolmetin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1403,tolmetin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1404,tolmetin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1405,tolmetin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1406,tolmetin,osteoarthritis,prostaglandin-endoperoxide synthase 2
1407,tolmetin,osteoarthritis,prostaglandin-endoperoxide synthase 1
1408,candesartan,hypertensive disorder,angiotensin ii receptor type 1
1409,milnacipran,fibromyalgia,solute carrier family 6 member 4
1410,milnacipran,fibromyalgia,solute carrier family 6 member 2
1411,armodafinil,narcolepsy,solute carrier family 6 member 3
1412,alclometasone dipropionate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1413,alclometasone dipropionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1414,alclometasone dipropionate,exanthem,nuclear receptor subfamily 3 group c member 1
1415,alclometasone dipropionate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1416,alclometasone dipropionate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1417,alclometasone dipropionate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1418,alclometasone dipropionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1419,alclometasone dipropionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1420,alclometasone dipropionate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1421,calcitonin (salmon),bone paget disease,calcitonin receptor
1422,calcitonin (salmon),postmenopausal osteoporosis,calcitonin receptor
1423,(-)-menthol,pruritus,transient receptor potential cation channel subfamily m member 8
1424,(-)-menthol,pruritus,transient receptor potential cation channel subfamily a member 1
1425,(-)-menthol,pruritus,transient receptor potential cation channel subfamily v member 3
1426,(-)-menthol,back pain,transient receptor potential cation channel subfamily m member 8
1427,(-)-menthol,back pain,transient receptor potential cation channel subfamily a member 1
1428,(-)-menthol,back pain,transient receptor potential cation channel subfamily v member 3
1429,vardenafil,erectile dysfunction,phosphodiesterase 5a
1430,trifluridine,colonic neoplasm,thymidylate synthetase
1431,paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
1432,paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 h
1433,paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 i
1434,paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 g
1435,paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 h
1436,paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 i
1437,meloxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1438,meloxicam,osteoarthritis,prostaglandin-endoperoxide synthase 2
1439,meloxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1440,dimethyl fumarate,psoriasis,hydroxycarboxylic acid receptor 2
1441,moxonidine,essential hypertension,adrenoceptor alpha 2a
1442,moxonidine,essential hypertension,nischarin
1443,istradefylline,parkinson disease,adenosine a2a receptor
1444,alclofenac,pain,prostaglandin-endoperoxide synthase 2
1445,reserpine,psychotic disorder,solute carrier family 18 member a2
1446,reserpine,hypertensive disorder,solute carrier family 18 member a2
1447,clomipramine,obsessive-compulsive disorder,solute carrier family 6 member 4
1448,midostaurin,systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
1449,midostaurin,acute myeloid leukemia,fms related receptor tyrosine kinase 3
1450,midostaurin,acute myeloid leukemia,"kit proto-oncogene, receptor tyrosine kinase"
1451,midostaurin,acute myeloid leukemia,protein kinase c alpha
1452,midostaurin,acute myeloid leukemia,platelet derived growth factor receptor beta
1453,midostaurin,acute myeloid leukemia,platelet derived growth factor receptor alpha
1454,midostaurin,acute myeloid leukemia,kinase insert domain receptor
1455,midostaurin,mast cell leukemia,fms related receptor tyrosine kinase 3
1456,midostaurin,mast cell leukemia,"kit proto-oncogene, receptor tyrosine kinase"
1457,midostaurin,mast cell leukemia,protein kinase c alpha
1458,midostaurin,mast cell leukemia,platelet derived growth factor receptor beta
1459,midostaurin,mast cell leukemia,platelet derived growth factor receptor alpha
1460,midostaurin,mast cell leukemia,kinase insert domain receptor
1461,phentolamine,peripheral vascular disease,adrenoceptor alpha 1b
1462,phentolamine,peripheral vascular disease,adrenoceptor alpha 1a
1463,phentolamine,peripheral vascular disease,adrenoceptor alpha 1d
1464,phentolamine,pheochromocytoma,adrenoceptor alpha 1b
1465,phentolamine,pheochromocytoma,adrenoceptor alpha 1a
1466,phentolamine,pheochromocytoma,adrenoceptor alpha 1d
1467,bunazosin,essential hypertension,adrenoceptor alpha 1a
1468,bunazosin,essential hypertension,adrenoceptor alpha 1d
1469,loratadine,sneeze,histamine receptor h1
1470,loratadine,vasomotor rhinitis,histamine receptor h1
1471,loratadine,seasonal allergic rhinitis,histamine receptor h1
1472,loratadine,common cold,histamine receptor h1
1473,loratadine,atopic conjunctivitis,histamine receptor h1
1474,fludarabine,b-cell chronic lymphocytic leukemia,"dna polymerase alpha 1, catalytic subunit"
1475,fludarabine,b-cell chronic lymphocytic leukemia,ribonucleotide reductase catalytic subunit m1
1476,fludarabine,b-cell chronic lymphocytic leukemia,dna primase subunit 2
1477,tiagabine,focal epilepsy,solute carrier family 6 member 1
1478,raloxifene,postmenopausal osteoporosis,estrogen receptor 1
1479,raloxifene,postmenopausal osteoporosis,estrogen receptor 2
1480,lornoxicam,pain,prostaglandin-endoperoxide synthase 1
1481,lornoxicam,pain,prostaglandin-endoperoxide synthase 2
1482,solifenacin,urge incontinence,cholinergic receptor muscarinic 3
1483,solifenacin,urge incontinence,cholinergic receptor muscarinic 2
1484,pyridostigmine,myasthenia gravis,acetylcholinesterase (yt blood group)
1485,tolcapone,parkinson disease,catechol-o-methyltransferase
1486,diclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1487,diclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1488,diclofenac,actinic keratosis,prostaglandin-endoperoxide synthase 2
1489,diclofenac,actinic keratosis,prostaglandin-endoperoxide synthase 1
1490,diclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1491,diclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1492,diclofenac,pain,prostaglandin-endoperoxide synthase 2
1493,diclofenac,pain,prostaglandin-endoperoxide synthase 1
1494,diclofenac,dysmenorrhea,prostaglandin-endoperoxide synthase 1
1495,diclofenac,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1496,diclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1497,diclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1498,(-)-pentazocine,pain,opioid receptor kappa 1
1499,tolterodine,urge incontinence,cholinergic receptor muscarinic 3
1500,dihydrotachysterol,hypophosphatemia,vitamin d receptor
1501,dihydrotachysterol,hypoparathyroidism,vitamin d receptor
1502,dihydrotachysterol,hypocalcemia,vitamin d receptor
1503,dihydrotachysterol,rickets,vitamin d receptor
1504,dihydrotachysterol,tetany,vitamin d receptor
1505,molindone,schizophrenia,dopamine receptor d2
1506,somatrem,pituitary dwarfism,growth hormone receptor
1507,lesinurad,hyperuricemia,solute carrier family 22 member 12
1508,lesinurad,hyperuricemia,solute carrier family 22 member 11
1509,imrecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
1510,desmopressin,polyuria,arginine vasopressin receptor 2
1511,desmopressin,von willebrand disease (hereditary or acquired),arginine vasopressin receptor 2
1512,desmopressin,hemophilia a,arginine vasopressin receptor 2
1513,desmopressin,nocturnal enuresis,arginine vasopressin receptor 2
1514,ulobetasol propionate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1515,ulobetasol propionate,exanthem,nuclear receptor subfamily 3 group c member 1
1516,ulobetasol propionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1517,ulobetasol propionate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1518,ulobetasol propionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1519,ulobetasol propionate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1520,ulobetasol propionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1521,ulobetasol propionate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1522,sulindac,tendinopathy,prostaglandin-endoperoxide synthase 1
1523,sulindac,tendinopathy,prostaglandin-endoperoxide synthase 2
1524,sulindac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1525,sulindac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1526,sulindac,gout,prostaglandin-endoperoxide synthase 1
1527,sulindac,gout,prostaglandin-endoperoxide synthase 2
1528,sulindac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1529,sulindac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1530,sulindac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1531,sulindac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1532,sulindac,bursitis,prostaglandin-endoperoxide synthase 2
1533,sulindac,bursitis,prostaglandin-endoperoxide synthase 1
1534,silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1535,silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
1536,silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1537,toloxatone,depressive disorder,monoamine oxidase a
1538,vinblastine,kaposi's sarcoma,tubulin alpha 1a
1539,vinblastine,kaposi's sarcoma,tubulin beta class i
1540,vinblastine,kaposi's sarcoma,tubulin delta 1
1541,vinblastine,kaposi's sarcoma,tubulin gamma 1
1542,vinblastine,kaposi's sarcoma,tubulin epsilon 1
1543,vinblastine,mycosis fungoides,tubulin alpha 1a
1544,vinblastine,mycosis fungoides,tubulin beta class i
1545,vinblastine,mycosis fungoides,tubulin delta 1
1546,vinblastine,mycosis fungoides,tubulin gamma 1
1547,vinblastine,mycosis fungoides,tubulin epsilon 1
1548,vinblastine,non-hodgkin lymphoma,tubulin alpha 1a
1549,vinblastine,non-hodgkin lymphoma,tubulin beta class i
1550,vinblastine,non-hodgkin lymphoma,tubulin delta 1
1551,vinblastine,non-hodgkin lymphoma,tubulin gamma 1
1552,vinblastine,non-hodgkin lymphoma,tubulin epsilon 1
1553,vinblastine,testicular cancer,tubulin alpha 1a
1554,vinblastine,testicular cancer,tubulin beta class i
1555,vinblastine,testicular cancer,tubulin delta 1
1556,vinblastine,testicular cancer,tubulin gamma 1
1557,vinblastine,testicular cancer,tubulin epsilon 1
1558,vinblastine,langerhans cell histiocytosis,tubulin alpha 1a
1559,vinblastine,langerhans cell histiocytosis,tubulin beta class i
1560,vinblastine,langerhans cell histiocytosis,tubulin delta 1
1561,vinblastine,langerhans cell histiocytosis,tubulin gamma 1
1562,vinblastine,langerhans cell histiocytosis,tubulin epsilon 1
1563,vinblastine,classic hodgkin lymphoma,tubulin alpha 1a
1564,vinblastine,classic hodgkin lymphoma,tubulin beta class i
1565,vinblastine,classic hodgkin lymphoma,tubulin delta 1
1566,vinblastine,classic hodgkin lymphoma,tubulin gamma 1
1567,vinblastine,classic hodgkin lymphoma,tubulin epsilon 1
1568,vinblastine,"hydatidiform mole, recurrent, 1",tubulin alpha 1a
1569,vinblastine,"hydatidiform mole, recurrent, 1",tubulin beta class i
1570,vinblastine,"hydatidiform mole, recurrent, 1",tubulin delta 1
1571,vinblastine,"hydatidiform mole, recurrent, 1",tubulin gamma 1
1572,vinblastine,"hydatidiform mole, recurrent, 1",tubulin epsilon 1
1573,sunitinib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
1574,sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 1
1575,sunitinib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
1576,sunitinib,gastrointestinal stromal tumor,kinase insert domain receptor
1577,sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 4
1578,sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 3
1579,sunitinib,gastrointestinal stromal tumor,colony stimulating factor 1 receptor
1580,sunitinib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
1581,sunitinib,renal cell carcinoma,platelet derived growth factor receptor beta
1582,sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 1
1583,sunitinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
1584,sunitinib,renal cell carcinoma,kinase insert domain receptor
1585,sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 4
1586,sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 3
1587,sunitinib,renal cell carcinoma,colony stimulating factor 1 receptor
1588,sunitinib,renal cell carcinoma,platelet derived growth factor receptor alpha
1589,warfarin,thromboembolism,vitamin k epoxide reductase complex subunit 1
1590,warfarin,intracranial embolism,vitamin k epoxide reductase complex subunit 1
1591,warfarin,thrombophilia due to thrombin defect,vitamin k epoxide reductase complex subunit 1
1592,warfarin,thrombotic disease,vitamin k epoxide reductase complex subunit 1
1593,tipiracil,colonic neoplasm,thymidine phosphorylase
1594,sermorelin,pituitary dwarfism,growth hormone releasing hormone receptor
1595,nadolol,hypertensive disorder,adrenoceptor beta 1
1596,nadolol,angina pectoris,adrenoceptor beta 1
1597,mephentermine,hypotensive disorder,adrenoceptor alpha 1a
1598,mephentermine,hypotensive disorder,adrenoceptor alpha 1b
1599,mephentermine,hypotensive disorder,adrenoceptor alpha 1d
1600,mephentermine,hypotensive disorder,adrenoceptor beta 1
1601,albiglutide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
1602,thiothixene,schizophrenia,dopamine receptor d2
1603,thiothixene,schizophrenia,5-hydroxytryptamine receptor 2a
1604,phenindamine,urticaria,histamine receptor h1
1605,phenindamine,pruritus,histamine receptor h1
1606,phenindamine,sneeze,histamine receptor h1
1607,phenindamine,allergic rhinitis,histamine receptor h1
1608,phenindamine,vasomotor rhinitis,histamine receptor h1
1609,phenindamine,atopic conjunctivitis,histamine receptor h1
1610,fluoxymesterone,delayed puberty,androgen receptor
1611,fluoxymesterone,klinefelter syndrome,androgen receptor
1612,fluoxymesterone,cryptorchidism,androgen receptor
1613,trichlormethiazide,hypertensive disorder,solute carrier family 12 member 3
1614,gemtuzumab ozogamicin,acute myeloid leukemia,cd33 molecule
1615,nitisinone,tyrosinemia,4-hydroxyphenylpyruvate dioxygenase
1616,colestipol,hypercholesterolemia,low density lipoprotein receptor
1617,colestipol,hyperlipidemia,low density lipoprotein receptor
1618,guanabenz,hypertensive disorder,adrenoceptor alpha 2a
1619,tamoxifen,breast ductal adenocarcinoma,estrogen receptor 1
1620,tamoxifen,breast ductal adenocarcinoma,estrogen receptor 2
1621,norethisterone,endometriosis,progesterone receptor
1622,norethisterone,metrorrhagia,progesterone receptor
1623,danazol,endometriosis,gonadotropin releasing hormone receptor
1624,danazol,endometriosis,androgen receptor
1625,fluorometholone,uveitis,nuclear receptor subfamily 3 group c member 1
1626,fluorometholone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
1627,fluorometholone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
1628,chlorpropamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1629,pentoxifylline,peripheral vascular disease,phosphodiesterase 3a
1630,pentoxifylline,peripheral vascular disease,phosphodiesterase 3b
1631,pentoxifylline,peripheral vascular disease,adenosine a2a receptor
1632,famotidine,gastric ulcer,histamine receptor h2
1633,famotidine,gastroesophageal reflux disease,histamine receptor h2
1634,famotidine,dyspepsia,histamine receptor h2
1635,famotidine,zollinger-ellison syndrome,histamine receptor h2
1636,famotidine,duodenal ulcer,histamine receptor h2
1637,famotidine,peptic esophagitis,histamine receptor h2
1638,carteolol,open-angle glaucoma,adrenoceptor beta 2
1639,carteolol,open-angle glaucoma,adrenoceptor beta 1
1640,carteolol,hypertensive disorder,adrenoceptor beta 2
1641,carteolol,hypertensive disorder,adrenoceptor beta 1
1642,carteolol,ocular hypertension,adrenoceptor beta 2
1643,carteolol,ocular hypertension,adrenoceptor beta 1
1644,acth,stevens-johnson syndrome,melanocortin 2 receptor
1645,acth,west syndrome,melanocortin 2 receptor
1646,bromfenac,pain,prostaglandin-endoperoxide synthase 1
1647,bromfenac,pain,prostaglandin-endoperoxide synthase 2
1648,aceclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1649,aceclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1650,aceclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1651,aceclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1652,aceclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1653,aceclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1654,aceclofenac,back pain,prostaglandin-endoperoxide synthase 1
1655,aceclofenac,back pain,prostaglandin-endoperoxide synthase 2
1656,rabeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1657,rabeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
1658,rabeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
1659,rabeprazole,systemic mastocytosis,atpase h+/k+ transporting subunit alpha
1660,rabeprazole,multiple endocrine neoplasia,atpase h+/k+ transporting subunit alpha
1661,rabeprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1662,celecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
1663,celecoxib,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1664,celecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1665,celecoxib,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1666,celecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1667,rasagiline,parkinson disease,bcl2 apoptosis regulator
1668,rasagiline,parkinson disease,monoamine oxidase b
1669,trihexyphenidyl,parkinson disease,cholinergic receptor muscarinic 1
1670,trihexyphenidyl,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
1671,trihexyphenidyl,basal ganglia disorder,cholinergic receptor muscarinic 1
1672,trihexyphenidyl,parkinsonian disorder,cholinergic receptor muscarinic 1
1673,methotrexate,head and neck neoplasm,thymidylate synthetase
1674,methotrexate,head and neck neoplasm,dihydrofolate reductase
1675,methotrexate,head and neck neoplasm,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1676,methotrexate,burkitt lymphoma,thymidylate synthetase
1677,methotrexate,burkitt lymphoma,dihydrofolate reductase
1678,methotrexate,burkitt lymphoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1679,methotrexate,lung neoplasm,thymidylate synthetase
1680,methotrexate,lung neoplasm,dihydrofolate reductase
1681,methotrexate,lung neoplasm,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1682,methotrexate,non-hodgkin lymphoma,thymidylate synthetase
1683,methotrexate,non-hodgkin lymphoma,dihydrofolate reductase
1684,methotrexate,non-hodgkin lymphoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1685,methotrexate,mycosis fungoides,thymidylate synthetase
1686,methotrexate,mycosis fungoides,dihydrofolate reductase
1687,methotrexate,mycosis fungoides,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1688,methotrexate,"hydatidiform mole, recurrent, 1",thymidylate synthetase
1689,methotrexate,"hydatidiform mole, recurrent, 1",dihydrofolate reductase
1690,methotrexate,"hydatidiform mole, recurrent, 1",5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1691,maprotiline,depressive disorder,solute carrier family 6 member 2
1692,macitentan,pulmonary arterial hypertension,endothelin receptor type a
1693,macitentan,pulmonary arterial hypertension,endothelin receptor type b
1694,progesterone,metrorrhagia,progesterone receptor
1695,progesterone,endometriosis,progesterone receptor
1696,progesterone,endometrium neoplasm,progesterone receptor
1697,tapentadol,pain,opioid receptor mu 1
1698,tapentadol,pain,solute carrier family 6 member 2
1699,udenafil,erectile dysfunction,phosphodiesterase 5a
1700,tafluprost,ocular hypertension,prostaglandin f receptor
1701,tafluprost,open-angle glaucoma,prostaglandin f receptor
1702,acarbose,type 2 diabetes mellitus,amylase alpha 2a
1703,acarbose,type 2 diabetes mellitus,maltase-glucoamylase
1704,probucol,hypercholesterolemia,atp binding cassette subfamily a member 1
1705,probucol,hyperlipidemia,atp binding cassette subfamily a member 1
1706,migalastat,fabry disease,galactosidase alpha
1707,orciprenaline,asthma,adrenoceptor beta 2
1708,orciprenaline,bronchitis,adrenoceptor beta 2
1709,orciprenaline,pulmonary emphysema,adrenoceptor beta 2
1710,ibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1711,ibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1712,ibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
1713,ibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
1714,ibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
1715,ibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1716,ibuprofen,headache disorder,prostaglandin-endoperoxide synthase 1
1717,ibuprofen,headache disorder,prostaglandin-endoperoxide synthase 2
1718,ibuprofen,fever,prostaglandin-endoperoxide synthase 1
1719,ibuprofen,fever,prostaglandin-endoperoxide synthase 2
1720,ibuprofen,patent ductus arteriosus,prostaglandin-endoperoxide synthase 1
1721,ibuprofen,patent ductus arteriosus,prostaglandin-endoperoxide synthase 2
1722,ibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1723,ibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1724,ibuprofen,pain,prostaglandin-endoperoxide synthase 2
1725,ibuprofen,pain,prostaglandin-endoperoxide synthase 1
1726,docetaxel,prostate cancer,tubulin beta 1 class vi
1727,docetaxel,prostate cancer,bcl2 apoptosis regulator
1728,docetaxel,non-small cell lung carcinoma,tubulin beta 1 class vi
1729,docetaxel,non-small cell lung carcinoma,bcl2 apoptosis regulator
1730,docetaxel,breast neoplasm,tubulin beta 1 class vi
1731,docetaxel,breast neoplasm,bcl2 apoptosis regulator
1732,docetaxel,head and neck neoplasm,tubulin beta 1 class vi
1733,docetaxel,head and neck neoplasm,bcl2 apoptosis regulator
1734,docetaxel,gastric neoplasm,tubulin beta 1 class vi
1735,docetaxel,gastric neoplasm,bcl2 apoptosis regulator
1736,dexamfetamine,narcolepsy,solute carrier family 6 member 2
1737,dexamfetamine,narcolepsy,solute carrier family 6 member 3
1738,dexamfetamine,narcolepsy,solute carrier family 18 member a2
1739,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
1740,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
1741,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
1742,edoxaban,pulmonary embolism,coagulation factor x
1743,edoxaban,embolism,coagulation factor x
1744,ergotamine,vascular headaches,adrenoceptor alpha 1a
1745,ergotamine,vascular headaches,adrenoceptor alpha 2a
1746,ergotamine,vascular headaches,adrenoceptor alpha 2c
1747,ergotamine,vascular headaches,adrenoceptor alpha 1d
1748,ergotamine,vascular headaches,adrenoceptor alpha 1b
1749,ergotamine,vascular headaches,adrenoceptor alpha 2b
1750,ergotamine,vascular headaches,5-hydroxytryptamine receptor 1d
1751,ergotamine,migraine disorder,adrenoceptor alpha 1a
1752,ergotamine,migraine disorder,adrenoceptor alpha 2a
1753,ergotamine,migraine disorder,adrenoceptor alpha 2c
1754,ergotamine,migraine disorder,adrenoceptor alpha 1d
1755,ergotamine,migraine disorder,adrenoceptor alpha 1b
1756,ergotamine,migraine disorder,adrenoceptor alpha 2b
1757,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1d
1758,ergotamine,cluster headache syndrome,adrenoceptor alpha 1a
1759,ergotamine,cluster headache syndrome,adrenoceptor alpha 2a
1760,ergotamine,cluster headache syndrome,adrenoceptor alpha 2c
1761,ergotamine,cluster headache syndrome,adrenoceptor alpha 1d
1762,ergotamine,cluster headache syndrome,adrenoceptor alpha 1b
1763,ergotamine,cluster headache syndrome,adrenoceptor alpha 2b
1764,ergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1d
1765,meclizine,motion sickness,histamine receptor h1
1766,meclizine,central nervous system origin vertigo,histamine receptor h1
1767,dimenhydrinate,motion sickness,histamine receptor h1
1768,dimenhydrinate,nausea,histamine receptor h1
1769,dimenhydrinate,central nervous system origin vertigo,histamine receptor h1
1770,dimenhydrinate,vomiting,histamine receptor h1
1771,hydroflumethiazide,edema,solute carrier family 12 member 3
1772,atenolol,myocardial infarction,adrenoceptor beta 1
1773,atenolol,angina pectoris,adrenoceptor beta 1
1774,atenolol,hypertensive disorder,adrenoceptor beta 1
1775,metipranolol,ocular hypertension,adrenoceptor beta 1
1776,metipranolol,ocular hypertension,adrenoceptor beta 2
1777,metipranolol,open-angle glaucoma,adrenoceptor beta 1
1778,metipranolol,open-angle glaucoma,adrenoceptor beta 2
1779,pirbuterol,bronchitis,adrenoceptor beta 2
1780,pirbuterol,asthma,adrenoceptor beta 2
1781,pirbuterol,pulmonary emphysema,adrenoceptor beta 2
1782,pirbuterol,bronchiectasis,adrenoceptor beta 2
1783,pirbuterol,lung disorder,adrenoceptor beta 2
1784,oxprenolol,angina pectoris,adrenoceptor beta 1
1785,oxprenolol,angina pectoris,adrenoceptor beta 2
1786,oxprenolol,hypertensive disorder,adrenoceptor beta 1
1787,oxprenolol,hypertensive disorder,adrenoceptor beta 2
1788,oxprenolol,anxiety,adrenoceptor beta 1
1789,oxprenolol,anxiety,adrenoceptor beta 2
1790,tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1791,tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1792,captopril,hypertensive disorder,angiotensin i converting enzyme
1793,captopril,diabetic kidney disease,angiotensin i converting enzyme
1794,sofalcone,gastric ulcer,15-hydroxyprostaglandin dehydrogenase
1795,pralidoxime,poisoning of animals with phosphate salts,acetylcholinesterase (yt blood group)
1796,ecallantide,hereditary angioedema,kallikrein b1
1797,ticagrelor,acute coronary syndrome,purinergic receptor p2y12
1798,ticagrelor,peripheral vascular disease,purinergic receptor p2y12
1799,tramazoline,seasonal allergic rhinitis,adrenoceptor alpha 2a
1800,tramazoline,allergic rhinitis,adrenoceptor alpha 2a
1801,tramazoline,atopic conjunctivitis,adrenoceptor alpha 2a
1802,tramazoline,sneeze,adrenoceptor alpha 2a
1803,tramazoline,vasomotor rhinitis,adrenoceptor alpha 2a
1804,tramazoline,common cold,adrenoceptor alpha 2a
1805,prazosin,hypertensive disorder,adrenoceptor alpha 1a
1806,prazosin,hypertensive disorder,adrenoceptor alpha 1b
1807,prazosin,hypertensive disorder,adrenoceptor alpha 1d
1808,methdilazine,sneeze,histamine receptor h1
1809,methdilazine,atopic conjunctivitis,histamine receptor h1
1810,methdilazine,angioedema,histamine receptor h1
1811,methdilazine,allergic rhinitis,histamine receptor h1
1812,methdilazine,pruritus,histamine receptor h1
1813,methdilazine,urticaria,histamine receptor h1
1814,mitiglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1815,parathyroid hormone,hypoparathyroidism,parathyroid hormone 1 receptor
1816,calcium acetate,hypocalcemia,calcium sensing receptor
1817,lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 10
1818,lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 9
1819,lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 5
1820,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 10
1821,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 9
1822,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 5
1823,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 10
1824,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 9
1825,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 5
1826,lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 10
1827,lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 9
1828,lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 5
1829,lidocaine,pruritus,sodium voltage-gated channel alpha subunit 10
1830,lidocaine,pruritus,sodium voltage-gated channel alpha subunit 9
1831,lidocaine,pruritus,sodium voltage-gated channel alpha subunit 5
1832,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 10
1833,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 9
1834,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 5
1835,lidocaine,scabies,sodium voltage-gated channel alpha subunit 10
1836,lidocaine,scabies,sodium voltage-gated channel alpha subunit 9
1837,lidocaine,scabies,sodium voltage-gated channel alpha subunit 5
1838,lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 10
1839,lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 9
1840,lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 5
1841,nateglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1842,pseudoephedrine,common cold,adrenoceptor alpha 1a
1843,pseudoephedrine,common cold,adrenoceptor beta 2
1844,pseudoephedrine,allergic rhinitis,adrenoceptor alpha 1a
1845,pseudoephedrine,vasomotor rhinitis,adrenoceptor alpha 1a
1846,pseudoephedrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
1847,pseudoephedrine,atopic conjunctivitis,adrenoceptor alpha 1a
1848,pseudoephedrine,rhinitis,adrenoceptor alpha 1a
1849,pseudoephedrine,headache disorder,adrenoceptor alpha 1a
1850,misoprostol (methyl ester),post-partum hemorrhage,prostaglandin e receptor 4
1851,ipragliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
1852,lansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1853,lansoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
1854,lansoprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
1855,lansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
1856,lansoprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1857,ketorolac,atopic conjunctivitis,prostaglandin-endoperoxide synthase 1
1858,ketorolac,atopic conjunctivitis,prostaglandin-endoperoxide synthase 2
1859,nizatidine,duodenal ulcer,histamine receptor h2
1860,nizatidine,gastric ulcer,histamine receptor h2
1861,nizatidine,gastroesophageal reflux disease,histamine receptor h2
1862,nizatidine,peptic esophagitis,histamine receptor h2
1863,nizatidine,peptic ulcer disease,histamine receptor h2
1864,tretinoin,acne,retinoic acid receptor alpha
1865,tretinoin,acne,retinoic acid receptor gamma
1866,tretinoin,acne,retinoic acid receptor beta
1867,tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor alpha
1868,tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor gamma
1869,tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor beta
1870,tretinoin,acute promyelocytic leukemia,retinoic acid receptor alpha
1871,tretinoin,acute promyelocytic leukemia,retinoic acid receptor gamma
1872,tretinoin,acute promyelocytic leukemia,retinoic acid receptor beta
1873,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
1874,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
1875,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
1876,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
1877,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
1878,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
1879,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
1880,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
1881,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
1882,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
1883,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
1884,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
1885,sirolimus,renal cell carcinoma,mechanistic target of rapamycin kinase
1886,aminobenzoic acid,pemphigus,monoamine oxidase a
1887,aminobenzoic acid,peyronie disease,monoamine oxidase a
1888,aminobenzoic acid,localized scleroderma,monoamine oxidase a
1889,aminobenzoic acid,dermatomyositis,monoamine oxidase a
1890,lorcaserin,obesity disorder,5-hydroxytryptamine receptor 2c
1891,ofatumumab,b-cell chronic lymphocytic leukemia,membrane spanning 4-domains a1
1892,dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
1893,dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
1894,bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
1895,bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
1896,bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
1897,probenecid,hyperuricemia,solute carrier family 22 member 6
1898,probenecid,hyperuricemia,solute carrier family 22 member 11
1899,probenecid,hyperuricemia,solute carrier family 22 member 8
1900,probenecid,gout,solute carrier family 22 member 6
1901,probenecid,gout,solute carrier family 22 member 11
1902,probenecid,gout,solute carrier family 22 member 8
1903,rosuvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
1904,rosuvastatin,hypercholesterolemia,low density lipoprotein receptor
1905,rosuvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
1906,rosuvastatin,"hyperlipidemia, familial combined, lpl related",low density lipoprotein receptor
1907,rosuvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
1908,rosuvastatin,hyperlipoproteinemia type 3,low density lipoprotein receptor
1909,rosuvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
1910,rosuvastatin,stroke disorder,low density lipoprotein receptor
1911,rosuvastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
1912,rosuvastatin,hypertriglyceridemia,low density lipoprotein receptor
1913,rosuvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
1914,rosuvastatin,arteriosclerosis disorder,low density lipoprotein receptor
1915,glisoxepide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
1916,vildagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
1917,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
1918,bumetanide,edema,solute carrier family 12 member 1
1919,orlistat,obesity disorder,"lipase f, gastric type"
1920,orlistat,obesity disorder,pancreatic lipase
1921,levetiracetam,focal epilepsy,synaptic vesicle glycoprotein 2a
1922,levetiracetam,focal epilepsy,calcium voltage-gated channel subunit alpha1 b
1923,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
1924,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
1925,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
1926,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
1927,insulin degludec,diabetes mellitus,insulin receptor
1928,buclizine,motion sickness,histamine receptor h1
1929,buclizine,motion sickness,cholinergic receptor muscarinic 1
1930,tolbutamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1931,isopropamide,peptic ulcer disease,cholinergic receptor muscarinic 3
1932,romidepsin,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
1933,romidepsin,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
1934,romidepsin,mature t-cell and nk-cell non-hodgkin lymphoma,histone deacetylase 1
1935,romidepsin,mature t-cell and nk-cell non-hodgkin lymphoma,histone deacetylase 2
1936,ziconotide,chronic pain,calcium voltage-gated channel subunit alpha1 b
1937,sivelestat,acute lung injury,"elastase, neutrophil expressed"
1938,ceritinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
1939,dorzolamide,ocular hypertension,carbonic anhydrase 2
1940,dorzolamide,open-angle glaucoma,carbonic anhydrase 2
1941,dobutamine,cardiogenic shock,adrenoceptor beta 1
1942,indomethacin,tenosynovitis,prostaglandin-endoperoxide synthase 1
1943,indomethacin,tenosynovitis,prostaglandin-endoperoxide synthase 2
1944,indomethacin,bursitis,prostaglandin-endoperoxide synthase 1
1945,indomethacin,bursitis,prostaglandin-endoperoxide synthase 2
1946,indomethacin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1947,indomethacin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1948,indomethacin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1949,indomethacin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1950,indomethacin,gout,prostaglandin-endoperoxide synthase 1
1951,indomethacin,gout,prostaglandin-endoperoxide synthase 2
1952,indomethacin,tendinopathy,prostaglandin-endoperoxide synthase 1
1953,indomethacin,tendinopathy,prostaglandin-endoperoxide synthase 2
1954,indomethacin,synovitis,prostaglandin-endoperoxide synthase 1
1955,indomethacin,synovitis,prostaglandin-endoperoxide synthase 2
1956,indomethacin,osteoarthritis,prostaglandin-endoperoxide synthase 1
1957,indomethacin,osteoarthritis,prostaglandin-endoperoxide synthase 2
1958,indomethacin,patent ductus arteriosus,prostaglandin-endoperoxide synthase 1
1959,indomethacin,patent ductus arteriosus,prostaglandin-endoperoxide synthase 2
1960,alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1961,alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
1962,alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1963,astemizole,sneeze,histamine receptor h1
1964,astemizole,atopic conjunctivitis,histamine receptor h1
1965,astemizole,chronic urticaria,histamine receptor h1
1966,astemizole,allergic rhinitis,histamine receptor h1
1967,fluocinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1968,fluocinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1969,fluocinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
1970,fluocinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1971,fluocinonide,exanthem,nuclear receptor subfamily 3 group c member 1
1972,fluocinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1973,lithium ion,bipolar disorder,inositol monophosphatase 1
1974,lithium ion,headache disorder,inositol monophosphatase 1
1975,lithium ion,pain,inositol monophosphatase 1
1976,lithium ion,osteoarthritis,inositol monophosphatase 1
1977,lithium ion,juvenile idiopathic arthritis,inositol monophosphatase 1
1978,lithium ion,rheumatoid arthritis,inositol monophosphatase 1
1979,lithium ion,dysmenorrhea,inositol monophosphatase 1
1980,lifitegrast,dry eye syndrome,integrin subunit alpha l
1981,menatetrenone,hemorrhagic disease of newborn,gamma-glutamyl carboxylase
1982,methapyrilene,urticaria,histamine receptor h1
1983,methapyrilene,vasomotor rhinitis,histamine receptor h1
1984,methapyrilene,allergic rhinitis,histamine receptor h1
1985,methapyrilene,sneeze,histamine receptor h1
1986,methapyrilene,atopic conjunctivitis,histamine receptor h1
1987,methapyrilene,pruritus,histamine receptor h1
1988,homatropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 1
1989,homatropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 5
1990,homatropine methylbromide,cough,cholinergic receptor muscarinic 2
1991,homatropine methylbromide,cough,cholinergic receptor muscarinic 3
1992,homatropine methylbromide,irritable bowel syndrome,cholinergic receptor muscarinic 2
1993,homatropine methylbromide,irritable bowel syndrome,cholinergic receptor muscarinic 3
1994,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1d
1995,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1b
1996,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1f
1997,pentostatin,hairy cell leukemia,adenosine deaminase
1998,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
1999,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
2000,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
2001,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
2002,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
2003,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
2004,n-methyl-n-(1-naphthalenylmethyl)-3-phenyl-2-propen-1-amine,tinea pedis,squalene epoxidase
2005,roxatidine acetate,gastroesophageal reflux disease,histamine receptor h2
2006,roxatidine acetate,zollinger-ellison syndrome,histamine receptor h2
2007,roxatidine acetate,gastric ulcer,histamine receptor h2
2008,levomilnacipran,major depressive disorder,solute carrier family 6 member 2
2009,levomilnacipran,major depressive disorder,solute carrier family 6 member 4
2010,pravastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
2011,pravastatin,arteriosclerosis disorder,low density lipoprotein receptor
2012,pravastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
2013,pravastatin,stroke disorder,low density lipoprotein receptor
2014,pravastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
2015,pravastatin,hyperlipoproteinemia type 3,low density lipoprotein receptor
2016,pravastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
2017,pravastatin,"hyperlipidemia, familial combined, lpl related",low density lipoprotein receptor
2018,pravastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
2019,pravastatin,hypertriglyceridemia,low density lipoprotein receptor
2020,pravastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
2021,pravastatin,hypercholesterolemia,low density lipoprotein receptor
2022,bupivacaine,pruritus,sodium voltage-gated channel alpha subunit 10
2023,dihydroergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1d
2024,dihydroergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1b
2025,dihydroergotamine,vascular headaches,5-hydroxytryptamine receptor 1d
2026,dihydroergotamine,vascular headaches,5-hydroxytryptamine receptor 1b
2027,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1d
2028,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1b
2029,pemirolast,allergic rhinitis,histamine receptor h1
2030,pemirolast,atopic conjunctivitis,histamine receptor h1
2031,pemirolast,asthma,histamine receptor h1
2032,salbutamol,bronchial disorder,adrenoceptor beta 2
2033,heparin,disseminated intravascular coagulation,coagulation factor x
2034,heparin,disseminated intravascular coagulation,serpin family c member 1
2035,heparin,thrombophilia due to thrombin defect,coagulation factor x
2036,heparin,thrombophilia due to thrombin defect,serpin family c member 1
2037,heparin,pulmonary embolism,coagulation factor x
2038,heparin,pulmonary embolism,serpin family c member 1
2039,ruxolitinib,myeloproliferative neoplasm,janus kinase 2
2040,ruxolitinib,myeloproliferative neoplasm,janus kinase 1
2041,ruxolitinib,acquired polycythemia vera,janus kinase 2
2042,ruxolitinib,acquired polycythemia vera,janus kinase 1
2043,somatropin,turner syndrome,growth hormone receptor
2044,somatropin,pituitary dwarfism,growth hormone receptor
2045,somatropin,prader-willi syndrome,growth hormone receptor
2046,pranlukast,asthma,cysteinyl leukotriene receptor 1
2047,pranlukast,allergic rhinitis,cysteinyl leukotriene receptor 1
2048,alteplase,pulmonary embolism,plasminogen
2049,methylergonovine,post-partum hemorrhage,5-hydroxytryptamine receptor 2b
2050,vincristine,rhabdomyosarcoma,tubulin beta class i
2051,vincristine,non-hodgkin lymphoma,tubulin beta class i
2052,vincristine,neuroblastoma,tubulin beta class i
2053,vincristine,burkitt lymphoma,tubulin beta class i
2054,vincristine,classic hodgkin lymphoma,tubulin beta class i
2055,vincristine,follicular lymphoma,tubulin beta class i
2056,vincristine,wilms tumor,tubulin beta class i
2057,vincristine,diffuse large b-cell lymphoma,tubulin beta class i
2058,fludroxycortide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2059,fludroxycortide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2060,fludroxycortide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2061,fludroxycortide,exanthem,nuclear receptor subfamily 3 group c member 1
2062,fludroxycortide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2063,fludroxycortide,pruritus ani,nuclear receptor subfamily 3 group c member 1
2064,fludroxycortide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2065,fludroxycortide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2066,fludroxycortide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2067,iloperidone,schizophrenia,5-hydroxytryptamine receptor 2a
2068,iloperidone,schizophrenia,dopamine receptor d1
2069,ramatroban,allergic rhinitis,prostaglandin d2 receptor 2
2070,ramatroban,allergic rhinitis,thromboxane a2 receptor
2071,duloxetine,major depressive disorder,solute carrier family 6 member 2
2072,duloxetine,fibromyalgia,solute carrier family 6 member 4
2073,duloxetine,fibromyalgia,solute carrier family 6 member 2
2074,dipyridamole,atrial fibrillation,phosphodiesterase 10a
2075,dipyridamole,atrial fibrillation,phosphodiesterase 5a
2076,dipyridamole,atrial fibrillation,phosphodiesterase 4a
2077,dipyridamole,atrial fibrillation,adenosine deaminase
2078,melatonin,insomnia,melatonin receptor 1a
2079,melatonin,insomnia,melatonin receptor 1b
2080,bupropion,seasonal affective disorder,solute carrier family 6 member 2
2081,bupropion,seasonal affective disorder,solute carrier family 6 member 3
2082,bupropion,major depressive disorder,solute carrier family 6 member 2
2083,bupropion,major depressive disorder,solute carrier family 6 member 3
2084,bupropion,nicotine dependence,solute carrier family 6 member 3
2085,bupropion,nicotine dependence,cholinergic receptor nicotinic alpha 3 subunit
2086,bupropion,depressive disorder,solute carrier family 6 member 2
2087,bupropion,depressive disorder,solute carrier family 6 member 3
2088,tiaprofenic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
2089,tiaprofenic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
2090,tiaprofenic acid,pain,prostaglandin-endoperoxide synthase 2
2091,tiaprofenic acid,pain,prostaglandin-endoperoxide synthase 1
2092,tiaprofenic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2093,tiaprofenic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2094,crotamiton,pruritus,transient receptor potential cation channel subfamily v member 4
2095,crotamiton,scabies,transient receptor potential cation channel subfamily v member 4
2096,esomeprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
2097,esomeprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
2098,esomeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
2099,trimethobenzamide,vomiting,dopamine receptor d2
2100,trimethobenzamide,nausea,dopamine receptor d2
2101,rimexolone,uveitis,nuclear receptor subfamily 3 group c member 1
2102,dasatinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
2103,dasatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
2104,calcium gluconate,hypocalcemia,calcium sensing receptor
2105,dimethyl fumarate,relapsing-remitting multiple sclerosis,kelch like ech associated protein 1
2106,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2107,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2108,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2109,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2110,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2111,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2112,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha1
2113,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha2
2114,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha3
2115,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha4
2116,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha5
2117,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha6
2118,glucagon,hypoglycemia,glucagon receptor
2119,phenelzine,depressive disorder,monoamine oxidase b
2120,phenelzine,depressive disorder,monoamine oxidase a
2121,terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
2122,terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
2123,terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
2124,terazosin,hypertensive disorder,adrenoceptor alpha 1a
2125,terazosin,hypertensive disorder,adrenoceptor alpha 1b
2126,terazosin,hypertensive disorder,adrenoceptor alpha 1d
2127,isocarboxazid,major depressive disorder,monoamine oxidase b
2128,isocarboxazid,major depressive disorder,monoamine oxidase a
2129,zuclopenthixol,schizophrenia,dopamine receptor d2
2130,zuclopenthixol,schizophrenia,dopamine receptor d5
2131,zuclopenthixol,schizophrenia,dopamine receptor d1
2132,pazopanib,sarcoma,platelet derived growth factor receptor beta
2133,pazopanib,sarcoma,fms related receptor tyrosine kinase 1
2134,pazopanib,sarcoma,"kit proto-oncogene, receptor tyrosine kinase"
2135,pazopanib,sarcoma,kinase insert domain receptor
2136,pazopanib,sarcoma,fms related receptor tyrosine kinase 4
2137,pazopanib,sarcoma,fms related receptor tyrosine kinase 3
2138,pazopanib,sarcoma,colony stimulating factor 1 receptor
2139,pazopanib,sarcoma,platelet derived growth factor receptor alpha
2140,pazopanib,renal cell carcinoma,platelet derived growth factor receptor beta
2141,pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 1
2142,pazopanib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
2143,pazopanib,renal cell carcinoma,kinase insert domain receptor
2144,pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 4
2145,pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 3
2146,pazopanib,renal cell carcinoma,colony stimulating factor 1 receptor
2147,pazopanib,renal cell carcinoma,platelet derived growth factor receptor alpha
2148,agomelatine,major depressive disorder,5-hydroxytryptamine receptor 2c
2149,agomelatine,major depressive disorder,melatonin receptor 1a
2150,agomelatine,major depressive disorder,melatonin receptor 1b
2151,antazoline,sneeze,histamine receptor h1
2152,antazoline,urticaria,histamine receptor h1
2153,antazoline,pruritus,histamine receptor h1
2154,antazoline,allergic rhinitis,histamine receptor h1
2155,antazoline,atopic conjunctivitis,histamine receptor h1
2156,cetuximab,colonic neoplasm,epidermal growth factor receptor
2157,risedronate,bone paget disease,atpase h+ transporting v1 subunit a
2158,risedronate,osteoporosis,atpase h+ transporting v1 subunit a
2159,risedronate,postmenopausal osteoporosis,atpase h+ transporting v1 subunit a
2160,hydromorphone,pain,opioid receptor mu 1
2161,lenalidomide,plasma cell myeloma,tumor necrosis factor
2162,lenalidomide,mantle cell lymphoma,tumor necrosis factor
2163,clocortolone pivalate,exanthem,nuclear receptor subfamily 3 group c member 1
2164,clocortolone pivalate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2165,clocortolone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2166,clocortolone pivalate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2167,clocortolone pivalate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2168,clocortolone pivalate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2169,clocortolone pivalate,pruritus ani,nuclear receptor subfamily 3 group c member 1
2170,clocortolone pivalate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2171,pirfenidone,acute interstitial pneumonia,tumor necrosis factor
2172,obinutuzumab,b-cell chronic lymphocytic leukemia,membrane spanning 4-domains a1
2173,5-fluorouracil,actinic keratosis,thymidylate synthetase
2174,5-fluorouracil,gastric neoplasm,thymidylate synthetase
2175,5-fluorouracil,colonic neoplasm,thymidylate synthetase
2176,medroxyprogesterone,endometrium neoplasm,progesterone receptor
2177,medroxyprogesterone,endometriosis,progesterone receptor
2178,medroxyprogesterone,metrorrhagia,progesterone receptor
2179,telmisartan,hypertensive disorder,angiotensin ii receptor type 1
2180,telmisartan,hypertensive disorder,peroxisome proliferator activated receptor gamma
2181,telmisartan,stroke disorder,angiotensin ii receptor type 1
2182,telmisartan,stroke disorder,peroxisome proliferator activated receptor gamma
2183,vernakalant,atrial fibrillation,potassium voltage-gated channel subfamily a member 5
2184,vernakalant,atrial fibrillation,potassium voltage-gated channel subfamily d member 3
2185,metoprolol,hypertensive disorder,adrenoceptor beta 1
2186,metoprolol,myocardial infarction,adrenoceptor beta 1
2187,metoprolol,acute coronary syndrome,adrenoceptor beta 1
2188,metoprolol,angina pectoris,adrenoceptor beta 1
2189,chlorpheniramine,atopic conjunctivitis,histamine receptor h1
2190,chlorpheniramine,seasonal allergic rhinitis,histamine receptor h1
2191,chlorpheniramine,sneeze,histamine receptor h1
2192,chlorpheniramine,vasomotor rhinitis,histamine receptor h1
2193,chlorpheniramine,pruritus,histamine receptor h1
2194,chlorpheniramine,allergic rhinitis,histamine receptor h1
2195,chlorpheniramine,urticaria,histamine receptor h1
2196,neostigmine,myasthenia gravis,acetylcholinesterase (yt blood group)
2197,neostigmine,urinary retention,acetylcholinesterase (yt blood group)
2198,cabozantinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
2199,cabozantinib,renal cell carcinoma,kinase insert domain receptor
2200,cabozantinib,renal cell carcinoma,ret proto-oncogene
2201,cabozantinib,medullary thyroid gland carcinoma,"met proto-oncogene, receptor tyrosine kinase"
2202,cabozantinib,medullary thyroid gland carcinoma,kinase insert domain receptor
2203,cabozantinib,medullary thyroid gland carcinoma,ret proto-oncogene
2204,perazine,anxiety,dopamine receptor d2
2205,perazine,schizophrenia,dopamine receptor d2
2206,halcinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2207,halcinonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2208,halcinonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2209,halcinonide,exanthem,nuclear receptor subfamily 3 group c member 1
2210,halcinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2211,halcinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
2212,halcinonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2213,halcinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2214,halcinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2215,colchicine,gout,tubulin beta class i
2216,colchicine,familial mediterranean fever,tubulin beta class i
2217,masoprocol,actinic keratosis,mechanistic target of rapamycin kinase
2218,cetirizine,allergic rhinitis,histamine receptor h1
2219,cetirizine,sneeze,histamine receptor h1
2220,cetirizine,vasomotor rhinitis,histamine receptor h1
2221,cetirizine,chronic urticaria,histamine receptor h1
2222,cetirizine,common cold,histamine receptor h1
2223,cetirizine,seasonal allergic rhinitis,histamine receptor h1
2224,cetirizine,atopic conjunctivitis,histamine receptor h1
2225,benzocaine,pharyngitis,sodium voltage-gated channel alpha subunit 10
2226,benzocaine,cough,sodium voltage-gated channel alpha subunit 10
2227,benzocaine,pruritus,sodium voltage-gated channel alpha subunit 10
2228,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 10
2229,piroxicam,osteoarthritis,prostaglandin-endoperoxide synthase 1
2230,piroxicam,osteoarthritis,prostaglandin-endoperoxide synthase 2
2231,piroxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2232,piroxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2233,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 1
2234,acetyldigitoxin,heart failure,atpase na+/k+ transporting subunit alpha 1
2235,zoledronic acid,postmenopausal osteoporosis,farnesyl diphosphate synthase
2236,zoledronic acid,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
2237,zoledronic acid,bone paget disease,farnesyl diphosphate synthase
2238,zoledronic acid,bone paget disease,geranylgeranyl diphosphate synthase 1
2239,zoledronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
2240,zoledronic acid,humoral hypercalcemia of malignancy,geranylgeranyl diphosphate synthase 1
2241,zoledronic acid,osteoporosis,farnesyl diphosphate synthase
2242,zoledronic acid,osteoporosis,geranylgeranyl diphosphate synthase 1
2243,escitalopram,major depressive disorder,solute carrier family 6 member 4
2244,sertindole,schizophrenia,dopamine receptor d2
2245,sertindole,schizophrenia,5-hydroxytryptamine receptor 2c
2246,sertindole,schizophrenia,5-hydroxytryptamine receptor 2a
2247,sertindole,schizophrenia,adrenoceptor alpha 1b
2248,sertindole,schizophrenia,adrenoceptor alpha 1a
2249,sertindole,schizophrenia,adrenoceptor alpha 1d
2250,zaleplon,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
2251,salicylic acid,synovitis,prostaglandin-endoperoxide synthase 1
2252,salicylic acid,synovitis,prostaglandin-endoperoxide synthase 2
2253,salicylic acid,pain,prostaglandin-endoperoxide synthase 1
2254,salicylic acid,pain,prostaglandin-endoperoxide synthase 2
2255,salicylic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2256,salicylic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2257,salicylic acid,tinea pedis,prostaglandin-endoperoxide synthase 1
2258,salicylic acid,tinea pedis,prostaglandin-endoperoxide synthase 2
2259,salicylic acid,acne,prostaglandin-endoperoxide synthase 1
2260,salicylic acid,acne,prostaglandin-endoperoxide synthase 2
2261,salicylic acid,common cold,prostaglandin-endoperoxide synthase 1
2262,salicylic acid,common cold,prostaglandin-endoperoxide synthase 2
2263,salicylic acid,fever,prostaglandin-endoperoxide synthase 1
2264,salicylic acid,fever,prostaglandin-endoperoxide synthase 2
2265,salicylic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
2266,salicylic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
2267,salicylic acid,allergic rhinitis,prostaglandin-endoperoxide synthase 1
2268,salicylic acid,allergic rhinitis,prostaglandin-endoperoxide synthase 2
2269,salicylic acid,seborrheic dermatitis,prostaglandin-endoperoxide synthase 1
2270,salicylic acid,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
2271,glipizide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
2272,glipizide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
2273,clofazimine,pyoderma gangrenosum,potassium voltage-gated channel subfamily a member 3
2274,torsemide,hypertensive disorder,solute carrier family 12 member 1
2275,torsemide,edema,solute carrier family 12 member 1
2276,conjugated estrogens,hot flashes,estrogen receptor 1
2277,conjugated estrogens,hot flashes,estrogen receptor 2
2278,conjugated estrogens,psychologic dyspareunia,estrogen receptor 1
2279,conjugated estrogens,psychologic dyspareunia,estrogen receptor 2
2280,dicumarol,intracranial embolism,vitamin k epoxide reductase complex subunit 1
2281,dicumarol,thromboembolism,vitamin k epoxide reductase complex subunit 1
2282,dicumarol,myocardial infarction,vitamin k epoxide reductase complex subunit 1
2283,dicumarol,thrombotic disease,vitamin k epoxide reductase complex subunit 1
2284,conivaptan,hyponatremia,arginine vasopressin receptor 1a
2285,conivaptan,hyponatremia,arginine vasopressin receptor 2
2286,doxylamine,sneeze,histamine receptor h1
2287,doxylamine,atopic conjunctivitis,histamine receptor h1
2288,doxylamine,urticaria,histamine receptor h1
2289,doxylamine,vasomotor rhinitis,histamine receptor h1
2290,doxylamine,common cold,histamine receptor h1
2291,doxylamine,seasonal allergic rhinitis,histamine receptor h1
2292,doxylamine,pruritus,histamine receptor h1
2293,fluvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
2294,fluvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
2295,fluvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
2296,lurasidone,bipolar disorder,dopamine receptor d2
2297,lurasidone,bipolar disorder,5-hydroxytryptamine receptor 2a
2298,lurasidone,schizophrenia,dopamine receptor d2
2299,lurasidone,schizophrenia,5-hydroxytryptamine receptor 2a
2300,diltiazem,angina pectoris,calcium voltage-gated channel subunit alpha1 c
2301,diltiazem,angina pectoris,calcium voltage-gated channel auxiliary subunit gamma 1
2302,diltiazem,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
2303,diltiazem,prinzmetal angina,calcium voltage-gated channel auxiliary subunit gamma 1
2304,diltiazem,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
2305,diltiazem,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
2306,diltiazem,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
2307,diltiazem,atrial fibrillation,calcium voltage-gated channel auxiliary subunit gamma 1
2308,polmacoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
2309,repaglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
2310,bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor gamma
2311,bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor alpha
2312,bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor delta
2313,bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor gamma
2314,bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
2315,bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor delta
2316,mefenamic acid,pain,prostaglandin-endoperoxide synthase 1
2317,mefenamic acid,pain,prostaglandin-endoperoxide synthase 2
2318,mefenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 1
2319,mefenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 2
2320,clofibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
2321,frovatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
2322,frovatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
2323,desipramine,depressive disorder,solute carrier family 6 member 2
2324,fluspirilene,schizophrenia,dopamine receptor d2
2325,naftopidil,benign prostatic hyperplasia,adrenoceptor alpha 1d
2326,fenoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2327,fenoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2328,fenoprofen,pain,prostaglandin-endoperoxide synthase 1
2329,fenoprofen,pain,prostaglandin-endoperoxide synthase 2
2330,fenoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
2331,fenoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
2332,tadalafil,erectile dysfunction,phosphodiesterase 5a
2333,tadalafil,pulmonary hypertension,phosphodiesterase 5a
2334,loxoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2335,loxoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2336,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
2337,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
2338,haloperidol,tourette syndrome,dopamine receptor d2
2339,haloperidol,psychotic disorder,dopamine receptor d2
2340,sumatriptan,cluster headache syndrome,5-hydroxytryptamine receptor 1d
2341,sumatriptan,cluster headache syndrome,5-hydroxytryptamine receptor 1b
2342,gliquidone,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
2343,quinestrol,hot flashes,estrogen receptor 1
2344,quinestrol,postmenopausal atrophic vaginitis,estrogen receptor 1
2345,cyclosporin a,dry eye syndrome,peptidylprolyl isomerase a
2346,cyclosporin a,xerophthalmia,peptidylprolyl isomerase a
2347,cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase a
2348,protriptyline,depressive disorder,solute carrier family 6 member 4
2349,protriptyline,depressive disorder,solute carrier family 6 member 2
2350,phenprocoumon,thrombotic disease,vitamin k epoxide reductase complex subunit 1
2351,phenprocoumon,myocardial infarction,vitamin k epoxide reductase complex subunit 1
2352,phenprocoumon,thromboembolism,vitamin k epoxide reductase complex subunit 1
2353,riociguat,pulmonary arterial hypertension,guanylate cyclase 1 soluble subunit alpha 2
2354,megestrol,endometrium neoplasm,progesterone receptor
2355,azatadine,sneeze,histamine receptor h1
2356,azatadine,seasonal allergic rhinitis,histamine receptor h1
2357,azatadine,pruritus,histamine receptor h1
2358,azatadine,common cold,histamine receptor h1
2359,azatadine,urticaria,histamine receptor h1
2360,azatadine,vasomotor rhinitis,histamine receptor h1
2361,azatadine,allergic rhinitis,histamine receptor h1
2362,azatadine,atopic conjunctivitis,histamine receptor h1
2363,bilastine,allergic rhinitis,histamine receptor h1
2364,bilastine,urticaria,histamine receptor h1
2365,rilmenidine,hypertensive disorder,nischarin
2366,olmutinib,non-small cell lung carcinoma,epidermal growth factor receptor
2367,flutamide,prostate cancer,androgen receptor
2368,fluphenazine,psychotic disorder,dopamine receptor d2
2369,furosemide,edema,solute carrier family 12 member 1
2370,furosemide,hypertensive disorder,solute carrier family 12 member 1
2371,voglibose,type 2 diabetes mellitus,maltase-glucoamylase
2372,voglibose,type 2 diabetes mellitus,alpha glucosidase
2373,voglibose,type 2 diabetes mellitus,sucrase-isomaltase
2374,voglibose,type 2 diabetes mellitus,maltase-glucoamylase 2 (putative)
2375,oxymetholone,aplastic anemia,androgen receptor
2376,oxymetholone,diamond-blackfan anemia,androgen receptor
2377,insulin aspart,diabetes mellitus,insulin receptor
2378,mianserin,major depressive disorder,5-hydroxytryptamine receptor 2a
2379,mianserin,major depressive disorder,5-hydroxytryptamine receptor 2c
2380,mianserin,major depressive disorder,solute carrier family 6 member 2
2381,mianserin,major depressive disorder,adrenoceptor alpha 2a
2382,mianserin,major depressive disorder,adrenoceptor alpha 2c
2383,mianserin,major depressive disorder,histamine receptor h1
2384,blonanserin,schizophrenia,dopamine receptor d2
2385,blonanserin,schizophrenia,dopamine receptor d3
2386,blonanserin,schizophrenia,5-hydroxytryptamine receptor 2a
2387,paroxetine,post-traumatic stress disorder,solute carrier family 6 member 4
2388,paroxetine,premenstrual dysphoric disorder,solute carrier family 6 member 4
2389,paroxetine,hot flashes,solute carrier family 6 member 4
2390,paroxetine,panic disorder,solute carrier family 6 member 4
2391,paroxetine,obsessive-compulsive disorder,solute carrier family 6 member 4
2392,paroxetine,major depressive disorder,solute carrier family 6 member 4
2393,paroxetine,social phobia,solute carrier family 6 member 4
2394,paroxetine,depressive disorder,solute carrier family 6 member 4
2395,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2396,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2397,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2398,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2399,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2400,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2401,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha1
2402,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha2
2403,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha3
2404,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha4
2405,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha5
2406,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha6
2407,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2408,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2409,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2410,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2411,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2412,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2413,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2414,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2415,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2416,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2417,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2418,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2419,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
2420,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
2421,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
2422,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
2423,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
2424,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
2425,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha1
2426,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha2
2427,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha3
2428,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha4
2429,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha5
2430,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha6
2431,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
2432,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
2433,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
2434,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
2435,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
2436,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
2437,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
2438,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
2439,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
2440,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
2441,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
2442,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
2443,amiloride,hypertensive disorder,sodium channel epithelial 1 subunit gamma
2444,amiloride,hypertensive disorder,sodium channel epithelial 1 subunit alpha
2445,amiloride,hypertensive disorder,sodium channel epithelial 1 subunit beta
2446,amiloride,edema,sodium channel epithelial 1 subunit gamma
2447,amiloride,edema,sodium channel epithelial 1 subunit alpha
2448,amiloride,edema,sodium channel epithelial 1 subunit beta
2449,nefazodone,major depressive disorder,solute carrier family 6 member 4
2450,nefazodone,major depressive disorder,solute carrier family 6 member 2
2451,nefazodone,major depressive disorder,5-hydroxytryptamine receptor 2a
2452,nefazodone,major depressive disorder,5-hydroxytryptamine receptor 2c
2453,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 4
2454,dronedarone,atrial fibrillation,potassium inwardly rectifying channel subfamily j member 2
2455,alogliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
2456,nicorandil,angina pectoris,atp binding cassette subfamily c member 9
2457,reproterol,asthma,adrenoceptor beta 2
2458,allopurinol,gout,xanthine dehydrogenase
2459,allopurinol,hyperuricemia,xanthine dehydrogenase
2460,ebastine,allergic rhinitis,histamine receptor h1
2461,ebastine,chronic urticaria,histamine receptor h1
2462,efonidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
2463,efonidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
2464,dopamine,decreased cardiac output,adrenoceptor beta 1
2465,mitoxantrone,relapsing-remitting multiple sclerosis,dna topoisomerase ii alpha
2466,mitoxantrone,acute myeloid leukemia,dna topoisomerase ii alpha
2467,dezocine,pain,opioid receptor mu 1
2468,dezocine,pain,opioid receptor kappa 1
2469,piretanide,hypertensive disorder,solute carrier family 12 member 1
2470,piretanide,edema,solute carrier family 12 member 1
2471,fluticasone,asthma,nuclear receptor subfamily 3 group c member 1
2472,fluticasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2473,icotinib,non-small cell lung carcinoma,epidermal growth factor receptor
2474,fluvoxamine,social phobia,solute carrier family 6 member 4
2475,fluvoxamine,obsessive-compulsive disorder,solute carrier family 6 member 4
2476,paracetamol,tension-type headache,prostaglandin-endoperoxide synthase 1
2477,paracetamol,tension-type headache,prostaglandin-endoperoxide synthase 2
2478,paracetamol,tension-type headache,prostaglandin e synthase 3
2479,paracetamol,migraine disorder,prostaglandin-endoperoxide synthase 1
2480,paracetamol,migraine disorder,prostaglandin-endoperoxide synthase 2
2481,paracetamol,migraine disorder,prostaglandin e synthase 3
2482,paracetamol,toothache,prostaglandin-endoperoxide synthase 1
2483,paracetamol,toothache,prostaglandin-endoperoxide synthase 2
2484,paracetamol,toothache,prostaglandin e synthase 3
2485,paracetamol,headache disorder,prostaglandin-endoperoxide synthase 1
2486,paracetamol,headache disorder,prostaglandin-endoperoxide synthase 2
2487,paracetamol,headache disorder,prostaglandin e synthase 3
2488,paracetamol,arthralgia,prostaglandin-endoperoxide synthase 1
2489,paracetamol,arthralgia,prostaglandin-endoperoxide synthase 2
2490,paracetamol,arthralgia,prostaglandin e synthase 3
2491,paracetamol,common cold,prostaglandin-endoperoxide synthase 1
2492,paracetamol,common cold,prostaglandin-endoperoxide synthase 2
2493,paracetamol,common cold,prostaglandin e synthase 3
2494,paracetamol,allergic rhinitis,prostaglandin-endoperoxide synthase 1
2495,paracetamol,allergic rhinitis,prostaglandin-endoperoxide synthase 2
2496,paracetamol,allergic rhinitis,prostaglandin e synthase 3
2497,alpha-methyltyrosine,pheochromocytoma,tyrosine hydroxylase
2498,captodiame,anxiety disorder,5-hydroxytryptamine receptor 2c
2499,captodiame,anxiety disorder,sigma non-opioid intracellular receptor 1
2500,fluoxetine,bipolar disorder,solute carrier family 6 member 4
2501,fluoxetine,panic disorder,solute carrier family 6 member 4
2502,fluoxetine,premenstrual dysphoric disorder,solute carrier family 6 member 4
2503,fluoxetine,depressive disorder,solute carrier family 6 member 4
2504,fluoxetine,bulimia nervosa,solute carrier family 6 member 4
2505,fluoxetine,major depressive disorder,solute carrier family 6 member 4
2506,fluoxetine,obsessive-compulsive disorder,solute carrier family 6 member 4
2507,topotecan,ovarian cancer,dna topoisomerase i
2508,topotecan,small cell lung carcinoma,dna topoisomerase i
2509,cyclizine,motion sickness,histamine receptor h1
2510,cyclizine,sneeze,histamine receptor h1
2511,cyclizine,seasonal allergic rhinitis,histamine receptor h1
2512,cyclizine,allergic rhinitis,histamine receptor h1
2513,cyclizine,common cold,histamine receptor h1
2514,cyclizine,atopic conjunctivitis,histamine receptor h1
2515,cyclizine,vasomotor rhinitis,histamine receptor h1
2516,cyclizine,cough,histamine receptor h1
2517,methyl salicylate,back pain,prostaglandin-endoperoxide synthase 1
2518,methyl salicylate,back pain,prostaglandin-endoperoxide synthase 2
2519,carbinoxamine,allergic rhinitis,histamine receptor h1
2520,carbinoxamine,common cold,histamine receptor h1
2521,carbinoxamine,pruritus,histamine receptor h1
2522,carbinoxamine,seasonal allergic rhinitis,histamine receptor h1
2523,carbinoxamine,urticaria,histamine receptor h1
2524,carbinoxamine,vasomotor rhinitis,histamine receptor h1
2525,gemigliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
2526,oxymorphone,chronic pain,opioid receptor mu 1
2527,oxymorphone,labor pain,opioid receptor mu 1
2528,oxymorphone,pain,opioid receptor mu 1
2529,ranitidine,duodenal ulcer,histamine receptor h2
2530,ranitidine,gastric ulcer,histamine receptor h2
2531,ranitidine,gastroesophageal reflux disease,histamine receptor h2
2532,ranitidine,dyspepsia,histamine receptor h2
2533,ranitidine,zollinger-ellison syndrome,histamine receptor h2
2534,rivastigmine,alzheimer disease,acetylcholinesterase (yt blood group)
2535,trazodone,major depressive disorder,solute carrier family 6 member 4
2536,diethylpropion,obesity disorder,solute carrier family 6 member 2
2537,diethylpropion,obesity disorder,solute carrier family 6 member 3
2538,risperidone,autism spectrum disorder,dopamine receptor d2
2539,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 2a
2540,risperidone,schizophrenia,dopamine receptor d2
2541,risperidone,schizophrenia,5-hydroxytryptamine receptor 2a
2542,salsalate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2543,salsalate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2544,salsalate,osteoarthritis,prostaglandin-endoperoxide synthase 1
2545,salsalate,osteoarthritis,prostaglandin-endoperoxide synthase 2
2546,tolazamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
2547,tolazamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
2548,trimetazidine,angina pectoris,acetyl-coa acyltransferase 2
2549,ambenonium,myasthenia gravis,acetylcholinesterase (yt blood group)
2550,benoxaprofen,rheumatoid arthritis,arachidonate 5-lipoxygenase
2551,flufenamic acid,pain,prostaglandin-endoperoxide synthase 1
2552,flufenamic acid,pain,prostaglandin-endoperoxide synthase 2
2553,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 2a
2554,methimazole,hyperthyroidism,thyroid peroxidase
2555,anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 1
2556,anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 2
2557,anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 3
2558,anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 1
2559,anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 2
2560,anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 3
2561,perampanel,focal epilepsy,glutamate ionotropic receptor ampa type subunit 1
2562,atorvastatin,angina pectoris,3-hydroxy-3-methylglutaryl-coa reductase
2563,atorvastatin,prinzmetal angina,3-hydroxy-3-methylglutaryl-coa reductase
2564,atorvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
2565,atorvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
2566,atorvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
2567,atorvastatin,"hyperlipidemia, familial combined, lpl related",lipoprotein lipase
2568,atorvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
2569,atorvastatin,hyperlipoproteinemia type 3,lipoprotein lipase
2570,atorvastatin,hypertriglyceridemia,lipoprotein lipase
2571,atorvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
2572,hydroquinone,dyschromatosis universalis hereditaria,tyrosinase
2573,fluticasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2574,fluticasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2575,fluticasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2576,fluticasone,exanthem,nuclear receptor subfamily 3 group c member 1
2577,fluticasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2578,fluticasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2579,fluticasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2580,fluticasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2581,fluticasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2582,fluticasone,pulmonary emphysema,nuclear receptor subfamily 3 group c member 1
2583,phenylephrine,common cold,adrenoceptor alpha 1a
2584,phenylephrine,common cold,adrenoceptor alpha 1b
2585,phenylephrine,common cold,adrenoceptor alpha 1d
2586,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1a
2587,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1b
2588,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1d
2589,phenylephrine,cough,adrenoceptor alpha 1a
2590,phenylephrine,cough,adrenoceptor alpha 1b
2591,phenylephrine,cough,adrenoceptor alpha 1d
2592,phenylephrine,fever,adrenoceptor alpha 1a
2593,phenylephrine,fever,adrenoceptor alpha 1b
2594,phenylephrine,fever,adrenoceptor alpha 1d
2595,phenylephrine,headache disorder,adrenoceptor alpha 1a
2596,phenylephrine,headache disorder,adrenoceptor alpha 1b
2597,phenylephrine,headache disorder,adrenoceptor alpha 1d
2598,phenylephrine,hemorrhoid,adrenoceptor alpha 1a
2599,phenylephrine,hemorrhoid,adrenoceptor alpha 1b
2600,phenylephrine,hemorrhoid,adrenoceptor alpha 1d
2601,phenylephrine,proctitis,adrenoceptor alpha 1a
2602,phenylephrine,proctitis,adrenoceptor alpha 1b
2603,phenylephrine,proctitis,adrenoceptor alpha 1d
2604,phenylephrine,pruritus ani,adrenoceptor alpha 1a
2605,phenylephrine,pruritus ani,adrenoceptor alpha 1b
2606,phenylephrine,pruritus ani,adrenoceptor alpha 1d
2607,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
2608,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1b
2609,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1d
2610,phenylephrine,allergic rhinitis,adrenoceptor alpha 1a
2611,phenylephrine,allergic rhinitis,adrenoceptor alpha 1b
2612,phenylephrine,allergic rhinitis,adrenoceptor alpha 1d
2613,phenylephrine,rhinitis,adrenoceptor alpha 1a
2614,phenylephrine,rhinitis,adrenoceptor alpha 1b
2615,phenylephrine,rhinitis,adrenoceptor alpha 1d
2616,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1a
2617,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1b
2618,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1d
2619,phenylephrine,sneeze,adrenoceptor alpha 1a
2620,phenylephrine,sneeze,adrenoceptor alpha 1b
2621,phenylephrine,sneeze,adrenoceptor alpha 1d
2622,incadronic acid,osteoporosis,farnesyl diphosphate synthase
2623,incadronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
2624,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
2625,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
2626,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
2627,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
2628,pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,dihydrofolate reductase
2629,pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,thymidylate synthetase
2630,ixazomib,plasma cell myeloma,proteasome 20s subunit beta 5
2631,ixazomib,plasma cell myeloma,proteasome 20s subunit beta 1
2632,caffeine,back pain,adenosine a2a receptor
2633,caffeine,back pain,adenosine a2b receptor
2634,caffeine,cluster headache syndrome,adenosine a2a receptor
2635,caffeine,cluster headache syndrome,adenosine a2b receptor
2636,caffeine,headache disorder,adenosine a2a receptor
2637,caffeine,headache disorder,adenosine a2b receptor
2638,caffeine,migraine disorder,adenosine a2a receptor
2639,caffeine,migraine disorder,adenosine a2b receptor
2640,caffeine,pain,adenosine a2a receptor
2641,caffeine,pain,adenosine a2b receptor
2642,caffeine,tension-type headache,adenosine a2a receptor
2643,caffeine,tension-type headache,adenosine a2b receptor
2644,caffeine,vascular headaches,adenosine a2a receptor
2645,caffeine,vascular headaches,adenosine a2b receptor
2646,desonide,asthma,nuclear receptor subfamily 3 group c member 1
2647,desonide,crohn disease,nuclear receptor subfamily 3 group c member 1
2648,desonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2649,desonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2650,desonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2651,desonide,exanthem,nuclear receptor subfamily 3 group c member 1
2652,desonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2653,desonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2654,desonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2655,desonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2656,desonide,otitis externa,nuclear receptor subfamily 3 group c member 1
2657,desonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
2658,desonide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2659,doxorubicin,kaposi's sarcoma,dna topoisomerase ii alpha
2660,doxorubicin,breast neoplasm,dna topoisomerase ii alpha
2661,doxorubicin,burkitt lymphoma,dna topoisomerase ii alpha
2662,doxorubicin,classic hodgkin lymphoma,dna topoisomerase ii alpha
2663,doxorubicin,acute myeloid leukemia,dna topoisomerase ii alpha
2664,doxorubicin,lung neoplasm,dna topoisomerase ii alpha
2665,doxorubicin,follicular lymphoma,dna topoisomerase ii alpha
2666,doxorubicin,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
2667,doxorubicin,non-hodgkin lymphoma,dna topoisomerase ii alpha
2668,doxorubicin,plasma cell myeloma,dna topoisomerase ii alpha
2669,doxorubicin,neuroblastoma,dna topoisomerase ii alpha
2670,doxorubicin,ovarian cancer,dna topoisomerase ii alpha
2671,doxorubicin,small cell lung carcinoma,dna topoisomerase ii alpha
2672,doxorubicin,wilms tumor,dna topoisomerase ii alpha
2673,cortisol,acne,nuclear receptor subfamily 3 group c member 1
2674,cortisol,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2675,cortisol,angioedema,nuclear receptor subfamily 3 group c member 1
2676,cortisol,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
2677,cortisol,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
2678,cortisol,corneal ulcer,nuclear receptor subfamily 3 group c member 1
2679,cortisol,crohn disease,nuclear receptor subfamily 3 group c member 1
2680,cortisol,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2681,cortisol,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2682,cortisol,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2683,cortisol,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2684,cortisol,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2685,cortisol,iritis,nuclear receptor subfamily 3 group c member 1
2686,cortisol,keratitis,nuclear receptor subfamily 3 group c member 1
2687,cortisol,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2688,cortisol,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2689,cortisol,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2690,cortisol,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2691,cortisol,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2692,cortisol,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2693,cortisol,otitis externa,nuclear receptor subfamily 3 group c member 1
2694,cortisol,proctitis,nuclear receptor subfamily 3 group c member 1
2695,cortisol,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2696,cortisol,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2697,cortisol,rosacea,nuclear receptor subfamily 3 group c member 1
2698,cortisol,canker sore,nuclear receptor subfamily 3 group c member 1
2699,cortisol,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2700,cortisol,tinea pedis,nuclear receptor subfamily 3 group c member 1
2701,cortisol,trichinellosis,nuclear receptor subfamily 3 group c member 1
2702,cortisol,uveitis,nuclear receptor subfamily 3 group c member 1
2703,naproxen,arthralgia,prostaglandin-endoperoxide synthase 1
2704,naproxen,arthralgia,prostaglandin-endoperoxide synthase 2
2705,naproxen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
2706,naproxen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
2707,naproxen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2708,naproxen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2709,naproxen,bursitis,prostaglandin-endoperoxide synthase 1
2710,naproxen,bursitis,prostaglandin-endoperoxide synthase 2
2711,naproxen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
2712,naproxen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
2713,naproxen,fever,prostaglandin-endoperoxide synthase 1
2714,naproxen,fever,prostaglandin-endoperoxide synthase 2
2715,naproxen,gout,prostaglandin-endoperoxide synthase 1
2716,naproxen,gout,prostaglandin-endoperoxide synthase 2
2717,naproxen,headache disorder,prostaglandin-endoperoxide synthase 1
2718,naproxen,headache disorder,prostaglandin-endoperoxide synthase 2
2719,naproxen,migraine disorder,prostaglandin-endoperoxide synthase 1
2720,naproxen,migraine disorder,prostaglandin-endoperoxide synthase 2
2721,naproxen,myalgia,prostaglandin-endoperoxide synthase 1
2722,naproxen,myalgia,prostaglandin-endoperoxide synthase 2
2723,naproxen,osteoarthritis,prostaglandin-endoperoxide synthase 1
2724,naproxen,osteoarthritis,prostaglandin-endoperoxide synthase 2
2725,naproxen,pain,prostaglandin-endoperoxide synthase 1
2726,naproxen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
2727,naproxen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
2728,naproxen,tendinopathy,prostaglandin-endoperoxide synthase 1
2729,naproxen,tendinopathy,prostaglandin-endoperoxide synthase 2
2730,naproxen,toothache,prostaglandin-endoperoxide synthase 1
2731,naproxen,toothache,prostaglandin-endoperoxide synthase 2
2732,pheniramine,common cold,histamine receptor h1
2733,pheniramine,atopic conjunctivitis,histamine receptor h1
2734,pheniramine,cough,histamine receptor h1
2735,pheniramine,fever,histamine receptor h1
2736,pheniramine,headache disorder,histamine receptor h1
2737,pheniramine,pharyngitis,histamine receptor h1
2738,pheniramine,pruritus,histamine receptor h1
2739,pheniramine,allergic rhinitis,histamine receptor h1
2740,pheniramine,seasonal allergic rhinitis,histamine receptor h1
2741,pheniramine,sneeze,histamine receptor h1
2742,pheniramine,urticaria,histamine receptor h1
2743,pheniramine,vasomotor rhinitis,histamine receptor h1
2744,levoketoconazole,adrenal gland hyperfunction,cytochrome p450 family 17 subfamily a member 1
2745,methylprednisolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2746,methylprednisolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2747,methylprednisolone,angioedema,nuclear receptor subfamily 3 group c member 1
2748,methylprednisolone,gout,nuclear receptor subfamily 3 group c member 1
2749,methylprednisolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2750,methylprednisolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2751,methylprednisolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2752,methylprednisolone,asthma,nuclear receptor subfamily 3 group c member 1
2753,methylprednisolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2754,methylprednisolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2755,methylprednisolone,brain edema,nuclear receptor subfamily 3 group c member 1
2756,methylprednisolone,bursitis,nuclear receptor subfamily 3 group c member 1
2757,methylprednisolone,crohn disease,nuclear receptor subfamily 3 group c member 1
2758,methylprednisolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2759,methylprednisolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2760,methylprednisolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2761,methylprednisolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2762,methylprednisolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2763,methylprednisolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2764,methylprednisolone,exanthem,nuclear receptor subfamily 3 group c member 1
2765,methylprednisolone,eye disorder,nuclear receptor subfamily 3 group c member 1
2766,methylprednisolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2767,methylprednisolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2768,methylprednisolone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
2769,methylprednisolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2770,methylprednisolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2771,methylprednisolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2772,methylprednisolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2773,methylprednisolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2774,methylprednisolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2775,methylprednisolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2776,methylprednisolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2777,methylprednisolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2778,methylprednisolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2779,methylprednisolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2780,methylprednisolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2781,methylprednisolone,pemphigus,nuclear receptor subfamily 3 group c member 1
2782,methylprednisolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2783,methylprednisolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2784,methylprednisolone,psoriasis,nuclear receptor subfamily 3 group c member 1
2785,methylprednisolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2786,methylprednisolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2787,methylprednisolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2788,methylprednisolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2789,methylprednisolone,serum sickness,nuclear receptor subfamily 3 group c member 1
2790,methylprednisolone,skin disorder,nuclear receptor subfamily 3 group c member 1
2791,methylprednisolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2792,methylprednisolone,synovitis,nuclear receptor subfamily 3 group c member 1
2793,methylprednisolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2794,methylprednisolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2795,methylprednisolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2796,methylprednisolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2797,methylprednisolone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2798,methylprednisolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2799,triamcinolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2800,triamcinolone,angioedema,nuclear receptor subfamily 3 group c member 1
2801,triamcinolone,gout,nuclear receptor subfamily 3 group c member 1
2802,triamcinolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2803,triamcinolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2804,triamcinolone,asthma,nuclear receptor subfamily 3 group c member 1
2805,triamcinolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2806,triamcinolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2807,triamcinolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2808,triamcinolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2809,triamcinolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2810,triamcinolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
2811,triamcinolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2812,triamcinolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2813,triamcinolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2814,triamcinolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2815,triamcinolone,sympathetic ophthalmia,nuclear receptor subfamily 3 group c member 1
2816,triamcinolone,psoriasis,nuclear receptor subfamily 3 group c member 1
2817,triamcinolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2818,triamcinolone,serum sickness,nuclear receptor subfamily 3 group c member 1
2819,triamcinolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2820,triamcinolone,synovitis,nuclear receptor subfamily 3 group c member 1
2821,triamcinolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2822,triamcinolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2823,triamcinolone,bursitis,nuclear receptor subfamily 3 group c member 1
2824,triamcinolone,cutaneous candidiasis,nuclear receptor subfamily 3 group c member 1
2825,triamcinolone,exanthem,nuclear receptor subfamily 3 group c member 1
2826,triamcinolone,eye disorder,nuclear receptor subfamily 3 group c member 1
2827,triamcinolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
2828,triamcinolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2829,triamcinolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2830,triamcinolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2831,triamcinolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2832,triamcinolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2833,triamcinolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2834,triamcinolone,seasonal allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2835,triamcinolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2836,triamcinolone,canker sore,nuclear receptor subfamily 3 group c member 1
2837,triamcinolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2838,triamcinolone,uveitis,nuclear receptor subfamily 3 group c member 1
2839,triamcinolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2840,triamcinolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2841,triamcinolone,brain edema,nuclear receptor subfamily 3 group c member 1
2842,triamcinolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2843,triamcinolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2844,triamcinolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2845,triamcinolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2846,triamcinolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2847,triamcinolone,pemphigus,nuclear receptor subfamily 3 group c member 1
2848,triamcinolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2849,triamcinolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2850,triamcinolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2851,triamcinolone,skin disorder,nuclear receptor subfamily 3 group c member 1
2852,triamcinolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2853,triamcinolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2854,triamcinolone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2855,triamcinolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2856,triamcinolone,diffuse alopecia areata,nuclear receptor subfamily 3 group c member 1
2857,triamcinolone,keloid,nuclear receptor subfamily 3 group c member 1
2858,triamcinolone,lichen planus,nuclear receptor subfamily 3 group c member 1
2859,triamcinolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2860,triamcinolone,necrobiosis lipoidica,nuclear receptor subfamily 3 group c member 1
2861,triamcinolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2862,cortisone,acne,nuclear receptor subfamily 3 group c member 1
2863,cortisone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2864,cortisone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2865,cortisone,angioedema,nuclear receptor subfamily 3 group c member 1
2866,cortisone,gout,nuclear receptor subfamily 3 group c member 1
2867,cortisone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2868,cortisone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2869,cortisone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2870,cortisone,asthma,nuclear receptor subfamily 3 group c member 1
2871,cortisone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2872,cortisone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2873,cortisone,brain edema,nuclear receptor subfamily 3 group c member 1
2874,cortisone,bursitis,nuclear receptor subfamily 3 group c member 1
2875,cortisone,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
2876,cortisone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
2877,cortisone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
2878,cortisone,crohn disease,nuclear receptor subfamily 3 group c member 1
2879,cortisone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2880,cortisone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2881,cortisone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2882,cortisone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2883,cortisone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2884,cortisone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2885,cortisone,exanthem,nuclear receptor subfamily 3 group c member 1
2886,cortisone,eye disorder,nuclear receptor subfamily 3 group c member 1
2887,cortisone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2888,cortisone,hemorrhoid,nuclear receptor subfamily 3 group c member 1
2889,cortisone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2890,cortisone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
2891,cortisone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2892,cortisone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2893,cortisone,iritis,nuclear receptor subfamily 3 group c member 1
2894,cortisone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2895,cortisone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2896,cortisone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2897,cortisone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2898,cortisone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2899,cortisone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2900,cortisone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2901,cortisone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2902,cortisone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2903,cortisone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2904,cortisone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2905,cortisone,otitis externa,nuclear receptor subfamily 3 group c member 1
2906,cortisone,pemphigus,nuclear receptor subfamily 3 group c member 1
2907,cortisone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2908,cortisone,proctitis,nuclear receptor subfamily 3 group c member 1
2909,cortisone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2910,cortisone,psoriasis,nuclear receptor subfamily 3 group c member 1
2911,cortisone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2912,cortisone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2913,cortisone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2914,cortisone,rosacea,nuclear receptor subfamily 3 group c member 1
2915,cortisone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2916,cortisone,serum sickness,nuclear receptor subfamily 3 group c member 1
2917,cortisone,skin disorder,nuclear receptor subfamily 3 group c member 1
2918,cortisone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2919,cortisone,canker sore,nuclear receptor subfamily 3 group c member 1
2920,cortisone,synovitis,nuclear receptor subfamily 3 group c member 1
2921,cortisone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2922,cortisone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2923,cortisone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2924,cortisone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2925,cortisone,tinea pedis,nuclear receptor subfamily 3 group c member 1
2926,cortisone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2927,cortisone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2928,cortisone,uveitis,nuclear receptor subfamily 3 group c member 1
2929,prednisolone,hypersensitivity pneumonitis,nuclear receptor subfamily 3 group c member 1
2930,prednisolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2931,prednisolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2932,prednisolone,angioedema,nuclear receptor subfamily 3 group c member 1
2933,prednisolone,gout,nuclear receptor subfamily 3 group c member 1
2934,prednisolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2935,prednisolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2936,prednisolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2937,prednisolone,allergic bronchopulmonary aspergillosis,nuclear receptor subfamily 3 group c member 1
2938,prednisolone,asthma,nuclear receptor subfamily 3 group c member 1
2939,prednisolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2940,prednisolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2941,prednisolone,brain edema,nuclear receptor subfamily 3 group c member 1
2942,prednisolone,bursitis,nuclear receptor subfamily 3 group c member 1
2943,prednisolone,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
2944,prednisolone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
2945,prednisolone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
2946,prednisolone,crohn disease,nuclear receptor subfamily 3 group c member 1
2947,prednisolone,dacryocystitis,nuclear receptor subfamily 3 group c member 1
2948,prednisolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2949,prednisolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2950,prednisolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2951,prednisolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2952,prednisolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2953,prednisolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2954,prednisolone,exanthem,nuclear receptor subfamily 3 group c member 1
2955,prednisolone,eye disorder,nuclear receptor subfamily 3 group c member 1
2956,prednisolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
2957,prednisolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2958,prednisolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2959,prednisolone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
2960,prednisolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2961,prednisolone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2962,prednisolone,iritis,nuclear receptor subfamily 3 group c member 1
2963,prednisolone,keratitis,nuclear receptor subfamily 3 group c member 1
2964,prednisolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2965,prednisolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2966,prednisolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2967,prednisolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2968,prednisolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2969,prednisolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2970,prednisolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2971,prednisolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2972,prednisolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2973,prednisolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2974,prednisolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2975,prednisolone,sympathetic ophthalmia,nuclear receptor subfamily 3 group c member 1
2976,prednisolone,pemphigus,nuclear receptor subfamily 3 group c member 1
2977,prednisolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2978,prednisolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
2979,prednisolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2980,prednisolone,psoriasis,nuclear receptor subfamily 3 group c member 1
2981,prednisolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2982,prednisolone,pulmonary fibrosis,nuclear receptor subfamily 3 group c member 1
2983,prednisolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2984,prednisolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2985,prednisolone,rosacea,nuclear receptor subfamily 3 group c member 1
2986,prednisolone,serum sickness,nuclear receptor subfamily 3 group c member 1
2987,prednisolone,sjogren syndrome,nuclear receptor subfamily 3 group c member 1
2988,prednisolone,skin disorder,nuclear receptor subfamily 3 group c member 1
2989,prednisolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2990,prednisolone,stevens-johnson syndrome,nuclear receptor subfamily 3 group c member 1
2991,prednisolone,synovitis,nuclear receptor subfamily 3 group c member 1
2992,prednisolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2993,prednisolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2994,prednisolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2995,prednisolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2996,prednisolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2997,prednisolone,uveitis,nuclear receptor subfamily 3 group c member 1
2998,betamethasone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2999,betamethasone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
3000,betamethasone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
3001,betamethasone,asthma,nuclear receptor subfamily 3 group c member 1
3002,betamethasone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
3003,betamethasone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
3004,betamethasone,brain edema,nuclear receptor subfamily 3 group c member 1
3005,betamethasone,bursitis,nuclear receptor subfamily 3 group c member 1
3006,betamethasone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
3007,betamethasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
3008,betamethasone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
3009,betamethasone,eye disorder,nuclear receptor subfamily 3 group c member 1
3010,betamethasone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3011,betamethasone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
3012,betamethasone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
3013,betamethasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
3014,betamethasone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
3015,betamethasone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
3016,betamethasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3017,betamethasone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
3018,betamethasone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3019,betamethasone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
3020,betamethasone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
3021,betamethasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
3022,betamethasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
3023,betamethasone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
3024,betamethasone,scalp dermatosis,nuclear receptor subfamily 3 group c member 1
3025,betamethasone,serum sickness,nuclear receptor subfamily 3 group c member 1
3026,betamethasone,skin disorder,nuclear receptor subfamily 3 group c member 1
3027,betamethasone,tendinopathy,nuclear receptor subfamily 3 group c member 1
3028,betamethasone,epicondylitis,nuclear receptor subfamily 3 group c member 1
3029,betamethasone,thyroiditis,nuclear receptor subfamily 3 group c member 1
3030,betamethasone,tinea pedis,nuclear receptor subfamily 3 group c member 1
3031,betamethasone,trichinellosis,nuclear receptor subfamily 3 group c member 1
3032,betamethasone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
3033,betamethasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
3034,betamethasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
3035,fluocinolone acetonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
3036,fluocinolone acetonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
3037,fluocinolone acetonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
3038,fluocinolone acetonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
3039,fluocinolone acetonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
3040,fluocinolone acetonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
3041,fluocinolone acetonide,exanthem,nuclear receptor subfamily 3 group c member 1
3042,fluocinolone acetonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3043,fluocinolone acetonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
3044,fluocinolone acetonide,choroiditis,nuclear receptor subfamily 3 group c member 1
3045,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
3046,eliglustat,gaucher disease,udp-glucose ceramide glucosyltransferase
3047,hydroxyurea,ovarian cancer,ribonucleotide reductase catalytic subunit m1
3048,hydroxyurea,head and neck neoplasm,ribonucleotide reductase catalytic subunit m1
3049,hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",ribonucleotide reductase catalytic subunit m1
3050,hydroxyurea,melanoma,ribonucleotide reductase catalytic subunit m1
3051,hydroxyurea,sickle cell anemia,ribonucleotide reductase catalytic subunit m1
3052,everolimus,renal cell carcinoma,mechanistic target of rapamycin kinase
3053,everolimus,breast neoplasm,mechanistic target of rapamycin kinase
3054,everolimus,sebaceous adenoma,mechanistic target of rapamycin kinase
3055,acetazolamide,absence epilepsy,carbonic anhydrase 2
3056,acetazolamide,open-angle glaucoma,carbonic anhydrase 1
3057,acetazolamide,open-angle glaucoma,carbonic anhydrase 14
3058,acetazolamide,open-angle glaucoma,carbonic anhydrase 3
3059,acetazolamide,open-angle glaucoma,carbonic anhydrase 2
3060,acetazolamide,open-angle glaucoma,carbonic anhydrase 4
3061,acetazolamide,open-angle glaucoma,carbonic anhydrase 7
3062,acetazolamide,open-angle glaucoma,carbonic anhydrase 12
3063,acetazolamide,edema,carbonic anhydrase 1
3064,acetazolamide,edema,carbonic anhydrase 14
3065,acetazolamide,edema,carbonic anhydrase 3
3066,acetazolamide,edema,carbonic anhydrase 2
3067,acetazolamide,edema,carbonic anhydrase 4
3068,acetazolamide,edema,carbonic anhydrase 7
3069,acetazolamide,edema,carbonic anhydrase 12
3070,acetazolamide,angle-closure glaucoma,carbonic anhydrase 1
3071,acetazolamide,angle-closure glaucoma,carbonic anhydrase 14
3072,acetazolamide,angle-closure glaucoma,carbonic anhydrase 3
3073,acetazolamide,angle-closure glaucoma,carbonic anhydrase 2
3074,acetazolamide,angle-closure glaucoma,carbonic anhydrase 4
3075,acetazolamide,angle-closure glaucoma,carbonic anhydrase 7
3076,acetazolamide,angle-closure glaucoma,carbonic anhydrase 12
3077,acetazolamide,altitude sickness,carbonic anhydrase 1
3078,acetazolamide,altitude sickness,carbonic anhydrase 14
3079,acetazolamide,altitude sickness,carbonic anhydrase 3
3080,acetazolamide,altitude sickness,carbonic anhydrase 2
3081,acetazolamide,altitude sickness,carbonic anhydrase 4
3082,acetazolamide,altitude sickness,carbonic anhydrase 7
3083,acetazolamide,altitude sickness,carbonic anhydrase 12
3084,diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 1
3085,diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 2
3086,diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 3
3087,acebutolol,hypertensive disorder,adrenoceptor beta 1
3088,dexamethasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
3089,dexamethasone,psoriasis,nuclear receptor subfamily 3 group c member 1
3090,dexamethasone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
3091,dexamethasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
3092,dexamethasone,crohn disease,nuclear receptor subfamily 3 group c member 1
3093,dexamethasone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
3094,dexamethasone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
3095,dexamethasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
3096,dexamethasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
3097,dexamethasone,keloid,nuclear receptor subfamily 3 group c member 1
3098,dexamethasone,keratitis,nuclear receptor subfamily 3 group c member 1
3099,dexamethasone,uveitis,nuclear receptor subfamily 3 group c member 1
3100,dexamethasone,bursitis,nuclear receptor subfamily 3 group c member 1
3101,dexamethasone,iritis,nuclear receptor subfamily 3 group c member 1
3102,dexamethasone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
3103,dexamethasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
3104,dexamethasone,asthma,nuclear receptor subfamily 3 group c member 1
3105,dexamethasone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
3106,dexamethasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
3107,dexamethasone,epicondylitis,nuclear receptor subfamily 3 group c member 1
3108,dexamethasone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
3109,dexamethasone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
3110,dexamethasone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
3111,dexamethasone,thyroiditis,nuclear receptor subfamily 3 group c member 1
3112,dexamethasone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
3113,dexamethasone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
3114,dexamethasone,pemphigus,nuclear receptor subfamily 3 group c member 1
3115,dexamethasone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3116,dexamethasone,trichinellosis,nuclear receptor subfamily 3 group c member 1
3117,dexamethasone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
3118,dexamethasone,otitis externa,nuclear receptor subfamily 3 group c member 1
3119,dexamethasone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
3120,dexamethasone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
3121,dexamethasone,rosacea,nuclear receptor subfamily 3 group c member 1
3122,dexamethasone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
3123,dexamethasone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
3124,dexamethasone,exanthem,nuclear receptor subfamily 3 group c member 1
3125,dexamethasone,anterior uveitis,nuclear receptor subfamily 3 group c member 1
3126,dexamethasone,gout,nuclear receptor subfamily 3 group c member 1
3127,dexamethasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
3128,dexamethasone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
3129,dexamethasone,burkitt lymphoma,nuclear receptor subfamily 3 group c member 1
3130,dexamethasone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
3131,dexamethasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
3132,dexamethasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3133,dexamethasone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
3134,dexamethasone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
3135,dexamethasone,diffuse large b-cell lymphoma,nuclear receptor subfamily 3 group c member 1
3136,dexamethasone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3137,dexamethasone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
3138,dexamethasone,serum sickness,nuclear receptor subfamily 3 group c member 1
3139,dexamethasone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3140,dexamethasone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
3141,dexamethasone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
3142,dexamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
3143,dexamethasone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3144,selumetinib,neurofibromatosis 1,structural maintenance of chromosomes 1a
3145,selumetinib,neurofibromatosis 1,structural maintenance of chromosomes 2
3146,selumetinib,neurofibromatosis 1,mitogen-activated protein kinase kinase 1
3147,selumetinib,neurofibromatosis 1,mitogen-activated protein kinase kinase 2
3148,ethinylestradiol,atrophic vulva,estrogen receptor 1
3149,ethinylestradiol,atrophic vulva,sex hormone binding globulin
3150,drospirenone,atrophic vulva,nuclear receptor subfamily 3 group c member 2
3151,drospirenone,atrophic vulva,progesterone receptor
3152,norethisterone,atrophic vulva,sex hormone binding globulin
3153,norethisterone,atrophic vulva,progesterone receptor
3154,norgestimate,atrophic vulva,estrogen receptor 1
3155,norgestimate,atrophic vulva,progesterone receptor
3156,estradiol valerate,atrophic vulva,estrogen related receptor beta
3157,estradiol valerate,atrophic vulva,estrogen receptor 1
3158,estradiol valerate,atrophic vulva,sex hormone binding globulin
3159,estradiol valerate,atrophic vulva,estrogen related receptor alpha
3160,ospemifene,atrophic vulva,estrogen receptor 1
3161,nizatidine,multiple endocrine neoplasia,histamine receptor h2
3162,duloxetine,generalized anxiety disorder,solute carrier family 6 member 4
3163,duloxetine,generalized anxiety disorder,solute carrier family 6 member 2
3164,duloxetine,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
3165,paroxetine,generalized anxiety disorder,solute carrier family 6 member 4
3166,paroxetine,generalized anxiety disorder,solute carrier family 6 member 2
3167,paroxetine,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
3168,pregabalin,generalized anxiety disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
3169,pregabalin,generalized anxiety disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 2
3170,escitalopram,generalized anxiety disorder,solute carrier family 6 member 4
3171,escitalopram,generalized anxiety disorder,solute carrier family 6 member 2
3172,buspirone,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
3173,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha5
3174,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha3
3175,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha2
3176,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha1
3177,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit gamma2
3178,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit beta2
3179,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit beta3
3180,venlafaxine,generalized anxiety disorder,solute carrier family 6 member 2
3181,venlafaxine,generalized anxiety disorder,solute carrier family 6 member 4
3182,desvenlafaxine,generalized anxiety disorder,solute carrier family 6 member 2
3183,desvenlafaxine,generalized anxiety disorder,solute carrier family 6 member 4
3184,citalopram,generalized anxiety disorder,solute carrier family 6 member 2
3185,citalopram,generalized anxiety disorder,solute carrier family 6 member 4
3186,hydroxychloroquine,plasmodium malariae malaria,toll like receptor 7
3187,hydroxychloroquine,plasmodium malariae malaria,toll like receptor 9
3188,hydroxychloroquine,plasmodium malariae malaria,transmembrane protein 97
3189,chloroquine,plasmodium malariae malaria,toll like receptor 9
3190,chloroquine,plasmodium malariae malaria,transmembrane protein 97
3191,biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
3192,biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 4
3193,benzatropine,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
3194,procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
3195,procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 4
3196,procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
3197,carbidopa,postencephalitic parkinson disease,dopa decarboxylase
3198,bromocriptine,postencephalitic parkinson disease,5-hydroxytryptamine receptor 6
3199,bromocriptine,postencephalitic parkinson disease,dopamine receptor d1
3200,levodopa,postencephalitic parkinson disease,dopa decarboxylase
3201,levodopa,postencephalitic parkinson disease,dopamine receptor d2
3202,levodopa,postencephalitic parkinson disease,dopamine receptor d1
3203,levodopa,postencephalitic parkinson disease,dopamine receptor d3
3204,amantadine,postencephalitic parkinson disease,dopa decarboxylase
3205,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2b
3206,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 3b
3207,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2c
3208,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2a
3209,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 1
3210,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2d
3211,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 3a
3212,dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3213,dextromethorphan,major depressive disorder,solute carrier family 6 member 4
3214,dextromethorphan,major depressive disorder,atp binding cassette subfamily b member 1
3215,dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3216,dextromethorphan,major depressive disorder,solute carrier family 6 member 2
3217,dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3218,vilazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3219,vilazodone,major depressive disorder,dopamine receptor d2
3220,vilazodone,major depressive disorder,5-hydroxytryptamine receptor 7
3221,mianserin,major depressive disorder,5-hydroxytryptamine receptor 6
3222,mianserin,major depressive disorder,solute carrier family 6 member 3
3223,mianserin,major depressive disorder,dopamine receptor d3
3224,mianserin,major depressive disorder,5-hydroxytryptamine receptor 2b
3225,mianserin,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3226,mianserin,major depressive disorder,5-hydroxytryptamine receptor 1a
3227,mianserin,major depressive disorder,5-hydroxytryptamine receptor 7
3228,mianserin,major depressive disorder,solute carrier family 6 member 4
3229,mianserin,major depressive disorder,5-hydroxytryptamine receptor 1d
3230,mianserin,major depressive disorder,dopamine receptor d2
3231,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 3a
3232,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 6
3233,olanzapine,major depressive disorder,dopamine receptor d3
3234,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 7
3235,olanzapine,major depressive disorder,dopamine receptor d4
3236,olanzapine,major depressive disorder,atp binding cassette subfamily b member 1
3237,olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3238,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1b
3239,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1a
3240,olanzapine,major depressive disorder,albumin
3241,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2b
3242,olanzapine,major depressive disorder,histamine receptor h1
3243,olanzapine,major depressive disorder,h1.0 linker histone
3244,olanzapine,major depressive disorder,adrenoceptor alpha 2c
3245,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2c
3246,olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3247,olanzapine,major depressive disorder,dopamine receptor d5
3248,olanzapine,major depressive disorder,adrenoceptor alpha 1a
3249,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1d
3250,olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3251,olanzapine,major depressive disorder,cholinergic receptor muscarinic 2
3252,olanzapine,major depressive disorder,adrenoceptor alpha 2a
3253,olanzapine,major depressive disorder,cholinergic receptor muscarinic 3
3254,paroxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3255,paroxetine,major depressive disorder,atp binding cassette subfamily b member 1
3256,paroxetine,major depressive disorder,cholinergic receptor muscarinic 3
3257,paroxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3258,paroxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3259,paroxetine,major depressive disorder,solute carrier family 6 member 3
3260,paroxetine,major depressive disorder,cholinergic receptor muscarinic 2
3261,paroxetine,major depressive disorder,solute carrier family 6 member 2
3262,paroxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
3263,paroxetine,major depressive disorder,adrenoceptor alpha 2a
3264,paroxetine,major depressive disorder,adrenoceptor alpha 1a
3265,ketamine,major depressive disorder,dopamine receptor d2
3266,ketamine,major depressive disorder,atp binding cassette subfamily b member 1
3267,ketamine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3268,ketamine,major depressive disorder,solute carrier family 6 member 2
3269,fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3270,fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3271,fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3272,fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3273,fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
3274,fluoxetine,major depressive disorder,albumin
3275,fluoxetine,major depressive disorder,solute carrier family 6 member 2
3276,fluoxetine,major depressive disorder,atp binding cassette subfamily b member 1
3277,fluoxetine,major depressive disorder,adrenoceptor alpha 2a
3278,fluoxetine,major depressive disorder,solute carrier family 6 member 3
3279,fluoxetine,major depressive disorder,histamine receptor h1
3280,fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2b
3281,fluoxetine,major depressive disorder,adrenoceptor alpha 1a
3282,fluoxetine,major depressive disorder,cholinergic receptor muscarinic 2
3283,fluoxetine,major depressive disorder,cholinergic receptor muscarinic 3
3284,bupropion,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3285,bupropion,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3286,bupropion,major depressive disorder,adrenoceptor alpha 1a
3287,bupropion,major depressive disorder,solute carrier family 6 member 4
3288,duloxetine,major depressive disorder,solute carrier family 6 member 3
3289,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3290,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 6
3291,duloxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3292,duloxetine,major depressive disorder,neuropeptide y receptor y1
3293,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
3294,duloxetine,major depressive disorder,adrenoceptor alpha 1a
3295,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 7
3296,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2b
3297,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1d
3298,duloxetine,major depressive disorder,cholinergic receptor muscarinic 2
3299,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
3300,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1b
3301,duloxetine,major depressive disorder,histamine receptor h1
3302,duloxetine,major depressive disorder,adrenoceptor alpha 2a
3303,selegiline,major depressive disorder,atp binding cassette subfamily b member 1
3304,selegiline,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3305,selegiline,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3306,selegiline,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3307,escitalopram,major depressive disorder,histamine receptor h1
3308,escitalopram,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3309,escitalopram,major depressive disorder,5-hydroxytryptamine receptor 2c
3310,escitalopram,major depressive disorder,solute carrier family 6 member 3
3311,escitalopram,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3312,escitalopram,major depressive disorder,adrenoceptor alpha 1a
3313,escitalopram,major depressive disorder,solute carrier family 6 member 2
3314,citalopram,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3315,citalopram,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3316,citalopram,major depressive disorder,solute carrier family 6 member 2
3317,citalopram,major depressive disorder,solute carrier family 6 member 3
3318,citalopram,major depressive disorder,atp binding cassette subfamily b member 1
3319,citalopram,major depressive disorder,adrenoceptor alpha 1a
3320,citalopram,major depressive disorder,histamine receptor h1
3321,citalopram,major depressive disorder,5-hydroxytryptamine receptor 2c
3322,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3323,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 6
3324,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 1b
3325,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 3a
3326,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
3327,vortioxetine,major depressive disorder,histamine receptor h1
3328,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 7
3329,vortioxetine,major depressive disorder,solute carrier family 6 member 4
3330,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
3331,nefazodone,major depressive disorder,atp binding cassette subfamily b member 1
3332,nefazodone,major depressive disorder,solute carrier family 6 member 3
3333,nefazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
3334,nefazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3335,nefazodone,major depressive disorder,adrenoceptor alpha 2a
3336,nefazodone,major depressive disorder,adrenoceptor alpha 1a
3337,nefazodone,major depressive disorder,dopamine receptor d2
3338,venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3339,venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3340,venlafaxine,major depressive disorder,neuropeptide y receptor y1
3341,venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3342,venlafaxine,major depressive disorder,atp binding cassette subfamily b member 1
3343,venlafaxine,major depressive disorder,adrenoceptor alpha 2a
3344,venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 6
3345,venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 2c
3346,venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 2a
3347,venlafaxine,major depressive disorder,cholinergic receptor muscarinic 2
3348,trazodone,major depressive disorder,histamine receptor h1
3349,trazodone,major depressive disorder,adrenoceptor alpha 2a
3350,trazodone,major depressive disorder,atp binding cassette subfamily b member 1
3351,trazodone,major depressive disorder,5-hydroxytryptamine receptor 2c
3352,trazodone,major depressive disorder,adrenoceptor alpha 1a
3353,trazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3354,trazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
3355,trazodone,major depressive disorder,5-hydroxytryptamine receptor 2b
3356,trazodone,major depressive disorder,5-hydroxytryptamine receptor 2a
3357,trazodone,major depressive disorder,solute carrier family 6 member 3
3358,trazodone,major depressive disorder,dopamine receptor d2
3359,trazodone,major depressive disorder,solute carrier family 6 member 2
3360,tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3361,tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3362,tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3363,tranylcypromine,major depressive disorder,solute carrier family 6 member 3
3364,tranylcypromine,major depressive disorder,solute carrier family 6 member 2
3365,tranylcypromine,major depressive disorder,5-hydroxytryptamine receptor 1a
3366,mirtazapine,major depressive disorder,solute carrier family 6 member 4
3367,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2c
3368,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 1a
3369,mirtazapine,major depressive disorder,dopamine receptor d2
3370,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2a
3371,mirtazapine,major depressive disorder,dopamine receptor d3
3372,mirtazapine,major depressive disorder,dopamine receptor d4
3373,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2b
3374,mirtazapine,major depressive disorder,adrenoceptor alpha 2c
3375,mirtazapine,major depressive disorder,adrenoceptor alpha 1a
3376,mirtazapine,major depressive disorder,histamine receptor h1
3377,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 3a
3378,mirtazapine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3379,mirtazapine,major depressive disorder,solute carrier family 6 member 2
3380,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 7
3381,mirtazapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3382,mirtazapine,major depressive disorder,adrenoceptor alpha 2a
3383,mirtazapine,major depressive disorder,solute carrier family 6 member 3
3384,gepirone,major depressive disorder,5-hydroxytryptamine receptor 2a
3385,gepirone,major depressive disorder,dopamine receptor d2
3386,hydroxocobalamin,methylmalonic acidemia,5-methyltetrahydrofolate-homocysteine methyltransferase
3387,hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated b
3388,hydroxocobalamin,methylmalonic acidemia,methylmalonyl-coa mutase
3389,hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated a
3390,hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated c
3391,hydroxocobalamin,methylmalonic acidemia,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
3392,sirolimus,lymphangioma,fkbp prolyl isomerase 1a
3393,sirolimus,lymphangioma,eukaryotic translation initiation factor 4e
3394,sirolimus,lymphangioma,fkbp prolyl isomerase 1b
3395,sirolimus,lymphangioma,fkbp prolyl isomerase 5
3396,nortriptyline,depressive disorder,histamine receptor h1
3397,nortriptyline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3398,nortriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3399,nortriptyline,depressive disorder,5-hydroxytryptamine receptor 1a
3400,nortriptyline,depressive disorder,5-hydroxytryptamine receptor 2c
3401,nortriptyline,depressive disorder,albumin
3402,nortriptyline,depressive disorder,5-hydroxytryptamine receptor 2a
3403,nortriptyline,depressive disorder,dopamine receptor d2
3404,nortriptyline,depressive disorder,cholinergic receptor muscarinic 2
3405,nortriptyline,depressive disorder,solute carrier family 6 member 3
3406,nortriptyline,depressive disorder,adrenoceptor alpha 2a
3407,trimipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3408,trimipramine,depressive disorder,solute carrier family 6 member 3
3409,trimipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3410,trimipramine,depressive disorder,solute carrier family 6 member 4
3411,trimipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3412,trimipramine,depressive disorder,5-hydroxytryptamine receptor 3a
3413,trimipramine,depressive disorder,5-hydroxytryptamine receptor 1a
3414,trimipramine,depressive disorder,adrenoceptor alpha 2b
3415,trimipramine,depressive disorder,atp binding cassette subfamily b member 1
3416,trimipramine,depressive disorder,solute carrier family 6 member 2
3417,trimipramine,depressive disorder,5-hydroxytryptamine receptor 1d
3418,trimipramine,depressive disorder,histamine receptor h1
3419,trimipramine,depressive disorder,adrenoceptor alpha 2a
3420,trimipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3421,trimipramine,depressive disorder,dopamine receptor d2
3422,amoxapine,depressive disorder,5-hydroxytryptamine receptor 2a
3423,amoxapine,depressive disorder,dopamine receptor d3
3424,amoxapine,depressive disorder,5-hydroxytryptamine receptor 2c
3425,amoxapine,depressive disorder,5-hydroxytryptamine receptor 3a
3426,amoxapine,depressive disorder,gamma-aminobutyric acid type a receptor subunit alpha1
3427,amoxapine,depressive disorder,solute carrier family 6 member 3
3428,amoxapine,depressive disorder,5-hydroxytryptamine receptor 1a
3429,amoxapine,depressive disorder,dopamine receptor d2
3430,amoxapine,depressive disorder,5-hydroxytryptamine receptor 1b
3431,amoxapine,depressive disorder,solute carrier family 6 member 2
3432,amoxapine,depressive disorder,histamine receptor h1
3433,amoxapine,depressive disorder,adrenoceptor alpha 2a
3434,amoxapine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3435,amoxapine,depressive disorder,5-hydroxytryptamine receptor 7
3436,amoxapine,depressive disorder,dopamine receptor d4
3437,fluvoxamine,depressive disorder,sigma non-opioid intracellular receptor 1
3438,fluvoxamine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3439,fluvoxamine,depressive disorder,solute carrier family 6 member 4
3440,fluvoxamine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3441,fluvoxamine,depressive disorder,solute carrier family 6 member 3
3442,fluvoxamine,depressive disorder,atp binding cassette subfamily b member 1
3443,fluvoxamine,depressive disorder,solute carrier family 6 member 2
3444,imipramine,depressive disorder,cholinergic receptor muscarinic 2
3445,imipramine,depressive disorder,histamine receptor h1
3446,imipramine,depressive disorder,dopamine receptor d2
3447,imipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3448,imipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3449,imipramine,depressive disorder,solute carrier family 6 member 3
3450,imipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3451,imipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3452,imipramine,depressive disorder,atp binding cassette subfamily b member 1
3453,imipramine,depressive disorder,5-hydroxytryptamine receptor 1a
3454,imipramine,depressive disorder,5-hydroxytryptamine receptor 7
3455,imipramine,depressive disorder,dopamine receptor d3
3456,imipramine,depressive disorder,adrenoceptor alpha 2a
3457,protriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3458,protriptyline,depressive disorder,atp binding cassette subfamily b member 1
3459,protriptyline,depressive disorder,solute carrier family 6 member 3
3460,fluoxetine,depressive disorder,5-hydroxytryptamine receptor 2a
3461,fluoxetine,depressive disorder,sigma non-opioid intracellular receptor 1
3462,fluoxetine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3463,fluoxetine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3464,fluoxetine,depressive disorder,5-hydroxytryptamine receptor 2c
3465,fluoxetine,depressive disorder,albumin
3466,fluoxetine,depressive disorder,solute carrier family 6 member 2
3467,fluoxetine,depressive disorder,atp binding cassette subfamily b member 1
3468,fluoxetine,depressive disorder,adrenoceptor alpha 2a
3469,fluoxetine,depressive disorder,solute carrier family 6 member 3
3470,fluoxetine,depressive disorder,histamine receptor h1
3471,fluoxetine,depressive disorder,cholinergic receptor muscarinic 2
3472,citalopram,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3473,citalopram,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3474,citalopram,depressive disorder,solute carrier family 6 member 2
3475,citalopram,depressive disorder,solute carrier family 6 member 3
3476,citalopram,depressive disorder,atp binding cassette subfamily b member 1
3477,citalopram,depressive disorder,histamine receptor h1
3478,citalopram,depressive disorder,5-hydroxytryptamine receptor 2c
3479,sertraline,depressive disorder,atp binding cassette subfamily b member 1
3480,sertraline,depressive disorder,sigma non-opioid intracellular receptor 1
3481,sertraline,depressive disorder,monoamine oxidase b
3482,sertraline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3483,sertraline,depressive disorder,solute carrier family 6 member 2
3484,sertraline,depressive disorder,solute carrier family 6 member 3
3485,sertraline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3486,sertraline,depressive disorder,monoamine oxidase a
3487,lofepramine,depressive disorder,dopamine receptor d2
3488,lofepramine,depressive disorder,cholinergic receptor muscarinic 2
3489,lofepramine,depressive disorder,solute carrier family 6 member 2
3490,lofepramine,depressive disorder,5-hydroxytryptamine receptor 2c
3491,lofepramine,depressive disorder,5-hydroxytryptamine receptor 1a
3492,lofepramine,depressive disorder,adrenoceptor alpha 2a
3493,lofepramine,depressive disorder,histamine receptor h1
3494,lofepramine,depressive disorder,solute carrier family 6 member 4
3495,moclobemide,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3496,moclobemide,depressive disorder,monoamine oxidase a
3497,moclobemide,depressive disorder,monoamine oxidase b
3498,moclobemide,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3499,moclobemide,depressive disorder,5-hydroxytryptamine receptor 1a
3500,clomipramine,depressive disorder,adrenoceptor alpha 2a
3501,clomipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3502,clomipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3503,clomipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3504,clomipramine,depressive disorder,solute carrier family 6 member 2
3505,clomipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3506,clomipramine,depressive disorder,atp binding cassette subfamily b member 1
3507,clomipramine,depressive disorder,solute carrier family 6 member 4
3508,clomipramine,depressive disorder,albumin
3509,clomipramine,depressive disorder,dopamine receptor d3
3510,clomipramine,depressive disorder,dopamine receptor d2
3511,clomipramine,depressive disorder,solute carrier family 6 member 3
3512,clomipramine,depressive disorder,dopamine receptor d1
3513,doxepin,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3514,doxepin,depressive disorder,adrenoceptor alpha 2a
3515,doxepin,depressive disorder,5-hydroxytryptamine receptor 2a
3516,doxepin,depressive disorder,5-hydroxytryptamine receptor 2c
3517,doxepin,depressive disorder,atp binding cassette subfamily b member 1
3518,doxepin,depressive disorder,solute carrier family 6 member 2
3519,doxepin,depressive disorder,adrenoceptor alpha 2c
3520,doxepin,depressive disorder,histamine receptor h1
3521,doxepin,depressive disorder,dopamine receptor d2
3522,doxepin,depressive disorder,adrenoceptor alpha 2b
3523,doxepin,depressive disorder,solute carrier family 6 member 4
3524,doxepin,depressive disorder,5-hydroxytryptamine receptor 1a
3525,doxepin,depressive disorder,cholinergic receptor muscarinic 2
3526,doxepin,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3527,desipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3528,desipramine,depressive disorder,cholinergic receptor muscarinic 2
3529,desipramine,depressive disorder,atp binding cassette subfamily b member 1
3530,desipramine,depressive disorder,5-hydroxytryptamine receptor 1a
3531,desipramine,depressive disorder,adrenoceptor beta 1
3532,desipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3533,desipramine,depressive disorder,dopamine receptor d2
3534,desipramine,depressive disorder,solute carrier family 6 member 3
3535,desipramine,depressive disorder,solute carrier family 6 member 4
3536,desipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3537,desipramine,depressive disorder,histamine receptor h1
3538,desipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3539,desipramine,depressive disorder,sphingomyelin phosphodiesterase 1
3540,desipramine,depressive disorder,dopamine receptor d1
3541,desipramine,depressive disorder,albumin
3542,desipramine,depressive disorder,adrenoceptor alpha 2a
3543,toloxatone,depressive disorder,monoamine oxidase b
3544,methylphenidate,depressive disorder,solute carrier family 6 member 4
3545,methylphenidate,depressive disorder,solute carrier family 6 member 3
3546,methylphenidate,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3547,methylphenidate,depressive disorder,solute carrier family 6 member 2
3548,paroxetine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3549,paroxetine,depressive disorder,tachykinin receptor 1
3550,paroxetine,depressive disorder,atp binding cassette subfamily b member 1
3551,paroxetine,depressive disorder,5-hydroxytryptamine receptor 2a
3552,paroxetine,depressive disorder,solute carrier family 6 member 3
3553,paroxetine,depressive disorder,cholinergic receptor muscarinic 2
3554,paroxetine,depressive disorder,solute carrier family 6 member 2
3555,paroxetine,depressive disorder,5-hydroxytryptamine receptor 1a
3556,paroxetine,depressive disorder,adrenoceptor alpha 2a
3557,paroxetine,depressive disorder,g protein-coupled receptor kinase 2
3558,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1a
3559,amitriptyline,depressive disorder,solute carrier family 6 member 4
3560,amitriptyline,depressive disorder,neurotrophic receptor tyrosine kinase 2
3561,amitriptyline,depressive disorder,albumin
3562,amitriptyline,depressive disorder,dopamine receptor d2
3563,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1d
3564,amitriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3565,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 2c
3566,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 2a
3567,amitriptyline,depressive disorder,opioid receptor mu 1
3568,amitriptyline,depressive disorder,opioid receptor kappa 1
3569,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1b
3570,amitriptyline,depressive disorder,atp binding cassette subfamily b member 1
3571,amitriptyline,depressive disorder,cholinergic receptor muscarinic 2
3572,amitriptyline,depressive disorder,histamine receptor h1
3573,amitriptyline,depressive disorder,dopamine receptor d3
3574,amitriptyline,depressive disorder,solute carrier family 6 member 2
3575,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 7
3576,amitriptyline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3577,amitriptyline,depressive disorder,sigma non-opioid intracellular receptor 1
3578,amitriptyline,depressive disorder,adrenoceptor alpha 2a
3579,amitriptyline,depressive disorder,solute carrier family 6 member 3
3580,amitriptyline,depressive disorder,dopamine receptor d1
3581,amitriptyline,depressive disorder,dopamine receptor d5
3582,bupropion,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3583,bupropion,depressive disorder,solute carrier family 6 member 4
3584,prednisolone,musculoskeletal system disorder,serpin family a member 6
3585,triamcinolone,musculoskeletal system disorder,serpin family a member 6
3586,cortisol,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3587,cortisol,musculoskeletal system disorder,sex hormone binding globulin
3588,cortisol,musculoskeletal system disorder,serpin family a member 6
3589,prednisone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3590,phenytoin,status epilepticus,atp binding cassette subfamily c member 2
3591,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 3
3592,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 1
3593,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 5
3594,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 2
3595,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 8
3596,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 4
3597,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 9
3598,levetiracetam,status epilepticus,calcium voltage-gated channel subunit alpha1 b
3599,levetiracetam,status epilepticus,atp binding cassette subfamily c member 2
3600,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
3601,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
3602,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma3
3603,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3604,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
3605,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
3606,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3607,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3608,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit delta
3609,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3610,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3611,secobarbital,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
3612,phenobarbital,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
3613,phenobarbital,status epilepticus,atp binding cassette subfamily c member 2
3614,phenobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3615,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3616,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
3617,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
3618,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
3619,pentobarbitone,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
3620,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3621,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
3622,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
3623,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3624,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
3625,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3626,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
3627,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit delta
3628,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma3
3629,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3630,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
3631,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
3632,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3633,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
3634,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
3635,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
3636,cortisol,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3637,cortisol,adrenocortical insufficiency,sex hormone binding globulin
3638,cortisol,adrenocortical insufficiency,serpin family a member 6
3639,triamcinolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3640,triamcinolone,adrenocortical insufficiency,serpin family a member 6
3641,prednisone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3642,betamethasone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3643,prednisolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3644,prednisolone,adrenocortical insufficiency,serpin family a member 6
3645,methylprednisolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3646,vasopressin,nocturnal enuresis,arginine vasopressin receptor 2
3647,medroxyprogesterone,precocious puberty,nuclear receptor subfamily 3 group c member 1
3648,progesterone,precocious puberty,nuclear receptor subfamily 3 group c member 1
3649,danazol,precocious puberty,gonadotropin releasing hormone receptor
3650,amiodarone,ventricular fibrillation,potassium voltage-gated channel subfamily h member 2
3651,"1,25-dihydroxyvitamin d3",hypophosphatemia,gc vitamin d binding protein
3652,"1,25-dihydroxyvitamin d3",hypophosphatemia,cytochrome p450 family 3 subfamily a member 4
3653,calcifediol,hypophosphatemia,vitamin d receptor
3654,calcifediol,hypophosphatemia,cytochrome p450 family 27 subfamily b member 1
3655,pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,solute carrier family 19 member 1
3656,biotin,nutritional biotin deficiency,solute carrier family 5 member 6
3657,biotin,nutritional biotin deficiency,holocarboxylase synthetase
3658,isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
3659,isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
3660,isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
3661,tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
3662,tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
3663,tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
3664,acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
3665,acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
3666,acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
3667,mometasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3668,prednisone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3669,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 6
3670,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
3671,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
3672,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 3
3673,bupropion,seasonal affective disorder,solute carrier family 6 member 4
3674,fluoxetine,seasonal affective disorder,5-hydroxytryptamine receptor 2a
3675,fluoxetine,seasonal affective disorder,solute carrier family 6 member 4
3676,fluoxetine,seasonal affective disorder,5-hydroxytryptamine receptor 2c
3677,fluoxetine,seasonal affective disorder,solute carrier family 6 member 2
3678,fluoxetine,seasonal affective disorder,solute carrier family 6 member 3
3679,sertraline,seasonal affective disorder,solute carrier family 6 member 4
3680,sertraline,seasonal affective disorder,solute carrier family 6 member 2
3681,sertraline,seasonal affective disorder,solute carrier family 6 member 3
3682,(-)-adrenaline,cardiac arrest,adrenoceptor beta 1
3683,(-)-adrenaline,cardiac arrest,adrenoceptor beta 2
3684,(-)-adrenaline,cardiac arrest,adrenoceptor beta 3
3685,(-)-adrenaline,cardiac arrest,tumor necrosis factor
3686,phenprocoumon,thrombotic disease,albumin
3687,warfarin,thrombotic disease,cytochrome p450 family 2 subfamily c member 19
3688,warfarin,thrombotic disease,albumin
3689,dicumarol,thrombotic disease,g protein-coupled receptor 35
3690,ceftriaxone,endometritis,synuclein alpha
3691,5-fluorouracil,small intestine cancer,thymidylate synthetase
3692,oxaliplatin,gastric cancer,glutathione s-transferase pi 1
3693,oxaliplatin,gastric cancer,metallothionein 2a
3694,oxaliplatin,gastric cancer,glutathione s-transferase theta 1
3695,oxaliplatin,gastric cancer,glutathione s-transferase mu 1
3696,tipiracil,gastric cancer,thymidine phosphorylase
3697,capecitabine,gastric cancer,thymidine phosphorylase
3698,capecitabine,gastric cancer,dihydropyrimidine dehydrogenase
3699,capecitabine,gastric cancer,thymidylate synthetase
3700,docetaxel,gastric cancer,epidermal growth factor receptor
3701,docetaxel,gastric cancer,tubulin beta 6 class v
3702,docetaxel,gastric cancer,tubulin beta 2b class iib
3703,docetaxel,gastric cancer,tubulin beta 2a class iia
3704,docetaxel,gastric cancer,tubulin beta class i
3705,docetaxel,gastric cancer,tubulin beta 3 class iii
3706,docetaxel,gastric cancer,tubulin beta 1 class vi
3707,docetaxel,gastric cancer,tubulin beta 4a class iva
3708,docetaxel,gastric cancer,tubulin beta 4b class ivb
3709,docetaxel,gastric cancer,tubulin beta 8 class viii
3710,5-fluorouracil,gastric cancer,cytochrome p450 family 2 subfamily a member 6
3711,5-fluorouracil,gastric cancer,thymidine phosphorylase
3712,5-fluorouracil,gastric cancer,albumin
3713,5-fluorouracil,gastric cancer,thymidylate synthetase
3714,5-fluorouracil,gastric cancer,methylenetetrahydrofolate reductase
3715,5-fluorouracil,gastric cancer,dihydropyrimidine dehydrogenase
3716,5-fluorouracil,gastric cancer,uridine monophosphate synthetase
3717,trifluridine,gastric cancer,thymidylate synthetase
3718,trifluridine,gastric cancer,thymidine phosphorylase
3719,ergocalciferol,osteomalacia,cytochrome p450 family 2 subfamily r member 1
3720,ergocalciferol,osteomalacia,vitamin d receptor
3721,ergocalciferol,osteomalacia,cytochrome p450 family 27 subfamily b member 1
3722,ceftriaxone,acute gonococcal cervicitis,synuclein alpha
3723,esomeprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
3724,pantoprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
3725,pantoprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
3726,cimetidine,gastric ulcer,solute carrier family 47 member 1
3727,lansoprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
3728,famotidine,gastric ulcer,solute carrier family 47 member 1
3729,fenoldopam,malignant essential hypertension,dopamine receptor d1
3730,5-fluorouracil,urinary bladder cancer,thymidine phosphorylase
3731,5-fluorouracil,urinary bladder cancer,thymidylate synthetase
3732,5-fluorouracil,urinary bladder cancer,methylenetetrahydrofolate reductase
3733,mitomycin c,urinary bladder cancer,cytochrome p450 oxidoreductase
3734,carboplatin,urinary bladder cancer,glutathione s-transferase theta 1
3735,carboplatin,urinary bladder cancer,metallothionein 1a
3736,carboplatin,urinary bladder cancer,nad(p)h quinone dehydrogenase 1
3737,carboplatin,urinary bladder cancer,metallothionein 2a
3738,carboplatin,urinary bladder cancer,myeloperoxidase
3739,carboplatin,urinary bladder cancer,glutathione s-transferase pi 1
3740,carboplatin,urinary bladder cancer,glutathione s-transferase mu 1
3741,gemcitabine,urinary bladder cancer,ribonucleotide reductase regulatory subunit m2
3742,gemcitabine,urinary bladder cancer,thymidylate synthetase
3743,prednisolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3744,prednisolone,acquired thrombocytopenia,serpin family a member 6
3745,prednisone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3746,methylprednisolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3747,betamethasone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3748,cortisol,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3749,cortisol,acquired thrombocytopenia,sex hormone binding globulin
3750,cortisol,acquired thrombocytopenia,serpin family a member 6
3751,triamcinolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3752,triamcinolone,acquired thrombocytopenia,serpin family a member 6
3753,"1,25-dihydroxyvitamin d3",hypoparathyroidism,gc vitamin d binding protein
3754,alfacalcidol,hypoparathyroidism,cytochrome p450 family 27 subfamily b member 1
3755,alfacalcidol,hypoparathyroidism,gc vitamin d binding protein
3756,alfacalcidol,hypoparathyroidism,vitamin d receptor
3757,ergocalciferol,hypoparathyroidism,vitamin d receptor
3758,ergocalciferol,hypoparathyroidism,cytochrome p450 family 27 subfamily b member 1
3759,sertraline,social phobia,solute carrier family 6 member 2
3760,sertraline,social phobia,solute carrier family 6 member 3
3761,desvenlafaxine,social phobia,solute carrier family 6 member 2
3762,desvenlafaxine,social phobia,solute carrier family 6 member 4
3763,desvenlafaxine,social phobia,solute carrier family 6 member 3
3764,fluvoxamine,social phobia,solute carrier family 6 member 3
3765,fluvoxamine,social phobia,solute carrier family 6 member 2
3766,paroxetine,social phobia,solute carrier family 6 member 3
3767,paroxetine,social phobia,solute carrier family 6 member 2
3768,ceftriaxone,streptococcal meningitis,synuclein alpha
3769,bimatoprost,hypertrichosis of eyelid,prostaglandin f receptor
3770,theophylline,bronchial disorder,phosphodiesterase 4c
3771,theophylline,bronchial disorder,phosphodiesterase 4a
3772,theophylline,bronchial disorder,phosphodiesterase 4d
3773,theophylline,bronchial disorder,phosphodiesterase 4b
3774,triamcinolone,thyroiditis,serpin family a member 6
3775,prednisone,thyroiditis,nuclear receptor subfamily 3 group c member 1
3776,cortisol,thyroiditis,nuclear receptor subfamily 3 group c member 1
3777,cortisol,thyroiditis,sex hormone binding globulin
3778,cortisol,thyroiditis,serpin family a member 6
3779,prednisolone,thyroiditis,serpin family a member 6
3780,duloxetine,female stress incontinence,solute carrier family 6 member 4
3781,duloxetine,female stress incontinence,solute carrier family 6 member 2
3782,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha3
3783,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit gamma2
3784,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha2
3785,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit beta3
3786,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha1
3787,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit beta2
3788,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha5
3789,lansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3790,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 5
3791,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 4
3792,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 2
3793,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 3
3794,pantoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3795,rabeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3796,esomeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3797,atropine,peptic ulcer disease,cholinergic receptor muscarinic 5
3798,atropine,peptic ulcer disease,cholinergic receptor muscarinic 4
3799,atropine,peptic ulcer disease,cholinergic receptor muscarinic 3
3800,atropine,peptic ulcer disease,cholinergic receptor muscarinic 2
3801,atropine,peptic ulcer disease,cholinergic receptor muscarinic 1
3802,ceftriaxone,acute gonococcal endometritis,synuclein alpha
3803,ceftriaxone,gonorrhea,synuclein alpha
3804,diazoxide,hyperinsulinism,atp binding cassette subfamily c member 8
3805,magnesium sulfate,constipation disorder,calcium voltage-gated channel subunit alpha1 s
3806,magnesium sulfate,constipation disorder,calcium voltage-gated channel subunit alpha1 c
3807,olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase 2
3808,olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase 1
3809,olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase family member 4
3810,olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase family member 3
3811,nizatidine,dyspepsia,histamine receptor h2
3812,lovastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
3813,simvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
3814,cortisol,blepharoconjunctivitis,nuclear receptor subfamily 3 group c member 1
3815,cortisol,blepharoconjunctivitis,sex hormone binding globulin
3816,cortisol,blepharoconjunctivitis,serpin family a member 6
3817,prednisolone,blepharoconjunctivitis,nuclear receptor subfamily 3 group c member 1
3818,prednisolone,blepharoconjunctivitis,serpin family a member 6
3819,cromoglicic acid,vernal conjunctivitis,g protein-coupled receptor 35
3820,cinnarizine,central nervous system origin vertigo,calcium voltage-gated channel subunit alpha1 c
3821,cinnarizine,central nervous system origin vertigo,calcium voltage-gated channel subunit alpha1 g
3822,everolimus,sebaceous adenoma,fkbp prolyl isomerase 1a
3823,sirolimus,sebaceous adenoma,fkbp prolyl isomerase 1a
3824,sirolimus,sebaceous adenoma,eukaryotic translation initiation factor 4e
3825,sirolimus,sebaceous adenoma,mechanistic target of rapamycin kinase
3826,sirolimus,sebaceous adenoma,fkbp prolyl isomerase 1b
3827,sirolimus,sebaceous adenoma,fkbp prolyl isomerase 5
3828,indomethacin,synovitis,c-x-c motif chemokine ligand 8
3829,indomethacin,synovitis,aldo-keto reductase family 1 member c3
3830,betamethasone,synovitis,prostaglandin-endoperoxide synthase 2
3831,betamethasone,synovitis,nuclear receptor subfamily 3 group c member 1
3832,triamcinolone,synovitis,prostaglandin-endoperoxide synthase 2
3833,triamcinolone,synovitis,serpin family a member 6
3834,cortisol,synovitis,nuclear receptor subfamily 3 group c member 1
3835,cortisol,synovitis,sex hormone binding globulin
3836,cortisol,synovitis,serpin family a member 6
3837,prednisolone,synovitis,serpin family a member 6
3838,lidocaine,dermatitis,epidermal growth factor receptor
3839,clobetasol propionate,dermatitis,nuclear receptor subfamily 3 group c member 1
3840,cortisol,dermatitis,nuclear receptor subfamily 3 group c member 1
3841,tandospirone,bruxism,5-hydroxytryptamine receptor 1a
3842,tandospirone,bruxism,dopamine receptor d4
3843,progesterone,endometrial carcinoma,progesterone receptor
3844,progesterone,endometrial carcinoma,sex hormone binding globulin
3845,progesterone,endometrial carcinoma,estrogen receptor 1
3846,progesterone,endometrial carcinoma,serpin family a member 6
3847,paclitaxel,endometrial carcinoma,cytochrome p450 family 19 subfamily a member 1
3848,tamoxifen,endometrial carcinoma,estrogen receptor 2
3849,tamoxifen,endometrial carcinoma,cytochrome p450 family 19 subfamily a member 1
3850,tamoxifen,endometrial carcinoma,estrogen receptor 1
3851,megestrol,endometrial carcinoma,progesterone receptor
3852,lenvatinib,endometrial carcinoma,kinase insert domain receptor
3853,lenvatinib,endometrial carcinoma,receptor interacting serine/threonine kinase 2
3854,lenvatinib,endometrial carcinoma,ret proto-oncogene
3855,medroxyprogesterone,endometrial carcinoma,aldo-keto reductase family 1 member c3
3856,medroxyprogesterone,endometrial carcinoma,sex hormone binding globulin
3857,medroxyprogesterone,endometrial carcinoma,progesterone receptor
3858,medroxyprogesterone,endometrial carcinoma,estrogen receptor 1
3859,triamcinolone,bursitis,prostaglandin-endoperoxide synthase 2
3860,triamcinolone,bursitis,serpin family a member 6
3861,etodolac,bursitis,prostaglandin-endoperoxide synthase 1
3862,etodolac,bursitis,prostaglandin-endoperoxide synthase 2
3863,prednisolone,bursitis,serpin family a member 6
3864,naproxen,bursitis,aldo-keto reductase family 1 member c3
3865,indomethacin,bursitis,c-x-c motif chemokine ligand 8
3866,indomethacin,bursitis,aldo-keto reductase family 1 member c3
3867,diclofenac,bursitis,prostaglandin-endoperoxide synthase 2
3868,diclofenac,bursitis,prostaglandin-endoperoxide synthase 1
3869,diclofenac,bursitis,c-x-c motif chemokine ligand 8
3870,cortisol,bursitis,nuclear receptor subfamily 3 group c member 1
3871,cortisol,bursitis,sex hormone binding globulin
3872,cortisol,bursitis,serpin family a member 6
3873,betamethasone,bursitis,prostaglandin-endoperoxide synthase 2
3874,carmustine,brain glioblastoma,glutathione-disulfide reductase
3875,chlorhexidine,gingivitis,solute carrier family 47 member 1
3876,chlorhexidine,gingivitis,solute carrier family 22 member 1
3877,chlorhexidine,gingivitis,solute carrier family 47 member 2
3878,chlorhexidine,gingivitis,solute carrier family 22 member 3
3879,chlorhexidine,gingivitis,solute carrier family 22 member 2
3880,pexidartinib,tenosynovial giant cell tumor,protein kinase c theta
3881,betamethasone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3882,cortisol,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3883,cortisol,aspiration pneumonitis,sex hormone binding globulin
3884,cortisol,aspiration pneumonitis,serpin family a member 6
3885,triamcinolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3886,triamcinolone,aspiration pneumonitis,serpin family a member 6
3887,methylprednisolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3888,prednisolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3889,prednisolone,aspiration pneumonitis,serpin family a member 6
3890,ifosfamide,bone osteosarcoma,cytochrome p450 family 3 subfamily a member 4
3891,epirubicin,bone osteosarcoma,dna topoisomerase ii alpha
3892,etoposide,bone osteosarcoma,glutathione s-transferase pi 1
3893,etoposide,bone osteosarcoma,dna topoisomerase ii alpha
3894,etoposide,bone osteosarcoma,cytochrome p450 family 3 subfamily a member 4
3895,floxuridine,liver cancer,thymidylate synthetase
3896,prednisolone,pulmonary fibrosis,serpin family a member 6
3897,butenafine,dermatophytosis of groin and perianal area,squalene epoxidase
3898,betamethasone,dermatophytosis of groin and perianal area,nuclear receptor subfamily 3 group c member 1
3899,clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
3900,clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 17 subfamily a member 1
3901,clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 51 subfamily a member 1
3902,clotrimazole,dermatophytosis of groin and perianal area,potassium calcium-activated channel subfamily n member 4
3903,cortisol,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 2
3904,cortisol,dermatophytosis of groin and perianal area,nuclear receptor subfamily 3 group c member 1
3905,cortisol,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
3906,cortisol,dermatophytosis of groin and perianal area,sex hormone binding globulin
3907,cortisol,dermatophytosis of groin and perianal area,serpin family a member 6
3908,miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 51 subfamily a member 1
3909,miconazole,dermatophytosis of groin and perianal area,potassium calcium-activated channel subfamily n member 4
3910,miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 17 subfamily a member 1
3911,miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
3912,ethinylestradiol,postmenopausal atrophic vaginitis,estrogen receptor 2
3913,medroxyprogesterone,postmenopausal atrophic vaginitis,progesterone receptor
3914,medroxyprogesterone,postmenopausal atrophic vaginitis,estrogen receptor 1
3915,norgestimate,postmenopausal atrophic vaginitis,estrogen receptor 1
3916,norgestimate,postmenopausal atrophic vaginitis,progesterone receptor
3917,norethisterone,postmenopausal atrophic vaginitis,progesterone receptor
3918,progesterone,postmenopausal atrophic vaginitis,progesterone receptor
3919,progesterone,postmenopausal atrophic vaginitis,estrogen receptor 1
3920,butenafine,tinea corporis,squalene epoxidase
3921,cortisol,tinea corporis,cytochrome p450 family 11 subfamily b member 2
3922,cortisol,tinea corporis,nuclear receptor subfamily 3 group c member 1
3923,cortisol,tinea corporis,cytochrome p450 family 11 subfamily b member 1
3924,cortisol,tinea corporis,sex hormone binding globulin
3925,cortisol,tinea corporis,serpin family a member 6
3926,betamethasone,tinea corporis,nuclear receptor subfamily 3 group c member 1
3927,clotrimazole,tinea corporis,cytochrome p450 family 11 subfamily b member 1
3928,clotrimazole,tinea corporis,cytochrome p450 family 17 subfamily a member 1
3929,clotrimazole,tinea corporis,cytochrome p450 family 51 subfamily a member 1
3930,clotrimazole,tinea corporis,potassium calcium-activated channel subfamily n member 4
3931,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 11
3932,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 5
3933,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 10
3934,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 9
3935,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 3
3936,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 7
3937,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 2
3938,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 8
3939,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 1
3940,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 4
3941,miconazole,tinea corporis,cytochrome p450 family 51 subfamily a member 1
3942,miconazole,tinea corporis,potassium calcium-activated channel subfamily n member 4
3943,miconazole,tinea corporis,cytochrome p450 family 17 subfamily a member 1
3944,miconazole,tinea corporis,cytochrome p450 family 11 subfamily b member 1
3945,loteprednol etabonate,punctate epithelial keratoconjunctivitis,nuclear receptor subfamily 3 group c member 1
3946,ethacrynic acid,hypercalcemia disease,solute carrier family 12 member 1
3947,bumetanide,hypercalcemia disease,solute carrier family 12 member 1
3948,furosemide,hypercalcemia disease,solute carrier family 12 member 1
3949,danazol,gynecomastia disorder,androgen receptor
3950,danazol,gynecomastia disorder,cytochrome p450 family 19 subfamily a member 1
3951,danazol,gynecomastia disorder,gonadotropin releasing hormone receptor
3952,chloroquine,plasmodium ovale malaria,toll like receptor 9
3953,chloroquine,plasmodium ovale malaria,transmembrane protein 97
3954,hydroxychloroquine,plasmodium ovale malaria,toll like receptor 7
3955,hydroxychloroquine,plasmodium ovale malaria,toll like receptor 9
3956,hydroxychloroquine,plasmodium ovale malaria,transmembrane protein 97
3957,morphine,diarrheal disease,opioid receptor mu 1
3958,morphine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3959,clonidine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3960,clonidine,diarrheal disease,solute carrier family 22 member 5
3961,diphenoxylate,diarrheal disease,opioid receptor mu 1
3962,difenoxin,diarrheal disease,opioid receptor mu 1
3963,loperamide,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3964,loperamide,diarrheal disease,calcium voltage-gated channel subunit alpha1 a
3965,codeine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3966,codeine,diarrheal disease,opioid receptor mu 1
3967,alfacalcidol,hyperparathyroidism,cytochrome p450 family 27 subfamily b member 1
3968,alfacalcidol,hyperparathyroidism,vitamin d receptor
3969,diclofenamide,angle-closure glaucoma,carbonic anhydrase 14
3970,diclofenamide,angle-closure glaucoma,carbonic anhydrase 3
3971,acetazolamide,angle-closure glaucoma,carbonic anhydrase 11
3972,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 2
3973,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 3
3974,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 5
3975,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 1
3976,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 2
3977,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 3
3978,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 4
3979,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 2
3980,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 9
3981,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 3
3982,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 5
3983,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 10
3984,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 4
3985,ceftriaxone,chancroid,synuclein alpha
3986,flibanserin,hypoactive sexual desire disorder,5-hydroxytryptamine receptor 1a
3987,lisuride,amenorrhea,5-hydroxytryptamine receptor 2b
3988,lisuride,amenorrhea,dopamine receptor d4
3989,lisuride,amenorrhea,dopamine receptor d5
3990,norethisterone,amenorrhea,sex hormone binding globulin
3991,ethinylestradiol,amenorrhea,sex hormone binding globulin
3992,desogestrel,amenorrhea,sex hormone binding globulin
3993,estradiol valerate,amenorrhea,sex hormone binding globulin
3994,estrone,amenorrhea,sex hormone binding globulin
3995,triamcinolone,epicondylitis,serpin family a member 6
3996,prednisolone,epicondylitis,serpin family a member 6
3997,prednisone,epicondylitis,nuclear receptor subfamily 3 group c member 1
3998,(-)-adrenaline,toxic shock syndrome,tumor necrosis factor
3999,clomiphene,oligospermia,estrogen receptor 1
4000,ceftriaxone,rhinoscleroma,synuclein alpha
4001,ivermectin,strongyloidiasis,glycine receptor alpha 3
4002,betamethasone,tinea pedis,prostaglandin-endoperoxide synthase 2
4003,sertaconazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
4004,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 11
4005,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 5
4006,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 9
4007,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 3
4008,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 7
4009,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 2
4010,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 8
4011,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 1
4012,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 4
4013,cortisol,tinea pedis,cytochrome p450 family 11 subfamily b member 2
4014,cortisol,tinea pedis,cytochrome p450 family 11 subfamily b member 1
4015,cortisol,tinea pedis,sex hormone binding globulin
4016,cortisol,tinea pedis,serpin family a member 6
4017,miconazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
4018,miconazole,tinea pedis,potassium calcium-activated channel subfamily n member 4
4019,miconazole,tinea pedis,cytochrome p450 family 17 subfamily a member 1
4020,miconazole,tinea pedis,cytochrome p450 family 11 subfamily b member 1
4021,clotrimazole,tinea pedis,cytochrome p450 family 11 subfamily b member 1
4022,clotrimazole,tinea pedis,cytochrome p450 family 17 subfamily a member 1
4023,clotrimazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
4024,clotrimazole,tinea pedis,potassium calcium-activated channel subfamily n member 4
4025,azelastine,vasomotor rhinitis,adrenoceptor alpha 1b
4026,azelastine,vasomotor rhinitis,adrenoceptor alpha 1a
4027,dextromethorphan,vasomotor rhinitis,solute carrier family 6 member 2
4028,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 4
4029,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 5
4030,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 2
4031,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 3
4032,promethazine,vasomotor rhinitis,adrenoceptor alpha 1a
4033,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 1
4034,chlorpheniramine,vasomotor rhinitis,solute carrier family 6 member 2
4035,pseudoephedrine,vasomotor rhinitis,adrenoceptor alpha 2a
4036,pseudoephedrine,vasomotor rhinitis,solute carrier family 6 member 2
4037,pseudoephedrine,vasomotor rhinitis,adrenoceptor beta 2
4038,ephedrine,vasomotor rhinitis,solute carrier family 6 member 2
4039,ephedrine,vasomotor rhinitis,adrenoceptor beta 2
4040,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 1
4041,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 5
4042,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 2
4043,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 3
4044,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 4
4045,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 2
4046,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 4
4047,diphenhydramine,vasomotor rhinitis,solute carrier family 6 member 2
4048,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 1
4049,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 5
4050,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 3
4051,beclometasone,vasomotor rhinitis,nuclear receptor subfamily 3 group c member 1
4052,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 4
4053,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 2
4054,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 5
4055,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 3
4056,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 1
4057,clemastine,vasomotor rhinitis,adrenoceptor alpha 2a
4058,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 4
4059,clemastine,vasomotor rhinitis,transmembrane protein 97
4060,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 3
4061,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 5
4062,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 1
4063,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 2
4064,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 2a
4065,doxylamine,vasomotor rhinitis,cholinergic receptor muscarinic 1
4066,imiquimod,superficial multifocal basal cell carcinoma,toll like receptor 7
4067,5-fluorouracil,superficial multifocal basal cell carcinoma,thymidylate synthetase
4068,paclitaxel,cervical cancer,tubulin beta class i
4069,5-fluorouracil,cervical cancer,methylenetetrahydrofolate reductase
4070,topotecan,cervical cancer,dna topoisomerase i mitochondrial
4071,spironolactone,hyperaldosteronism,nuclear receptor subfamily 3 group c member 1
4072,spironolactone,hyperaldosteronism,cytochrome p450 family 11 subfamily b member 2
4073,spironolactone,hyperaldosteronism,cytochrome p450 family 11 subfamily b member 1
4074,dextromethorphan,rhinitis,opioid receptor mu 1
4075,dextromethorphan,rhinitis,solute carrier family 6 member 2
4076,beclometasone,rhinitis,nuclear receptor subfamily 3 group c member 1
4077,hydrocodone,rhinitis,opioid receptor mu 1
4078,ephedrine,rhinitis,adrenoceptor alpha 1a
4079,ephedrine,rhinitis,solute carrier family 6 member 2
4080,ephedrine,rhinitis,adrenoceptor beta 2
4081,pseudoephedrine,rhinitis,solute carrier family 6 member 2
4082,pseudoephedrine,rhinitis,adrenoceptor beta 2
4083,codeine,rhinitis,opioid receptor mu 1
4084,triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit beta
4085,triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit gamma
4086,triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit alpha
4087,cortisol,keratitis,annexin a1
4088,cortisol,keratitis,sex hormone binding globulin
4089,cortisol,keratitis,serpin family a member 6
4090,prednisolone,keratitis,serpin family a member 6
4091,propylthiouracil,hyperthyroidism,iodothyronine deiodinase 1
4092,carbimazole,hyperthyroidism,thyroid peroxidase
4093,lidocaine,scabies,sodium voltage-gated channel alpha subunit 2
4094,lidocaine,scabies,sodium voltage-gated channel alpha subunit 3
4095,lidocaine,scabies,sodium voltage-gated channel alpha subunit 4
4096,everolimus,kidney angiomyolipoma,fkbp prolyl isomerase 1a
4097,fluorometholone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
4098,fluorometholone,corneal ulcer,serpin family a member 6
4099,prednisolone,corneal ulcer,serpin family a member 6
4100,cortisol,corneal ulcer,sex hormone binding globulin
4101,cortisol,corneal ulcer,serpin family a member 6
4102,mupirocin,impetigo,isoleucyl-trna synthetase 1
4103,ceftriaxone,bacterial pneumonia,synuclein alpha
4104,hydroxocobalamin,homocystinuria,5-methyltetrahydrofolate-homocysteine methyltransferase
4105,hydroxocobalamin,homocystinuria,metabolism of cobalamin associated a
4106,hydroxocobalamin,homocystinuria,metabolism of cobalamin associated c
4107,hydroxocobalamin,homocystinuria,methylenetetrahydrofolate reductase
4108,hydroxocobalamin,homocystinuria,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
4109,montelukast,intrinsic asthma,cysteinyl leukotriene receptor 1
4110,montelukast,intrinsic asthma,arachidonate 5-lipoxygenase
4111,mometasone,intrinsic asthma,nuclear receptor subfamily 3 group c member 1
4112,salmeterol,intrinsic asthma,adrenoceptor beta 2
4113,fluticasone,intrinsic asthma,nuclear receptor subfamily 3 group c member 1
4114,zileuton,intrinsic asthma,arachidonate 5-lipoxygenase
4115,zileuton,intrinsic asthma,epoxide hydrolase 2
4116,formoterol,intrinsic asthma,adrenoceptor beta 2
4117,fluorometholone,iridocyclitis,serpin family a member 6
4118,cortisol,iridocyclitis,sex hormone binding globulin
4119,cortisol,iridocyclitis,serpin family a member 6
4120,prednisolone,iridocyclitis,serpin family a member 6
4121,fluticasone,allergic asthma,nuclear receptor subfamily 3 group c member 1
4122,montelukast,allergic asthma,cysteinyl leukotriene receptor 1
4123,montelukast,allergic asthma,arachidonate 5-lipoxygenase
4124,formoterol,allergic asthma,adrenoceptor beta 2
4125,zileuton,allergic asthma,arachidonate 5-lipoxygenase
4126,zileuton,allergic asthma,epoxide hydrolase 2
4127,mometasone,allergic asthma,nuclear receptor subfamily 3 group c member 1
4128,salmeterol,allergic asthma,adrenoceptor beta 2
4129,fluorometholone,otitis externa,nuclear receptor subfamily 3 group c member 1
4130,fluorometholone,otitis externa,serpin family a member 6
4131,prednisolone,otitis externa,nuclear receptor subfamily 3 group c member 1
4132,prednisolone,otitis externa,serpin family a member 6
4133,cortisol,otitis externa,sex hormone binding globulin
4134,cortisol,otitis externa,serpin family a member 6
4135,(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 2a
4136,(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 2b
4137,(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 1b
4138,(-)-noradrenaline,bronchiectasis,adrenoceptor beta 1
4139,(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 1a
4140,(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 2c
4141,(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 1d
4142,terbutaline,bronchiectasis,adrenoceptor beta 2
4143,terbutaline,bronchiectasis,adrenoceptor beta 1
4144,(-)-adrenaline,bronchiectasis,tumor necrosis factor
4145,(-)-adrenaline,bronchiectasis,adrenoceptor alpha 2c
4146,5-fluorouracil,oral mucosa leukoplakia,thymidylate synthetase
4147,formoterol,pulmonary emphysema,cytochrome p450 family 2 subfamily a member 6
4148,formoterol,pulmonary emphysema,adrenoceptor beta 1
4149,formoterol,pulmonary emphysema,adrenoceptor beta 3
4150,(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 2a
4151,(-)-noradrenaline,pulmonary emphysema,adrenoceptor beta 3
4152,(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 2b
4153,(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 1b
4154,(-)-noradrenaline,pulmonary emphysema,adrenoceptor beta 1
4155,(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 1a
4156,(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 2c
4157,(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 1d
4158,(-)-adrenaline,pulmonary emphysema,adrenoceptor beta 3
4159,(-)-adrenaline,pulmonary emphysema,tumor necrosis factor
4160,(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 2c
4161,salmeterol,pulmonary emphysema,adrenoceptor beta 3
4162,salmeterol,pulmonary emphysema,adrenoceptor beta 1
4163,dyphylline,pulmonary emphysema,adenosine a1 receptor
4164,dyphylline,pulmonary emphysema,adenosine a2a receptor
4165,dyphylline,pulmonary emphysema,phosphodiesterase 3a
4166,terbutaline,pulmonary emphysema,adrenoceptor beta 1
4167,theophylline,pulmonary emphysema,adenosine a2a receptor
4168,theophylline,pulmonary emphysema,adenosine a2b receptor
4169,theophylline,pulmonary emphysema,phosphodiesterase 4c
4170,theophylline,pulmonary emphysema,phosphodiesterase 4a
4171,theophylline,pulmonary emphysema,phosphodiesterase 3a
4172,theophylline,pulmonary emphysema,phosphodiesterase 4d
4173,theophylline,pulmonary emphysema,phosphodiesterase 4b
4174,theophylline,pulmonary emphysema,adenosine a1 receptor
4175,theophylline,pulmonary emphysema,adenosine a3 receptor
4176,cortisol,tenosynovitis,sex hormone binding globulin
4177,cortisol,tenosynovitis,serpin family a member 6
4178,indomethacin,tenosynovitis,c-x-c motif chemokine ligand 8
4179,indomethacin,tenosynovitis,aldo-keto reductase family 1 member c3
4180,diclofenac,tenosynovitis,prostaglandin-endoperoxide synthase 2
4181,diclofenac,tenosynovitis,prostaglandin-endoperoxide synthase 1
4182,diclofenac,tenosynovitis,c-x-c motif chemokine ligand 8
4183,betamethasone,tenosynovitis,prostaglandin-endoperoxide synthase 2
4184,betamethasone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
4185,triamcinolone,tenosynovitis,prostaglandin-endoperoxide synthase 2
4186,triamcinolone,tenosynovitis,serpin family a member 6
4187,salicylic acid,tenosynovitis,prostaglandin-endoperoxide synthase 1
4188,salicylic acid,tenosynovitis,prostaglandin-endoperoxide synthase 2
4189,prednisolone,tenosynovitis,serpin family a member 6
4190,betamethasone,tendinitis,prostaglandin-endoperoxide synthase 2
4191,betamethasone,tendinitis,nuclear receptor subfamily 3 group c member 1
4192,sulindac,tendinitis,prostaglandin-endoperoxide synthase 1
4193,sulindac,tendinitis,prostaglandin-endoperoxide synthase 2
4194,triamcinolone,tendinitis,nuclear receptor subfamily 3 group c member 1
4195,triamcinolone,tendinitis,prostaglandin-endoperoxide synthase 2
4196,triamcinolone,tendinitis,serpin family a member 6
4197,salicylic acid,tendinitis,prostaglandin-endoperoxide synthase 1
4198,salicylic acid,tendinitis,prostaglandin-endoperoxide synthase 2
4199,diclofenac,tendinitis,prostaglandin-endoperoxide synthase 2
4200,diclofenac,tendinitis,prostaglandin-endoperoxide synthase 1
4201,diclofenac,tendinitis,c-x-c motif chemokine ligand 8
4202,cortisol,tendinitis,nuclear receptor subfamily 3 group c member 1
4203,cortisol,tendinitis,sex hormone binding globulin
4204,cortisol,tendinitis,serpin family a member 6
4205,methylprednisolone,tendinitis,nuclear receptor subfamily 3 group c member 1
4206,naproxen,tendinitis,prostaglandin-endoperoxide synthase 1
4207,naproxen,tendinitis,aldo-keto reductase family 1 member c3
4208,naproxen,tendinitis,prostaglandin-endoperoxide synthase 2
4209,indomethacin,tendinitis,c-x-c motif chemokine ligand 8
4210,indomethacin,tendinitis,prostaglandin-endoperoxide synthase 1
4211,indomethacin,tendinitis,prostaglandin-endoperoxide synthase 2
4212,indomethacin,tendinitis,aldo-keto reductase family 1 member c3
4213,prednisolone,tendinitis,nuclear receptor subfamily 3 group c member 1
4214,prednisolone,tendinitis,serpin family a member 6
4215,etodolac,tendinitis,prostaglandin-endoperoxide synthase 1
4216,etodolac,tendinitis,prostaglandin-endoperoxide synthase 2
4217,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 2
4218,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 3
4219,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 4
4220,cortisol,hemorrhoid,nuclear receptor subfamily 3 group c member 1
4221,cortisol,hemorrhoid,sex hormone binding globulin
4222,cortisol,hemorrhoid,serpin family a member 6
4223,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 2
4224,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 9
4225,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 3
4226,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 5
4227,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 10
4228,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 4
4229,terbutaline,bronchitis,adrenoceptor beta 1
4230,theophylline,bronchitis,adenosine a2a receptor
4231,theophylline,bronchitis,adenosine a2b receptor
4232,theophylline,bronchitis,phosphodiesterase 4a
4233,theophylline,bronchitis,phosphodiesterase 3a
4234,theophylline,bronchitis,phosphodiesterase 4b
4235,theophylline,bronchitis,adenosine a1 receptor
4236,theophylline,bronchitis,adenosine a3 receptor
4237,ephedrine,bronchitis,adrenoceptor alpha 1a
4238,minocycline,bronchitis,vascular endothelial growth factor a
4239,methylprednisolone,bronchitis,nuclear receptor subfamily 3 group c member 1
4240,betamethasone,bronchitis,nuclear receptor subfamily 3 group c member 1
4241,prednisolone,bronchitis,nuclear receptor subfamily 3 group c member 1
4242,(-)-noradrenaline,bronchitis,adrenoceptor alpha 2a
4243,(-)-noradrenaline,bronchitis,adrenoceptor beta 3
4244,(-)-noradrenaline,bronchitis,adrenoceptor alpha 2b
4245,(-)-noradrenaline,bronchitis,adrenoceptor alpha 1b
4246,(-)-noradrenaline,bronchitis,adrenoceptor beta 1
4247,(-)-noradrenaline,bronchitis,adrenoceptor alpha 1a
4248,(-)-noradrenaline,bronchitis,adrenoceptor alpha 2c
4249,(-)-noradrenaline,bronchitis,adrenoceptor alpha 1d
4250,(-)-adrenaline,bronchitis,adrenoceptor beta 3
4251,(-)-adrenaline,bronchitis,adrenoceptor alpha 2c
4252,triamcinolone,bronchitis,nuclear receptor subfamily 3 group c member 1
4253,betahistine,meniere disease,histamine receptor h3
4254,betahistine,meniere disease,histamine receptor h1
4255,cinnarizine,motion sickness,calcium voltage-gated channel subunit alpha1 c
4256,clotrimazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
4257,clotrimazole,vulvovaginal candidiasis,potassium calcium-activated channel subfamily n member 4
4258,tioconazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
4259,miconazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
4260,miconazole,vulvovaginal candidiasis,potassium calcium-activated channel subfamily n member 4
4261,amlodipine,prinzmetal angina,atp binding cassette subfamily b member 1
4262,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4263,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4264,diltiazem,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4265,diltiazem,prinzmetal angina,atp binding cassette subfamily b member 1
4266,nifedipine,prinzmetal angina,atp binding cassette subfamily b member 1
4267,nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4268,nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4269,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 f
4270,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4271,verapamil,prinzmetal angina,atp binding cassette subfamily b member 1
4272,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 i
4273,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4274,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
4275,felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4276,felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
4277,felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4278,felodipine,prinzmetal angina,atp binding cassette subfamily b member 1
4279,nicardipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4280,nicardipine,prinzmetal angina,atp binding cassette subfamily b member 1
4281,nicardipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
4282,irinotecan,pancreatic adenocarcinoma,dna topoisomerase i
4283,gemcitabine,pancreatic adenocarcinoma,ribonucleotide reductase regulatory subunit m2
4284,gemcitabine,pancreatic adenocarcinoma,ribonucleotide reductase catalytic subunit m1
4285,gemcitabine,pancreatic adenocarcinoma,"dna polymerase epsilon, catalytic subunit"
4286,gemcitabine,pancreatic adenocarcinoma,"dna polymerase delta 1, catalytic subunit"
4287,gemcitabine,pancreatic adenocarcinoma,"dna polymerase alpha 1, catalytic subunit"
4288,gemcitabine,pancreatic adenocarcinoma,thymidylate synthetase
4289,5-fluorouracil,pancreatic adenocarcinoma,thymidylate synthetase
4290,capecitabine,pancreatic adenocarcinoma,thymidylate synthetase
4291,erlotinib,pancreatic adenocarcinoma,mitogen-activated protein kinase kinase kinase 19
4292,erlotinib,pancreatic adenocarcinoma,serine/threonine kinase 10
4293,erlotinib,pancreatic adenocarcinoma,ste20 like kinase
4294,erlotinib,pancreatic adenocarcinoma,solute carrier organic anion transporter family member 2b1
4295,erlotinib,pancreatic adenocarcinoma,epidermal growth factor receptor
4296,erlotinib,pancreatic adenocarcinoma,cyclin g associated kinase
4297,aminosalicylic acid,pulmonary tuberculosis,prostaglandin-endoperoxide synthase 1
4298,aminosalicylic acid,pulmonary tuberculosis,prostaglandin-endoperoxide synthase 2
4299,daunorubicin,wilms tumor,nuclear receptor subfamily 5 group a member 1
4300,daunorubicin,wilms tumor,dna topoisomerase ii alpha
4301,vincristine,wilms tumor,nuclear receptor subfamily 0 group b member 1
4302,bosutinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
4303,bosutinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
4304,imatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
4305,imatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
4306,dasatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
4307,sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 1a
4308,sirolimus,lung lymphangioleiomyomatosis,eukaryotic translation initiation factor 4e
4309,sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 1b
4310,sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 5
4311,propranolol,hemangioma,adrenoceptor beta 2
4312,propranolol,hemangioma,adrenoceptor beta 1
4313,desloratadine,allergic urticaria,histamine receptor h1
4314,prednisolone,erythema multiforme,serpin family a member 6
4315,triamcinolone,erythema multiforme,serpin family a member 6
4316,prednisone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
4317,cortisol,erythema multiforme,nuclear receptor subfamily 3 group c member 1
4318,cortisol,erythema multiforme,sex hormone binding globulin
4319,cortisol,erythema multiforme,serpin family a member 6
4320,cortisol,exanthem,nuclear receptor subfamily 3 group c member 1
4321,cortisol,exanthem,sex hormone binding globulin
4322,cortisol,exanthem,serpin family a member 6
4323,prednisolone,exanthem,serpin family a member 6
4324,fluocinolone acetonide,exanthem,serpin family a member 6
4325,betamethasone,exanthem,nuclear receptor subfamily 3 group c member 1
4326,mometasone,exanthem,nuclear receptor subfamily 3 group c member 1
4327,triamcinolone,exanthem,serpin family a member 6
4328,amcinonide,exanthem,nuclear receptor subfamily 3 group c member 1
4329,flumethasone pivalate,exanthem,serpin family a member 6
4330,fluticasone,exanthem,serpin family a member 6
4331,alclometasone dipropionate,exanthem,serpin family a member 6
4332,fluocinolone acetonide,granuloma annulare,serpin family a member 6
4333,prednisolone,granuloma annulare,serpin family a member 6
4334,triamcinolone,granuloma annulare,serpin family a member 6
4335,alclometasone dipropionate,granuloma annulare,serpin family a member 6
4336,mometasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
4337,fluticasone,granuloma annulare,serpin family a member 6
4338,cortisol,granuloma annulare,sex hormone binding globulin
4339,cortisol,granuloma annulare,serpin family a member 6
4340,clocortolone pivalate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
4341,flumethasone pivalate,granuloma annulare,serpin family a member 6
4342,amcinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
4343,prednisolone,pemphigus,serpin family a member 6
4344,betamethasone,pemphigus,nuclear receptor subfamily 3 group c member 1
4345,triamcinolone,pemphigus,serpin family a member 6
4346,prednisone,pemphigus,nuclear receptor subfamily 3 group c member 1
4347,cortisol,pemphigus,nuclear receptor subfamily 3 group c member 1
4348,cortisol,pemphigus,sex hormone binding globulin
4349,cortisol,pemphigus,serpin family a member 6
4350,cortisol,rosacea,sex hormone binding globulin
4351,cortisol,rosacea,serpin family a member 6
4352,prednisolone,rosacea,serpin family a member 6
4353,loteprednol etabonate,rosacea,nuclear receptor subfamily 3 group c member 1
4354,fluorometholone,rosacea,nuclear receptor subfamily 3 group c member 1
4355,fluorometholone,rosacea,serpin family a member 6
4356,clobetasol propionate,scalp dermatosis,nuclear receptor subfamily 3 group c member 1
4357,fluticasone,seborrheic dermatitis,serpin family a member 6
4358,betamethasone,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
4359,prednisolone,seborrheic dermatitis,serpin family a member 6
4360,cortisol,seborrheic dermatitis,cytochrome p450 family 11 subfamily b member 2
4361,cortisol,seborrheic dermatitis,cytochrome p450 family 11 subfamily b member 1
4362,cortisol,seborrheic dermatitis,sex hormone binding globulin
4363,cortisol,seborrheic dermatitis,serpin family a member 6
4364,(-)-menthol,seborrheic dermatitis,transient receptor potential cation channel subfamily m member 8
4365,alclometasone dipropionate,seborrheic dermatitis,serpin family a member 6
4366,triamcinolone,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
4367,triamcinolone,seborrheic dermatitis,serpin family a member 6
4368,clobetasol propionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
4369,flumethasone pivalate,seborrheic dermatitis,serpin family a member 6
4370,fluocinolone acetonide,seborrheic dermatitis,serpin family a member 6
4371,mometasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
4372,metyrapone,adrenal gland hyperfunction,cytochrome p450 family 11 subfamily b member 1
4373,metyrapone,adrenal gland hyperfunction,cytochrome p450 family 11 subfamily b member 2
4374,prednisolone,bacterial conjunctivitis,nuclear receptor subfamily 3 group c member 1
4375,prednisolone,bacterial conjunctivitis,serpin family a member 6
4376,ceftriaxone,bacterial meningitis,synuclein alpha
4377,minoxidil,alopecia,potassium inwardly rectifying channel subfamily j member 11
4378,minoxidil,alopecia,atp binding cassette subfamily c member 9
4379,prednisolone,dacryocystitis,serpin family a member 6
4380,prednisone,b-cell chronic lymphocytic leukemia,nuclear receptor subfamily 3 group c member 1
4381,acalabrutinib,b-cell chronic lymphocytic leukemia,bruton tyrosine kinase
4382,acalabrutinib,b-cell chronic lymphocytic leukemia,txk tyrosine kinase
4383,acalabrutinib,b-cell chronic lymphocytic leukemia,bmx non-receptor tyrosine kinase
4384,acalabrutinib,b-cell chronic lymphocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
4385,acalabrutinib,b-cell chronic lymphocytic leukemia,tec protein tyrosine kinase
4386,venetoclax,b-cell chronic lymphocytic leukemia,bcl2 like 2
4387,venetoclax,b-cell chronic lymphocytic leukemia,bcl2 like 1
4388,ibrutinib,b-cell chronic lymphocytic leukemia,bmx non-receptor tyrosine kinase
4389,ibrutinib,b-cell chronic lymphocytic leukemia,tec protein tyrosine kinase
4390,ibrutinib,b-cell chronic lymphocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
4391,ibrutinib,b-cell chronic lymphocytic leukemia,txk tyrosine kinase
4392,carmustine,hodgkins lymphoma,glutathione-disulfide reductase
4393,vincristine,hodgkins lymphoma,atp binding cassette subfamily b member 1
4394,vincristine,hodgkins lymphoma,tubulin beta 8 class viii
4395,vincristine,hodgkins lymphoma,tubulin beta 3 class iii
4396,vincristine,hodgkins lymphoma,tubulin beta class i
4397,vincristine,hodgkins lymphoma,tubulin beta 1 class vi
4398,vincristine,hodgkins lymphoma,tubulin beta 4a class iva
4399,vincristine,hodgkins lymphoma,tubulin beta 2a class iia
4400,vincristine,hodgkins lymphoma,tubulin beta 2b class iib
4401,vincristine,hodgkins lymphoma,tubulin beta 4b class ivb
4402,vincristine,hodgkins lymphoma,tubulin beta 6 class v
4403,prednisolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4404,prednisolone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4405,prednisolone,hodgkins lymphoma,serpin family a member 6
4406,cortisol,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4407,cortisol,hodgkins lymphoma,atp binding cassette subfamily b member 1
4408,cortisol,hodgkins lymphoma,sex hormone binding globulin
4409,cortisol,hodgkins lymphoma,serpin family a member 6
4410,etoposide,hodgkins lymphoma,glutathione s-transferase pi 1
4411,etoposide,hodgkins lymphoma,dna topoisomerase ii alpha
4412,etoposide,hodgkins lymphoma,udp glucuronosyltransferase family 1 member a1
4413,etoposide,hodgkins lymphoma,atp binding cassette subfamily b member 1
4414,betamethasone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4415,betamethasone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4416,triamcinolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4417,triamcinolone,hodgkins lymphoma,serpin family a member 6
4418,chlorambucil,hodgkins lymphoma,glutathione s-transferase pi 1
4419,epirubicin,hodgkins lymphoma,dna topoisomerase ii alpha
4420,vinblastine,hodgkins lymphoma,tubulin beta 4a class iva
4421,vinblastine,hodgkins lymphoma,tubulin gamma 1
4422,vinblastine,hodgkins lymphoma,tubulin beta 1 class vi
4423,vinblastine,hodgkins lymphoma,tubulin beta 8 class viii
4424,vinblastine,hodgkins lymphoma,atp binding cassette subfamily b member 1
4425,vinblastine,hodgkins lymphoma,tubulin alpha 1a
4426,vinblastine,hodgkins lymphoma,tubulin beta 2b class iib
4427,vinblastine,hodgkins lymphoma,tubulin beta 4b class ivb
4428,vinblastine,hodgkins lymphoma,tubulin beta class i
4429,vinblastine,hodgkins lymphoma,tubulin beta 2a class iia
4430,vinblastine,hodgkins lymphoma,tubulin beta 3 class iii
4431,vinblastine,hodgkins lymphoma,tubulin delta 1
4432,vinblastine,hodgkins lymphoma,tubulin beta 6 class v
4433,vinblastine,hodgkins lymphoma,tubulin epsilon 1
4434,prednisone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4435,prednisone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4436,cyclophosphamide,hodgkins lymphoma,atp binding cassette subfamily b member 1
4437,methylprednisolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4438,methylprednisolone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4439,tamoxifen,invasive ductal breast carcinoma,ebp cholestenol delta-isomerase
4440,tamoxifen,invasive ductal breast carcinoma,7-dehydrocholesterol reductase
4441,tamoxifen,invasive ductal breast carcinoma,ebp like
4442,tamoxifen,invasive ductal breast carcinoma,estrogen receptor 1
4443,prednisolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4444,prednisolone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4445,prednisolone,acute lymphoblastic leukemia,serpin family a member 6
4446,cytarabine,acute lymphoblastic leukemia,"dna polymerase alpha 1, catalytic subunit"
4447,cytarabine,acute lymphoblastic leukemia,"dna polymerase delta 1, catalytic subunit"
4448,cytarabine,acute lymphoblastic leukemia,"dna polymerase epsilon, catalytic subunit"
4449,daunorubicin,acute lymphoblastic leukemia,cytochrome p450 family 1 subfamily b member 1
4450,daunorubicin,acute lymphoblastic leukemia,dna topoisomerase ii alpha
4451,daunorubicin,acute lymphoblastic leukemia,cytochrome p450 family 1 subfamily a member 2
4452,daunorubicin,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4453,mercaptopurine,acute lymphoblastic leukemia,phosphoribosyl pyrophosphate amidotransferase
4454,cyclophosphamide,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4455,cyclophosphamide,acute lymphoblastic leukemia,cytochrome p450 family 2 subfamily c member 8
4456,cortisol,acute lymphoblastic leukemia,cytochrome p450 family 2 subfamily c member 8
4457,cortisol,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4458,cortisol,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4459,cortisol,acute lymphoblastic leukemia,sex hormone binding globulin
4460,cortisol,acute lymphoblastic leukemia,serpin family a member 6
4461,prednisone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4462,prednisone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4463,vincristine,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4464,vincristine,acute lymphoblastic leukemia,tubulin beta 8 class viii
4465,vincristine,acute lymphoblastic leukemia,tubulin beta 3 class iii
4466,vincristine,acute lymphoblastic leukemia,tubulin beta class i
4467,vincristine,acute lymphoblastic leukemia,tubulin beta 1 class vi
4468,vincristine,acute lymphoblastic leukemia,tubulin beta 4a class iva
4469,vincristine,acute lymphoblastic leukemia,tubulin beta 2a class iia
4470,vincristine,acute lymphoblastic leukemia,tubulin beta 2b class iib
4471,vincristine,acute lymphoblastic leukemia,tubulin beta 4b class ivb
4472,vincristine,acute lymphoblastic leukemia,tubulin beta 6 class v
4473,teniposide,acute lymphoblastic leukemia,dna topoisomerase ii alpha
4474,clofarabine,acute lymphoblastic leukemia,ribonucleotide reductase catalytic subunit m1
4475,clofarabine,acute lymphoblastic leukemia,"dna polymerase alpha 1, catalytic subunit"
4476,clofarabine,acute lymphoblastic leukemia,ribonucleotide reductase regulatory subunit m2
4477,triamcinolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4478,triamcinolone,acute lymphoblastic leukemia,serpin family a member 6
4479,betamethasone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4480,betamethasone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4481,methylprednisolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4482,methylprednisolone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4483,galantamine,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
4484,galantamine,alzheimer disease,cholinergic receptor nicotinic alpha 4 subunit
4485,galantamine,alzheimer disease,cholinergic receptor nicotinic beta 2 subunit
4486,galantamine,alzheimer disease,butyrylcholinesterase
4487,galantamine,alzheimer disease,cholinergic receptor nicotinic alpha 7 subunit
4488,galantamine,alzheimer disease,acetylcholinesterase (yt blood group)
4489,rivastigmine,alzheimer disease,butyrylcholinesterase
4490,rivastigmine,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
4491,donepezil,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
4492,donepezil,alzheimer disease,5-hydroxytryptamine receptor 2a
4493,donepezil,alzheimer disease,butyrylcholinesterase
4494,terbutaline,asthma,adrenoceptor beta 1
4495,betamethasone,asthma,prostaglandin-endoperoxide synthase 2
4496,theophylline,asthma,adenosine a2a receptor
4497,theophylline,asthma,adenosine a2b receptor
4498,theophylline,asthma,phosphodiesterase 4c
4499,theophylline,asthma,phosphodiesterase 4a
4500,theophylline,asthma,phosphodiesterase 3a
4501,theophylline,asthma,phosphodiesterase 4d
4502,theophylline,asthma,phosphodiesterase 4b
4503,theophylline,asthma,adenosine deaminase
4504,theophylline,asthma,adenosine a1 receptor
4505,theophylline,asthma,adenosine a3 receptor
4506,prednisone,asthma,nuclear receptor subfamily 3 group c member 1
4507,prednisone,asthma,albumin
4508,beclometasone,asthma,serpin family a member 6
4509,beclometasone,asthma,nuclear receptor subfamily 3 group c member 1
4510,(-)-noradrenaline,asthma,adrenoceptor alpha 2a
4511,(-)-noradrenaline,asthma,adrenoceptor beta 3
4512,(-)-noradrenaline,asthma,adrenoceptor alpha 1b
4513,(-)-noradrenaline,asthma,adrenoceptor beta 1
4514,(-)-noradrenaline,asthma,adrenoceptor alpha 1a
4515,(-)-noradrenaline,asthma,adrenoceptor alpha 2c
4516,(-)-noradrenaline,asthma,solute carrier family 22 member 5
4517,(-)-noradrenaline,asthma,adrenoceptor alpha 1d
4518,mometasone,asthma,nuclear receptor subfamily 3 group c member 1
4519,triamcinolone,asthma,prostaglandin-endoperoxide synthase 2
4520,triamcinolone,asthma,serpin family a member 6
4521,indacaterol,asthma,adrenoceptor beta 2
4522,indacaterol,asthma,adrenoceptor beta 1
4523,indacaterol,asthma,cholinergic receptor muscarinic 3
4524,nedocromil,asthma,prostaglandin d2 receptor
4525,(-)-adrenaline,asthma,adrenoceptor beta 1
4526,(-)-adrenaline,asthma,adrenoceptor beta 2
4527,(-)-adrenaline,asthma,adrenoceptor alpha 1a
4528,(-)-adrenaline,asthma,solute carrier family 22 member 5
4529,(-)-adrenaline,asthma,adrenoceptor alpha 1b
4530,(-)-adrenaline,asthma,adrenoceptor alpha 2a
4531,(-)-adrenaline,asthma,adrenoceptor alpha 1d
4532,(-)-adrenaline,asthma,adrenoceptor beta 3
4533,(-)-adrenaline,asthma,tumor necrosis factor
4534,(-)-adrenaline,asthma,adrenoceptor alpha 2c
4535,flunisolide,asthma,serpin family a member 6
4536,zafirlukast,asthma,cysteinyl leukotriene receptor 1
4537,zafirlukast,asthma,cysteinyl leukotriene receptor 2
4538,zafirlukast,asthma,prostaglandin-endoperoxide synthase 1
4539,zafirlukast,asthma,leukotriene b4 receptor
4540,prednisolone,asthma,serpin family a member 6
4541,fluticasone,asthma,serpin family a member 6
4542,fluticasone,asthma,phospholipase a2 group iva
4543,cortisol,asthma,nuclear receptor subfamily 3 group c member 1
4544,cortisol,asthma,sex hormone binding globulin
4545,cortisol,asthma,serpin family a member 6
4546,dyphylline,asthma,adenosine a1 receptor
4547,dyphylline,asthma,adenosine a2a receptor
4548,dyphylline,asthma,phosphodiesterase 3a
4549,prednisolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4550,prednisolone,atopic eczema,serpin family a member 6
4551,triamcinolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4552,triamcinolone,atopic eczema,serpin family a member 6
4553,methylprednisolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4554,betamethasone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4555,dronedarone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4556,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
4557,dronedarone,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
4558,dronedarone,atrial fibrillation,potassium two pore domain channel subfamily k member 2
4559,dronedarone,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
4560,dronedarone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4561,dronedarone,atrial fibrillation,sodium voltage-gated channel alpha subunit 1
4562,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 1
4563,dronedarone,atrial fibrillation,adrenoceptor beta 1
4564,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 3
4565,dronedarone,atrial fibrillation,calcium voltage-gated channel auxiliary subunit beta 2
4566,dronedarone,atrial fibrillation,atp binding cassette subfamily b member 1
4567,flecainide,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4568,propranolol,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4569,propranolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4570,propranolol,atrial fibrillation,atp binding cassette subfamily b member 1
4571,digoxin,atrial fibrillation,fxyd domain containing ion transport regulator 2
4572,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 1
4573,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 3
4574,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 3
4575,digoxin,atrial fibrillation,atp binding cassette subfamily b member 1
4576,digoxin,atrial fibrillation,solute carrier organic anion transporter family member 4a1
4577,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 1
4578,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 2
4579,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 2
4580,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 4
4581,rivaroxaban,atrial fibrillation,atp binding cassette subfamily b member 1
4582,rivaroxaban,atrial fibrillation,coagulation factor x
4583,metoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4584,metoprolol,atrial fibrillation,atp binding cassette subfamily b member 1
4585,metoprolol,atrial fibrillation,adrenoceptor beta 2
4586,metoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4587,metoprolol,atrial fibrillation,adrenoceptor beta 1
4588,benazepril,atrial fibrillation,methylenetetrahydrofolate reductase
4589,benazepril,atrial fibrillation,angiotensin i converting enzyme
4590,clopidogrel,atrial fibrillation,atp binding cassette subfamily b member 1
4591,clopidogrel,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4592,clopidogrel,atrial fibrillation,purinergic receptor p2y12
4593,quinapril,atrial fibrillation,angiotensin i converting enzyme
4594,losartan,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4595,losartan,atrial fibrillation,angiotensin i converting enzyme
4596,losartan,atrial fibrillation,atp binding cassette subfamily b member 1
4597,losartan,atrial fibrillation,solute carrier family 2 member 9
4598,perindopril,atrial fibrillation,angiotensin i converting enzyme
4599,perindopril,atrial fibrillation,atp binding cassette subfamily b member 1
4600,ramipril,atrial fibrillation,angiotensin i converting enzyme
4601,carvedilol,atrial fibrillation,selectin e
4602,carvedilol,atrial fibrillation,adrenoceptor beta 2
4603,carvedilol,atrial fibrillation,natriuretic peptide b
4604,carvedilol,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4605,carvedilol,atrial fibrillation,atp binding cassette subfamily b member 1
4606,carvedilol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4607,carvedilol,atrial fibrillation,adrenoceptor beta 1
4608,telmisartan,atrial fibrillation,atp binding cassette subfamily b member 1
4609,telmisartan,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4610,telmisartan,atrial fibrillation,angiotensin i converting enzyme
4611,bisoprolol,atrial fibrillation,adrenoceptor beta 2
4612,bisoprolol,atrial fibrillation,adrenoceptor beta 1
4613,bisoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4614,trandolapril,atrial fibrillation,angiotensin i converting enzyme
4615,diltiazem,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4616,diltiazem,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
4617,diltiazem,atrial fibrillation,atp binding cassette subfamily b member 1
4618,diltiazem,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4619,diltiazem,atrial fibrillation,potassium voltage-gated channel subfamily a member 5
4620,amiodarone,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4621,amiodarone,atrial fibrillation,adrenoceptor beta 1
4622,amiodarone,atrial fibrillation,atp binding cassette subfamily b member 1
4623,amiodarone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4624,amiodarone,atrial fibrillation,thyroid hormone receptor beta
4625,amiodarone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4626,nebivolol,atrial fibrillation,adrenoceptor beta 2
4627,nebivolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4628,nebivolol,atrial fibrillation,adrenoceptor beta 1
4629,dipyridamole,atrial fibrillation,phosphodiesterase 3b
4630,dipyridamole,atrial fibrillation,solute carrier family 29 member 1 (augustine blood group)
4631,dipyridamole,atrial fibrillation,phosphodiesterase 2a
4632,dipyridamole,atrial fibrillation,phosphodiesterase 1b
4633,dipyridamole,atrial fibrillation,phosphodiesterase 7a
4634,dipyridamole,atrial fibrillation,phosphodiesterase 1c
4635,dipyridamole,atrial fibrillation,phosphodiesterase 3a
4636,dipyridamole,atrial fibrillation,phosphodiesterase 7b
4637,dipyridamole,atrial fibrillation,atp binding cassette subfamily b member 1
4638,dipyridamole,atrial fibrillation,phosphodiesterase 8a
4639,dipyridamole,atrial fibrillation,prune exopolyphosphatase 1
4640,dipyridamole,atrial fibrillation,phosphodiesterase 6d
4641,dipyridamole,atrial fibrillation,phosphodiesterase 6b
4642,dipyridamole,atrial fibrillation,phosphodiesterase 11a
4643,dipyridamole,atrial fibrillation,phosphodiesterase 6c
4644,dipyridamole,atrial fibrillation,phosphodiesterase 6a
4645,dipyridamole,atrial fibrillation,phosphodiesterase 1a
4646,dipyridamole,atrial fibrillation,phosphodiesterase 6g
4647,dipyridamole,atrial fibrillation,phosphodiesterase 6h
4648,dipyridamole,atrial fibrillation,phosphodiesterase 8b
4649,captopril,atrial fibrillation,atp binding cassette subfamily b member 1
4650,captopril,atrial fibrillation,angiotensin i converting enzyme
4651,captopril,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4652,verapamil,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4653,verapamil,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4654,verapamil,atrial fibrillation,atp binding cassette subfamily b member 1
4655,verapamil,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4656,verapamil,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
4657,verapamil,atrial fibrillation,calcium voltage-gated channel auxiliary subunit beta 2
4658,verapamil,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
4659,verapamil,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
4660,candesartan,atrial fibrillation,atp binding cassette subfamily b member 1
4661,propafenone,atrial fibrillation,adrenoceptor beta 1
4662,propafenone,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
4663,propafenone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4664,propafenone,atrial fibrillation,atp binding cassette subfamily b member 1
4665,propafenone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4666,irbesartan,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4667,esmolol,atrial fibrillation,adrenoceptor beta 1
4668,esmolol,atrial fibrillation,adrenoceptor beta 2
4669,quinine,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4670,quinine,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4671,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 3
4672,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 1
4673,quinine,atrial fibrillation,atp binding cassette subfamily b member 1
4674,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
4675,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 2
4676,quinine,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4677,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 4
4678,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 2
4679,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 2
4680,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 1
4681,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 3
4682,acetyldigitoxin,atrial fibrillation,fxyd domain containing ion transport regulator 2
4683,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 3
4684,atenolol,atrial fibrillation,adrenoceptor beta 1
4685,atenolol,atrial fibrillation,adrenoceptor beta 2
4686,atenolol,atrial fibrillation,atp binding cassette subfamily b member 1
4687,lisinopril,atrial fibrillation,atp binding cassette subfamily b member 1
4688,lisinopril,atrial fibrillation,angiotensin i converting enzyme
4689,ziprasidone,bipolar disorder,h1.0 linker histone
4690,ziprasidone,bipolar disorder,dopamine receptor d1
4691,ziprasidone,bipolar disorder,adrenoceptor alpha 1a
4692,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 2c
4693,ziprasidone,bipolar disorder,adrenoceptor alpha 2c
4694,ziprasidone,bipolar disorder,dopamine receptor d2
4695,ziprasidone,bipolar disorder,dopamine receptor d4
4696,ziprasidone,bipolar disorder,dopamine receptor d5
4697,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 6
4698,ziprasidone,bipolar disorder,solute carrier family 6 member 4
4699,ziprasidone,bipolar disorder,cholinergic receptor muscarinic 2
4700,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 2a
4701,ziprasidone,bipolar disorder,histamine receptor h1
4702,ziprasidone,bipolar disorder,dopamine receptor d3
4703,ziprasidone,bipolar disorder,cholinergic receptor muscarinic 3
4704,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1e
4705,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1b
4706,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 3a
4707,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1a
4708,ziprasidone,bipolar disorder,tachykinin precursor 1
4709,ziprasidone,bipolar disorder,adrenoceptor beta 2
4710,risperidone,bipolar disorder,dopamine receptor d2
4711,risperidone,bipolar disorder,5-hydroxytryptamine receptor 1b
4712,risperidone,bipolar disorder,h1.0 linker histone
4713,risperidone,bipolar disorder,dopamine receptor d4
4714,risperidone,bipolar disorder,5-hydroxytryptamine receptor 2a
4715,risperidone,bipolar disorder,adrenoceptor alpha 2c
4716,risperidone,bipolar disorder,adrenoceptor alpha 1a
4717,risperidone,bipolar disorder,5-hydroxytryptamine receptor 2c
4718,risperidone,bipolar disorder,dopamine receptor d1
4719,risperidone,bipolar disorder,dopamine receptor d3
4720,risperidone,bipolar disorder,5-hydroxytryptamine receptor 1a
4721,risperidone,bipolar disorder,histamine receptor h1
4722,risperidone,bipolar disorder,atp binding cassette subfamily b member 1
4723,risperidone,bipolar disorder,5-hydroxytryptamine receptor 1e
4724,risperidone,bipolar disorder,cholinergic receptor muscarinic 2
4725,risperidone,bipolar disorder,tachykinin precursor 1
4726,risperidone,bipolar disorder,dopamine receptor d5
4727,risperidone,bipolar disorder,solute carrier family 6 member 4
4728,risperidone,bipolar disorder,5-hydroxytryptamine receptor 6
4729,risperidone,bipolar disorder,adrenoceptor beta 2
4730,cariprazine,bipolar disorder,histamine receptor h1
4731,cariprazine,bipolar disorder,vitamin d receptor
4732,cariprazine,bipolar disorder,dopamine receptor d3
4733,cariprazine,bipolar disorder,5-hydroxytryptamine receptor 2a
4734,cariprazine,bipolar disorder,dopamine receptor d5
4735,cariprazine,bipolar disorder,dopamine receptor d4
4736,cariprazine,bipolar disorder,5-hydroxytryptamine receptor 1a
4737,cariprazine,bipolar disorder,5-hydroxytryptamine receptor 2c
4738,cariprazine,bipolar disorder,dopamine receptor d1
4739,cariprazine,bipolar disorder,dopamine receptor d2
4740,loxapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4741,loxapine,bipolar disorder,5-hydroxytryptamine receptor 5a
4742,loxapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4743,loxapine,bipolar disorder,cholinergic receptor muscarinic 3
4744,loxapine,bipolar disorder,dopamine receptor d4
4745,loxapine,bipolar disorder,dopamine receptor d5
4746,loxapine,bipolar disorder,dopamine receptor d1
4747,loxapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4748,loxapine,bipolar disorder,adrenoceptor alpha 1a
4749,loxapine,bipolar disorder,cholinergic receptor muscarinic 2
4750,loxapine,bipolar disorder,histamine receptor h1
4751,loxapine,bipolar disorder,5-hydroxytryptamine receptor 3a
4752,loxapine,bipolar disorder,5-hydroxytryptamine receptor 6
4753,loxapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4754,loxapine,bipolar disorder,solute carrier family 6 member 2
4755,loxapine,bipolar disorder,adrenoceptor alpha 2c
4756,loxapine,bipolar disorder,dopamine receptor d3
4757,loxapine,bipolar disorder,solute carrier family 6 member 4
4758,loxapine,bipolar disorder,solute carrier family 6 member 3
4759,paliperidone,bipolar disorder,dopamine receptor d2
4760,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1a
4761,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 2c
4762,paliperidone,bipolar disorder,dopamine receptor d3
4763,paliperidone,bipolar disorder,adrenoceptor alpha 1a
4764,paliperidone,bipolar disorder,dopamine receptor d1
4765,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 2a
4766,paliperidone,bipolar disorder,histamine receptor h1
4767,paliperidone,bipolar disorder,adrenoceptor alpha 2c
4768,paliperidone,bipolar disorder,dopamine receptor d4
4769,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1b
4770,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1e
4771,paliperidone,bipolar disorder,adrenoceptor beta 2
4772,paliperidone,bipolar disorder,cholinergic receptor muscarinic 2
4773,paliperidone,bipolar disorder,tachykinin precursor 1
4774,quetiapine,bipolar disorder,adrenoceptor alpha 1a
4775,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4776,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 3a
4777,quetiapine,bipolar disorder,dopamine receptor d5
4778,quetiapine,bipolar disorder,histamine receptor h1
4779,quetiapine,bipolar disorder,adrenoceptor alpha 2c
4780,quetiapine,bipolar disorder,dopamine receptor d3
4781,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4782,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4783,quetiapine,bipolar disorder,atp binding cassette subfamily b member 1
4784,quetiapine,bipolar disorder,dopamine receptor d4
4785,quetiapine,bipolar disorder,cholinergic receptor muscarinic 3
4786,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 2a
4787,quetiapine,bipolar disorder,cholinergic receptor muscarinic 2
4788,quetiapine,bipolar disorder,h1.0 linker histone
4789,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4790,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 6
4791,quetiapine,bipolar disorder,dopamine receptor d1
4792,quetiapine,bipolar disorder,dopamine receptor d2
4793,quetiapine,bipolar disorder,tachykinin precursor 1
4794,quetiapine,bipolar disorder,solute carrier family 6 member 4
4795,quetiapine,bipolar disorder,adrenoceptor beta 2
4796,carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 4
4797,carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 5
4798,carbamazepine,bipolar disorder,atp binding cassette subfamily b member 1
4799,carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 9
4800,carbamazepine,bipolar disorder,solute carrier family 6 member 4
4801,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 3a
4802,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 6
4803,olanzapine,bipolar disorder,dopamine receptor d3
4804,olanzapine,bipolar disorder,dopamine receptor d4
4805,olanzapine,bipolar disorder,atp binding cassette subfamily b member 1
4806,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4807,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4808,olanzapine,bipolar disorder,dopamine receptor d1
4809,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4810,olanzapine,bipolar disorder,histamine receptor h1
4811,olanzapine,bipolar disorder,h1.0 linker histone
4812,olanzapine,bipolar disorder,adrenoceptor alpha 2c
4813,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 5a
4814,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4815,olanzapine,bipolar disorder,dopamine receptor d5
4816,olanzapine,bipolar disorder,adrenoceptor alpha 1a
4817,olanzapine,bipolar disorder,cholinergic receptor muscarinic 2
4818,olanzapine,bipolar disorder,cholinergic receptor muscarinic 3
4819,asenapine,bipolar disorder,dopamine receptor d4
4820,asenapine,bipolar disorder,5-hydroxytryptamine receptor 2a
4821,asenapine,bipolar disorder,dopamine receptor d1
4822,asenapine,bipolar disorder,solute carrier family 6 member 4
4823,asenapine,bipolar disorder,adrenoceptor alpha 1a
4824,asenapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4825,asenapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4826,asenapine,bipolar disorder,adrenoceptor alpha 2c
4827,asenapine,bipolar disorder,dopamine receptor d3
4828,asenapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4829,asenapine,bipolar disorder,histamine receptor h1
4830,asenapine,bipolar disorder,dopamine receptor d2
4831,asenapine,bipolar disorder,5-hydroxytryptamine receptor 5a
4832,asenapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4833,asenapine,bipolar disorder,adrenoceptor beta 2
4834,asenapine,bipolar disorder,5-hydroxytryptamine receptor 6
4835,asenapine,bipolar disorder,cholinergic receptor muscarinic 2
4836,asenapine,bipolar disorder,tachykinin precursor 1
4837,aripiprazole,bipolar disorder,adrenoceptor alpha 2c
4838,aripiprazole,bipolar disorder,cholinergic receptor muscarinic 3
4839,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1e
4840,aripiprazole,bipolar disorder,h1.0 linker histone
4841,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 2c
4842,aripiprazole,bipolar disorder,cholinergic receptor muscarinic 2
4843,aripiprazole,bipolar disorder,dopamine receptor d5
4844,aripiprazole,bipolar disorder,histamine receptor h1
4845,aripiprazole,bipolar disorder,atp binding cassette subfamily b member 1
4846,aripiprazole,bipolar disorder,dopamine receptor d3
4847,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1a
4848,aripiprazole,bipolar disorder,dopamine receptor d4
4849,aripiprazole,bipolar disorder,dopamine receptor d1
4850,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 6
4851,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 3a
4852,aripiprazole,bipolar disorder,solute carrier family 6 member 4
4853,aripiprazole,bipolar disorder,adrenoceptor alpha 1a
4854,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1b
4855,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 2a
4856,aripiprazole,bipolar disorder,dopamine receptor d2
4857,aripiprazole,bipolar disorder,solute carrier family 6 member 2
4858,aripiprazole,bipolar disorder,adrenoceptor beta 2
4859,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 5a
4860,aripiprazole,bipolar disorder,solute carrier family 6 member 3
4861,docetaxel,breast carcinoma,epidermal growth factor receptor
4862,docetaxel,breast carcinoma,tubulin beta 6 class v
4863,docetaxel,breast carcinoma,tubulin beta 2b class iib
4864,docetaxel,breast carcinoma,tubulin beta 2a class iia
4865,docetaxel,breast carcinoma,tubulin beta class i
4866,docetaxel,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4867,docetaxel,breast carcinoma,tubulin beta 3 class iii
4868,docetaxel,breast carcinoma,bcl2 apoptosis regulator
4869,docetaxel,breast carcinoma,atp binding cassette subfamily g member 2 (jr blood group)
4870,docetaxel,breast carcinoma,tubulin beta 1 class vi
4871,docetaxel,breast carcinoma,atp binding cassette subfamily b member 1
4872,docetaxel,breast carcinoma,tubulin beta 4a class iva
4873,docetaxel,breast carcinoma,tubulin beta 4b class ivb
4874,docetaxel,breast carcinoma,tubulin beta 8 class viii
4875,docetaxel,breast carcinoma,cytochrome p450 family 1 subfamily b member 1
4876,docetaxel,breast carcinoma,atp binding cassette subfamily c member 1 (abcc1 blood group)
4877,epirubicin,breast carcinoma,atp binding cassette subfamily c member 1 (abcc1 blood group)
4878,epirubicin,breast carcinoma,aurora kinase a
4879,epirubicin,breast carcinoma,phospholipase a2 group iva
4880,epirubicin,breast carcinoma,dna topoisomerase ii alpha
4881,paclitaxel,breast carcinoma,atp binding cassette subfamily c member 1 (abcc1 blood group)
4882,paclitaxel,breast carcinoma,tubulin beta 2b class iib
4883,paclitaxel,breast carcinoma,bcl2 apoptosis regulator
4884,paclitaxel,breast carcinoma,cytochrome p450 family 19 subfamily a member 1
4885,paclitaxel,breast carcinoma,atp binding cassette subfamily b member 1
4886,paclitaxel,breast carcinoma,tubulin beta 1 class vi
4887,paclitaxel,breast carcinoma,tubulin beta 6 class v
4888,paclitaxel,breast carcinoma,atp binding cassette subfamily g member 2 (jr blood group)
4889,paclitaxel,breast carcinoma,tubulin beta class i
4890,paclitaxel,breast carcinoma,tubulin beta 3 class iii
4891,paclitaxel,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4892,paclitaxel,breast carcinoma,tubulin beta 8 class viii
4893,paclitaxel,breast carcinoma,cytochrome p450 family 1 subfamily b member 1
4894,paclitaxel,breast carcinoma,tubulin beta 4a class iva
4895,paclitaxel,breast carcinoma,tubulin beta 2a class iia
4896,paclitaxel,breast carcinoma,tubulin beta 4b class ivb
4897,paclitaxel,breast carcinoma,solute carrier organic anion transporter family member 1b1
4898,5-fluorouracil,breast carcinoma,atp binding cassette subfamily g member 2 (jr blood group)
4899,5-fluorouracil,breast carcinoma,thymidylate synthetase
4900,5-fluorouracil,breast carcinoma,methylenetetrahydrofolate reductase
4901,5-fluorouracil,breast carcinoma,dihydropyrimidine dehydrogenase
4902,5-fluorouracil,breast carcinoma,uridine monophosphate synthetase
4903,cyclophosphamide,breast carcinoma,atp binding cassette subfamily b member 1
4904,cyclophosphamide,breast carcinoma,cytochrome p450 family 2 subfamily d member 6
4905,cyclophosphamide,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4906,everolimus,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4907,everolimus,breast carcinoma,fkbp prolyl isomerase 1a
4908,ixabepilone,breast carcinoma,tubulin beta class i
4909,ixabepilone,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4910,ixabepilone,breast carcinoma,tubulin beta 1 class vi
4911,ixabepilone,breast carcinoma,tubulin beta 2a class iia
4912,ixabepilone,breast carcinoma,tubulin beta 4a class iva
4913,ixabepilone,breast carcinoma,tubulin beta 8 class viii
4914,ixabepilone,breast carcinoma,tubulin beta 2b class iib
4915,ixabepilone,breast carcinoma,tubulin beta 4b class ivb
4916,ixabepilone,breast carcinoma,tubulin beta 3 class iii
4917,ixabepilone,breast carcinoma,tubulin beta 6 class v
4918,ixabepilone,breast carcinoma,bcl2 apoptosis regulator
4919,methylprednisolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4920,methylprednisolone,chronic obstructive pulmonary disease,glucose-6-phosphate dehydrogenase
4921,formoterol,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily a member 6
4922,fluticasone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4923,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 5
4924,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 1
4925,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 4
4926,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 2
4927,triamcinolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4928,triamcinolone,chronic obstructive pulmonary disease,prostaglandin-endoperoxide synthase 2
4929,salbutamol,chronic obstructive pulmonary disease,adrenoceptor beta 2
4930,prednisolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4931,prednisolone,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily a member 6
4932,prednisolone,chronic obstructive pulmonary disease,solute carrier organic anion transporter family member 1a2
4933,prednisone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4934,prednisone,chronic obstructive pulmonary disease,solute carrier organic anion transporter family member 1a2
4935,prednisone,chronic obstructive pulmonary disease,albumin
4936,betamethasone,chronic obstructive pulmonary disease,prostaglandin-endoperoxide synthase 2
4937,betamethasone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4938,losartan,congestive heart failure,angiotensin i converting enzyme
4939,losartan,congestive heart failure,albumin
4940,losartan,congestive heart failure,angiotensin ii receptor type 1
4941,metoprolol,congestive heart failure,adrenoceptor beta 1
4942,metoprolol,congestive heart failure,adrenoceptor beta 3
4943,ramipril,congestive heart failure,butyrylcholinesterase
4944,ramipril,congestive heart failure,angiotensin i converting enzyme
4945,nebivolol,congestive heart failure,adrenoceptor beta 1
4946,valsartan,congestive heart failure,albumin
4947,valsartan,congestive heart failure,angiotensin ii receptor type 1
4948,isosorbide mononitrate,congestive heart failure,guanylate cyclase 1 soluble subunit beta 1
4949,isosorbide dinitrate,congestive heart failure,guanylate cyclase 1 soluble subunit beta 1
4950,isosorbide dinitrate,congestive heart failure,natriuretic peptide receptor 1
4951,irbesartan,congestive heart failure,endothelin receptor type a
4952,irbesartan,congestive heart failure,prostaglandin-endoperoxide synthase 1
4953,irbesartan,congestive heart failure,angiotensin ii receptor type 1
4954,benazepril,congestive heart failure,angiotensin i converting enzyme
4955,olmesartan,congestive heart failure,angiotensin ii receptor type 1
4956,dipyridamole,congestive heart failure,phosphodiesterase 11a
4957,digoxin,congestive heart failure,fxyd domain containing ion transport regulator 2
4958,digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 1
4959,digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 3
4960,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 3
4961,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 1
4962,digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 2
4963,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 2
4964,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 4
4965,lisinopril,congestive heart failure,angiotensin i converting enzyme
4966,bisoprolol,congestive heart failure,adrenoceptor beta 1
4967,bisoprolol,congestive heart failure,adrenoceptor beta 3
4968,quinapril,congestive heart failure,angiotensin i converting enzyme
4969,enalapril,congestive heart failure,angiotensin i converting enzyme
4970,trandolapril,congestive heart failure,angiotensin i converting enzyme
4971,atenolol,congestive heart failure,adrenoceptor beta 1
4972,atenolol,congestive heart failure,adrenoceptor beta 3
4973,candesartan,congestive heart failure,angiotensin ii receptor type 1
4974,candesartan,congestive heart failure,prostaglandin-endoperoxide synthase 1
4975,eprosartan,congestive heart failure,angiotensin ii receptor type 1
4976,levosimendan,congestive heart failure,"troponin c1, slow skeletal and cardiac type"
4977,carvedilol,congestive heart failure,vascular endothelial growth factor a
4978,carvedilol,congestive heart failure,natriuretic peptide b
4979,carvedilol,congestive heart failure,xanthine dehydrogenase
4980,carvedilol,congestive heart failure,adrenoceptor alpha 2c
4981,carvedilol,congestive heart failure,hypoxia inducible factor 1 subunit alpha
4982,carvedilol,congestive heart failure,adrenoceptor beta 3
4983,carvedilol,congestive heart failure,prostaglandin-endoperoxide synthase 1
4984,carvedilol,congestive heart failure,adrenoceptor beta 1
4985,telmisartan,congestive heart failure,peroxisome proliferator activated receptor gamma
4986,telmisartan,congestive heart failure,angiotensin ii receptor type 1
4987,telmisartan,congestive heart failure,angiotensin i converting enzyme
4988,spironolactone,congestive heart failure,nuclear receptor subfamily 3 group c member 2
4989,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 1
4990,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 4
4991,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 2
4992,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 2
4993,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 1
4994,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 3
4995,acetyldigitoxin,congestive heart failure,fxyd domain containing ion transport regulator 2
4996,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 3
4997,captopril,congestive heart failure,renin
4998,captopril,congestive heart failure,albumin
4999,captopril,congestive heart failure,angiotensin i converting enzyme
5000,captopril,congestive heart failure,prostaglandin-endoperoxide synthase 2
5001,captopril,congestive heart failure,prostaglandin-endoperoxide synthase 1
5002,hydrochlorothiazide,congestive heart failure,albumin
5003,perindopril,congestive heart failure,butyrylcholinesterase
5004,perindopril,congestive heart failure,angiotensin i converting enzyme
5005,prednisone,crohn disease,nuclear receptor subfamily 3 group c member 1
5006,prednisone,crohn disease,albumin
5007,prednisone,crohn disease,atp binding cassette subfamily b member 1
5008,sulfasalazine,crohn disease,prostaglandin-endoperoxide synthase 2
5009,sulfasalazine,crohn disease,solute carrier family 7 member 11
5010,sulfasalazine,crohn disease,acetyl-coa acetyltransferase 1
5011,sulfasalazine,crohn disease,peroxisome proliferator activated receptor gamma
5012,betamethasone,crohn disease,prostaglandin-endoperoxide synthase 2
5013,betamethasone,crohn disease,atp binding cassette subfamily b member 1
5014,aminosalicylic acid,crohn disease,phospholipase a2 group iie
5015,aminosalicylic acid,crohn disease,myeloperoxidase
5016,aminosalicylic acid,crohn disease,prostaglandin-endoperoxide synthase 2
5017,mesalazine,crohn disease,prostaglandin-endoperoxide synthase 2
5018,mesalazine,crohn disease,peroxisome proliferator activated receptor gamma
5019,mesalazine,crohn disease,myeloperoxidase
5020,prednisolone,crohn disease,atp binding cassette subfamily b member 1
5021,prednisolone,crohn disease,serpin family a member 6
5022,methylprednisolone,crohn disease,atp binding cassette subfamily b member 1
5023,triamcinolone,crohn disease,prostaglandin-endoperoxide synthase 2
5024,triamcinolone,crohn disease,serpin family a member 6
5025,cortisol,crohn disease,atp binding cassette subfamily b member 1
5026,cortisol,crohn disease,sex hormone binding globulin
5027,cortisol,crohn disease,serpin family a member 6
5028,salicylic acid,crohn disease,albumin
5029,salicylic acid,crohn disease,prostaglandin-endoperoxide synthase 2
5030,salicylic acid,crohn disease,atp binding cassette subfamily b member 1
5031,ramipril,diabetic kidney disease,angiotensin i converting enzyme
5032,perindopril,diabetic kidney disease,angiotensin i converting enzyme
5033,telmisartan,diabetic kidney disease,peroxisome proliferator activated receptor gamma
5034,telmisartan,diabetic kidney disease,angiotensin ii receptor type 1
5035,telmisartan,diabetic kidney disease,angiotensin i converting enzyme
5036,captopril,diabetic kidney disease,albumin
5037,quinapril,diabetic kidney disease,angiotensin i converting enzyme
5038,valsartan,diabetic kidney disease,albumin
5039,valsartan,diabetic kidney disease,angiotensin ii receptor type 1
5040,benazepril,diabetic kidney disease,angiotensin i converting enzyme
5041,losartan,diabetic kidney disease,angiotensin i converting enzyme
5042,losartan,diabetic kidney disease,albumin
5043,candesartan,diabetic kidney disease,angiotensin ii receptor type 1
5044,lisinopril,diabetic kidney disease,angiotensin i converting enzyme
5045,lisinopril,diabetic kidney disease,angiotensin converting enzyme 2
5046,trandolapril,diabetic kidney disease,angiotensin i converting enzyme
5047,eprosartan,diabetic kidney disease,angiotensin ii receptor type 1
5048,phenytoin,epilepsy,atp binding cassette subfamily c member 2
5049,phenytoin,epilepsy,albumin
5050,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 3
5051,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 1
5052,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 5
5053,phenytoin,epilepsy,cytochrome p450 family 2 subfamily c member 19
5054,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 2
5055,phenytoin,epilepsy,atp binding cassette subfamily b member 1
5056,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 8
5057,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 4
5058,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 9
5059,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta3
5060,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
5061,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit pi
5062,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma3
5063,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit epsilon
5064,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
5065,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit theta
5066,diazepam,epilepsy,cytochrome p450 family 2 subfamily c member 19
5067,diazepam,epilepsy,albumin
5068,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
5069,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
5070,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma1
5071,diazepam,epilepsy,atp binding cassette subfamily b member 1
5072,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
5073,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta1
5074,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
5075,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit delta
5076,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
5077,thiopental,epilepsy,glutamate ionotropic receptor kainate type subunit 2
5078,thiopental,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
5079,thiopental,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
5080,thiopental,epilepsy,glutamate ionotropic receptor ampa type subunit 2
5081,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
5082,thiopental,epilepsy,fatty acid amide hydrolase
5083,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 1
5084,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 9
5085,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 8
5086,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 4
5087,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 3
5088,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 5
5089,lamotrigine,epilepsy,atp binding cassette subfamily b member 1
5090,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 10
5091,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 2
5092,trimethadione,epilepsy,cytochrome p450 family 2 subfamily c member 19
5093,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
5094,methylphenobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
5095,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
5096,methylphenobarbital,epilepsy,cytochrome p450 family 2 subfamily c member 19
5097,methylphenobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
5098,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
5099,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
5100,methylphenobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
5101,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
5102,methylphenobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
5103,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
5104,acetazolamide,epilepsy,carbonic anhydrase 4
5105,acetazolamide,epilepsy,aquaporin 1 (colton blood group)
5106,acetazolamide,epilepsy,carbonic anhydrase 13
5107,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
5108,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
5109,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
5110,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
5111,pentobarbitone,epilepsy,glutamate ionotropic receptor ampa type subunit 2
5112,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
5113,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
5114,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta3
5115,pentobarbitone,epilepsy,cytochrome p450 family 2 subfamily c member 19
5116,pentobarbitone,epilepsy,glutamate ionotropic receptor kainate type subunit 2
5117,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
5118,pentobarbitone,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
5119,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
5120,pentobarbitone,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
5121,phenobarbital,epilepsy,atp binding cassette subfamily b member 1
5122,phenobarbital,epilepsy,cytochrome p450 family 2 subfamily c member 19
5123,phenobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
5124,phenobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
5125,phenobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
5126,phenobarbital,epilepsy,atp binding cassette subfamily c member 2
5127,phenobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
5128,valproic acid,epilepsy,aldehyde dehydrogenase 5 family member a1
5129,valproic acid,epilepsy,4-aminobutyrate aminotransferase
5130,valproic acid,epilepsy,acyl-coa dehydrogenase short/branched chain
5131,valproic acid,epilepsy,cytochrome p450 family 2 subfamily c member 19
5132,secobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
5133,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
5134,secobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
5135,secobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
5136,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
5137,secobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
5138,felbamate,epilepsy,glutamate ionotropic receptor nmda type subunit 2a
5139,felbamate,epilepsy,glutamate ionotropic receptor nmda type subunit 2b
5140,felbamate,epilepsy,cytochrome p450 family 2 subfamily c member 19
5141,carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 4
5142,carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 5
5143,carbamazepine,epilepsy,cytochrome p450 family 2 subfamily c member 19
5144,carbamazepine,epilepsy,atp binding cassette subfamily b member 1
5145,carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 9
5146,carbamazepine,epilepsy,atp binding cassette subfamily c member 2
5147,carbamazepine,epilepsy,solute carrier family 6 member 4
5148,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
5149,primidone,epilepsy,cytochrome p450 family 2 subfamily c member 19
5150,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
5151,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
5152,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
5153,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
5154,primidone,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
5155,primidone,epilepsy,glutamate ionotropic receptor kainate type subunit 2
5156,primidone,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
5157,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
5158,primidone,epilepsy,glutamate ionotropic receptor ampa type subunit 2
5159,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
5160,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
5161,anagrelide,essential thrombocythemia,phosphodiesterase 3a
5162,lenvatinib,thyroid gland follicular carcinoma,kinase insert domain receptor
5163,lenvatinib,thyroid gland follicular carcinoma,receptor interacting serine/threonine kinase 2
5164,acetylcholine,glaucoma,cholinergic receptor muscarinic 3
5165,bisoprolol,hypertensive disorder,adrenoceptor beta 2
5166,bisoprolol,hypertensive disorder,adrenoceptor beta 3
5167,ketanserin,hypertensive disorder,adrenoceptor alpha 2b
5168,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 1b
5169,ketanserin,hypertensive disorder,adrenoceptor alpha 2a
5170,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 2b
5171,ketanserin,hypertensive disorder,solute carrier family 18 member a2
5172,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 7
5173,ketanserin,hypertensive disorder,dopamine receptor d4
5174,ketanserin,hypertensive disorder,dopamine receptor d2
5175,ketanserin,hypertensive disorder,adrenoceptor alpha 1a
5176,trandolapril,hypertensive disorder,angiotensin i converting enzyme
5177,bumetanide,hypertensive disorder,solute carrier family 12 member 2
5178,bumetanide,hypertensive disorder,prostaglandin-endoperoxide synthase 2
5179,bumetanide,hypertensive disorder,solute carrier family 12 member 1
5180,bumetanide,hypertensive disorder,carbonic anhydrase 9
5181,bumetanide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5182,bumetanide,hypertensive disorder,carbonic anhydrase 2
5183,paclitaxel,hypertensive disorder,atp binding cassette subfamily c member 1 (abcc1 blood group)
5184,paclitaxel,hypertensive disorder,tubulin beta 2b class iib
5185,paclitaxel,hypertensive disorder,bcl2 apoptosis regulator
5186,paclitaxel,hypertensive disorder,cytochrome p450 family 19 subfamily a member 1
5187,paclitaxel,hypertensive disorder,atp binding cassette subfamily b member 1
5188,paclitaxel,hypertensive disorder,tubulin beta 1 class vi
5189,paclitaxel,hypertensive disorder,tubulin beta 6 class v
5190,paclitaxel,hypertensive disorder,tubulin beta class i
5191,paclitaxel,hypertensive disorder,tubulin beta 3 class iii
5192,paclitaxel,hypertensive disorder,tubulin beta 8 class viii
5193,paclitaxel,hypertensive disorder,tubulin beta 4a class iva
5194,paclitaxel,hypertensive disorder,tubulin beta 2a class iia
5195,paclitaxel,hypertensive disorder,tubulin beta 4b class ivb
5196,paclitaxel,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5197,paclitaxel,hypertensive disorder,paraoxonase 1
5198,prazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5199,prazosin,hypertensive disorder,atp binding cassette subfamily b member 1
5200,prazosin,hypertensive disorder,adrenoceptor alpha 2b
5201,prazosin,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5202,prazosin,hypertensive disorder,adrenoceptor alpha 2a
5203,prazosin,hypertensive disorder,adrenoceptor alpha 2c
5204,prazosin,hypertensive disorder,dopamine receptor d4
5205,indapamide,hypertensive disorder,carbonic anhydrase 2
5206,indapamide,hypertensive disorder,potassium voltage-gated channel subfamily q member 1
5207,indapamide,hypertensive disorder,carbonic anhydrase 9
5208,nicardipine,hypertensive disorder,adrenoceptor alpha 1b
5209,nicardipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5210,nicardipine,hypertensive disorder,adrenoceptor alpha 1d
5211,nicardipine,hypertensive disorder,adrenoceptor alpha 1a
5212,nicardipine,hypertensive disorder,calmodulin 2
5213,nicardipine,hypertensive disorder,atp binding cassette subfamily b member 1
5214,nicardipine,hypertensive disorder,calmodulin 1
5215,captopril,hypertensive disorder,leukotriene a4 hydrolase
5216,captopril,hypertensive disorder,matrix metallopeptidase 9
5217,captopril,hypertensive disorder,"coagulation factor ii, thrombin"
5218,captopril,hypertensive disorder,renin
5219,captopril,hypertensive disorder,atp binding cassette subfamily b member 1
5220,captopril,hypertensive disorder,albumin
5221,captopril,hypertensive disorder,matrix metallopeptidase 2
5222,captopril,hypertensive disorder,prostaglandin-endoperoxide synthase 2
5223,captopril,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5224,perindopril,hypertensive disorder,angiotensin i converting enzyme
5225,perindopril,hypertensive disorder,atp binding cassette subfamily b member 1
5226,acebutolol,hypertensive disorder,adrenoceptor beta 2
5227,acebutolol,hypertensive disorder,atp binding cassette subfamily b member 1
5228,acebutolol,hypertensive disorder,adrenoceptor beta 3
5229,hydralazine,hypertensive disorder,ryanodine receptor 2
5230,hydralazine,hypertensive disorder,amine oxidase copper containing 3
5231,hydralazine,hypertensive disorder,glutamic-oxaloacetic transaminase 1
5232,amlodipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5233,amlodipine,hypertensive disorder,atp binding cassette subfamily b member 1
5234,amlodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5235,amlodipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5236,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5237,amlodipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5238,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5239,amlodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
5240,diltiazem,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5241,diltiazem,hypertensive disorder,atp binding cassette subfamily b member 1
5242,diltiazem,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5243,diltiazem,hypertensive disorder,potassium voltage-gated channel subfamily a member 5
5244,isotretinoin,hypertensive disorder,retinoic acid receptor beta
5245,hydrochlorothiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
5246,hydrochlorothiazide,hypertensive disorder,carbonic anhydrase 9
5247,hydrochlorothiazide,hypertensive disorder,carbonic anhydrase 2
5248,hydrochlorothiazide,hypertensive disorder,albumin
5249,amiloride,hypertensive disorder,amine oxidase copper containing 1
5250,amiloride,hypertensive disorder,solute carrier family 9 member a1
5251,amiloride,hypertensive disorder,solute carrier family 22 member 4
5252,amiloride,hypertensive disorder,acid sensing ion channel subunit 1
5253,telmisartan,hypertensive disorder,atp binding cassette subfamily b member 1
5254,telmisartan,hypertensive disorder,cytochrome p450 family 2 subfamily j member 2
5255,telmisartan,hypertensive disorder,angiotensin i converting enzyme
5256,metoprolol,hypertensive disorder,atp binding cassette subfamily b member 1
5257,metoprolol,hypertensive disorder,adrenoceptor beta 2
5258,metoprolol,hypertensive disorder,adrenoceptor beta 3
5259,clonidine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5260,clonidine,hypertensive disorder,solute carrier family 22 member 4
5261,clonidine,hypertensive disorder,adrenoceptor alpha 1d
5262,clonidine,hypertensive disorder,adrenoceptor alpha 1b
5263,clonidine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5264,clonidine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5265,clonidine,hypertensive disorder,atp binding cassette subfamily b member 1
5266,clonidine,hypertensive disorder,nischarin
5267,clonidine,hypertensive disorder,solute carrier family 6 member 2
5268,clonidine,hypertensive disorder,adrenoceptor alpha 1a
5269,olmesartan,hypertensive disorder,angiotensin ii receptor type 1
5270,verapamil,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5271,verapamil,hypertensive disorder,cytochrome p450 family 2 subfamily c member 18
5272,verapamil,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5273,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 g
5274,verapamil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 11
5275,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
5276,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5277,verapamil,hypertensive disorder,atp binding cassette subfamily b member 1
5278,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
5279,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
5280,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5281,verapamil,hypertensive disorder,solute carrier family 6 member 4
5282,verapamil,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 1
5283,verapamil,hypertensive disorder,solute carrier family 22 member 4
5284,verapamil,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5285,verapamil,hypertensive disorder,atp binding cassette subfamily c member 1 (abcc1 blood group)
5286,verapamil,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5287,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
5288,lisinopril,hypertensive disorder,atp binding cassette subfamily b member 1
5289,lisinopril,hypertensive disorder,angiotensin converting enzyme 2
5290,hydroflumethiazide,hypertensive disorder,solute carrier family 12 member 3
5291,hydroflumethiazide,hypertensive disorder,solute carrier family 12 member 1
5292,hydroflumethiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
5293,hydroflumethiazide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5294,hydroflumethiazide,hypertensive disorder,carbonic anhydrase 2
5295,hydroflumethiazide,hypertensive disorder,carbonic anhydrase 9
5296,cilazapril,hypertensive disorder,atp binding cassette subfamily b member 1
5297,benazepril,hypertensive disorder,methylenetetrahydrofolate reductase
5298,benazepril,hypertensive disorder,angiotensin i converting enzyme
5299,felodipine,hypertensive disorder,atp binding cassette subfamily b member 1
5300,felodipine,hypertensive disorder,calmodulin 2
5301,felodipine,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
5302,felodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5303,felodipine,hypertensive disorder,calmodulin 1
5304,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
5305,felodipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5306,felodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
5307,reserpine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5308,reserpine,hypertensive disorder,atp binding cassette subfamily b member 1
5309,reserpine,hypertensive disorder,solute carrier family 18 member a1
5310,reserpine,hypertensive disorder,dopamine receptor d3
5311,reserpine,hypertensive disorder,dopamine receptor d2
5312,reserpine,hypertensive disorder,solute carrier family 6 member 4
5313,guanfacine,hypertensive disorder,nischarin
5314,guanfacine,hypertensive disorder,adrenoceptor alpha 2b
5315,guanfacine,hypertensive disorder,adrenoceptor alpha 2c
5316,irbesartan,hypertensive disorder,endothelin receptor type a
5317,irbesartan,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5318,irbesartan,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5319,irbesartan,hypertensive disorder,"jun proto-oncogene, ap-1 transcription factor subunit"
5320,atenolol,hypertensive disorder,adrenoceptor beta 2
5321,atenolol,hypertensive disorder,atp binding cassette subfamily b member 1
5322,atenolol,hypertensive disorder,adrenoceptor beta 3
5323,candesartan,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5324,candesartan,hypertensive disorder,atp binding cassette subfamily b member 1
5325,labetalol,hypertensive disorder,adrenoceptor beta 1
5326,labetalol,hypertensive disorder,adrenoceptor beta 3
5327,labetalol,hypertensive disorder,adrenoceptor beta 2
5328,chlorothiazide,hypertensive disorder,solute carrier family 12 member 3
5329,chlorothiazide,hypertensive disorder,carbonic anhydrase 2
5330,losartan,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5331,losartan,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5332,losartan,hypertensive disorder,angiotensin i converting enzyme
5333,losartan,hypertensive disorder,atp binding cassette subfamily b member 1
5334,losartan,hypertensive disorder,albumin
5335,losartan,hypertensive disorder,angiotensin ii receptor type 2
5336,nisoldipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5337,nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5338,nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5339,nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
5340,nisoldipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5341,nisoldipine,hypertensive disorder,atp binding cassette subfamily b member 1
5342,furosemide,hypertensive disorder,albumin
5343,furosemide,hypertensive disorder,carbonic anhydrase 9
5344,furosemide,hypertensive disorder,carbonic anhydrase 2
5345,furosemide,hypertensive disorder,paraoxonase 1
5346,terazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5347,terazosin,hypertensive disorder,atp binding cassette subfamily b member 1
5348,terazosin,hypertensive disorder,adrenoceptor alpha 2c
5349,terazosin,hypertensive disorder,adrenoceptor alpha 2b
5350,terazosin,hypertensive disorder,adrenoceptor alpha 2a
5351,bendroflumethiazide,hypertensive disorder,carbonic anhydrase 2
5352,bendroflumethiazide,hypertensive disorder,solute carrier family 12 member 3
5353,bendroflumethiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
5354,propranolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5355,propranolol,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5356,propranolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5357,propranolol,hypertensive disorder,atp binding cassette subfamily b member 1
5358,propranolol,hypertensive disorder,5-hydroxytryptamine receptor 1b
5359,propranolol,hypertensive disorder,adrenoceptor beta 3
5360,propranolol,hypertensive disorder,albumin
5361,l-α-methyldopa,hypertensive disorder,adrenoceptor alpha 2a
5362,l-α-methyldopa,hypertensive disorder,catechol-o-methyltransferase
5363,guanadrel,hypertensive disorder,solute carrier family 6 member 2
5364,ethacrynic acid,hypertensive disorder,solute carrier family 12 member 1
5365,ethacrynic acid,hypertensive disorder,albumin
5366,ethacrynic acid,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5367,ethacrynic acid,hypertensive disorder,glutathione s-transferase alpha 2
5368,betaxolol,hypertensive disorder,adrenoceptor beta 2
5369,betaxolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5370,timolol,hypertensive disorder,atp binding cassette subfamily b member 1
5371,timolol,hypertensive disorder,adrenoceptor beta 3
5372,timolol,hypertensive disorder,adrenoceptor beta 1
5373,timolol,hypertensive disorder,adrenoceptor beta 2
5374,doxazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5375,doxazosin,hypertensive disorder,adrenoceptor alpha 1b
5376,doxazosin,hypertensive disorder,atp binding cassette subfamily b member 1
5377,doxazosin,hypertensive disorder,adrenoceptor alpha 2a
5378,doxazosin,hypertensive disorder,adrenoceptor alpha 2c
5379,valsartan,hypertensive disorder,albumin
5380,valsartan,hypertensive disorder,angiotensin ii receptor type 1
5381,valsartan,hypertensive disorder,angiotensin ii receptor type 2
5382,spironolactone,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
5383,spironolactone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 2
5384,spironolactone,hypertensive disorder,androgen receptor
5385,spironolactone,hypertensive disorder,atp binding cassette subfamily b member 1
5386,spironolactone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 1
5387,minoxidil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 11
5388,minoxidil,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5389,minoxidil,hypertensive disorder,atp binding cassette subfamily c member 9
5390,triamterene,hypertensive disorder,sodium channel epithelial 1 subunit beta
5391,triamterene,hypertensive disorder,sodium channel epithelial 1 subunit gamma
5392,triamterene,hypertensive disorder,sodium channel epithelial 1 subunit alpha
5393,triamterene,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5394,torsemide,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5395,trichlormethiazide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5396,trichlormethiazide,hypertensive disorder,solute carrier family 12 member 1
5397,trichlormethiazide,hypertensive disorder,carbonic anhydrase 9
5398,trichlormethiazide,hypertensive disorder,carbonic anhydrase 2
5399,metolazone,hypertensive disorder,carbonic anhydrase 9
5400,metolazone,hypertensive disorder,solute carrier family 12 member 1
5401,metolazone,hypertensive disorder,carbonic anhydrase 2
5402,pindolol,hypertensive disorder,adrenoceptor beta 3
5403,pindolol,hypertensive disorder,5-hydroxytryptamine receptor 1b
5404,pindolol,hypertensive disorder,5-hydroxytryptamine receptor 2a
5405,pindolol,hypertensive disorder,5-hydroxytryptamine receptor 2b
5406,guanethidine,hypertensive disorder,solute carrier family 6 member 2
5407,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
5408,nifedipine,hypertensive disorder,atp binding cassette subfamily b member 1
5409,nifedipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5410,nifedipine,hypertensive disorder,calmodulin 1
5411,nifedipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5412,nifedipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5413,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5414,nifedipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
5415,nifedipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5416,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5417,nifedipine,hypertensive disorder,calmodulin 2
5418,enalapril,hypertensive disorder,atp binding cassette subfamily b member 1
5419,enalapril,hypertensive disorder,angiotensin i converting enzyme
5420,eplerenone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 2
5421,eplerenone,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5422,eplerenone,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
5423,guanabenz,hypertensive disorder,nischarin
5424,guanabenz,hypertensive disorder,adrenoceptor alpha 2b
5425,guanabenz,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5426,guanabenz,hypertensive disorder,adrenoceptor alpha 2c
5427,nebivolol,hypertensive disorder,adrenoceptor beta 2
5428,nebivolol,hypertensive disorder,macrophage migration inhibitory factor
5429,quinapril,hypertensive disorder,angiotensin i converting enzyme
5430,spirapril,hypertensive disorder,angiotensin i converting enzyme
5431,carvedilol,hypertensive disorder,adrenoceptor alpha 2b
5432,carvedilol,hypertensive disorder,adrenoceptor alpha 1b
5433,carvedilol,hypertensive disorder,vascular endothelial growth factor a
5434,carvedilol,hypertensive disorder,selectin e
5435,carvedilol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5436,carvedilol,hypertensive disorder,adrenoceptor beta 2
5437,carvedilol,hypertensive disorder,natriuretic peptide b
5438,carvedilol,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5439,carvedilol,hypertensive disorder,atp binding cassette subfamily b member 1
5440,carvedilol,hypertensive disorder,xanthine dehydrogenase
5441,carvedilol,hypertensive disorder,adrenoceptor alpha 2c
5442,carvedilol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5443,carvedilol,hypertensive disorder,adrenoceptor alpha 2a
5444,carvedilol,hypertensive disorder,hypoxia inducible factor 1 subunit alpha
5445,carvedilol,hypertensive disorder,adrenoceptor beta 3
5446,carvedilol,hypertensive disorder,gap junction protein alpha 1
5447,carvedilol,hypertensive disorder,adrenoceptor alpha 1d
5448,carvedilol,hypertensive disorder,vascular cell adhesion molecule 1
5449,carvedilol,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5450,ramipril,hypertensive disorder,angiotensin i converting enzyme
5451,n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 1
5452,n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 2
5453,n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 3
5454,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
5455,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
5456,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
5457,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit beta3
5458,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
5459,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit beta2
5460,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
5461,dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 2
5462,dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 1
5463,atropine,irritable bowel syndrome,cholinergic receptor muscarinic 3
5464,atropine,irritable bowel syndrome,cholinergic receptor muscarinic 2
5465,atropine,irritable bowel syndrome,cholinergic receptor muscarinic 1
5466,etoposide,kaposi's sarcoma,dna topoisomerase ii alpha
5467,etoposide,kaposi's sarcoma,atp binding cassette subfamily b member 1
5468,vinblastine,kaposi's sarcoma,tubulin beta 4a class iva
5469,vinblastine,kaposi's sarcoma,tubulin beta 1 class vi
5470,vinblastine,kaposi's sarcoma,tubulin beta 8 class viii
5471,vinblastine,kaposi's sarcoma,atp binding cassette subfamily b member 1
5472,vinblastine,kaposi's sarcoma,tubulin beta 2b class iib
5473,vinblastine,kaposi's sarcoma,tubulin beta 4b class ivb
5474,vinblastine,kaposi's sarcoma,tubulin beta 2a class iia
5475,vinblastine,kaposi's sarcoma,tubulin beta 3 class iii
5476,vinblastine,kaposi's sarcoma,tubulin beta 6 class v
5477,paclitaxel,kaposi's sarcoma,tubulin beta 2b class iib
5478,paclitaxel,kaposi's sarcoma,atp binding cassette subfamily b member 1
5479,paclitaxel,kaposi's sarcoma,tubulin beta 6 class v
5480,paclitaxel,kaposi's sarcoma,tubulin beta class i
5481,paclitaxel,kaposi's sarcoma,tubulin beta 3 class iii
5482,paclitaxel,kaposi's sarcoma,tubulin beta 8 class viii
5483,paclitaxel,kaposi's sarcoma,tubulin beta 4a class iva
5484,paclitaxel,kaposi's sarcoma,tubulin beta 2a class iia
5485,paclitaxel,kaposi's sarcoma,tubulin beta 4b class ivb
5486,daunorubicin,kaposi's sarcoma,dna topoisomerase ii alpha
5487,daunorubicin,kaposi's sarcoma,atp binding cassette subfamily b member 1
5488,vinorelbine,kaposi's sarcoma,tubulin beta 2b class iib
5489,vinorelbine,kaposi's sarcoma,tubulin beta 6 class v
5490,vinorelbine,kaposi's sarcoma,tubulin beta 1 class vi
5491,vinorelbine,kaposi's sarcoma,tubulin beta 2a class iia
5492,vinorelbine,kaposi's sarcoma,tubulin beta 4a class iva
5493,vinorelbine,kaposi's sarcoma,atp binding cassette subfamily b member 1
5494,vinorelbine,kaposi's sarcoma,tubulin beta class i
5495,vinorelbine,kaposi's sarcoma,tubulin beta 4b class ivb
5496,vinorelbine,kaposi's sarcoma,tubulin beta 8 class viii
5497,vinorelbine,kaposi's sarcoma,tubulin beta 3 class iii
5498,eribulin,liposarcoma,tubulin beta 1 class vi
5499,eribulin,liposarcoma,tubulin beta 2b class iib
5500,eribulin,liposarcoma,tubulin beta 8 class viii
5501,eribulin,liposarcoma,tubulin beta 4b class ivb
5502,eribulin,liposarcoma,tubulin beta 2a class iia
5503,eribulin,liposarcoma,tubulin beta 6 class v
5504,eribulin,liposarcoma,tubulin beta 3 class iii
5505,eribulin,liposarcoma,tubulin beta class i
5506,eribulin,liposarcoma,tubulin beta 4a class iva
5507,dicumarol,myocardial infarction,g protein-coupled receptor 35
5508,nitroglycerin,myocardial infarction,guanylate cyclase 1 soluble subunit alpha 1
5509,nitroglycerin,myocardial infarction,guanylate cyclase 1 soluble subunit beta 1
5510,nitroglycerin,myocardial infarction,aldehyde dehydrogenase 2 family member
5511,aspirin,myocardial infarction,heat shock protein family a (hsp70) member 5
5512,aspirin,myocardial infarction,endothelin receptor type a
5513,aspirin,myocardial infarction,tumor protein p53
5514,cyclophosphamide,neuroblastoma,atp binding cassette subfamily b member 1
5515,etoposide,neuroblastoma,dna topoisomerase ii alpha
5516,etoposide,neuroblastoma,atp binding cassette subfamily b member 1
5517,vincristine,neuroblastoma,atp binding cassette subfamily b member 1
5518,vincristine,neuroblastoma,tubulin beta 8 class viii
5519,vincristine,neuroblastoma,tubulin beta 3 class iii
5520,vincristine,neuroblastoma,tubulin beta 1 class vi
5521,vincristine,neuroblastoma,tubulin beta 4a class iva
5522,vincristine,neuroblastoma,tubulin beta 2a class iia
5523,vincristine,neuroblastoma,tubulin beta 2b class iib
5524,vincristine,neuroblastoma,tubulin beta 4b class ivb
5525,vincristine,neuroblastoma,tubulin beta 6 class v
5526,daunorubicin,neuroblastoma,dna topoisomerase ii alpha
5527,daunorubicin,neuroblastoma,atp binding cassette subfamily b member 1
5528,teniposide,neuroblastoma,dna topoisomerase ii alpha
5529,vinblastine,neuroblastoma,tubulin beta 4a class iva
5530,vinblastine,neuroblastoma,tubulin beta 1 class vi
5531,vinblastine,neuroblastoma,tubulin beta 8 class viii
5532,vinblastine,neuroblastoma,atp binding cassette subfamily b member 1
5533,vinblastine,neuroblastoma,tubulin beta 2b class iib
5534,vinblastine,neuroblastoma,tubulin beta 4b class ivb
5535,vinblastine,neuroblastoma,tubulin beta class i
5536,vinblastine,neuroblastoma,tubulin beta 2a class iia
5537,vinblastine,neuroblastoma,tubulin beta 3 class iii
5538,vinblastine,neuroblastoma,tubulin beta 6 class v
5539,lenvatinib,thyroid gland papillary carcinoma,kinase insert domain receptor
5540,lenvatinib,thyroid gland papillary carcinoma,receptor interacting serine/threonine kinase 2
5541,minocycline,periodontitis,interleukin 1 beta
5542,minocycline,periodontitis,matrix metallopeptidase 9
5543,prednisolone,psoriasis,serpin family a member 6
5544,triamcinolone,psoriasis,serpin family a member 6
5545,cortisol,psoriasis,nuclear receptor subfamily 3 group c member 1
5546,cortisol,psoriasis,sex hormone binding globulin
5547,cortisol,psoriasis,serpin family a member 6
5548,calcipotriol,psoriasis,vitamin d receptor
5549,betamethasone,psoriasis,nuclear receptor subfamily 3 group c member 1
5550,prednisone,psoriasis,nuclear receptor subfamily 3 group c member 1
5551,lenvatinib,renal cell carcinoma,traf2 and nck interacting kinase
5552,lenvatinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5553,lenvatinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5554,lenvatinib,renal cell carcinoma,ste20 like kinase
5555,lenvatinib,renal cell carcinoma,kinase insert domain receptor
5556,lenvatinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5557,lenvatinib,renal cell carcinoma,serine/threonine kinase 10
5558,lenvatinib,renal cell carcinoma,aurora kinase b
5559,cabozantinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5560,cabozantinib,renal cell carcinoma,aurora kinase a
5561,cabozantinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5562,cabozantinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5563,cabozantinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5564,sunitinib,renal cell carcinoma,serine/threonine kinase 33
5565,sunitinib,renal cell carcinoma,myosin light chain kinase family member 4
5566,sunitinib,renal cell carcinoma,leucine rich repeat kinase 2
5567,sunitinib,renal cell carcinoma,fibroblast growth factor receptor 1
5568,sunitinib,renal cell carcinoma,homeodomain interacting protein kinase 4
5569,sunitinib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5570,sunitinib,renal cell carcinoma,death associated protein kinase 3
5571,sunitinib,renal cell carcinoma,serine/threonine kinase 17a
5572,sunitinib,renal cell carcinoma,cdc like kinase 4
5573,sunitinib,renal cell carcinoma,p21 (rac1) activated kinase 3
5574,sunitinib,renal cell carcinoma,cdc like kinase 2
5575,sunitinib,renal cell carcinoma,ribosomal protein s6 kinase a2
5576,sunitinib,renal cell carcinoma,cdc like kinase 1
5577,sunitinib,renal cell carcinoma,death associated protein kinase 1
5578,sunitinib,renal cell carcinoma,alk receptor tyrosine kinase
5579,sunitinib,renal cell carcinoma,homeodomain interacting protein kinase 2
5580,sunitinib,renal cell carcinoma,ribosomal protein s6 kinase a5
5581,sunitinib,renal cell carcinoma,il2 inducible t cell kinase
5582,sunitinib,renal cell carcinoma,ste20 like kinase
5583,sunitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5584,sunitinib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
5585,sunitinib,renal cell carcinoma,bmp2 inducible kinase
5586,sunitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5587,sunitinib,renal cell carcinoma,checkpoint kinase 2
5588,sunitinib,renal cell carcinoma,myosin light chain kinase
5589,sunitinib,renal cell carcinoma,ret proto-oncogene
5590,sunitinib,renal cell carcinoma,phosphorylase kinase catalytic subunit gamma 2
5591,sunitinib,renal cell carcinoma,phosphorylase kinase catalytic subunit gamma 1
5592,sunitinib,renal cell carcinoma,serine/threonine kinase 4
5593,sunitinib,renal cell carcinoma,serine/threonine kinase 11
5594,sunitinib,renal cell carcinoma,serine/threonine kinase 10
5595,sunitinib,renal cell carcinoma,polo like kinase 4
5596,sunitinib,renal cell carcinoma,axl receptor tyrosine kinase
5597,sunitinib,renal cell carcinoma,aurora kinase c
5598,sunitinib,renal cell carcinoma,traf2 and nck interacting kinase
5599,sunitinib,renal cell carcinoma,myosin light chain kinase 3
5600,sunitinib,renal cell carcinoma,cyclin g associated kinase
5601,sunitinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
5602,sunitinib,renal cell carcinoma,"src proto-oncogene, non-receptor tyrosine kinase"
5603,sunitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 1
5604,sunitinib,renal cell carcinoma,casein kinase 1 delta
5605,sunitinib,renal cell carcinoma,bub1 mitotic checkpoint serine/threonine kinase
5606,sunitinib,renal cell carcinoma,delta like non-canonical notch ligand 1
5607,sunitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5608,sunitinib,renal cell carcinoma,ap2 associated kinase 1
5609,sunitinib,renal cell carcinoma,misshapen like kinase 1
5610,sunitinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5611,sunitinib,renal cell carcinoma,fibroblast growth factor receptor 3
5612,sunitinib,renal cell carcinoma,aurora kinase b
5613,sunitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 2
5614,sunitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5615,sunitinib,renal cell carcinoma,aurora kinase a
5616,sirolimus,renal cell carcinoma,fkbp prolyl isomerase 1a
5617,sirolimus,renal cell carcinoma,eukaryotic translation initiation factor 4e
5618,sirolimus,renal cell carcinoma,fkbp prolyl isomerase 1b
5619,sirolimus,renal cell carcinoma,fkbp prolyl isomerase 5
5620,everolimus,renal cell carcinoma,fkbp prolyl isomerase 1a
5621,sorafenib,renal cell carcinoma,fibroblast growth factor receptor 1
5622,sorafenib,renal cell carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
5623,sorafenib,renal cell carcinoma,epoxide hydrolase 2
5624,sorafenib,renal cell carcinoma,serine/threonine kinase 10
5625,sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 3
5626,sorafenib,renal cell carcinoma,ret proto-oncogene
5627,sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 1
5628,sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 4
5629,sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5630,sorafenib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
5631,sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 20
5632,sorafenib,renal cell carcinoma,aurora kinase c
5633,sorafenib,renal cell carcinoma,kinase insert domain receptor
5634,sorafenib,renal cell carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
5635,sorafenib,renal cell carcinoma,homeodomain interacting protein kinase 4
5636,sorafenib,renal cell carcinoma,platelet derived growth factor receptor alpha
5637,sorafenib,renal cell carcinoma,platelet derived growth factor receptor beta
5638,sorafenib,renal cell carcinoma,colony stimulating factor 1 receptor
5639,sorafenib,renal cell carcinoma,homeodomain interacting protein kinase 2
5640,sorafenib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5641,sorafenib,renal cell carcinoma,polo like kinase 4
5642,sorafenib,renal cell carcinoma,aurora kinase b
5643,sorafenib,renal cell carcinoma,axl receptor tyrosine kinase
5644,sorafenib,renal cell carcinoma,traf2 and nck interacting kinase
5645,sorafenib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5646,sorafenib,renal cell carcinoma,ste20 like kinase
5647,sorafenib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5648,sorafenib,renal cell carcinoma,serine/threonine kinase 33
5649,sorafenib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5650,sorafenib,renal cell carcinoma,cdc like kinase 1
5651,sorafenib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5652,sorafenib,renal cell carcinoma,eph receptor b2
5653,sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5654,sorafenib,renal cell carcinoma,myosin light chain kinase 3
5655,sorafenib,renal cell carcinoma,tek receptor tyrosine kinase
5656,sorafenib,renal cell carcinoma,fibroblast growth factor receptor 3
5657,pazopanib,renal cell carcinoma,aurora kinase c
5658,pazopanib,renal cell carcinoma,il2 inducible t cell kinase
5659,pazopanib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5660,pazopanib,renal cell carcinoma,fibroblast growth factor receptor 1
5661,pazopanib,renal cell carcinoma,serine/threonine kinase 10
5662,pazopanib,renal cell carcinoma,polo like kinase 4
5663,pazopanib,renal cell carcinoma,fibroblast growth factor receptor 3
5664,pazopanib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5665,pazopanib,renal cell carcinoma,bmp2 inducible kinase
5666,pazopanib,renal cell carcinoma,tek receptor tyrosine kinase
5667,pazopanib,renal cell carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
5668,pazopanib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5669,pazopanib,renal cell carcinoma,"src proto-oncogene, non-receptor tyrosine kinase"
5670,pazopanib,renal cell carcinoma,ste20 like kinase
5671,pazopanib,renal cell carcinoma,ret proto-oncogene
5672,pazopanib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5673,pazopanib,renal cell carcinoma,aurora kinase a
5674,pazopanib,renal cell carcinoma,cyclin g associated kinase
5675,pazopanib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
5676,pazopanib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5677,pazopanib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5678,pazopanib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
5679,pazopanib,renal cell carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
5680,pazopanib,renal cell carcinoma,traf2 and nck interacting kinase
5681,pazopanib,renal cell carcinoma,ap2 associated kinase 1
5682,pazopanib,renal cell carcinoma,alk receptor tyrosine kinase
5683,pazopanib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5684,axitinib,renal cell carcinoma,leucine rich repeat kinase 2
5685,axitinib,renal cell carcinoma,aurora kinase b
5686,axitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5687,axitinib,renal cell carcinoma,traf2 and nck interacting kinase
5688,axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5689,axitinib,renal cell carcinoma,colony stimulating factor 1 receptor
5690,axitinib,renal cell carcinoma,ap2 associated kinase 1
5691,axitinib,renal cell carcinoma,misshapen like kinase 1
5692,axitinib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5693,axitinib,renal cell carcinoma,platelet derived growth factor receptor alpha
5694,axitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 2
5695,axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 20
5696,axitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5697,axitinib,renal cell carcinoma,tek receptor tyrosine kinase
5698,axitinib,renal cell carcinoma,polo like kinase 4
5699,axitinib,renal cell carcinoma,serine/threonine kinase 4
5700,axitinib,renal cell carcinoma,cyclin g associated kinase
5701,axitinib,renal cell carcinoma,aurora kinase c
5702,axitinib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
5703,axitinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
5704,axitinib,renal cell carcinoma,bmp2 inducible kinase
5705,axitinib,renal cell carcinoma,aurora kinase a
5706,axitinib,renal cell carcinoma,myosin light chain kinase 3
5707,axitinib,renal cell carcinoma,serine/threonine kinase 10
5708,axitinib,renal cell carcinoma,fibroblast growth factor receptor 1
5709,axitinib,renal cell carcinoma,il2 inducible t cell kinase
5710,axitinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5711,axitinib,renal cell carcinoma,ste20 like kinase
5712,axitinib,renal cell carcinoma,platelet derived growth factor receptor beta
5713,axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5714,axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 3
5715,axitinib,renal cell carcinoma,ret proto-oncogene
5716,axitinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5717,axitinib,renal cell carcinoma,axl receptor tyrosine kinase
5718,axitinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
5719,axitinib,renal cell carcinoma,fibroblast growth factor receptor 3
5720,pazopanib,sarcoma,bone morphogenetic protein receptor type 1b
5721,pazopanib,sarcoma,tek receptor tyrosine kinase
5722,pazopanib,sarcoma,"raf-1 proto-oncogene, serine/threonine kinase"
5723,pazopanib,sarcoma,"src proto-oncogene, non-receptor tyrosine kinase"
5724,pazopanib,sarcoma,"b-raf proto-oncogene, serine/threonine kinase"
5725,paliperidone,schizophrenia,dopamine receptor d2
5726,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1d
5727,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1a
5728,paliperidone,schizophrenia,adrenoceptor alpha 2a
5729,paliperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5730,paliperidone,schizophrenia,5-hydroxytryptamine receptor 2c
5731,paliperidone,schizophrenia,dopamine receptor d3
5732,paliperidone,schizophrenia,adrenoceptor alpha 1a
5733,paliperidone,schizophrenia,dopamine receptor d1
5734,paliperidone,schizophrenia,5-hydroxytryptamine receptor 2a
5735,paliperidone,schizophrenia,adrenoceptor alpha 1b
5736,paliperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5737,paliperidone,schizophrenia,histamine receptor h1
5738,paliperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5739,paliperidone,schizophrenia,dopamine receptor d4
5740,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1b
5741,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1e
5742,paliperidone,schizophrenia,cholinergic receptor muscarinic 2
5743,paliperidone,schizophrenia,tachykinin precursor 1
5744,prochlorperazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5745,prochlorperazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5746,prochlorperazine,schizophrenia,histamine receptor h1
5747,prochlorperazine,schizophrenia,dopamine receptor d2
5748,prochlorperazine,schizophrenia,cholinergic receptor muscarinic 2
5749,prochlorperazine,schizophrenia,dopamine receptor d3
5750,prochlorperazine,schizophrenia,5-hydroxytryptamine receptor 2c
5751,prochlorperazine,schizophrenia,adrenoceptor alpha 1a
5752,prochlorperazine,schizophrenia,5-hydroxytryptamine receptor 1a
5753,prochlorperazine,schizophrenia,adrenoceptor alpha 2a
5754,prochlorperazine,schizophrenia,dopamine receptor d4
5755,fluphenazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5756,fluphenazine,schizophrenia,cytochrome p450 family 2 subfamily e member 1
5757,fluphenazine,schizophrenia,adrenoceptor alpha 2a
5758,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 2c
5759,fluphenazine,schizophrenia,atp binding cassette subfamily b member 1
5760,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 6
5761,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 1a
5762,fluphenazine,schizophrenia,dopamine receptor d3
5763,fluphenazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5764,fluphenazine,schizophrenia,histamine receptor h1
5765,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 2a
5766,fluphenazine,schizophrenia,calmodulin 1
5767,fluphenazine,schizophrenia,adrenoceptor alpha 1a
5768,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 7
5769,fluphenazine,schizophrenia,cholinergic receptor muscarinic 2
5770,fluphenazine,schizophrenia,dopamine receptor d4
5771,fluphenazine,schizophrenia,dopamine receptor d5
5772,cariprazine,schizophrenia,histamine receptor h1
5773,cariprazine,schizophrenia,vitamin d receptor
5774,cariprazine,schizophrenia,dopamine receptor d3
5775,cariprazine,schizophrenia,5-hydroxytryptamine receptor 7
5776,cariprazine,schizophrenia,5-hydroxytryptamine receptor 2a
5777,cariprazine,schizophrenia,dopamine receptor d5
5778,cariprazine,schizophrenia,dopamine receptor d4
5779,cariprazine,schizophrenia,5-hydroxytryptamine receptor 1a
5780,cariprazine,schizophrenia,5-hydroxytryptamine receptor 2c
5781,cariprazine,schizophrenia,dopamine receptor d1
5782,cariprazine,schizophrenia,dopamine receptor d2
5783,ziprasidone,schizophrenia,h1.0 linker histone
5784,ziprasidone,schizophrenia,dopamine receptor d1
5785,ziprasidone,schizophrenia,cholinergic receptor muscarinic 5
5786,ziprasidone,schizophrenia,adrenoceptor alpha 2a
5787,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 7
5788,ziprasidone,schizophrenia,adrenoceptor alpha 1a
5789,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 2c
5790,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1d
5791,ziprasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5792,ziprasidone,schizophrenia,cholinergic receptor muscarinic 1
5793,ziprasidone,schizophrenia,potassium voltage-gated channel subfamily h member 2
5794,ziprasidone,schizophrenia,dopamine receptor d4
5795,ziprasidone,schizophrenia,dopamine receptor d5
5796,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 6
5797,ziprasidone,schizophrenia,adrenoceptor alpha 1b
5798,ziprasidone,schizophrenia,solute carrier family 6 member 4
5799,ziprasidone,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5800,ziprasidone,schizophrenia,cholinergic receptor muscarinic 2
5801,ziprasidone,schizophrenia,histamine receptor h1
5802,ziprasidone,schizophrenia,dopamine receptor d3
5803,ziprasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5804,ziprasidone,schizophrenia,cholinergic receptor muscarinic 4
5805,ziprasidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5806,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1e
5807,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1b
5808,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 3a
5809,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1a
5810,ziprasidone,schizophrenia,tachykinin precursor 1
5811,haloperidol,schizophrenia,atp binding cassette subfamily b member 1
5812,haloperidol,schizophrenia,5-hydroxytryptamine receptor 2a
5813,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1b
5814,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1d
5815,haloperidol,schizophrenia,ebp cholestenol delta-isomerase
5816,haloperidol,schizophrenia,histamine receptor h1
5817,haloperidol,schizophrenia,dopamine receptor d4
5818,haloperidol,schizophrenia,dopamine receptor d2
5819,haloperidol,schizophrenia,dopamine receptor d1
5820,haloperidol,schizophrenia,dopamine receptor d3
5821,haloperidol,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5822,haloperidol,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5823,haloperidol,schizophrenia,glutamate ionotropic receptor nmda type subunit 2b
5824,haloperidol,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5825,haloperidol,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5826,haloperidol,schizophrenia,potassium voltage-gated channel subfamily h member 2
5827,haloperidol,schizophrenia,h1.0 linker histone
5828,haloperidol,schizophrenia,sigma non-opioid intracellular receptor 1
5829,haloperidol,schizophrenia,5-hydroxytryptamine receptor 6
5830,haloperidol,schizophrenia,cholinergic receptor muscarinic 1
5831,haloperidol,schizophrenia,solute carrier family 6 member 2
5832,haloperidol,schizophrenia,"major histocompatibility complex, class i, a"
5833,haloperidol,schizophrenia,adrenoceptor alpha 2a
5834,haloperidol,schizophrenia,opioid receptor mu 1
5835,haloperidol,schizophrenia,5-hydroxytryptamine receptor 2c
5836,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1a
5837,haloperidol,schizophrenia,adrenoceptor alpha 1a
5838,haloperidol,schizophrenia,transmembrane protein 97
5839,haloperidol,schizophrenia,solute carrier family 6 member 4
5840,haloperidol,schizophrenia,dopamine receptor d5
5841,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1f
5842,haloperidol,schizophrenia,5-hydroxytryptamine receptor 7
5843,haloperidol,schizophrenia,tachykinin precursor 1
5844,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1e
5845,chlorpromazine,schizophrenia,adrenoceptor alpha 1b
5846,chlorpromazine,schizophrenia,dopamine receptor d5
5847,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 1a
5848,chlorpromazine,schizophrenia,calmodulin 1
5849,chlorpromazine,schizophrenia,adrenoceptor alpha 1a
5850,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 7
5851,chlorpromazine,schizophrenia,adrenoceptor alpha 2a
5852,chlorpromazine,schizophrenia,cytochrome p450 family 2 subfamily e member 1
5853,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 2a
5854,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 6
5855,chlorpromazine,schizophrenia,histamine receptor h1
5856,chlorpromazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5857,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 1
5858,chlorpromazine,schizophrenia,dopamine receptor d3
5859,chlorpromazine,schizophrenia,dopamine receptor d4
5860,chlorpromazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5861,chlorpromazine,schizophrenia,dopamine receptor d1
5862,chlorpromazine,schizophrenia,atp binding cassette subfamily b member 1
5863,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 2
5864,chlorpromazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5865,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 2c
5866,chlorpromazine,schizophrenia,potassium voltage-gated channel subfamily h member 2
5867,chlorpromazine,schizophrenia,solute carrier family 6 member 4
5868,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 4
5869,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 5
5870,mesoridazine,schizophrenia,histamine receptor h1
5871,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 6
5872,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 2c
5873,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 2a
5874,mesoridazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5875,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 1a
5876,mesoridazine,schizophrenia,dopamine receptor d2
5877,mesoridazine,schizophrenia,cholinergic receptor muscarinic 2
5878,mesoridazine,schizophrenia,potassium voltage-gated channel subfamily h member 2
5879,mesoridazine,schizophrenia,dopamine receptor d3
5880,mesoridazine,schizophrenia,cholinergic receptor muscarinic 5
5881,mesoridazine,schizophrenia,adrenoceptor alpha 1a
5882,mesoridazine,schizophrenia,adrenoceptor alpha 2a
5883,mesoridazine,schizophrenia,dopamine receptor d4
5884,mesoridazine,schizophrenia,cholinergic receptor muscarinic 4
5885,mesoridazine,schizophrenia,cholinergic receptor muscarinic 1
5886,risperidone,schizophrenia,5-hydroxytryptamine receptor 1b
5887,risperidone,schizophrenia,adrenoceptor alpha 1b
5888,risperidone,schizophrenia,h1.0 linker histone
5889,risperidone,schizophrenia,dopamine receptor d4
5890,risperidone,schizophrenia,5-hydroxytryptamine receptor 1d
5891,risperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5892,risperidone,schizophrenia,adrenoceptor alpha 1a
5893,risperidone,schizophrenia,5-hydroxytryptamine receptor 2c
5894,risperidone,schizophrenia,potassium voltage-gated channel subfamily h member 2
5895,risperidone,schizophrenia,dopamine receptor d1
5896,risperidone,schizophrenia,dopamine receptor d3
5897,risperidone,schizophrenia,5-hydroxytryptamine receptor 7
5898,risperidone,schizophrenia,5-hydroxytryptamine receptor 1a
5899,risperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5900,risperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5901,risperidone,schizophrenia,adrenoceptor alpha 2a
5902,risperidone,schizophrenia,histamine receptor h1
5903,risperidone,schizophrenia,atp binding cassette subfamily b member 1
5904,risperidone,schizophrenia,cholinergic receptor muscarinic 1
5905,risperidone,schizophrenia,5-hydroxytryptamine receptor 1e
5906,risperidone,schizophrenia,cholinergic receptor muscarinic 2
5907,risperidone,schizophrenia,5-hydroxytryptamine receptor 1f
5908,risperidone,schizophrenia,tachykinin precursor 1
5909,risperidone,schizophrenia,dopamine receptor d5
5910,risperidone,schizophrenia,sigma non-opioid intracellular receptor 1
5911,risperidone,schizophrenia,solute carrier family 6 member 4
5912,risperidone,schizophrenia,cholinergic receptor muscarinic 4
5913,risperidone,schizophrenia,5-hydroxytryptamine receptor 6
5914,aripiprazole,schizophrenia,adrenoceptor alpha 2a
5915,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1e
5916,aripiprazole,schizophrenia,h1.0 linker histone
5917,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 2c
5918,aripiprazole,schizophrenia,cholinergic receptor muscarinic 2
5919,aripiprazole,schizophrenia,cholinergic receptor muscarinic 1
5920,aripiprazole,schizophrenia,dopamine receptor d5
5921,aripiprazole,schizophrenia,histamine receptor h1
5922,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 7
5923,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1d
5924,aripiprazole,schizophrenia,atp binding cassette subfamily b member 1
5925,aripiprazole,schizophrenia,dopamine receptor d3
5926,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1a
5927,aripiprazole,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5928,aripiprazole,schizophrenia,dopamine receptor d4
5929,aripiprazole,schizophrenia,dopamine receptor d1
5930,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 6
5931,aripiprazole,schizophrenia,adrenoceptor alpha 1b
5932,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 3a
5933,aripiprazole,schizophrenia,potassium voltage-gated channel subfamily h member 2
5934,aripiprazole,schizophrenia,cholinergic receptor muscarinic 4
5935,aripiprazole,schizophrenia,solute carrier family 6 member 4
5936,aripiprazole,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5937,aripiprazole,schizophrenia,adrenoceptor alpha 1a
5938,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1b
5939,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 2a
5940,aripiprazole,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5941,aripiprazole,schizophrenia,dopamine receptor d2
5942,aripiprazole,schizophrenia,cholinergic receptor muscarinic 5
5943,aripiprazole,schizophrenia,solute carrier family 6 member 2
5944,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 5a
5945,aripiprazole,schizophrenia,solute carrier family 6 member 3
5946,mosapramine,schizophrenia,dopamine receptor d4
5947,trifluoperazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5948,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 6
5949,trifluoperazine,schizophrenia,sigma non-opioid intracellular receptor 1
5950,trifluoperazine,schizophrenia,adrenoceptor alpha 1a
5951,trifluoperazine,schizophrenia,atp binding cassette subfamily b member 1
5952,trifluoperazine,schizophrenia,cholinergic receptor muscarinic 2
5953,trifluoperazine,schizophrenia,histamine receptor h1
5954,trifluoperazine,schizophrenia,calmodulin 1
5955,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 1a
5956,trifluoperazine,schizophrenia,ebp like
5957,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 2a
5958,trifluoperazine,schizophrenia,ebp cholestenol delta-isomerase
5959,trifluoperazine,schizophrenia,calcyon neuron specific vesicular protein
5960,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 2c
5961,trifluoperazine,schizophrenia,adrenoceptor alpha 2a
5962,trifluoperazine,schizophrenia,dopamine receptor d3
5963,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 7
5964,trifluoperazine,schizophrenia,dopamine receptor d4
5965,iloperidone,schizophrenia,adrenoceptor alpha 2a
5966,iloperidone,schizophrenia,cytochrome p450 family 2 subfamily e member 1
5967,iloperidone,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5968,iloperidone,schizophrenia,histamine receptor h1
5969,iloperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5970,iloperidone,schizophrenia,5-hydroxytryptamine receptor 1a
5971,iloperidone,schizophrenia,dopamine receptor d2
5972,iloperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5973,iloperidone,schizophrenia,sigma non-opioid intracellular receptor 1
5974,iloperidone,schizophrenia,adrenoceptor alpha 1a
5975,iloperidone,schizophrenia,5-hydroxytryptamine receptor 7
5976,iloperidone,schizophrenia,5-hydroxytryptamine receptor 2c
5977,iloperidone,schizophrenia,5-hydroxytryptamine receptor 1d
5978,iloperidone,schizophrenia,5-hydroxytryptamine receptor 6
5979,iloperidone,schizophrenia,dopamine receptor d3
5980,iloperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5981,iloperidone,schizophrenia,dopamine receptor d4
5982,iloperidone,schizophrenia,cholinergic receptor muscarinic 1
5983,iloperidone,schizophrenia,solute carrier family 6 member 3
5984,iloperidone,schizophrenia,solute carrier family 6 member 2
5985,iloperidone,schizophrenia,cholinergic receptor muscarinic 2
5986,iloperidone,schizophrenia,cholinergic receptor muscarinic 4
5987,iloperidone,schizophrenia,dopamine receptor d5
5988,asenapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5989,asenapine,schizophrenia,histamine receptor h2
5990,asenapine,schizophrenia,dopamine receptor d4
5991,asenapine,schizophrenia,dopamine receptor d1
5992,asenapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5993,asenapine,schizophrenia,solute carrier family 6 member 4
5994,asenapine,schizophrenia,adrenoceptor alpha 1a
5995,asenapine,schizophrenia,5-hydroxytryptamine receptor 1b
5996,asenapine,schizophrenia,5-hydroxytryptamine receptor 1a
5997,asenapine,schizophrenia,5-hydroxytryptamine receptor 1d
5998,asenapine,schizophrenia,adrenoceptor alpha 2a
5999,asenapine,schizophrenia,dopamine receptor d3
6000,asenapine,schizophrenia,5-hydroxytryptamine receptor 1e
6001,asenapine,schizophrenia,histamine receptor h1
6002,asenapine,schizophrenia,5-hydroxytryptamine receptor 5a
6003,asenapine,schizophrenia,5-hydroxytryptamine receptor 2c
6004,asenapine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
6005,asenapine,schizophrenia,5-hydroxytryptamine receptor 7
6006,asenapine,schizophrenia,5-hydroxytryptamine receptor 6
6007,asenapine,schizophrenia,cholinergic receptor muscarinic 2
6008,asenapine,schizophrenia,tachykinin precursor 1
6009,zuclopenthixol,schizophrenia,histamine receptor h1
6010,zuclopenthixol,schizophrenia,5-hydroxytryptamine receptor 6
6011,zuclopenthixol,schizophrenia,cytochrome p450 family 2 subfamily d member 6
6012,zuclopenthixol,schizophrenia,5-hydroxytryptamine receptor 2a
6013,zuclopenthixol,schizophrenia,adrenoceptor alpha 1a
6014,zuclopenthixol,schizophrenia,adrenoceptor alpha 2a
6015,sertindole,schizophrenia,5-hydroxytryptamine receptor 1d
6016,sertindole,schizophrenia,solute carrier family 6 member 4
6017,sertindole,schizophrenia,dopamine receptor d3
6018,sertindole,schizophrenia,adrenoceptor alpha 2a
6019,sertindole,schizophrenia,cytochrome p450 family 2 subfamily d member 6
6020,sertindole,schizophrenia,5-hydroxytryptamine receptor 1e
6021,sertindole,schizophrenia,potassium voltage-gated channel subfamily h member 2
6022,sertindole,schizophrenia,cytochrome p450 family 3 subfamily a member 4
6023,sertindole,schizophrenia,5-hydroxytryptamine receptor 1b
6024,sertindole,schizophrenia,histamine receptor h1
6025,sertindole,schizophrenia,5-hydroxytryptamine receptor 1f
6026,sertindole,schizophrenia,dopamine receptor d4
6027,sertindole,schizophrenia,5-hydroxytryptamine receptor 1a
6028,sertindole,schizophrenia,5-hydroxytryptamine receptor 6
6029,sertindole,schizophrenia,dopamine receptor d1
6030,sertindole,schizophrenia,tachykinin precursor 1
6031,sertindole,schizophrenia,cholinergic receptor muscarinic 2
6032,sertindole,schizophrenia,5-hydroxytryptamine receptor 7
6033,quetiapine,schizophrenia,adrenoceptor alpha 1a
6034,quetiapine,schizophrenia,cytochrome p450 family 3 subfamily a member 5
6035,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1e
6036,quetiapine,schizophrenia,5-hydroxytryptamine receptor 7
6037,quetiapine,schizophrenia,5-hydroxytryptamine receptor 3a
6038,quetiapine,schizophrenia,adrenoceptor alpha 1d
6039,quetiapine,schizophrenia,dopamine receptor d5
6040,quetiapine,schizophrenia,cholinergic receptor muscarinic 4
6041,quetiapine,schizophrenia,histamine receptor h1
6042,quetiapine,schizophrenia,adrenoceptor alpha 2a
6043,quetiapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
6044,quetiapine,schizophrenia,cholinergic receptor muscarinic 5
6045,quetiapine,schizophrenia,cholinergic receptor muscarinic 1
6046,quetiapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
6047,quetiapine,schizophrenia,dopamine receptor d3
6048,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1b
6049,quetiapine,schizophrenia,adrenoceptor alpha 1b
6050,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1a
6051,quetiapine,schizophrenia,atp binding cassette subfamily b member 1
6052,quetiapine,schizophrenia,dopamine receptor d4
6053,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1d
6054,quetiapine,schizophrenia,cholinergic receptor muscarinic 2
6055,quetiapine,schizophrenia,h1.0 linker histone
6056,quetiapine,schizophrenia,5-hydroxytryptamine receptor 2c
6057,quetiapine,schizophrenia,5-hydroxytryptamine receptor 6
6058,quetiapine,schizophrenia,dopamine receptor d1
6059,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1f
6060,quetiapine,schizophrenia,tachykinin precursor 1
6061,quetiapine,schizophrenia,solute carrier family 6 member 4
6062,quetiapine,schizophrenia,potassium voltage-gated channel subfamily h member 2
6063,lurasidone,schizophrenia,5-hydroxytryptamine receptor 1a
6064,lurasidone,schizophrenia,adrenoceptor alpha 2a
6065,lurasidone,schizophrenia,5-hydroxytryptamine receptor 7
6066,lurasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
6067,lurasidone,schizophrenia,dopamine receptor d4
6068,spiperone,schizophrenia,"major histocompatibility complex, class i, a"
6069,spiperone,schizophrenia,cholinergic receptor muscarinic 2
6070,spiperone,schizophrenia,adrenoceptor alpha 1b
6071,spiperone,schizophrenia,dopamine receptor d5
6072,spiperone,schizophrenia,dopamine receptor d1
6073,spiperone,schizophrenia,5-hydroxytryptamine receptor 6
6074,spiperone,schizophrenia,dopamine receptor d2
6075,spiperone,schizophrenia,5-hydroxytryptamine receptor 5a
6076,spiperone,schizophrenia,5-hydroxytryptamine receptor 1a
6077,spiperone,schizophrenia,5-hydroxytryptamine receptor 1b
6078,spiperone,schizophrenia,adrenoceptor alpha 1a
6079,spiperone,schizophrenia,5-hydroxytryptamine receptor 7
6080,spiperone,schizophrenia,dopamine receptor d4
6081,spiperone,schizophrenia,histamine receptor h1
6082,spiperone,schizophrenia,5-hydroxytryptamine receptor 2c
6083,spiperone,schizophrenia,5-hydroxytryptamine receptor 1f
6084,spiperone,schizophrenia,dopamine receptor d3
6085,spiperone,schizophrenia,adrenoceptor alpha 2a
6086,spiperone,schizophrenia,sigma non-opioid intracellular receptor 1
6087,spiperone,schizophrenia,5-hydroxytryptamine receptor 1d
6088,spiperone,schizophrenia,5-hydroxytryptamine receptor 2a
6089,spiperone,schizophrenia,5-hydroxytryptamine receptor 1e
6090,spiperone,schizophrenia,adrenoceptor alpha 1d
6091,sulpiride,schizophrenia,carbonic anhydrase 2
6092,sulpiride,schizophrenia,dopamine receptor d4
6093,loxapine,schizophrenia,5-hydroxytryptamine receptor 1e
6094,loxapine,schizophrenia,5-hydroxytryptamine receptor 5a
6095,loxapine,schizophrenia,5-hydroxytryptamine receptor 1a
6096,loxapine,schizophrenia,cholinergic receptor muscarinic 5
6097,loxapine,schizophrenia,dopamine receptor d4
6098,loxapine,schizophrenia,histamine receptor h2
6099,loxapine,schizophrenia,dopamine receptor d5
6100,loxapine,schizophrenia,dopamine receptor d1
6101,loxapine,schizophrenia,adrenoceptor alpha 2a
6102,loxapine,schizophrenia,5-hydroxytryptamine receptor 2c
6103,loxapine,schizophrenia,cholinergic receptor muscarinic 1
6104,loxapine,schizophrenia,adrenoceptor alpha 1a
6105,loxapine,schizophrenia,cholinergic receptor muscarinic 2
6106,loxapine,schizophrenia,5-hydroxytryptamine receptor 7
6107,loxapine,schizophrenia,5-hydroxytryptamine receptor 1d
6108,loxapine,schizophrenia,histamine receptor h1
6109,loxapine,schizophrenia,adrenoceptor alpha 1b
6110,loxapine,schizophrenia,5-hydroxytryptamine receptor 3a
6111,loxapine,schizophrenia,5-hydroxytryptamine receptor 6
6112,loxapine,schizophrenia,5-hydroxytryptamine receptor 1b
6113,loxapine,schizophrenia,cholinergic receptor muscarinic 4
6114,loxapine,schizophrenia,solute carrier family 6 member 2
6115,loxapine,schizophrenia,dopamine receptor d3
6116,loxapine,schizophrenia,solute carrier family 6 member 4
6117,loxapine,schizophrenia,solute carrier family 6 member 3
6118,olanzapine,schizophrenia,5-hydroxytryptamine receptor 3a
6119,olanzapine,schizophrenia,adrenoceptor alpha 1b
6120,olanzapine,schizophrenia,5-hydroxytryptamine receptor 6
6121,olanzapine,schizophrenia,cholinergic receptor muscarinic 5
6122,olanzapine,schizophrenia,dopamine receptor d3
6123,olanzapine,schizophrenia,cholinergic receptor muscarinic 1
6124,olanzapine,schizophrenia,5-hydroxytryptamine receptor 7
6125,olanzapine,schizophrenia,dopamine receptor d4
6126,olanzapine,schizophrenia,atp binding cassette subfamily b member 1
6127,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1b
6128,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1a
6129,olanzapine,schizophrenia,dopamine receptor d1
6130,olanzapine,schizophrenia,cholinergic receptor muscarinic 4
6131,olanzapine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
6132,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1e
6133,olanzapine,schizophrenia,histamine receptor h1
6134,olanzapine,schizophrenia,h1.0 linker histone
6135,olanzapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
6136,olanzapine,schizophrenia,5-hydroxytryptamine receptor 2a
6137,olanzapine,schizophrenia,5-hydroxytryptamine receptor 5a
6138,olanzapine,schizophrenia,5-hydroxytryptamine receptor 2c
6139,olanzapine,schizophrenia,histamine receptor h2
6140,olanzapine,schizophrenia,dopamine receptor d5
6141,olanzapine,schizophrenia,adrenoceptor alpha 1a
6142,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1d
6143,olanzapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
6144,olanzapine,schizophrenia,cholinergic receptor muscarinic 2
6145,olanzapine,schizophrenia,adrenoceptor alpha 2a
6146,perphenazine,schizophrenia,5-hydroxytryptamine receptor 1a
6147,perphenazine,schizophrenia,dopamine receptor d1
6148,perphenazine,schizophrenia,5-hydroxytryptamine receptor 2c
6149,perphenazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
6150,perphenazine,schizophrenia,histamine receptor h1
6151,perphenazine,schizophrenia,calmodulin 1
6152,perphenazine,schizophrenia,5-hydroxytryptamine receptor 2a
6153,perphenazine,schizophrenia,5-hydroxytryptamine receptor 6
6154,perphenazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
6155,perphenazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
6156,perphenazine,schizophrenia,5-hydroxytryptamine receptor 7
6157,perphenazine,schizophrenia,adrenoceptor alpha 2a
6158,perphenazine,schizophrenia,adrenoceptor alpha 1a
6159,perphenazine,schizophrenia,cholinergic receptor muscarinic 2
6160,perphenazine,schizophrenia,dopamine receptor d3
6161,perphenazine,schizophrenia,dopamine receptor d4
6162,promazine,schizophrenia,dopamine receptor d4
6163,promazine,schizophrenia,adrenoceptor alpha 1a
6164,promazine,schizophrenia,adrenoceptor alpha 1b
6165,promazine,schizophrenia,5-hydroxytryptamine receptor 2c
6166,promazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
6167,promazine,schizophrenia,cholinergic receptor muscarinic 5
6168,promazine,schizophrenia,adrenoceptor alpha 2a
6169,promazine,schizophrenia,5-hydroxytryptamine receptor 2a
6170,promazine,schizophrenia,dopamine receptor d2
6171,promazine,schizophrenia,cholinergic receptor muscarinic 1
6172,promazine,schizophrenia,adrenoceptor alpha 1d
6173,promazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
6174,promazine,schizophrenia,cholinergic receptor muscarinic 4
6175,promazine,schizophrenia,dopamine receptor d1
6176,promazine,schizophrenia,histamine receptor h1
6177,promazine,schizophrenia,cholinergic receptor muscarinic 2
6178,promazine,schizophrenia,dopamine receptor d3
6179,betamethasone,skin disorder,prostaglandin-endoperoxide synthase 2
6180,prednisolone,skin disorder,serpin family a member 6
6181,prednisone,skin disorder,nuclear receptor subfamily 3 group c member 1
6182,prednisone,skin disorder,albumin
6183,triamcinolone,skin disorder,prostaglandin-endoperoxide synthase 2
6184,triamcinolone,skin disorder,serpin family a member 6
6185,lovastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
6186,simvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
6187,rosuvastatin,stroke disorder,albumin
6188,ramipril,stroke disorder,angiotensin i converting enzyme
6189,fluvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
6190,telmisartan,stroke disorder,angiotensin i converting enzyme
6191,nimodipine,subarachnoid hemorrhage,calcium voltage-gated channel subunit alpha1 c
6192,mesalazine,ulcerative colitis,myeloperoxidase
6193,sulfasalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6194,sulfasalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6195,sulfasalazine,ulcerative colitis,peroxisome proliferator activated receptor gamma
6196,prednisolone,ulcerative colitis,atp binding cassette subfamily b member 1
6197,prednisolone,ulcerative colitis,serpin family a member 6
6198,cortisol,ulcerative colitis,atp binding cassette subfamily b member 1
6199,cortisol,ulcerative colitis,sex hormone binding globulin
6200,cortisol,ulcerative colitis,serpin family a member 6
6201,aminosalicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6202,aminosalicylic acid,ulcerative colitis,phospholipase a2 group iie
6203,aminosalicylic acid,ulcerative colitis,myeloperoxidase
6204,aminosalicylic acid,ulcerative colitis,arachidonate 5-lipoxygenase
6205,aminosalicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6206,balsalazide,ulcerative colitis,peroxisome proliferator activated receptor gamma
6207,balsalazide,ulcerative colitis,arachidonate 5-lipoxygenase
6208,balsalazide,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6209,balsalazide,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6210,tofacitinib,ulcerative colitis,doublecortin like kinase 3
6211,tofacitinib,ulcerative colitis,ribosomal protein s6 kinase a2
6212,tofacitinib,ulcerative colitis,janus kinase 3
6213,tofacitinib,ulcerative colitis,calcium/calmodulin dependent protein kinase ii alpha
6214,tofacitinib,ulcerative colitis,janus kinase 1
6215,tofacitinib,ulcerative colitis,ribosomal protein s6 kinase a6
6216,tofacitinib,ulcerative colitis,tyrosine kinase 2
6217,tofacitinib,ulcerative colitis,bmp2 inducible kinase
6218,tofacitinib,ulcerative colitis,janus kinase 2
6219,salicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6220,salicylic acid,ulcerative colitis,albumin
6221,salicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6222,salicylic acid,ulcerative colitis,atp binding cassette subfamily b member 1
6223,hydroxyurea,melanoma,ribonucleotide reductase regulatory subunit m2
6224,darunavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6225,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 43
6226,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6227,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6228,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6229,zalcitabine,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6230,zalcitabine,hiv infectious disease,albumin
6231,efavirenz,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6232,efavirenz,hiv infectious disease,cytochrome p450 family 46 subfamily a member 1
6233,lopinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6234,delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6235,delavirdine,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6236,delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6237,delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6238,nevirapine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6239,nevirapine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6240,fosamprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6241,atazanavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6242,saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6243,saquinavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6244,saquinavir,hiv infectious disease,albumin
6245,saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6246,saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6247,abacavir,hiv infectious disease,albumin
6248,zidovudine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6249,zidovudine,hiv infectious disease,albumin
6250,amprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6251,amprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6252,nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6253,nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6254,nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6255,nelfinavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6256,tipranavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6257,lamivudine,hiv infectious disease,albumin
6258,emtricitabine,hiv infectious disease,albumin
6259,raltegravir,hiv infectious disease,c-c motif chemokine receptor 1
6260,ritonavir,hiv infectious disease,solute carrier family 47 member 1
6261,ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6262,ritonavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6263,ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6264,ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6265,pemetrexed,malignant pleural mesothelioma,dihydrofolate reductase
6266,pemetrexed,malignant pleural mesothelioma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
6267,pemetrexed,malignant pleural mesothelioma,solute carrier family 46 member 1
6268,pemetrexed,malignant pleural mesothelioma,thymidylate synthetase
6269,dapsone,leprosy,myeloperoxidase
6270,danazol,endometriosis,estrogen receptor 1
6271,danazol,endometriosis,progesterone receptor
6272,danazol,endometriosis,cytochrome p450 family 19 subfamily a member 1
6273,danazol,endometriosis,sex hormone binding globulin
6274,progesterone,endometriosis,androgen receptor
6275,progesterone,endometriosis,nuclear receptor subfamily 3 group c member 2
6276,progesterone,endometriosis,sex hormone binding globulin
6277,progesterone,endometriosis,nuclear receptor subfamily 3 group c member 1
6278,progesterone,endometriosis,estrogen receptor 1
6279,progesterone,endometriosis,serpin family a member 6
6280,medroxyprogesterone,endometriosis,aldo-keto reductase family 1 member c3
6281,medroxyprogesterone,endometriosis,nuclear receptor subfamily 3 group c member 1
6282,medroxyprogesterone,endometriosis,sex hormone binding globulin
6283,medroxyprogesterone,endometriosis,estrogen receptor 1
6284,medroxyprogesterone,endometriosis,androgen receptor
6285,norethisterone,endometriosis,sex hormone binding globulin
6286,levonorgestrel,endometriosis,steroid 5 alpha-reductase 1
6287,levonorgestrel,endometriosis,cytochrome p450 family 19 subfamily a member 1
6288,levonorgestrel,endometriosis,androgen receptor
6289,levonorgestrel,endometriosis,progesterone receptor
6290,levonorgestrel,endometriosis,sex hormone binding globulin
6291,levonorgestrel,endometriosis,estrogen receptor 1
6292,mestranol,endometriosis,estrogen receptor 1
6293,quinine,malaria,cytochrome p450 family 2 subfamily d member 6
6294,quinine,malaria,sodium voltage-gated channel alpha subunit 3
6295,quinine,malaria,sodium voltage-gated channel alpha subunit 1
6296,quinine,malaria,sodium voltage-gated channel alpha subunit 5
6297,quinine,malaria,sodium voltage-gated channel alpha subunit 2
6298,pyrimethamine,malaria,dihydrofolate reductase
6299,pyrimethamine,malaria,cytochrome p450 family 2 subfamily d member 6
6300,citalopram,post-traumatic stress disorder,solute carrier family 6 member 4
6301,fluoxetine,post-traumatic stress disorder,solute carrier family 6 member 4
6302,escitalopram,post-traumatic stress disorder,solute carrier family 6 member 4
6303,venlafaxine,post-traumatic stress disorder,solute carrier family 6 member 4
6304,fluvoxamine,post-traumatic stress disorder,solute carrier family 6 member 4
6305,mirtazapine,post-traumatic stress disorder,solute carrier family 6 member 4
6306,amitriptyline,post-traumatic stress disorder,solute carrier family 6 member 4
6307,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 4
6308,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 1
6309,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 11
6310,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 2
6311,glimepiride,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
6312,nateglinide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6313,nateglinide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6314,nateglinide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6315,nateglinide,type 2 diabetes mellitus,albumin
6316,sitagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6317,troglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6318,alogliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6319,acarbose,type 2 diabetes mellitus,amylase alpha 1c
6320,acarbose,type 2 diabetes mellitus,alpha glucosidase
6321,acarbose,type 2 diabetes mellitus,amylase alpha 1b
6322,acarbose,type 2 diabetes mellitus,sucrase-isomaltase
6323,acarbose,type 2 diabetes mellitus,amylase alpha 1a
6324,pioglitazone,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6325,pioglitazone,type 2 diabetes mellitus,cdgsh iron sulfur domain 1
6326,canagliflozin,type 2 diabetes mellitus,albumin
6327,canagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
6328,canagliflozin,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
6329,canagliflozin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6330,glibenclamide,type 2 diabetes mellitus,albumin
6331,glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
6332,glibenclamide,type 2 diabetes mellitus,carnitine palmitoyltransferase 1a
6333,glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily b member 11
6334,glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
6335,glibenclamide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6336,glibenclamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6337,glibenclamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
6338,glibenclamide,type 2 diabetes mellitus,cdgsh iron sulfur domain 1
6339,glibenclamide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6340,linagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6341,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 3
6342,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a10
6343,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s3
6344,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 2
6345,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit v1
6346,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a12
6347,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b9
6348,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit s5
6349,metformin,type 2 diabetes mellitus,solute carrier family 22 member 3
6350,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit s4
6351,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit ab1
6352,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit c2
6353,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b10
6354,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a6
6355,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a7
6356,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a13
6357,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s7
6358,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 4
6359,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit v2
6360,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 1
6361,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b2
6362,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit v3
6363,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a9
6364,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s1
6365,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b4
6366,metformin,type 2 diabetes mellitus,ndufa4 mitochondrial complex associated like 2
6367,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a11
6368,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b3
6369,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a8
6370,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b8
6371,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit s6
6372,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s8
6373,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a1
6374,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a2
6375,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b1
6376,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit c1
6377,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a5
6378,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b6
6379,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b7
6380,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a3
6381,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b5
6382,metformin,type 2 diabetes mellitus,ndufa4 mitochondrial complex associated
6383,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s2
6384,metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b11
6385,tolazamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
6386,glipizide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6387,glipizide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6388,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 4
6389,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
6390,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 11
6391,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
6392,dapagliflozin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6393,dapagliflozin,type 2 diabetes mellitus,cytochrome p450 family 1 subfamily a member 2
6394,saxagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6395,saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 8
6396,saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 9
6397,chlorpropamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6398,chlorpropamide,type 2 diabetes mellitus,albumin
6399,tolbutamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
6400,tolbutamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6401,tolbutamide,type 2 diabetes mellitus,albumin
6402,glymidine,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
6403,diclofenac,actinic keratosis,c-x-c motif chemokine receptor 1
6404,diclofenac,actinic keratosis,c-x-c motif chemokine ligand 8
6405,masoprocol,actinic keratosis,leukotriene b4 receptor
6406,meclofenamic acid,osteoarthritis,arachidonate 5-lipoxygenase
6407,meclofenamic acid,osteoarthritis,aldo-keto reductase family 1 member c3
6408,tolmetin,osteoarthritis,c-x-c motif chemokine ligand 8
6409,lumiracoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
6410,lumiracoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6411,celecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6412,diclofenac,osteoarthritis,c-x-c motif chemokine receptor 1
6413,diclofenac,osteoarthritis,arachidonate 5-lipoxygenase
6414,diclofenac,osteoarthritis,c-x-c motif chemokine ligand 8
6415,duloxetine,osteoarthritis,solute carrier family 6 member 4
6416,duloxetine,osteoarthritis,solute carrier family 6 member 2
6417,duloxetine,osteoarthritis,histamine receptor h1
6418,nabumetone,osteoarthritis,prostaglandin-endoperoxide synthase 1
6419,nabumetone,osteoarthritis,prostaglandin-endoperoxide synthase 2
6420,ketoprofen,osteoarthritis,c-x-c motif chemokine ligand 8
6421,ketoprofen,osteoarthritis,c-x-c motif chemokine receptor 1
6422,ketoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
6423,ketoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
6424,histamine,osteoarthritis,histamine receptor h4
6425,histamine,osteoarthritis,histamine receptor h1
6426,indomethacin,osteoarthritis,c-x-c motif chemokine ligand 8
6427,indomethacin,osteoarthritis,peroxisome proliferator activated receptor gamma
6428,indomethacin,osteoarthritis,aldo-keto reductase family 1 member c3
6429,salicylic acid,osteoarthritis,aldo-keto reductase family 1 member c1
6430,rofecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6431,ibuprofen,osteoarthritis,c-x-c motif chemokine ligand 8
6432,ibuprofen,osteoarthritis,peroxisome proliferator activated receptor gamma
6433,aspirin,osteoarthritis,heat shock protein family a (hsp70) member 5
6434,aspirin,osteoarthritis,aldo-keto reductase family 1 member c1
6435,naproxen,osteoarthritis,aldo-keto reductase family 1 member c3
6436,meloxicam,osteoarthritis,prostaglandin-endoperoxide synthase 1
6437,valdecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6438,valdecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
6439,pimavanserin,parkinson disease,5-hydroxytryptamine receptor 2a
6440,levodopa,parkinson disease,dopa decarboxylase
6441,levodopa,parkinson disease,dopamine receptor d2
6442,levodopa,parkinson disease,dopamine receptor d5
6443,levodopa,parkinson disease,dopamine receptor d1
6444,levodopa,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6445,levodopa,parkinson disease,dopamine receptor d4
6446,levodopa,parkinson disease,dopamine receptor d3
6447,amantadine,parkinson disease,dopa decarboxylase
6448,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2b
6449,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 3b
6450,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2c
6451,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2a
6452,amantadine,parkinson disease,monoamine oxidase b
6453,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 1
6454,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2d
6455,amantadine,parkinson disease,atp binding cassette subfamily b member 1
6456,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 3a
6457,pramipexole,parkinson disease,adrenoceptor alpha 2b
6458,pramipexole,parkinson disease,dopamine receptor d5
6459,pramipexole,parkinson disease,5-hydroxytryptamine receptor 1a
6460,pramipexole,parkinson disease,dopamine receptor d1
6461,pramipexole,parkinson disease,adrenoceptor alpha 2a
6462,pramipexole,parkinson disease,5-hydroxytryptamine receptor 2a
6463,pramipexole,parkinson disease,adrenoceptor alpha 2c
6464,pramipexole,parkinson disease,5-hydroxytryptamine receptor 7
6465,benzatropine,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6466,benzatropine,parkinson disease,cholinergic receptor muscarinic 2
6467,rasagiline,parkinson disease,5-hydroxytryptamine receptor 6
6468,rasagiline,parkinson disease,monoamine oxidase a
6469,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 6
6470,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 1a
6471,bromocriptine,parkinson disease,dopamine receptor d1
6472,bromocriptine,parkinson disease,adrenoceptor alpha 2a
6473,bromocriptine,parkinson disease,dopamine receptor d4
6474,bromocriptine,parkinson disease,adrenoceptor alpha 1b
6475,bromocriptine,parkinson disease,atp binding cassette subfamily b member 1
6476,bromocriptine,parkinson disease,adrenoceptor alpha 1d
6477,bromocriptine,parkinson disease,adrenoceptor alpha 1a
6478,bromocriptine,parkinson disease,dopamine receptor d5
6479,bromocriptine,parkinson disease,adrenoceptor alpha 2b
6480,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 7
6481,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 2a
6482,bromocriptine,parkinson disease,adrenoceptor beta 1
6483,bromocriptine,parkinson disease,adrenoceptor alpha 2c
6484,bromocriptine,parkinson disease,adrenoceptor beta 2
6485,apomorphine,parkinson disease,adrenoceptor alpha 2c
6486,apomorphine,parkinson disease,adrenoceptor alpha 2a
6487,apomorphine,parkinson disease,adrenoceptor alpha 2b
6488,apomorphine,parkinson disease,adrenoceptor alpha 1d
6489,apomorphine,parkinson disease,dopamine receptor d5
6490,apomorphine,parkinson disease,5-hydroxytryptamine receptor 2a
6491,apomorphine,parkinson disease,dopamine receptor d1
6492,apomorphine,parkinson disease,5-hydroxytryptamine receptor 1a
6493,apomorphine,parkinson disease,adrenoceptor alpha 1b
6494,apomorphine,parkinson disease,adrenoceptor alpha 1a
6495,droxidopa,parkinson disease,adrenoceptor alpha 2b
6496,droxidopa,parkinson disease,adrenoceptor beta 3
6497,droxidopa,parkinson disease,adrenoceptor beta 2
6498,droxidopa,parkinson disease,adrenoceptor alpha 1d
6499,droxidopa,parkinson disease,adrenoceptor alpha 1b
6500,droxidopa,parkinson disease,adrenoceptor alpha 2a
6501,droxidopa,parkinson disease,adrenoceptor alpha 1a
6502,droxidopa,parkinson disease,adrenoceptor beta 1
6503,droxidopa,parkinson disease,dopa decarboxylase
6504,droxidopa,parkinson disease,adrenoceptor alpha 2c
6505,carbidopa,parkinson disease,dopa decarboxylase
6506,selegiline,parkinson disease,atp binding cassette subfamily b member 1
6507,selegiline,parkinson disease,cytochrome p450 family 2 subfamily e member 1
6508,selegiline,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6509,procyclidine,parkinson disease,cholinergic receptor muscarinic 2
6510,procyclidine,parkinson disease,cholinergic receptor muscarinic 4
6511,procyclidine,parkinson disease,cholinergic receptor muscarinic 1
6512,ropinirole,parkinson disease,dopamine receptor d1
6513,ropinirole,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6514,ropinirole,parkinson disease,dopamine receptor d4
6515,ropinirole,parkinson disease,adrenoceptor alpha 2a
6516,ropinirole,parkinson disease,5-hydroxytryptamine receptor 2a
6517,ropinirole,parkinson disease,adrenoceptor alpha 2c
6518,ropinirole,parkinson disease,5-hydroxytryptamine receptor 1a
6519,ropinirole,parkinson disease,dopamine receptor d5
6520,ropinirole,parkinson disease,adrenoceptor alpha 2b
6521,ropinirole,parkinson disease,5-hydroxytryptamine receptor 7
6522,biperiden,parkinson disease,atp binding cassette subfamily b member 1
6523,biperiden,parkinson disease,cholinergic receptor muscarinic 2
6524,biperiden,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6525,biperiden,parkinson disease,cholinergic receptor muscarinic 4
6526,dabrafenib,metastatic melanoma,salt inducible kinase 1
6527,dabrafenib,metastatic melanoma,"fyn proto-oncogene, src family tyrosine kinase"
6528,dabrafenib,metastatic melanoma,cyclin dependent kinase 6
6529,vincristine,rhabdomyosarcoma,tubulin beta 8 class viii
6530,vincristine,rhabdomyosarcoma,tubulin beta 3 class iii
6531,vincristine,rhabdomyosarcoma,tubulin beta 1 class vi
6532,vincristine,rhabdomyosarcoma,tubulin beta 4a class iva
6533,vincristine,rhabdomyosarcoma,tubulin beta 2a class iia
6534,vincristine,rhabdomyosarcoma,tubulin beta 2b class iib
6535,vincristine,rhabdomyosarcoma,tubulin beta 4b class ivb
6536,vincristine,rhabdomyosarcoma,tubulin beta 6 class v
6537,danazol,breast fibrocystic disease,androgen receptor
6538,danazol,breast fibrocystic disease,progesterone receptor
6539,danazol,breast fibrocystic disease,sex hormone binding globulin
6540,danazol,breast fibrocystic disease,gonadotropin releasing hormone receptor
6541,etoposide,non-small cell lung carcinoma,glutathione s-transferase pi 1
6542,etoposide,non-small cell lung carcinoma,cytochrome p450 family 2 subfamily e member 1
6543,etoposide,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6544,vinblastine,non-small cell lung carcinoma,tubulin beta 4a class iva
6545,vinblastine,non-small cell lung carcinoma,tubulin beta 1 class vi
6546,vinblastine,non-small cell lung carcinoma,tubulin beta 8 class viii
6547,vinblastine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6548,vinblastine,non-small cell lung carcinoma,tubulin beta 2b class iib
6549,vinblastine,non-small cell lung carcinoma,tubulin beta 4b class ivb
6550,vinblastine,non-small cell lung carcinoma,tubulin beta class i
6551,vinblastine,non-small cell lung carcinoma,tubulin beta 2a class iia
6552,vinblastine,non-small cell lung carcinoma,tubulin beta 3 class iii
6553,vinblastine,non-small cell lung carcinoma,tubulin beta 6 class v
6554,carboplatin,non-small cell lung carcinoma,nad(p)h quinone dehydrogenase 1
6555,carboplatin,non-small cell lung carcinoma,glutathione s-transferase pi 1
6556,gemcitabine,non-small cell lung carcinoma,ribonucleotide reductase regulatory subunit m2
6557,gemcitabine,non-small cell lung carcinoma,ribonucleotide reductase catalytic subunit m1
6558,gemcitabine,non-small cell lung carcinoma,"dna polymerase epsilon, catalytic subunit"
6559,gemcitabine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6560,gemcitabine,non-small cell lung carcinoma,"dna polymerase delta 1, catalytic subunit"
6561,gemcitabine,non-small cell lung carcinoma,cytidine/uridine monophosphate kinase 1
6562,gemcitabine,non-small cell lung carcinoma,"dna polymerase alpha 1, catalytic subunit"
6563,gemcitabine,non-small cell lung carcinoma,thymidylate synthetase
6564,ifosfamide,non-small cell lung carcinoma,cytochrome p450 family 2 subfamily a member 6
6565,gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6566,gefitinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6567,gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
6568,gefitinib,non-small cell lung carcinoma,serine/threonine kinase 10
6569,gefitinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6570,gefitinib,non-small cell lung carcinoma,ste20 like kinase
6571,gefitinib,non-small cell lung carcinoma,nuak family kinase 2
6572,gefitinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6573,gefitinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6574,gefitinib,non-small cell lung carcinoma,eph receptor b6
6575,gefitinib,non-small cell lung carcinoma,cyclin g associated kinase
6576,gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6577,gefitinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6578,gefitinib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
6579,gefitinib,non-small cell lung carcinoma,erb-b2 receptor tyrosine kinase 2
6580,docetaxel,non-small cell lung carcinoma,epidermal growth factor receptor
6581,docetaxel,non-small cell lung carcinoma,tubulin beta 6 class v
6582,docetaxel,non-small cell lung carcinoma,tubulin beta 2b class iib
6583,docetaxel,non-small cell lung carcinoma,tubulin beta 2a class iia
6584,docetaxel,non-small cell lung carcinoma,tubulin beta class i
6585,docetaxel,non-small cell lung carcinoma,tubulin beta 3 class iii
6586,docetaxel,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6587,docetaxel,non-small cell lung carcinoma,tubulin beta 4a class iva
6588,docetaxel,non-small cell lung carcinoma,tubulin beta 4b class ivb
6589,docetaxel,non-small cell lung carcinoma,tubulin beta 8 class viii
6590,paclitaxel,non-small cell lung carcinoma,tubulin beta 2b class iib
6591,paclitaxel,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6592,paclitaxel,non-small cell lung carcinoma,tubulin beta 6 class v
6593,paclitaxel,non-small cell lung carcinoma,tubulin beta class i
6594,paclitaxel,non-small cell lung carcinoma,tubulin beta 3 class iii
6595,paclitaxel,non-small cell lung carcinoma,tubulin beta 8 class viii
6596,paclitaxel,non-small cell lung carcinoma,tubulin beta 4a class iva
6597,paclitaxel,non-small cell lung carcinoma,tubulin beta 2a class iia
6598,paclitaxel,non-small cell lung carcinoma,tubulin beta 4b class ivb
6599,pemetrexed,non-small cell lung carcinoma,solute carrier family 46 member 1
6600,irinotecan,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6601,irinotecan,non-small cell lung carcinoma,dna topoisomerase i
6602,ceritinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6603,ceritinib,non-small cell lung carcinoma,protein tyrosine kinase 2
6604,ceritinib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
6605,ceritinib,non-small cell lung carcinoma,cdc like kinase 1
6606,ceritinib,non-small cell lung carcinoma,fer tyrosine kinase
6607,ceritinib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
6608,ceritinib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
6609,ceritinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6610,vinorelbine,non-small cell lung carcinoma,tubulin beta 2b class iib
6611,vinorelbine,non-small cell lung carcinoma,tubulin beta 6 class v
6612,vinorelbine,non-small cell lung carcinoma,tubulin beta 1 class vi
6613,vinorelbine,non-small cell lung carcinoma,tubulin beta 2a class iia
6614,vinorelbine,non-small cell lung carcinoma,tubulin beta 4a class iva
6615,vinorelbine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6616,vinorelbine,non-small cell lung carcinoma,tubulin beta class i
6617,vinorelbine,non-small cell lung carcinoma,tubulin beta 4b class ivb
6618,vinorelbine,non-small cell lung carcinoma,tubulin beta 8 class viii
6619,vinorelbine,non-small cell lung carcinoma,tubulin beta 3 class iii
6620,mitomycin c,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6621,sotorasib,non-small cell lung carcinoma,"kras proto-oncogene, gtpase"
6622,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6623,nintedanib,non-small cell lung carcinoma,alk receptor tyrosine kinase
6624,nintedanib,non-small cell lung carcinoma,fibroblast growth factor receptor 3
6625,nintedanib,non-small cell lung carcinoma,kinase insert domain receptor
6626,nintedanib,non-small cell lung carcinoma,cdc like kinase 1
6627,nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 3
6628,nintedanib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6629,nintedanib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6630,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 1
6631,nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 1
6632,nintedanib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
6633,nintedanib,non-small cell lung carcinoma,nuak family kinase 2
6634,nintedanib,non-small cell lung carcinoma,insulin receptor related receptor
6635,nintedanib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
6636,nintedanib,non-small cell lung carcinoma,cyclin dependent kinase 16
6637,nintedanib,non-small cell lung carcinoma,eph receptor b6
6638,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 16
6639,nintedanib,non-small cell lung carcinoma,rio kinase 1
6640,nintedanib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
6641,nintedanib,non-small cell lung carcinoma,ste20 like kinase
6642,nintedanib,non-small cell lung carcinoma,platelet derived growth factor receptor beta
6643,nintedanib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
6644,nintedanib,non-small cell lung carcinoma,maternal embryonic leucine zipper kinase
6645,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 2
6646,nintedanib,non-small cell lung carcinoma,cdc like kinase 4
6647,nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
6648,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 11
6649,nintedanib,non-small cell lung carcinoma,srsf protein kinase 3
6650,nintedanib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
6651,nintedanib,non-small cell lung carcinoma,testis specific serine kinase 1b
6652,nintedanib,non-small cell lung carcinoma,ttk protein kinase
6653,nintedanib,non-small cell lung carcinoma,platelet derived growth factor receptor alpha
6654,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 4
6655,nintedanib,non-small cell lung carcinoma,protein kinase cgmp-dependent 1
6656,nintedanib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
6657,nintedanib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6658,nintedanib,non-small cell lung carcinoma,bmp2 inducible kinase
6659,nintedanib,non-small cell lung carcinoma,ret proto-oncogene
6660,nintedanib,non-small cell lung carcinoma,pre-mrna processing factor kinase prp4k
6661,nintedanib,non-small cell lung carcinoma,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
6662,nintedanib,non-small cell lung carcinoma,protein tyrosine kinase 2
6663,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 10
6664,nintedanib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
6665,nintedanib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6666,nintedanib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6667,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 7
6668,nintedanib,non-small cell lung carcinoma,fibroblast growth factor receptor 1
6669,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6670,nintedanib,non-small cell lung carcinoma,fer tyrosine kinase
6671,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
6672,nintedanib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6673,nintedanib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
6674,crizotinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6675,crizotinib,non-small cell lung carcinoma,serine/threonine kinase 4
6676,crizotinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6677,crizotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6678,crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6679,crizotinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6680,crizotinib,non-small cell lung carcinoma,ste20 like kinase
6681,crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 1
6682,crizotinib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
6683,crizotinib,non-small cell lung carcinoma,serine/threonine kinase 10
6684,crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6685,crizotinib,non-small cell lung carcinoma,insulin receptor related receptor
6686,crizotinib,non-small cell lung carcinoma,bmp2 inducible kinase
6687,crizotinib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
6688,crizotinib,non-small cell lung carcinoma,fer tyrosine kinase
6689,crizotinib,non-small cell lung carcinoma,nuak family kinase 2
6690,crizotinib,non-small cell lung carcinoma,eph receptor b6
6691,crizotinib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
6692,crizotinib,non-small cell lung carcinoma,protein tyrosine kinase 2
6693,crizotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
6694,crizotinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6695,crizotinib,non-small cell lung carcinoma,srsf protein kinase 3
6696,crizotinib,non-small cell lung carcinoma,ret proto-oncogene
6697,crizotinib,non-small cell lung carcinoma,fibroblast growth factor receptor 3
6698,crizotinib,non-small cell lung carcinoma,epidermal growth factor receptor
6699,crizotinib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
6700,crizotinib,non-small cell lung carcinoma,rio kinase 1
6701,crizotinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6702,crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 3
6703,crizotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
6704,crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
6705,crizotinib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
6706,crizotinib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
6707,crizotinib,non-small cell lung carcinoma,macrophage stimulating 1 receptor
6708,crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 7
6709,lorlatinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6710,lorlatinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
6711,lorlatinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
6712,alectinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6713,alectinib,non-small cell lung carcinoma,acyl-coa oxidase 1
6714,alectinib,non-small cell lung carcinoma,cyclin g associated kinase
6715,alectinib,non-small cell lung carcinoma,fer tyrosine kinase
6716,alectinib,non-small cell lung carcinoma,cdc like kinase 1
6717,erlotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6718,erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6719,erlotinib,non-small cell lung carcinoma,serine/threonine kinase 10
6720,erlotinib,non-small cell lung carcinoma,ste20 like kinase
6721,erlotinib,non-small cell lung carcinoma,solute carrier organic anion transporter family member 2b1
6722,erlotinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6723,erlotinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6724,erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
6725,erlotinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
6726,erlotinib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
6727,erlotinib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
6728,erlotinib,non-small cell lung carcinoma,platelet derived growth factor receptor beta
6729,erlotinib,non-small cell lung carcinoma,ttk protein kinase
6730,erlotinib,non-small cell lung carcinoma,cyclin g associated kinase
6731,erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6732,erlotinib,non-small cell lung carcinoma,erb-b2 receptor tyrosine kinase 2
6733,erlotinib,non-small cell lung carcinoma,fibroblast growth factor receptor 2
6734,erlotinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6735,erlotinib,non-small cell lung carcinoma,ret proto-oncogene
6736,erlotinib,non-small cell lung carcinoma,eph receptor b6
6737,erlotinib,non-small cell lung carcinoma,platelet derived growth factor receptor alpha
6738,erlotinib,non-small cell lung carcinoma,bmp2 inducible kinase
6739,erlotinib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
6740,erlotinib,non-small cell lung carcinoma,srsf protein kinase 3
6741,erlotinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6742,erlotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 4
6743,erlotinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6744,erlotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
6745,erlotinib,non-small cell lung carcinoma,kinase insert domain receptor
6746,cefmetazole,pneumonia,albumin
6747,minocycline,pneumonia,caspase 1
6748,minocycline,pneumonia,interleukin 1 beta
6749,cefalotin,pneumonia,albumin
6750,tetracycline,pneumonia,albumin
6751,ofloxacin,pneumonia,albumin
6752,cefonicid,pneumonia,albumin
6753,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1d
6754,aripiprazole,autism spectrum disorder,dopamine receptor d3
6755,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1a
6756,aripiprazole,autism spectrum disorder,dopamine receptor d1
6757,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 3a
6758,aripiprazole,autism spectrum disorder,cholinergic receptor muscarinic 4
6759,aripiprazole,autism spectrum disorder,solute carrier family 6 member 4
6760,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1b
6761,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 2a
6762,aripiprazole,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
6763,aripiprazole,autism spectrum disorder,dopamine receptor d2
6764,aripiprazole,autism spectrum disorder,adrenoceptor beta 2
6765,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 5a
6766,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1b
6767,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1d
6768,risperidone,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
6769,risperidone,autism spectrum disorder,dopamine receptor d1
6770,risperidone,autism spectrum disorder,dopamine receptor d3
6771,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1a
6772,risperidone,autism spectrum disorder,solute carrier family 6 member 4
6773,risperidone,autism spectrum disorder,cholinergic receptor muscarinic 4
6774,risperidone,autism spectrum disorder,neutrophil cytosolic factor 1
6775,risperidone,autism spectrum disorder,adrenoceptor beta 2
6776,paliperidone,autism spectrum disorder,dopamine receptor d2
6777,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1d
6778,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1a
6779,paliperidone,autism spectrum disorder,dopamine receptor d3
6780,paliperidone,autism spectrum disorder,dopamine receptor d1
6781,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 2a
6782,paliperidone,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
6783,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1b
6784,paliperidone,autism spectrum disorder,adrenoceptor beta 2
6785,triamcinolone,inflammatory bowel disease,prostaglandin-endoperoxide synthase 2
6786,triamcinolone,inflammatory bowel disease,serpin family a member 6
6787,betamethasone,inflammatory bowel disease,prostaglandin-endoperoxide synthase 2
6788,betamethasone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6789,cortisol,inflammatory bowel disease,atp binding cassette subfamily b member 1
6790,cortisol,inflammatory bowel disease,sex hormone binding globulin
6791,cortisol,inflammatory bowel disease,serpin family a member 6
6792,prednisone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
6793,prednisone,inflammatory bowel disease,albumin
6794,prednisone,inflammatory bowel disease,hydroxysteroid 11-beta dehydrogenase 1
6795,prednisone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6796,methylprednisolone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6797,cromoglicic acid,inflammatory bowel disease,g protein-coupled receptor 35
6798,prednisolone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6799,prednisolone,inflammatory bowel disease,serpin family a member 6
6800,theophylline,lung disorder,adenosine a2a receptor
6801,theophylline,lung disorder,adenosine a2b receptor
6802,theophylline,lung disorder,phosphodiesterase 4a
6803,theophylline,lung disorder,histone deacetylase 2
6804,theophylline,lung disorder,phosphodiesterase 3a
6805,theophylline,lung disorder,adenosine a1 receptor
6806,theophylline,lung disorder,adenosine a3 receptor
6807,phenazone,migraine disorder,prostaglandin-endoperoxide synthase 1
6808,phenazone,migraine disorder,prostaglandin-endoperoxide synthase 2
6809,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha6
6810,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha2
6811,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha1
6812,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha4
6813,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit gamma2
6814,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha3
6815,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha5
6816,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6817,caffeine,migraine disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"
6818,caffeine,migraine disorder,phosphodiesterase 4b
6819,caffeine,migraine disorder,adenosine a1 receptor
6820,caffeine,migraine disorder,atm serine/threonine kinase
6821,diphenhydramine,migraine disorder,prostaglandin-endoperoxide synthase 1
6822,diphenhydramine,migraine disorder,solute carrier family 6 member 4
6823,lisuride,migraine disorder,adrenoceptor alpha 2c
6824,lisuride,migraine disorder,5-hydroxytryptamine receptor 1a
6825,lisuride,migraine disorder,5-hydroxytryptamine receptor 2b
6826,lisuride,migraine disorder,5-hydroxytryptamine receptor 2c
6827,lisuride,migraine disorder,5-hydroxytryptamine receptor 1d
6828,lisuride,migraine disorder,5-hydroxytryptamine receptor 2a
6829,lisuride,migraine disorder,dopamine receptor d4
6830,lisuride,migraine disorder,5-hydroxytryptamine receptor 1b
6831,lisuride,migraine disorder,adrenoceptor alpha 1b
6832,lisuride,migraine disorder,dopamine receptor d5
6833,lisuride,migraine disorder,adrenoceptor alpha 2b
6834,lisuride,migraine disorder,adrenoceptor alpha 2a
6835,lisuride,migraine disorder,adrenoceptor alpha 1d
6836,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6837,paracetamol,migraine disorder,transient receptor potential cation channel subfamily v member 1
6838,paracetamol,migraine disorder,cannabinoid receptor 1
6839,rofecoxib,migraine disorder,prostaglandin-endoperoxide synthase 1
6840,aspirin,migraine disorder,endothelin receptor type a
6841,aspirin,migraine disorder,tumor protein p53
6842,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1e
6843,eletriptan,migraine disorder,5-hydroxytryptamine receptor 2b
6844,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1f
6845,eletriptan,migraine disorder,prostaglandin-endoperoxide synthase 1
6846,eletriptan,migraine disorder,5-hydroxytryptamine receptor 7
6847,ergotamine,migraine disorder,5-hydroxytryptamine receptor 2c
6848,ergotamine,migraine disorder,5-hydroxytryptamine receptor 2a
6849,ergotamine,migraine disorder,5-hydroxytryptamine receptor 2b
6850,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1e
6851,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1b
6852,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1f
6853,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1a
6854,ergotamine,migraine disorder,5-hydroxytryptamine receptor 5a
6855,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6856,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1a
6857,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 6
6858,dihydroergotamine,migraine disorder,adrenoceptor alpha 2a
6859,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 2b
6860,naproxen,migraine disorder,aldo-keto reductase family 1 member c3
6861,olanzapine,migraine disorder,5-hydroxytryptamine receptor 3a
6862,olanzapine,migraine disorder,adrenoceptor alpha 1b
6863,olanzapine,migraine disorder,5-hydroxytryptamine receptor 6
6864,olanzapine,migraine disorder,5-hydroxytryptamine receptor 7
6865,olanzapine,migraine disorder,dopamine receptor d4
6866,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1b
6867,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1a
6868,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1e
6869,olanzapine,migraine disorder,5-hydroxytryptamine receptor 2b
6870,olanzapine,migraine disorder,adrenoceptor alpha 2b
6871,olanzapine,migraine disorder,adrenoceptor alpha 2c
6872,olanzapine,migraine disorder,5-hydroxytryptamine receptor 2a
6873,olanzapine,migraine disorder,5-hydroxytryptamine receptor 5a
6874,olanzapine,migraine disorder,5-hydroxytryptamine receptor 2c
6875,olanzapine,migraine disorder,dopamine receptor d5
6876,olanzapine,migraine disorder,adrenoceptor alpha 1a
6877,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1d
6878,olanzapine,migraine disorder,adrenoceptor alpha 2a
6879,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1f
6880,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 3a
6881,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6882,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 2c
6883,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 2a
6884,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 7
6885,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1e
6886,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 6
6887,prochlorperazine,migraine disorder,5-hydroxytryptamine receptor 2c
6888,prochlorperazine,migraine disorder,adrenoceptor alpha 1a
6889,prochlorperazine,migraine disorder,5-hydroxytryptamine receptor 1a
6890,prochlorperazine,migraine disorder,adrenoceptor alpha 2a
6891,prochlorperazine,migraine disorder,dopamine receptor d4
6892,dabigatran etexilate,pulmonary embolism,"coagulation factor ii, thrombin"
6893,rivaroxaban,pulmonary embolism,coagulation factor x
6894,phentolamine,peripheral vascular disease,adrenoceptor alpha 2a
6895,phentolamine,peripheral vascular disease,adrenoceptor alpha 2c
6896,phentolamine,peripheral vascular disease,adrenoceptor alpha 2b
6897,papaverine,peripheral vascular disease,phosphodiesterase 3b
6898,papaverine,peripheral vascular disease,phosphodiesterase 3a
6899,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 2
6900,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 3
6901,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 4
6902,ergocalciferol,osteoporosis,cytochrome p450 family 24 subfamily a member 1
6903,ergocalciferol,osteoporosis,cytochrome p450 family 27 subfamily a member 1
6904,ergocalciferol,osteoporosis,vitamin d receptor
6905,benzocaine,osteoporosis,sodium voltage-gated channel alpha subunit 4
6906,zoledronic acid,osteoporosis,carbonic anhydrase 2
6907,dapagliflozin,chronic kidney disease,solute carrier family 5 member 4
6908,dapagliflozin,chronic kidney disease,cytochrome p450 family 1 subfamily a member 1
6909,dapagliflozin,chronic kidney disease,solute carrier family 5 member 11
6910,dapagliflozin,chronic kidney disease,solute carrier family 5 member 2
6911,dapagliflozin,chronic kidney disease,cytochrome p450 family 3 subfamily a member 4
6912,dapagliflozin,chronic kidney disease,atp binding cassette subfamily b member 1
6913,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 5
6914,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 3
6915,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 3
6916,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 3
6917,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 4
6918,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 3
6919,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 5
6920,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 4
6921,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 2
6922,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily v member 2
6923,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily b member 1
6924,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 2
6925,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 1
6926,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 2
6927,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 2
6928,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 6
6929,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 4
6930,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 4
6931,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 1
6932,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 7
6933,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 8
6934,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 6
6935,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 1
6936,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 5
6937,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 2
6938,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily b member 2
6939,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 4
6940,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily f member 1
6941,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 1
6942,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily v member 1
6943,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 10
6944,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 3
6945,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 1
6946,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 3
6947,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 7
6948,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 1
6949,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 2
6950,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 3
6951,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 1
6952,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 2
6953,prednisolone,multiple sclerosis,serpin family a member 6
6954,triamcinolone,multiple sclerosis,butyrylcholinesterase
6955,triamcinolone,multiple sclerosis,serpin family a member 6
6956,prednisone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
6957,prednisone,multiple sclerosis,albumin
6958,betamethasone,multiple sclerosis,progesterone receptor
6959,cortisol,multiple sclerosis,sex hormone binding globulin
6960,cortisol,multiple sclerosis,serpin family a member 6
6961,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6962,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6963,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6964,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6965,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6966,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6967,clonidine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6968,carbamazepine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6969,desipramine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6970,desipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6971,desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6972,desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6973,desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6974,desipramine,"attention deficit hyperactivity disorder, inattentive type",sphingomyelin phosphodiesterase 1
6975,desipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d1
6976,desipramine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6977,dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6978,guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6979,guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
6980,guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
6981,amphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase b
6982,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6983,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6984,amphetamine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6985,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6986,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6987,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 1b
6988,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6989,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6990,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
6991,methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6992,methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6993,methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6994,imipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6995,imipramine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6996,imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6997,imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6998,imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6999,imipramine,"attention deficit hyperactivity disorder, inattentive type",potassium voltage-gated channel subfamily d member 2
7000,imipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d3
7001,imipramine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
7002,bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
7003,bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
7004,bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
7005,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
7006,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
7007,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
7008,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
7009,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
7010,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
7011,diclofenac,ankylosing spondylitis,c-x-c motif chemokine receptor 1
7012,diclofenac,ankylosing spondylitis,c-x-c motif chemokine ligand 8
7013,ketoprofen,ankylosing spondylitis,c-x-c motif chemokine ligand 8
7014,ketoprofen,ankylosing spondylitis,c-x-c motif chemokine receptor 1
7015,ketoprofen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7016,ketoprofen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7017,cortisol,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
7018,cortisol,ankylosing spondylitis,sex hormone binding globulin
7019,cortisol,ankylosing spondylitis,serpin family a member 6
7020,meloxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7021,meloxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7022,prednisolone,ankylosing spondylitis,serpin family a member 6
7023,nabumetone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7024,nabumetone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7025,celecoxib,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7026,etodolac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7027,etodolac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7028,triamcinolone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7029,triamcinolone,ankylosing spondylitis,serpin family a member 6
7030,oxaprozin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7031,oxaprozin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7032,indomethacin,ankylosing spondylitis,c-x-c motif chemokine ligand 8
7033,indomethacin,ankylosing spondylitis,aldo-keto reductase family 1 member c3
7034,tolmetin,ankylosing spondylitis,c-x-c motif chemokine ligand 8
7035,tolmetin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7036,tolmetin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7037,prednisone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
7038,naproxen,ankylosing spondylitis,aldo-keto reductase family 1 member c3
7039,meclofenamic acid,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7040,meclofenamic acid,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7041,meclofenamic acid,ankylosing spondylitis,aldo-keto reductase family 1 member c3
7042,betamethasone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7043,betamethasone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
7044,piroxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
7045,piroxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
7046,misoprostol (methyl ester),ankylosing spondylitis,prostaglandin e receptor 4
7047,cladribine,relapsing-remitting multiple sclerosis,ribonucleotide reductase catalytic subunit m1
7048,mitoxantrone,relapsing-remitting multiple sclerosis,solute carrier family 47 member 2
7049,mitoxantrone,relapsing-remitting multiple sclerosis,solute carrier family 47 member 1
7050,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 3
7051,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 5
7052,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 1
7053,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 4
7054,azelastine,seasonal allergic rhinitis,adrenoceptor alpha 1b
7055,azelastine,seasonal allergic rhinitis,adrenoceptor alpha 1a
7056,pseudoephedrine,seasonal allergic rhinitis,adrenoceptor alpha 2a
7057,methylprednisolone,seasonal allergic rhinitis,nuclear receptor subfamily 3 group c member 1
7058,promethazine,seasonal allergic rhinitis,adrenoceptor alpha 1a
7059,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 2a
7060,triamcinolone,eye disorder,serpin family a member 6
7061,cortisol,eye disorder,nuclear receptor subfamily 3 group c member 1
7062,cortisol,eye disorder,sex hormone binding globulin
7063,cortisol,eye disorder,serpin family a member 6
7064,prednisolone,eye disorder,serpin family a member 6
7065,bimatoprost,open-angle glaucoma,prostaglandin f receptor
7066,pilocarpine,open-angle glaucoma,cholinergic receptor muscarinic 3
7067,betaxolol,open-angle glaucoma,adrenoceptor beta 2
7068,brinzolamide,open-angle glaucoma,carbonic anhydrase 12
7069,brinzolamide,open-angle glaucoma,carbonic anhydrase 14
7070,brinzolamide,open-angle glaucoma,carbonic anhydrase 7
7071,brinzolamide,open-angle glaucoma,carbonic anhydrase 1
7072,brinzolamide,open-angle glaucoma,carbonic anhydrase 4
7073,brinzolamide,open-angle glaucoma,carbonic anhydrase 3
7074,physostigmine,open-angle glaucoma,butyrylcholinesterase
7075,diclofenamide,open-angle glaucoma,carbonic anhydrase 14
7076,diclofenamide,open-angle glaucoma,carbonic anhydrase 3
7077,brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 1a
7078,dipivefrine,open-angle glaucoma,adrenoceptor alpha 1a
7079,dipivefrine,open-angle glaucoma,adrenoceptor alpha 2a
7080,dipivefrine,open-angle glaucoma,adrenoceptor beta 2
7081,dipivefrine,open-angle glaucoma,acetylcholinesterase (yt blood group)
7082,dipivefrine,open-angle glaucoma,adrenoceptor alpha 2b
7083,dipivefrine,open-angle glaucoma,butyrylcholinesterase
7084,dipivefrine,open-angle glaucoma,adrenoceptor alpha 2c
7085,dorzolamide,open-angle glaucoma,carbonic anhydrase 7
7086,dorzolamide,open-angle glaucoma,carbonic anhydrase 12
7087,dorzolamide,open-angle glaucoma,carbonic anhydrase 14
7088,dorzolamide,open-angle glaucoma,carbonic anhydrase 4
7089,dorzolamide,open-angle glaucoma,carbonic anhydrase 1
7090,dorzolamide,open-angle glaucoma,carbonic anhydrase 3
7091,apraclonidine,open-angle glaucoma,adrenoceptor alpha 2c
7092,apraclonidine,open-angle glaucoma,adrenoceptor alpha 2b
7093,apraclonidine,open-angle glaucoma,adrenoceptor alpha 1a
7094,clonidine,open-angle glaucoma,adrenoceptor alpha 1d
7095,clonidine,open-angle glaucoma,adrenoceptor alpha 1b
7096,clonidine,open-angle glaucoma,adrenoceptor alpha 1a
7097,paclitaxel,open-angle glaucoma,tubulin beta 2b class iib
7098,paclitaxel,open-angle glaucoma,tubulin beta 1 class vi
7099,paclitaxel,open-angle glaucoma,tubulin beta 6 class v
7100,paclitaxel,open-angle glaucoma,tubulin beta class i
7101,paclitaxel,open-angle glaucoma,tubulin beta 3 class iii
7102,paclitaxel,open-angle glaucoma,tubulin beta 8 class viii
7103,paclitaxel,open-angle glaucoma,cytochrome p450 family 1 subfamily b member 1
7104,paclitaxel,open-angle glaucoma,tubulin beta 4a class iva
7105,paclitaxel,open-angle glaucoma,tubulin beta 2a class iia
7106,paclitaxel,open-angle glaucoma,tubulin beta 4b class ivb
7107,timolol,open-angle glaucoma,adrenoceptor beta 1
7108,timolol,open-angle glaucoma,adrenoceptor beta 2
7109,(-)-adrenaline,open-angle glaucoma,adrenoceptor beta 1
7110,(-)-adrenaline,open-angle glaucoma,adrenoceptor beta 2
7111,(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 1a
7112,(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 1b
7113,(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 2b
7114,(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 1d
7115,(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 2c
7116,acetazolamide,open-angle glaucoma,carbonic anhydrase 11
7117,vismodegib,skin basal cell carcinoma,"smoothened, frizzled class receptor"
7118,vismodegib,skin basal cell carcinoma,sonic hedgehog signaling molecule
7119,sonidegib,skin basal cell carcinoma,"smoothened, frizzled class receptor"
7120,fenofibrate,hypertriglyceridemia,peroxisome proliferator activated receptor alpha
7121,simvastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
7122,epa,hypertriglyceridemia,peroxisome proliferator activated receptor gamma
7123,nicotinic acid,hypertriglyceridemia,hydroxycarboxylic acid receptor 2
7124,nicotinic acid,hypertriglyceridemia,hydroxycarboxylic acid receptor 3
7125,lovastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
7126,budesonide,eosinophilic esophagitis,nuclear receptor subfamily 3 group c member 1
7127,tadalafil,erectile dysfunction,phosphodiesterase 11a
7128,vardenafil,erectile dysfunction,phosphodiesterase 11a
7129,pge1,erectile dysfunction,prostaglandin e receptor 1
7130,carbimazole,graves disease,thyroid peroxidase
7131,clomiphene,male infertility,cytochrome p450 family 19 subfamily a member 1
7132,clomiphene,male infertility,estrogen receptor 1
7133,clomiphene,male infertility,cytochrome p450 family 1 subfamily a member 1
7134,prednisolone,nephrotic syndrome,serpin family a member 6
7135,triamcinolone,nephrotic syndrome,serpin family a member 6
7136,cortisol,nephrotic syndrome,sex hormone binding globulin
7137,cortisol,nephrotic syndrome,serpin family a member 6
7138,prednisone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
7139,prednisone,nephrotic syndrome,albumin
7140,alendronate,bone paget disease,farnesyl diphosphate synthase
7141,alendronate,bone paget disease,atpase h+ transporting v1 subunit a
7142,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
7143,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
7144,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
7145,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
7146,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
7147,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
7148,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
7149,escitalopram,panic disorder,solute carrier family 6 member 4
7150,escitalopram,panic disorder,solute carrier family 6 member 2
7151,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
7152,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
7153,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
7154,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
7155,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
7156,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
7157,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
7158,venlafaxine,panic disorder,adrenoceptor alpha 2a
7159,venlafaxine,panic disorder,5-hydroxytryptamine receptor 2a
7160,paroxetine,panic disorder,5-hydroxytryptamine receptor 2a
7161,paroxetine,panic disorder,solute carrier family 6 member 2
7162,paroxetine,panic disorder,5-hydroxytryptamine receptor 1a
7163,paroxetine,panic disorder,adrenoceptor alpha 2a
7164,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
7165,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
7166,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
7167,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
7168,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
7169,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
7170,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
7171,desvenlafaxine,panic disorder,solute carrier family 6 member 2
7172,desvenlafaxine,panic disorder,solute carrier family 6 member 4
7173,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
7174,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
7175,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
7176,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
7177,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
7178,clomipramine,panic disorder,adrenoceptor alpha 2a
7179,clomipramine,panic disorder,5-hydroxytryptamine receptor 2a
7180,clomipramine,panic disorder,solute carrier family 6 member 2
7181,clomipramine,panic disorder,solute carrier family 6 member 4
7182,desipramine,panic disorder,5-hydroxytryptamine receptor 1a
7183,desipramine,panic disorder,5-hydroxytryptamine receptor 2a
7184,desipramine,panic disorder,solute carrier family 6 member 4
7185,desipramine,panic disorder,solute carrier family 6 member 2
7186,desipramine,panic disorder,adrenoceptor alpha 2a
7187,citalopram,panic disorder,solute carrier family 6 member 2
7188,citalopram,panic disorder,solute carrier family 6 member 4
7189,sertraline,panic disorder,solute carrier family 6 member 2
7190,sertraline,panic disorder,monoamine oxidase a
7191,fluoxetine,panic disorder,5-hydroxytryptamine receptor 2a
7192,fluoxetine,panic disorder,solute carrier family 6 member 2
7193,fluoxetine,panic disorder,adrenoceptor alpha 2a
7194,imipramine,panic disorder,5-hydroxytryptamine receptor 2a
7195,imipramine,panic disorder,solute carrier family 6 member 2
7196,imipramine,panic disorder,solute carrier family 6 member 4
7197,imipramine,panic disorder,5-hydroxytryptamine receptor 1a
7198,imipramine,panic disorder,5-hydroxytryptamine receptor 7
7199,imipramine,panic disorder,adrenoceptor alpha 2a
7200,oxcarbazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 5
7201,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 3
7202,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 1
7203,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 5
7204,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 2
7205,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 8
7206,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 4
7207,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 9
7208,carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 4
7209,carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 5
7210,carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 9
7211,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
7212,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
7213,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
7214,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
7215,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
7216,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
7217,primidone,focal epilepsy,glutamate ionotropic receptor ampa type subunit 2
7218,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
7219,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
7220,ropinirole,restless legs syndrome,dopamine receptor d1
7221,ropinirole,restless legs syndrome,dopamine receptor d4
7222,ropinirole,restless legs syndrome,dopamine receptor d2
7223,ropinirole,restless legs syndrome,dopamine receptor d3
7224,ropinirole,restless legs syndrome,dopamine receptor d5
7225,pramipexole,restless legs syndrome,dopamine receptor d5
7226,pramipexole,restless legs syndrome,dopamine receptor d1
7227,levodopa,restless legs syndrome,dopamine receptor d2
7228,levodopa,restless legs syndrome,dopamine receptor d5
7229,levodopa,restless legs syndrome,dopamine receptor d1
7230,levodopa,restless legs syndrome,dopamine receptor d4
7231,levodopa,restless legs syndrome,dopamine receptor d3
7232,gabapentin,restless legs syndrome,calcium voltage-gated channel auxiliary subunit alpha2delta 2
7233,indomethacin,gout,solute carrier family 22 member 11
7234,indomethacin,gout,c-x-c motif chemokine ligand 8
7235,indomethacin,gout,atp binding cassette subfamily c member 1 (abcc1 blood group)
7236,indomethacin,gout,solute carrier family 22 member 6
7237,indomethacin,gout,aldo-keto reductase family 1 member c3
7238,indomethacin,gout,solute carrier family 22 member 8
7239,phenylbutazone,gout,prostaglandin-endoperoxide synthase 2
7240,phenylbutazone,gout,solute carrier family 22 member 8
7241,phenylbutazone,gout,solute carrier family 22 member 6
7242,phenylbutazone,gout,solute carrier family 22 member 11
7243,phenylbutazone,gout,prostaglandin-endoperoxide synthase 1
7244,triamcinolone,gout,prostaglandin-endoperoxide synthase 2
7245,triamcinolone,gout,serpin family a member 6
7246,sulindac,gout,solute carrier family 22 member 6
7247,ketoprofen,gout,c-x-c motif chemokine ligand 8
7248,ketoprofen,gout,solute carrier family 22 member 8
7249,ketoprofen,gout,solute carrier family 22 member 6
7250,ketoprofen,gout,solute carrier family 22 member 11
7251,ketoprofen,gout,prostaglandin-endoperoxide synthase 2
7252,ketoprofen,gout,prostaglandin-endoperoxide synthase 1
7253,prednisone,gout,nuclear receptor subfamily 3 group c member 1
7254,naproxen,gout,aldo-keto reductase family 1 member c3
7255,naproxen,gout,solute carrier family 22 member 6
7256,prednisolone,gout,serpin family a member 6
7257,allopurinol,gout,solute carrier family 22 member 8
7258,probenecid,gout,solute carrier family 2 member 9
7259,probenecid,gout,solute carrier family 22 member 12
7260,probenecid,gout,atp binding cassette subfamily c member 1 (abcc1 blood group)
7261,cortisol,gout,atp binding cassette subfamily g member 2 (jr blood group)
7262,cortisol,gout,nuclear receptor subfamily 3 group c member 1
7263,cortisol,gout,sex hormone binding globulin
7264,cortisol,gout,serpin family a member 6
7265,betamethasone,gout,prostaglandin-endoperoxide synthase 2
7266,betamethasone,gout,nuclear receptor subfamily 3 group c member 1
7267,etodolac,gout,prostaglandin-endoperoxide synthase 1
7268,etodolac,gout,solute carrier family 22 member 6
7269,etodolac,gout,prostaglandin-endoperoxide synthase 2
7270,colchicine,gout,atp binding cassette subfamily c member 1 (abcc1 blood group)
7271,cimetidine,duodenal ulcer,solute carrier family 47 member 1
7272,famotidine,duodenal ulcer,solute carrier family 47 member 1
7273,esomeprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7274,rabeprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7275,pantoprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
7276,pantoprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7277,lansoprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7278,gemcitabine,testicular cancer,atp binding cassette subfamily b member 1
7279,vinblastine,testicular cancer,tubulin beta 4a class iva
7280,vinblastine,testicular cancer,tubulin beta 1 class vi
7281,vinblastine,testicular cancer,tubulin beta 8 class viii
7282,vinblastine,testicular cancer,atp binding cassette subfamily b member 1
7283,vinblastine,testicular cancer,tubulin beta 2b class iib
7284,vinblastine,testicular cancer,tubulin beta 4b class ivb
7285,vinblastine,testicular cancer,tubulin beta 2a class iia
7286,vinblastine,testicular cancer,tubulin beta 3 class iii
7287,vinblastine,testicular cancer,tubulin beta 6 class v
7288,paclitaxel,testicular cancer,tubulin beta 2b class iib
7289,paclitaxel,testicular cancer,atp binding cassette subfamily b member 1
7290,paclitaxel,testicular cancer,tubulin beta 1 class vi
7291,paclitaxel,testicular cancer,tubulin beta 6 class v
7292,paclitaxel,testicular cancer,tubulin beta class i
7293,paclitaxel,testicular cancer,tubulin beta 3 class iii
7294,paclitaxel,testicular cancer,tubulin beta 8 class viii
7295,paclitaxel,testicular cancer,tubulin beta 4a class iva
7296,paclitaxel,testicular cancer,tubulin beta 2a class iia
7297,paclitaxel,testicular cancer,tubulin beta 4b class ivb
7298,etoposide,testicular cancer,atp binding cassette subfamily b member 1
7299,amitriptyline,bulimia nervosa,solute carrier family 6 member 4
7300,imipramine,bulimia nervosa,solute carrier family 6 member 4
7301,desipramine,bulimia nervosa,solute carrier family 6 member 4
7302,pentamidine,human african trypanosomiasis,amine oxidase copper containing 1
7303,pentamidine,human african trypanosomiasis,s100 calcium binding protein b
7304,suramin,human african trypanosomiasis,sirtuin 1
7305,dopamine,hypotensive disorder,dopamine receptor d2
7306,dopamine,hypotensive disorder,solute carrier family 6 member 2
7307,dopamine,hypotensive disorder,monoamine oxidase b
7308,dopamine,hypotensive disorder,dopamine receptor d1
7309,dopamine,hypotensive disorder,monoamine oxidase a
7310,dopamine,hypotensive disorder,adrenoceptor beta 1
7311,dopamine,hypotensive disorder,adrenoceptor alpha 1a
7312,phenylephrine,hypotensive disorder,adrenoceptor alpha 1a
7313,phenylephrine,hypotensive disorder,monoamine oxidase a
7314,phenylephrine,hypotensive disorder,adrenoceptor alpha 1b
7315,phenylephrine,hypotensive disorder,adrenoceptor alpha 1d
7316,phenylephrine,hypotensive disorder,adrenoceptor alpha 2a
7317,(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 1a
7318,(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 1b
7319,(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 2a
7320,(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 1d
7321,(-)-adrenaline,hypotensive disorder,tumor necrosis factor
7322,(-)-adrenaline,hypotensive disorder,dopamine receptor d2
7323,(-)-adrenaline,hypotensive disorder,dopamine receptor d1
7324,phentermine,hypotensive disorder,monoamine oxidase a
7325,phentermine,hypotensive disorder,monoamine oxidase b
7326,(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 2a
7327,(-)-noradrenaline,hypotensive disorder,adrenoceptor beta 1
7328,(-)-noradrenaline,hypotensive disorder,dopamine receptor d2
7329,(-)-noradrenaline,hypotensive disorder,solute carrier family 6 member 2
7330,(-)-noradrenaline,hypotensive disorder,dopamine receptor d1
7331,methoxamine,hypotensive disorder,adrenoceptor alpha 1d
7332,midodrine,orthostatic hypotension,adrenoceptor alpha 1a
7333,droxidopa,orthostatic hypotension,adrenoceptor alpha 1a
7334,magnesium sulfate,torsades de pointes,calcium voltage-gated channel subunit alpha1 c
7335,fluocinolone acetonide,contact dermatitis,serpin family a member 6
7336,clobetasol propionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7337,clobetasol propionate,contact dermatitis,cytochrome p450 family 1 subfamily a member 1
7338,flumethasone pivalate,contact dermatitis,serpin family a member 6
7339,mometasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7340,triamcinolone,contact dermatitis,serpin family a member 6
7341,alclometasone dipropionate,contact dermatitis,serpin family a member 6
7342,prednisolone,contact dermatitis,serpin family a member 6
7343,cortisol,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7344,cortisol,contact dermatitis,sex hormone binding globulin
7345,cortisol,contact dermatitis,serpin family a member 6
7346,betamethasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7347,fluticasone,contact dermatitis,serpin family a member 6
7348,methylprednisolone,contact dermatitis,glucose-6-phosphate dehydrogenase
7349,prednisone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7350,acetophenazine,psychotic disorder,dopamine receptor d1
7351,triflupromazine,psychotic disorder,atp binding cassette subfamily b member 1
7352,promazine,psychotic disorder,dopamine receptor d4
7353,promazine,psychotic disorder,5-hydroxytryptamine receptor 2a
7354,promazine,psychotic disorder,dopamine receptor d2
7355,promazine,psychotic disorder,cholinergic receptor muscarinic 1
7356,promazine,psychotic disorder,dopamine receptor d1
7357,promazine,psychotic disorder,cholinergic receptor muscarinic 2
7358,fluphenazine,psychotic disorder,atp binding cassette subfamily b member 1
7359,fluphenazine,psychotic disorder,dopamine receptor d1
7360,fluphenazine,psychotic disorder,5-hydroxytryptamine receptor 2a
7361,fluphenazine,psychotic disorder,cholinergic receptor muscarinic 2
7362,fluphenazine,psychotic disorder,dopamine receptor d4
7363,fluphenazine,psychotic disorder,dopamine receptor d5
7364,paliperidone,psychotic disorder,dopamine receptor d2
7365,paliperidone,psychotic disorder,dopamine receptor d1
7366,paliperidone,psychotic disorder,5-hydroxytryptamine receptor 2a
7367,paliperidone,psychotic disorder,dopamine receptor d4
7368,paliperidone,psychotic disorder,5-hydroxytryptamine receptor 1b
7369,paliperidone,psychotic disorder,cholinergic receptor muscarinic 2
7370,chlorpromazine,psychotic disorder,dopamine receptor d5
7371,chlorpromazine,psychotic disorder,5-hydroxytryptamine receptor 2a
7372,chlorpromazine,psychotic disorder,cholinergic receptor muscarinic 1
7373,chlorpromazine,psychotic disorder,dopamine receptor d4
7374,chlorpromazine,psychotic disorder,dopamine receptor d1
7375,chlorpromazine,psychotic disorder,atp binding cassette subfamily b member 1
7376,chlorpromazine,psychotic disorder,5-hydroxytryptamine receptor 2b
7377,chlorpromazine,psychotic disorder,cholinergic receptor muscarinic 2
7378,chlorpromazine,psychotic disorder,potassium voltage-gated channel subfamily h member 2
7379,reserpine,psychotic disorder,atp binding cassette subfamily b member 1
7380,reserpine,psychotic disorder,solute carrier family 18 member a1
7381,reserpine,psychotic disorder,dopamine receptor d2
7382,reserpine,psychotic disorder,dopamine receptor d1
7383,haloperidol,psychotic disorder,atp binding cassette subfamily b member 1
7384,haloperidol,psychotic disorder,5-hydroxytryptamine receptor 2a
7385,haloperidol,psychotic disorder,5-hydroxytryptamine receptor 1b
7386,haloperidol,psychotic disorder,dopamine receptor d4
7387,haloperidol,psychotic disorder,dopamine receptor d1
7388,haloperidol,psychotic disorder,5-hydroxytryptamine receptor 2b
7389,haloperidol,psychotic disorder,potassium voltage-gated channel subfamily h member 2
7390,haloperidol,psychotic disorder,cholinergic receptor muscarinic 1
7391,haloperidol,psychotic disorder,opioid receptor mu 1
7392,haloperidol,psychotic disorder,transmembrane protein 97
7393,haloperidol,psychotic disorder,dopamine receptor d5
7394,paliperidone,schizoaffective disorder,dopamine receptor d2
7395,paliperidone,schizoaffective disorder,5-hydroxytryptamine receptor 2a
7396,paliperidone,schizoaffective disorder,5-hydroxytryptamine receptor 1b
7397,cyproheptadine,urticaria,5-hydroxytryptamine receptor 2a
7398,cyproheptadine,urticaria,dopamine receptor d2
7399,promethazine,urticaria,dopamine receptor d2
7400,promethazine,urticaria,5-hydroxytryptamine receptor 2a
7401,clemastine,urticaria,transmembrane protein 97
7402,loratadine,urticaria,histamine receptor h1
7403,astemizole,urticaria,histamine receptor h1
7404,astemizole,urticaria,transmembrane protein 97
7405,hydroxyzine,urticaria,5-hydroxytryptamine receptor 2a
7406,hydroxyzine,urticaria,dopamine receptor d2
7407,promazine,urticaria,5-hydroxytryptamine receptor 2a
7408,promazine,urticaria,dopamine receptor d2
7409,promazine,urticaria,histamine receptor h1
7410,cetirizine,urticaria,histamine receptor h1
7411,calcifediol,rickets,vitamin d receptor
7412,calcifediol,rickets,cytochrome p450 family 27 subfamily b member 1
7413,calcifediol,rickets,cytochrome p450 family 24 subfamily a member 1
7414,"1,25-dihydroxyvitamin d3",rickets,gc vitamin d binding protein
7415,"1,25-dihydroxyvitamin d3",rickets,vitamin d receptor
7416,"1,25-dihydroxyvitamin d3",rickets,cytochrome p450 family 24 subfamily a member 1
7417,ergocalciferol,rickets,cytochrome p450 family 2 subfamily r member 1
7418,ergocalciferol,rickets,cytochrome p450 family 24 subfamily a member 1
7419,ergocalciferol,rickets,vitamin d receptor
7420,ergocalciferol,rickets,cytochrome p450 family 27 subfamily b member 1
7421,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit beta3
7422,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha2
7423,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit gamma3
7424,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit gamma2
7425,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha3
7426,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha5
7427,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha1
7428,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit beta2
7429,naloxone,opiate dependence,atp binding cassette subfamily b member 1
7430,buprenorphine,opiate dependence,opioid related nociceptin receptor 1
7431,buprenorphine,opiate dependence,opioid receptor delta 1
7432,buprenorphine,opiate dependence,atp binding cassette subfamily b member 1
7433,cortisol,proctitis,sex hormone binding globulin
7434,cortisol,proctitis,serpin family a member 6
7435,esmolol,acute coronary syndrome,adrenoceptor beta 1
7436,heparin,acute coronary syndrome,serpin family c member 1
7437,verapamil,acute coronary syndrome,calcium voltage-gated channel subunit alpha1 c
7438,fondaparinux,acute coronary syndrome,serpin family c member 1
7439,cortisol,brain edema,nuclear receptor subfamily 3 group c member 1
7440,terbutaline,dry eye syndrome,adrenoceptor beta 2
7441,terbutaline,dry eye syndrome,adrenoceptor beta 3
7442,cyclosporin a,dry eye syndrome,protein phosphatase 3 catalytic subunit alpha
7443,cyclosporin a,dry eye syndrome,fkbp prolyl isomerase 1b
7444,cyclosporin a,dry eye syndrome,fkbp prolyl isomerase 4
7445,cyclosporin a,dry eye syndrome,atp binding cassette subfamily b member 11
7446,cyclosporin a,dry eye syndrome,solute carrier organic anion transporter family member 1b1
7447,cyclosporin a,dry eye syndrome,peptidylprolyl isomerase d
7448,cyclosporin a,dry eye syndrome,peptidylprolyl isomerase b
7449,cyclosporin a,dry eye syndrome,solute carrier organic anion transporter family member 1b3
7450,diclofenac,frozen shoulder,prostaglandin-endoperoxide synthase 2
7451,dicumarol,intracranial embolism,g protein-coupled receptor 35
7452,cortisol,iritis,sex hormone binding globulin
7453,cortisol,iritis,serpin family a member 6
7454,fluorometholone,iritis,nuclear receptor subfamily 3 group c member 1
7455,fluorometholone,iritis,serpin family a member 6
7456,prednisolone,iritis,serpin family a member 6
7457,ceftriaxone,arthropathy,synuclein alpha
7458,fluoxymesterone,klinefelter syndrome,sex hormone binding globulin
7459,methyltestosterone,klinefelter syndrome,androgen receptor
7460,methyltestosterone,klinefelter syndrome,sex hormone binding globulin
7461,timolol,ocular hypertension,adrenoceptor beta 1
7462,timolol,ocular hypertension,adrenoceptor beta 2
7463,pilocarpine,ocular hypertension,cholinergic receptor muscarinic 3
7464,clonidine,ocular hypertension,adrenoceptor alpha 2a
7465,clonidine,ocular hypertension,adrenoceptor alpha 2b
7466,clonidine,ocular hypertension,adrenoceptor alpha 2c
7467,apraclonidine,ocular hypertension,adrenoceptor alpha 2c
7468,apraclonidine,ocular hypertension,adrenoceptor alpha 2b
7469,apraclonidine,ocular hypertension,adrenoceptor alpha 2a
7470,paclitaxel,ocular hypertension,tubulin beta 2b class iib
7471,paclitaxel,ocular hypertension,tubulin beta 1 class vi
7472,paclitaxel,ocular hypertension,tubulin beta 6 class v
7473,paclitaxel,ocular hypertension,tubulin beta class i
7474,paclitaxel,ocular hypertension,tubulin beta 3 class iii
7475,paclitaxel,ocular hypertension,tubulin beta 8 class viii
7476,paclitaxel,ocular hypertension,tubulin beta 4a class iva
7477,paclitaxel,ocular hypertension,tubulin beta 2a class iia
7478,paclitaxel,ocular hypertension,tubulin beta 4b class ivb
7479,betaxolol,ocular hypertension,adrenoceptor beta 2
7480,bimatoprost,ocular hypertension,prostaglandin f receptor
7481,esomeprazole,peptic esophagitis,atpase h+/k+ transporting subunit beta
7482,famotidine,peptic esophagitis,solute carrier family 47 member 1
7483,trimetaphan,pulmonary edema,cholinergic receptor nicotinic alpha 10 subunit
7484,trimetaphan,pulmonary edema,cholinergic receptor nicotinic alpha 3 subunit
7485,trimetaphan,pulmonary edema,cholinergic receptor nicotinic beta 4 subunit
7486,norfloxacin,pyelonephritis,dna topoisomerase ii alpha
7487,ofloxacin,pyelonephritis,dna topoisomerase ii alpha
7488,dihydrotachysterol,renal osteodystrophy,vitamin d receptor
7489,calcifediol,renal osteodystrophy,vitamin d receptor
7490,calcifediol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
7491,alfacalcidol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
7492,alfacalcidol,renal osteodystrophy,gc vitamin d binding protein
7493,alfacalcidol,renal osteodystrophy,vitamin d receptor
7494,"1,25-dihydroxyvitamin d3",renal osteodystrophy,gc vitamin d binding protein
7495,ergocalciferol,renal osteodystrophy,vitamin d receptor
7496,ergocalciferol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
7497,prednisolone,rheumatic heart disease,serpin family a member 6
7498,cortisol,rheumatic heart disease,sex hormone binding globulin
7499,cortisol,rheumatic heart disease,serpin family a member 6
7500,betamethasone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
7501,prednisone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
7502,triamcinolone,rheumatic heart disease,serpin family a member 6
7503,propylthiouracil,thyroid crisis,iodothyronine deiodinase 1
7504,methimazole,thyroid crisis,thyroid peroxidase
7505,gabapentin,alcohol dependence,adenosine a1 receptor
7506,acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 1
7507,acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 2a
7508,acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit beta3
7509,acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit gamma2
7510,acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 2b
7511,acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit alpha1
7512,naltrexone,alcohol dependence,opioid receptor mu 1
7513,naltrexone,alcohol dependence,opioid receptor kappa 1
7514,naltrexone,alcohol dependence,opioid receptor delta 1
7515,topiramate,alcohol dependence,carbonic anhydrase 2
7516,topiramate,alcohol dependence,glutamate ionotropic receptor kainate type subunit 3
7517,topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit alpha1
7518,topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit beta2
7519,topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit gamma2
7520,topiramate,alcohol dependence,glutamate ionotropic receptor kainate type subunit 1
7521,disulfiram,alcohol dependence,cytochrome p450 family 2 subfamily e member 1
7522,disulfiram,alcohol dependence,dopamine beta-hydroxylase
7523,disulfiram,alcohol dependence,aldehyde dehydrogenase 2 family member
7524,betamethasone,autoimmune disease,prostaglandin-endoperoxide synthase 2
7525,prednisone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
7526,prednisone,autoimmune disease,albumin
7527,cortisol,autoimmune disease,nuclear receptor subfamily 3 group c member 1
7528,cortisol,autoimmune disease,serpin family a member 6
7529,triamcinolone,autoimmune disease,prostaglandin-endoperoxide synthase 2
7530,triamcinolone,autoimmune disease,serpin family a member 6
7531,prednisolone,autoimmune disease,serpin family a member 6
7532,lansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7533,famotidine,gastroesophageal reflux disease,solute carrier family 47 member 1
7534,cisapride,gastroesophageal reflux disease,dopamine receptor d2
7535,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3a
7536,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3b
7537,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3c
7538,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3e
7539,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3d
7540,pantoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7541,esomeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7542,cimetidine,gastroesophageal reflux disease,solute carrier family 47 member 1
7543,rabeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7544,baclofen,gastroesophageal reflux disease,gamma-aminobutyric acid type b receptor subunit 2
7545,vincristine,burkitt lymphoma,tubulin beta 8 class viii
7546,vincristine,burkitt lymphoma,tubulin beta 3 class iii
7547,vincristine,burkitt lymphoma,tubulin beta 1 class vi
7548,vincristine,burkitt lymphoma,tubulin beta 4a class iva
7549,vincristine,burkitt lymphoma,tubulin beta 2a class iia
7550,vincristine,burkitt lymphoma,tubulin beta 2b class iib
7551,vincristine,burkitt lymphoma,tubulin beta 4b class ivb
7552,vincristine,burkitt lymphoma,tubulin beta 6 class v
7553,etoposide,burkitt lymphoma,dna topoisomerase ii alpha
7554,etoposide,burkitt lymphoma,cytochrome p450 family 2 subfamily e member 1
7555,carboplatin,breast cancer,atp binding cassette subfamily g member 2 (jr blood group)
7556,carboplatin,breast cancer,glutathione s-transferase theta 1
7557,carboplatin,breast cancer,atpase copper transporting beta
7558,carboplatin,breast cancer,xanthine dehydrogenase
7559,carboplatin,breast cancer,nad(p)h quinone dehydrogenase 1
7560,carboplatin,breast cancer,glutathione s-transferase pi 1
7561,carboplatin,breast cancer,glutathione s-transferase mu 1
7562,dromostanolone propionate,breast cancer,cytochrome p450 family 19 subfamily a member 1
7563,dromostanolone propionate,breast cancer,sex hormone binding globulin
7564,dromostanolone propionate,breast cancer,androgen receptor
7565,cabozantinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7566,cabozantinib,hepatocellular carcinoma,aurora kinase a
7567,cabozantinib,hepatocellular carcinoma,kinase insert domain receptor
7568,cabozantinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7569,sorafenib,hepatocellular carcinoma,fibroblast growth factor receptor 1
7570,sorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily b member 6
7571,sorafenib,hepatocellular carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
7572,sorafenib,hepatocellular carcinoma,epoxide hydrolase 2
7573,sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 3
7574,sorafenib,hepatocellular carcinoma,ret proto-oncogene
7575,sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 1
7576,sorafenib,hepatocellular carcinoma,cytochrome p450 family 1 subfamily a member 2
7577,sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 4
7578,sorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily c member 8
7579,sorafenib,hepatocellular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
7580,sorafenib,hepatocellular carcinoma,mitogen-activated protein kinase kinase kinase 20
7581,sorafenib,hepatocellular carcinoma,atp binding cassette subfamily b member 1
7582,sorafenib,hepatocellular carcinoma,kinase insert domain receptor
7583,sorafenib,hepatocellular carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
7584,sorafenib,hepatocellular carcinoma,homeodomain interacting protein kinase 4
7585,sorafenib,hepatocellular carcinoma,platelet derived growth factor receptor alpha
7586,sorafenib,hepatocellular carcinoma,platelet derived growth factor receptor beta
7587,sorafenib,hepatocellular carcinoma,aurora kinase b
7588,sorafenib,hepatocellular carcinoma,ttk protein kinase
7589,sorafenib,hepatocellular carcinoma,axl receptor tyrosine kinase
7590,sorafenib,hepatocellular carcinoma,transforming growth factor beta receptor 2
7591,sorafenib,hepatocellular carcinoma,eph receptor a1
7592,sorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7593,sorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7594,sorafenib,hepatocellular carcinoma,cyclin dependent kinase 14
7595,sorafenib,hepatocellular carcinoma,tek receptor tyrosine kinase
7596,regorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily c member 8
7597,regorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 4
7598,regorafenib,hepatocellular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
7599,regorafenib,hepatocellular carcinoma,platelet derived growth factor receptor beta
7600,regorafenib,hepatocellular carcinoma,epoxide hydrolase 2
7601,regorafenib,hepatocellular carcinoma,ret proto-oncogene
7602,regorafenib,hepatocellular carcinoma,atp binding cassette subfamily b member 1
7603,regorafenib,hepatocellular carcinoma,tek receptor tyrosine kinase
7604,regorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily b member 6
7605,regorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7606,regorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7607,regorafenib,hepatocellular carcinoma,eph receptor a1
7608,regorafenib,hepatocellular carcinoma,mitogen-activated protein kinase kinase kinase 20
7609,regorafenib,hepatocellular carcinoma,ttk protein kinase
7610,lenvatinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7611,lenvatinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7612,lenvatinib,hepatocellular carcinoma,kinase insert domain receptor
7613,lenvatinib,hepatocellular carcinoma,ret proto-oncogene
7614,lenvatinib,hepatocellular carcinoma,aurora kinase b
7615,clomipramine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
7616,clomipramine,obsessive-compulsive disorder,solute carrier family 6 member 2
7617,clomipramine,obsessive-compulsive disorder,dopamine receptor d2
7618,sertraline,obsessive-compulsive disorder,solute carrier family 6 member 2
7619,citalopram,obsessive-compulsive disorder,solute carrier family 6 member 2
7620,citalopram,obsessive-compulsive disorder,solute carrier family 6 member 4
7621,fluvoxamine,obsessive-compulsive disorder,solute carrier family 6 member 2
7622,escitalopram,obsessive-compulsive disorder,solute carrier family 6 member 4
7623,escitalopram,obsessive-compulsive disorder,solute carrier family 6 member 2
7624,fluoxetine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
7625,fluoxetine,obsessive-compulsive disorder,solute carrier family 6 member 2
7626,paroxetine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
7627,paroxetine,obsessive-compulsive disorder,solute carrier family 6 member 2
7628,ergocalciferol,postmenopausal osteoporosis,vitamin d receptor
7629,norgestimate,postmenopausal osteoporosis,estrogen receptor 1
7630,norgestimate,postmenopausal osteoporosis,progesterone receptor
7631,alendronate,postmenopausal osteoporosis,farnesyl diphosphate synthase
7632,alendronate,postmenopausal osteoporosis,atpase h+ transporting v1 subunit a
7633,ethinylestradiol,postmenopausal osteoporosis,estrogen receptor 2
7634,medroxyprogesterone,postmenopausal osteoporosis,progesterone receptor
7635,medroxyprogesterone,postmenopausal osteoporosis,estrogen receptor 1
7636,progesterone,postmenopausal osteoporosis,progesterone receptor
7637,progesterone,postmenopausal osteoporosis,estrogen receptor 1
7638,norethisterone,postmenopausal osteoporosis,progesterone receptor
7639,levonorgestrel,postmenopausal osteoporosis,progesterone receptor
7640,levonorgestrel,postmenopausal osteoporosis,estrogen receptor 1
7641,cisplatin,ovarian cancer,atp binding cassette subfamily b member 1
7642,cisplatin,ovarian cancer,superoxide dismutase 1
7643,cisplatin,ovarian cancer,atpase copper transporting beta
7644,docetaxel,ovarian cancer,epidermal growth factor receptor
7645,docetaxel,ovarian cancer,tubulin beta 6 class v
7646,docetaxel,ovarian cancer,tubulin beta 2b class iib
7647,docetaxel,ovarian cancer,tubulin beta 2a class iia
7648,docetaxel,ovarian cancer,tubulin beta class i
7649,docetaxel,ovarian cancer,tubulin beta 3 class iii
7650,docetaxel,ovarian cancer,tubulin beta 1 class vi
7651,docetaxel,ovarian cancer,atp binding cassette subfamily b member 1
7652,docetaxel,ovarian cancer,tubulin beta 4a class iva
7653,docetaxel,ovarian cancer,tubulin beta 4b class ivb
7654,docetaxel,ovarian cancer,tubulin beta 8 class viii
7655,docetaxel,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
7656,megestrol,ovarian cancer,atp binding cassette subfamily b member 1
7657,megestrol,ovarian cancer,progesterone receptor
7658,etoposide,ovarian cancer,dna topoisomerase ii alpha
7659,etoposide,ovarian cancer,atp binding cassette subfamily b member 1
7660,paclitaxel,ovarian cancer,tubulin beta 2b class iib
7661,paclitaxel,ovarian cancer,atp binding cassette subfamily b member 1
7662,paclitaxel,ovarian cancer,tubulin beta 6 class v
7663,paclitaxel,ovarian cancer,tubulin beta class i
7664,paclitaxel,ovarian cancer,tubulin beta 3 class iii
7665,paclitaxel,ovarian cancer,tubulin beta 8 class viii
7666,paclitaxel,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
7667,paclitaxel,ovarian cancer,tubulin beta 4a class iva
7668,paclitaxel,ovarian cancer,tubulin beta 2a class iia
7669,paclitaxel,ovarian cancer,tubulin beta 4b class ivb
7670,topotecan,ovarian cancer,atp binding cassette subfamily b member 1
7671,topotecan,ovarian cancer,dna topoisomerase i mitochondrial
7672,gemcitabine,ovarian cancer,ribonucleotide reductase regulatory subunit m2
7673,gemcitabine,ovarian cancer,ribonucleotide reductase catalytic subunit m1
7674,gemcitabine,ovarian cancer,"dna polymerase epsilon, catalytic subunit"
7675,gemcitabine,ovarian cancer,atp binding cassette subfamily b member 1
7676,gemcitabine,ovarian cancer,"dna polymerase delta 1, catalytic subunit"
7677,gemcitabine,ovarian cancer,cytidine/uridine monophosphate kinase 1
7678,gemcitabine,ovarian cancer,"dna polymerase alpha 1, catalytic subunit"
7679,gemcitabine,ovarian cancer,thymidylate synthetase
7680,carboplatin,ovarian cancer,atpase copper transporting beta
7681,carboplatin,ovarian cancer,superoxide dismutase 1
7682,olaparib,ovarian cancer,poly(adp-ribose) polymerase family member 4
7683,olaparib,ovarian cancer,poly(adp-ribose) polymerase family member 10
7684,capecitabine,ovarian cancer,thymidylate synthetase
7685,cyclophosphamide,ovarian cancer,atp binding cassette subfamily b member 1
7686,hydroxyurea,ovarian cancer,ribonucleotide reductase regulatory subunit m2
7687,tamoxifen,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
7688,tamoxifen,ovarian cancer,atp binding cassette subfamily b member 1
7689,tamoxifen,ovarian cancer,estrogen receptor 1
7690,niraparib,ovarian cancer,poly(adp-ribose) polymerase family member 10
7691,niraparib,ovarian cancer,poly(adp-ribose) polymerase 2
7692,niraparib,ovarian cancer,poly(adp-ribose) polymerase family member 4
7693,niraparib,ovarian cancer,poly(adp-ribose) polymerase 1
7694,hydroxocobalamin,pernicious anemia,cobalamin binding intrinsic factor
7695,phentolamine,pheochromocytoma,adrenoceptor alpha 2a
7696,phentolamine,pheochromocytoma,adrenoceptor alpha 2c
7697,phentolamine,pheochromocytoma,adrenoceptor alpha 2b
7698,promazine,acute intermittent porphyria,5-hydroxytryptamine receptor 2a
7699,promazine,acute intermittent porphyria,dopamine receptor d2
7700,promazine,acute intermittent porphyria,histamine receptor h1
7701,chlorpromazine,acute intermittent porphyria,5-hydroxytryptamine receptor 2a
7702,chlorpromazine,acute intermittent porphyria,histamine receptor h1
7703,chlorpromazine,acute intermittent porphyria,atp binding cassette subfamily b member 1
7704,carbetocin,prader-willi syndrome,oxytocin receptor
7705,abiraterone acetate,prostate cancer,sulfotransferase family 2a member 1
7706,docetaxel,prostate cancer,epidermal growth factor receptor
7707,docetaxel,prostate cancer,tubulin beta 6 class v
7708,docetaxel,prostate cancer,tubulin beta 2b class iib
7709,docetaxel,prostate cancer,tubulin beta 2a class iia
7710,docetaxel,prostate cancer,tubulin beta class i
7711,docetaxel,prostate cancer,cytochrome p450 family 3 subfamily a member 4
7712,docetaxel,prostate cancer,tubulin beta 3 class iii
7713,docetaxel,prostate cancer,microtubule associated protein 2
7714,docetaxel,prostate cancer,cytochrome p450 family 3 subfamily a member 5
7715,docetaxel,prostate cancer,tubulin beta 4a class iva
7716,docetaxel,prostate cancer,tubulin beta 4b class ivb
7717,docetaxel,prostate cancer,tubulin beta 8 class viii
7718,docetaxel,prostate cancer,cytochrome p450 family 1 subfamily b member 1
7719,docetaxel,prostate cancer,paraoxonase 1
7720,enzalutamide,prostate cancer,cytochrome p450 family 3 subfamily a member 5
7721,enzalutamide,prostate cancer,cytochrome p450 family 2 subfamily c member 19
7722,enzalutamide,prostate cancer,cytochrome p450 family 3 subfamily a member 4
7723,enzalutamide,prostate cancer,cytochrome p450 family 2 subfamily c member 9
7724,enzalutamide,prostate cancer,nuclear receptor subfamily 3 group c member 1
7725,diflunisal,rheumatoid arthritis,transthyretin
7726,diflunisal,rheumatoid arthritis,albumin
7727,diflunisal,rheumatoid arthritis,dihydrofolate reductase
7728,diflunisal,rheumatoid arthritis,high mobility group box 1
7729,valdecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7730,valdecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7731,triamcinolone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7732,triamcinolone,rheumatoid arthritis,serpin family a member 6
7733,meloxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7734,meloxicam,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7735,piroxicam,rheumatoid arthritis,albumin
7736,naproxen,rheumatoid arthritis,albumin
7737,naproxen,rheumatoid arthritis,aldo-keto reductase family 1 member c3
7738,naproxen,rheumatoid arthritis,dihydrofolate reductase
7739,penicillamine,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7740,leflunomide,rheumatoid arthritis,dihydroorotate dehydrogenase (quinone)
7741,leflunomide,rheumatoid arthritis,aryl hydrocarbon receptor
7742,leflunomide,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
7743,tolmetin,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7744,tolmetin,rheumatoid arthritis,myeloperoxidase
7745,tolmetin,rheumatoid arthritis,albumin
7746,rofecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7747,betamethasone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7748,betamethasone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7749,tofacitinib,rheumatoid arthritis,doublecortin like kinase 3
7750,tofacitinib,rheumatoid arthritis,"lck proto-oncogene, src family tyrosine kinase"
7751,tofacitinib,rheumatoid arthritis,ribosomal protein s6 kinase a1
7752,tofacitinib,rheumatoid arthritis,mapk interacting serine/threonine kinase 2
7753,tofacitinib,rheumatoid arthritis,tyrosine kinase 2
7754,tofacitinib,rheumatoid arthritis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
7755,tofacitinib,rheumatoid arthritis,janus kinase 2
7756,celecoxib,rheumatoid arthritis,albumin
7757,celecoxib,rheumatoid arthritis,mitogen-activated protein kinase 14
7758,celecoxib,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7759,celecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7760,chloroquine,rheumatoid arthritis,tumor necrosis factor
7761,chloroquine,rheumatoid arthritis,toll like receptor 9
7762,chloroquine,rheumatoid arthritis,atp binding cassette subfamily b member 1
7763,chloroquine,rheumatoid arthritis,sigma non-opioid intracellular receptor 1
7764,chloroquine,rheumatoid arthritis,transmembrane protein 97
7765,salicylic acid,rheumatoid arthritis,albumin
7766,salicylic acid,rheumatoid arthritis,atp binding cassette subfamily b member 1
7767,salicylic acid,rheumatoid arthritis,high mobility group box 1
7768,hydroxychloroquine,rheumatoid arthritis,toll like receptor 7
7769,hydroxychloroquine,rheumatoid arthritis,toll like receptor 9
7770,hydroxychloroquine,rheumatoid arthritis,sigma non-opioid intracellular receptor 1
7771,hydroxychloroquine,rheumatoid arthritis,transmembrane protein 97
7772,ketoprofen,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7773,ketoprofen,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7774,ketoprofen,rheumatoid arthritis,albumin
7775,ketoprofen,rheumatoid arthritis,paraoxonase 1
7776,aspirin,rheumatoid arthritis,albumin
7777,aspirin,rheumatoid arthritis,atp binding cassette subfamily b member 1
7778,aspirin,rheumatoid arthritis,tumor protein p53
7779,aspirin,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
7780,etodolac,rheumatoid arthritis,albumin
7781,etodolac,rheumatoid arthritis,dihydrofolate reductase
7782,ibuprofen,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7783,ibuprofen,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7784,ibuprofen,rheumatoid arthritis,atp binding cassette subfamily b member 1
7785,ibuprofen,rheumatoid arthritis,albumin
7786,ibuprofen,rheumatoid arthritis,dihydrofolate reductase
7787,indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 3
7788,indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 2
7789,indomethacin,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7790,indomethacin,rheumatoid arthritis,albumin
7791,indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7792,indomethacin,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7793,indomethacin,rheumatoid arthritis,aldo-keto reductase family 1 member c3
7794,indomethacin,rheumatoid arthritis,atp binding cassette subfamily b member 1
7795,indomethacin,rheumatoid arthritis,solute carrier organic anion transporter family member 1b3
7796,indomethacin,rheumatoid arthritis,paraoxonase 1
7797,aceclofenac,rheumatoid arthritis,transthyretin
7798,auranofin,rheumatoid arthritis,albumin
7799,auranofin,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
7800,flurbiprofen,rheumatoid arthritis,albumin
7801,flurbiprofen,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7802,cortisol,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
7803,cortisol,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
7804,cortisol,rheumatoid arthritis,atp binding cassette subfamily b member 1
7805,cortisol,rheumatoid arthritis,sex hormone binding globulin
7806,cortisol,rheumatoid arthritis,serpin family a member 6
7807,baricitinib,rheumatoid arthritis,ap2 associated kinase 1
7808,baricitinib,rheumatoid arthritis,septin 9
7809,baricitinib,rheumatoid arthritis,cyclin g associated kinase
7810,methylprednisolone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7811,cyclosporin a,rheumatoid arthritis,protein phosphatase 3 catalytic subunit alpha
7812,cyclosporin a,rheumatoid arthritis,fkbp prolyl isomerase 1b
7813,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily b member 1
7814,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
7815,cyclosporin a,rheumatoid arthritis,fkbp prolyl isomerase 4
7816,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily c member 3
7817,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily c member 2
7818,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily b member 11
7819,cyclosporin a,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7820,cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase d
7821,cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase b
7822,cyclosporin a,rheumatoid arthritis,solute carrier organic anion transporter family member 1b3
7823,meclofenamic acid,rheumatoid arthritis,arachidonate 5-lipoxygenase
7824,meclofenamic acid,rheumatoid arthritis,aldo-keto reductase family 1 member c3
7825,meclofenamic acid,rheumatoid arthritis,transthyretin
7826,sulindac,rheumatoid arthritis,albumin
7827,sulindac,rheumatoid arthritis,complement c5
7828,diclofenac,rheumatoid arthritis,atp binding cassette subfamily b member 1
7829,diclofenac,rheumatoid arthritis,c-x-c motif chemokine receptor 1
7830,diclofenac,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
7831,diclofenac,rheumatoid arthritis,albumin
7832,diclofenac,rheumatoid arthritis,arachidonate 5-lipoxygenase
7833,diclofenac,rheumatoid arthritis,transthyretin
7834,diclofenac,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7835,diclofenac,rheumatoid arthritis,dihydrofolate reductase
7836,sulfasalazine,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7837,sulfasalazine,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7838,sulfasalazine,rheumatoid arthritis,arachidonate 5-lipoxygenase
7839,sulfasalazine,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
7840,sulfasalazine,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7841,sulfasalazine,rheumatoid arthritis,atp binding cassette subfamily c member 2
7842,sulfasalazine,rheumatoid arthritis,solute carrier family 46 member 1
7843,sulfasalazine,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
7844,minocycline,rheumatoid arthritis,caspase 1
7845,minocycline,rheumatoid arthritis,interleukin 1 beta
7846,minocycline,rheumatoid arthritis,matrix metallopeptidase 9
7847,minocycline,rheumatoid arthritis,vascular endothelial growth factor a
7848,minocycline,rheumatoid arthritis,arachidonate 5-lipoxygenase
7849,prednisolone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7850,prednisolone,rheumatoid arthritis,serpin family a member 6
7851,prednisone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
7852,prednisone,rheumatoid arthritis,albumin
7853,prednisone,rheumatoid arthritis,hydroxysteroid 11-beta dehydrogenase 1
7854,prednisone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7855,nabumetone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7856,nabumetone,rheumatoid arthritis,myeloperoxidase
7857,nabumetone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7858,oxaprozin,rheumatoid arthritis,complement c5
7859,etoposide,small cell lung carcinoma,udp glucuronosyltransferase family 1 member a1
7860,docetaxel,small cell lung carcinoma,epidermal growth factor receptor
7861,topotecan,small cell lung carcinoma,dna topoisomerase i mitochondrial
7862,irinotecan,small cell lung carcinoma,udp glucuronosyltransferase family 1 member a1
7863,irinotecan,small cell lung carcinoma,dna topoisomerase i
7864,irinotecan,small cell lung carcinoma,dna topoisomerase i mitochondrial
7865,ifosfamide,small cell lung carcinoma,cytochrome p450 family 2 subfamily a member 6
7866,metformin,polycystic ovary syndrome,nadh:ubiquinone oxidoreductase subunit a10
7867,metformin,polycystic ovary syndrome,nadh:ubiquinone oxidoreductase complex assembly factor 2
7868,metformin,polycystic ovary syndrome,nadh:ubiquinone oxidoreductase subunit a3
7869,progesterone,polycystic ovary syndrome,progesterone receptor
7870,progesterone,polycystic ovary syndrome,androgen receptor
7871,progesterone,polycystic ovary syndrome,sex hormone binding globulin
7872,progesterone,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
7873,progesterone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
7874,progesterone,polycystic ovary syndrome,estrogen receptor 1
7875,progesterone,polycystic ovary syndrome,cytochrome p450 family 17 subfamily a member 1
7876,estrone,polycystic ovary syndrome,estrogen receptor 1
7877,estrone,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
7878,estrone,polycystic ovary syndrome,sex hormone binding globulin
7879,letrozole,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
7880,desogestrel,polycystic ovary syndrome,sex hormone binding globulin
7881,desogestrel,polycystic ovary syndrome,progesterone receptor
7882,desogestrel,polycystic ovary syndrome,estrogen receptor 1
7883,estradiol valerate,polycystic ovary syndrome,estrogen receptor 1
7884,estradiol valerate,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
7885,estradiol valerate,polycystic ovary syndrome,sex hormone binding globulin
7886,estradiol valerate,polycystic ovary syndrome,androgen receptor
7887,norgestimate,polycystic ovary syndrome,estrogen receptor 1
7888,norgestimate,polycystic ovary syndrome,progesterone receptor
7889,medroxyprogesterone,polycystic ovary syndrome,aldo-keto reductase family 1 member c3
7890,medroxyprogesterone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
7891,medroxyprogesterone,polycystic ovary syndrome,sex hormone binding globulin
7892,medroxyprogesterone,polycystic ovary syndrome,progesterone receptor
7893,medroxyprogesterone,polycystic ovary syndrome,estrogen receptor 1
7894,medroxyprogesterone,polycystic ovary syndrome,androgen receptor
7895,medroxyprogesterone,polycystic ovary syndrome,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
7896,ethynodiol diacetate,polycystic ovary syndrome,progesterone receptor
7897,ethynodiol diacetate,polycystic ovary syndrome,estrogen receptor 1
7898,levonorgestrel,polycystic ovary syndrome,steroid 5 alpha-reductase 1
7899,levonorgestrel,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
7900,levonorgestrel,polycystic ovary syndrome,androgen receptor
7901,levonorgestrel,polycystic ovary syndrome,progesterone receptor
7902,levonorgestrel,polycystic ovary syndrome,sex hormone binding globulin
7903,levonorgestrel,polycystic ovary syndrome,estrogen receptor 1
7904,drospirenone,polycystic ovary syndrome,progesterone receptor
7905,drospirenone,polycystic ovary syndrome,androgen receptor
7906,ethinylestradiol,polycystic ovary syndrome,estrogen receptor 1
7907,ethinylestradiol,polycystic ovary syndrome,sex hormone binding globulin
7908,norethisterone,polycystic ovary syndrome,sex hormone binding globulin
7909,norethisterone,polycystic ovary syndrome,progesterone receptor
7910,spironolactone,polycystic ovary syndrome,progesterone receptor
7911,spironolactone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
7912,spironolactone,polycystic ovary syndrome,sex hormone binding globulin
7913,spironolactone,polycystic ovary syndrome,androgen receptor
7914,spironolactone,polycystic ovary syndrome,cytochrome p450 family 11 subfamily b member 1
7915,prednisone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
7916,prednisolone,temporal arteritis,serpin family a member 6
7917,methylprednisolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
7918,betamethasone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
7919,triamcinolone,temporal arteritis,serpin family a member 6
7920,pge1,tetralogy of fallot,prostaglandin e receptor 1
7921,acenocoumarol,thrombophilia due to thrombin defect,vitamin k epoxide reductase complex subunit 1
7922,bupropion,nicotine dependence,cytochrome p450 family 2 subfamily a member 6
7923,bupropion,nicotine dependence,solute carrier family 6 member 2
7924,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 4 subunit
7925,nicotine,nicotine dependence,cytochrome p450 family 2 subfamily a member 6
7926,nicotine,nicotine dependence,cytochrome p450 family 1 subfamily a member 1
7927,nicotine,nicotine dependence,cholinergic receptor nicotinic beta 2 subunit
7928,nicotine,nicotine dependence,cholinergic receptor nicotinic beta 4 subunit
7929,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 5 subunit
7930,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 3 subunit
7931,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 7 subunit
7932,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 2 subunit
7933,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 10 subunit
7934,nicotine,nicotine dependence,cholinergic receptor nicotinic beta 3 subunit
7935,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 6 subunit
7936,nicotine,nicotine dependence,monoamine oxidase b
7937,carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 4
7938,carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 5
7939,carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 9
7940,paroxetine,fibromyalgia,solute carrier family 6 member 4
7941,paroxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
7942,paroxetine,fibromyalgia,solute carrier family 6 member 2
7943,gabapentin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
7944,gabapentin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
7945,pregabalin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
7946,duloxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
7947,amitriptyline,fibromyalgia,solute carrier family 6 member 4
7948,amitriptyline,fibromyalgia,5-hydroxytryptamine receptor 2a
7949,amitriptyline,fibromyalgia,solute carrier family 6 member 2
7950,tramadol,fibromyalgia,solute carrier family 6 member 2
7951,tramadol,fibromyalgia,solute carrier family 6 member 4
7952,fluoxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
7953,fluoxetine,fibromyalgia,solute carrier family 6 member 4
7954,fluoxetine,fibromyalgia,solute carrier family 6 member 2
7955,cyclobenzaprine,fibromyalgia,5-hydroxytryptamine receptor 2a
7956,pramipexole,fibromyalgia,5-hydroxytryptamine receptor 2a
7957,cyclopentolate,cycloplegia,cholinergic receptor muscarinic 3
7958,cyclopentolate,cycloplegia,cholinergic receptor muscarinic 1
7959,morphine,neonatal abstinence syndrome,atp binding cassette subfamily b member 1
7960,diflunisal,arthritic joint disease,prostaglandin-endoperoxide synthase 2
7961,diflunisal,arthritic joint disease,albumin
7962,diflunisal,arthritic joint disease,prostaglandin-endoperoxide synthase 1
7963,diphenhydramine,anxiety disorder,solute carrier family 6 member 3
7964,diphenhydramine,anxiety disorder,solute carrier family 6 member 4
7965,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 2a
7966,haloperidol,anxiety disorder,dopamine receptor d2
7967,haloperidol,anxiety disorder,sigma non-opioid intracellular receptor 1
7968,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 2c
7969,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 1a
7970,haloperidol,anxiety disorder,solute carrier family 6 member 4
7971,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 7
7972,5-fluorouracil,head and neck cancer,thymidylate synthetase
7973,5-fluorouracil,head and neck cancer,dihydropyrimidine dehydrogenase
7974,gemcitabine,head and neck cancer,thymidylate synthetase
7975,docetaxel,head and neck cancer,epidermal growth factor receptor
7976,docetaxel,head and neck cancer,bcl2 apoptosis regulator
7977,paclitaxel,head and neck cancer,bcl2 apoptosis regulator
7978,carboplatin,head and neck cancer,atpase copper transporting beta
7979,carboplatin,head and neck cancer,glutathione s-transferase mu 1
7980,promethazine,atopic conjunctivitis,dopamine receptor d2
7981,promethazine,atopic conjunctivitis,adrenoceptor alpha 1a
7982,promethazine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7983,diphenhydramine,atopic conjunctivitis,prostaglandin-endoperoxide synthase 1
7984,diphenhydramine,atopic conjunctivitis,solute carrier family 6 member 2
7985,azelastine,atopic conjunctivitis,adrenoceptor alpha 1b
7986,azelastine,atopic conjunctivitis,adrenoceptor alpha 1a
7987,pseudoephedrine,atopic conjunctivitis,adrenoceptor alpha 2a
7988,pseudoephedrine,atopic conjunctivitis,solute carrier family 6 member 2
7989,pseudoephedrine,atopic conjunctivitis,adrenoceptor beta 2
7990,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 2a
7991,hydroxyzine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7992,hydroxyzine,atopic conjunctivitis,dopamine receptor d2
7993,cyproheptadine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7994,cyproheptadine,atopic conjunctivitis,solute carrier family 6 member 2
7995,cyproheptadine,atopic conjunctivitis,dopamine receptor d2
7996,epinastine,atopic conjunctivitis,adrenoceptor alpha 1a
7997,epinastine,atopic conjunctivitis,adrenoceptor alpha 2a
7998,epinastine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7999,cromoglicic acid,atopic conjunctivitis,s100 calcium binding protein p
8000,chlorpheniramine,atopic conjunctivitis,solute carrier family 6 member 2
8001,ephedrine,atopic conjunctivitis,solute carrier family 6 member 2
8002,ephedrine,atopic conjunctivitis,adrenoceptor beta 2
8003,prednisolone,atopic conjunctivitis,serpin family a member 6
8004,clemastine,atopic conjunctivitis,adrenoceptor alpha 2a
8005,clemastine,atopic conjunctivitis,transmembrane protein 97
8006,astemizole,atopic conjunctivitis,transmembrane protein 97
8007,fluorometholone,atopic conjunctivitis,serpin family a member 6
8008,cortisol,atopic conjunctivitis,sex hormone binding globulin
8009,cortisol,atopic conjunctivitis,serpin family a member 6
8010,promazine,atopic conjunctivitis,adrenoceptor alpha 1a
8011,promazine,atopic conjunctivitis,adrenoceptor alpha 1b
8012,promazine,atopic conjunctivitis,adrenoceptor alpha 2a
8013,promazine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
8014,promazine,atopic conjunctivitis,dopamine receptor d2
8015,promazine,atopic conjunctivitis,adrenoceptor alpha 1d
8016,promazine,atopic conjunctivitis,histamine receptor h1
8017,podophyllotoxin,anogenital human papillomavirus infection,tubulin alpha 4a
8018,bromodiphenhydramine,common cold,histamine receptor h1
8019,pseudoephedrine,common cold,adrenoceptor alpha 2a
8020,pseudoephedrine,common cold,solute carrier family 6 member 2
8021,pseudoephedrine,common cold,adrenoceptor beta 1
8022,hydromorphone,common cold,prostaglandin-endoperoxide synthase 1
8023,hydromorphone,common cold,opioid receptor mu 1
8024,phenylephrine,common cold,adrenoceptor alpha 2a
8025,mepyramine,common cold,histamine receptor h1
8026,dextromethorphan,common cold,opioid receptor mu 1
8027,dextromethorphan,common cold,solute carrier family 6 member 2
8028,codeine,common cold,opioid receptor mu 1
8029,caffeine,common cold,adenosine a2b receptor
8030,caffeine,common cold,phosphodiesterase 4b
8031,caffeine,common cold,adenosine a1 receptor
8032,caffeine,common cold,adenosine a2a receptor
8033,caffeine,common cold,adenosine a3 receptor
8034,chlorpheniramine,common cold,solute carrier family 6 member 2
8035,chlorpheniramine,common cold,histamine receptor h1
8036,doxylamine,common cold,cholinergic receptor muscarinic 1
8037,ephedrine,common cold,solute carrier family 6 member 2
8038,ephedrine,common cold,adrenoceptor beta 2
8039,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 1
8040,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 5
8041,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 2
8042,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 3
8043,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 4
8044,chlophedianol,common cold,histamine receptor h1
8045,hydrocodone,common cold,opioid receptor mu 1
8046,paracetamol,common cold,transient receptor potential cation channel subfamily v member 1
8047,paracetamol,common cold,cannabinoid receptor 1
8048,prednisolone,eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8049,prednisolone,eosinophilic pneumonia,serpin family a member 6
8050,acetazolamide,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 2
8051,acetazolamide,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 4
8052,phenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
8053,phenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
8054,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 3
8055,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
8056,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
8057,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 2
8058,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 8
8059,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
8060,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
8061,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
8062,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 8
8063,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 3
8064,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
8065,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 10
8066,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 2
8067,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 11
8068,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
8069,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
8070,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 7
8071,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 3
8072,topiramate,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 2
8073,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 4
8074,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 5
8075,topiramate,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
8076,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
8077,topiramate,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
8078,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 3
8079,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
8080,topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
8081,topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit beta2
8082,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 1
8083,topiramate,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 4
8084,topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit gamma2
8085,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 4
8086,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 1
8087,carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
8088,carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
8089,carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
8090,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
8091,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
8092,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
8093,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
8094,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
8095,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
8096,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
8097,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
8098,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
8099,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit beta2
8100,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
8101,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
8102,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
8103,primidone,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
8104,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
8105,primidone,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
8106,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
8107,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit gamma2
8108,fluoxymesterone,eunuchism,androgen receptor
8109,cabergoline,hyperprolactinemia,dopamine receptor d3
8110,oseltamivir,influenza,solute carrier family 22 member 8
8111,prednisolone,miliary tuberculosis,serpin family a member 6
8112,triamcinolone,miliary tuberculosis,serpin family a member 6
8113,miconazole,oral candidiasis,cytochrome p450 family 51 subfamily a member 1
8114,miconazole,oral candidiasis,potassium calcium-activated channel subfamily n member 4
8115,miconazole,oral candidiasis,cytochrome p450 family 17 subfamily a member 1
8116,miconazole,oral candidiasis,cytochrome p450 family 11 subfamily b member 1
8117,clotrimazole,oral candidiasis,cytochrome p450 family 11 subfamily b member 1
8118,clotrimazole,oral candidiasis,cytochrome p450 family 17 subfamily a member 1
8119,clotrimazole,oral candidiasis,cytochrome p450 family 51 subfamily a member 1
8120,clotrimazole,oral candidiasis,potassium calcium-activated channel subfamily n member 4
8121,miconazole,pityriasis versicolor,cytochrome p450 family 51 subfamily a member 1
8122,miconazole,pityriasis versicolor,potassium calcium-activated channel subfamily n member 4
8123,miconazole,pityriasis versicolor,cytochrome p450 family 17 subfamily a member 1
8124,miconazole,pityriasis versicolor,cytochrome p450 family 11 subfamily b member 1
8125,(-)-menthol,pityriasis versicolor,transient receptor potential cation channel subfamily m member 8
8126,clotrimazole,pityriasis versicolor,cytochrome p450 family 11 subfamily b member 1
8127,clotrimazole,pityriasis versicolor,cytochrome p450 family 17 subfamily a member 1
8128,clotrimazole,pityriasis versicolor,cytochrome p450 family 51 subfamily a member 1
8129,clotrimazole,pityriasis versicolor,potassium calcium-activated channel subfamily n member 4
8130,proguanil,plasmodium falciparum malaria,dihydrofolate reductase
8131,hydroxychloroquine,plasmodium falciparum malaria,toll like receptor 7
8132,hydroxychloroquine,plasmodium falciparum malaria,toll like receptor 9
8133,hydroxychloroquine,plasmodium falciparum malaria,transmembrane protein 97
8134,chloroquine,plasmodium falciparum malaria,toll like receptor 9
8135,chloroquine,plasmodium falciparum malaria,transmembrane protein 97
8136,chloroquine,plasmodium vivax malaria,toll like receptor 9
8137,chloroquine,plasmodium vivax malaria,transmembrane protein 97
8138,hydroxychloroquine,plasmodium vivax malaria,toll like receptor 7
8139,hydroxychloroquine,plasmodium vivax malaria,toll like receptor 9
8140,hydroxychloroquine,plasmodium vivax malaria,transmembrane protein 97
8141,fluoxetine,postpartum depression,solute carrier family 6 member 4
8142,azatadine,familial dermatographia,histamine receptor h1
8143,clemastine,familial dermatographia,histamine receptor h1
8144,clemastine,familial dermatographia,transmembrane protein 97
8145,brompheniramine,familial dermatographia,histamine receptor h1
8146,antazoline,familial dermatographia,histamine receptor h1
8147,diphenylpyraline,familial dermatographia,histamine receptor h1
8148,hydroxyzine,familial dermatographia,histamine receptor h1
8149,hydroxyzine,familial dermatographia,5-hydroxytryptamine receptor 2a
8150,hydroxyzine,familial dermatographia,dopamine receptor d2
8151,chlorpheniramine,familial dermatographia,histamine receptor h1
8152,mepyramine,familial dermatographia,histamine receptor h1
8153,carbinoxamine,familial dermatographia,histamine receptor h1
8154,doxylamine,familial dermatographia,histamine receptor h1
8155,promazine,familial dermatographia,5-hydroxytryptamine receptor 2a
8156,promazine,familial dermatographia,dopamine receptor d2
8157,promazine,familial dermatographia,histamine receptor h1
8158,dexbrompheniramine,familial dermatographia,histamine receptor h1
8159,cyproheptadine,familial dermatographia,5-hydroxytryptamine receptor 2a
8160,cyproheptadine,familial dermatographia,dopamine receptor d2
8161,cyproheptadine,familial dermatographia,histamine receptor h1
8162,triprolidine,familial dermatographia,histamine receptor h1
8163,methdilazine,familial dermatographia,histamine receptor h1
8164,zonisamide,lewy body dementia,sodium voltage-gated channel alpha subunit 1
8165,5-fluorouracil,esophageal cancer,cytochrome p450 family 2 subfamily a member 6
8166,5-fluorouracil,esophageal cancer,thymidine phosphorylase
8167,docetaxel,esophageal cancer,epidermal growth factor receptor
8168,docetaxel,esophageal cancer,nuclear receptor subfamily 1 group i member 2
8169,docetaxel,esophageal cancer,atp binding cassette subfamily c member 2
8170,docetaxel,esophageal cancer,bcl2 apoptosis regulator
8171,docetaxel,esophageal cancer,atp binding cassette subfamily b member 1
8172,docetaxel,esophageal cancer,cytochrome p450 family 1 subfamily b member 1
8173,clonidine,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
8174,haloperidol,tourette syndrome,5-hydroxytryptamine receptor 2a
8175,haloperidol,tourette syndrome,dopamine receptor d4
8176,haloperidol,tourette syndrome,dopamine receptor d3
8177,haloperidol,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
8178,haloperidol,tourette syndrome,transmembrane protein 97
8179,pimozide,tourette syndrome,5-hydroxytryptamine receptor 2a
8180,pimozide,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
8181,pimozide,tourette syndrome,dopamine receptor d4
8182,fenofibrate,"hyperlipidemia, familial combined, lpl related",peroxisome proliferator activated receptor alpha
8183,fenofibrate,"hyperlipidemia, familial combined, lpl related",fatty acid binding protein 2
8184,nicotinic acid,"hyperlipidemia, familial combined, lpl related",hydroxycarboxylic acid receptor 2
8185,nicotinic acid,"hyperlipidemia, familial combined, lpl related",hydroxycarboxylic acid receptor 3
8186,lovastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
8187,simvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
8188,ezetimibe,"hyperlipidemia, familial combined, lpl related",atp binding cassette subfamily g member 8
8189,diazoxide,islet cell adenomatosis,atp binding cassette subfamily c member 8
8190,norethisterone,uterine corpus leiomyoma,sex hormone binding globulin
8191,norethisterone,uterine corpus leiomyoma,progesterone receptor
8192,ruxolitinib,vitiligo,ribosomal protein s6 kinase a2
8193,ruxolitinib,vitiligo,serine/threonine kinase 25
8194,ruxolitinib,vitiligo,homeodomain interacting protein kinase 1
8195,ezetimibe,sitosterolemia,atp binding cassette subfamily g member 8
8196,ezetimibe,sitosterolemia,atp binding cassette subfamily g member 5
8197,fluoxymesterone,cryptorchidism,sex hormone binding globulin
8198,methyltestosterone,cryptorchidism,androgen receptor
8199,methyltestosterone,cryptorchidism,sex hormone binding globulin
8200,methyltestosterone,cryptorchidism,cytochrome p450 family 19 subfamily a member 1
8201,daunorubicin,acute monocytic leukemia,dna topoisomerase ii alpha
8202,chloroquine,systemic lupus erythematosus,tumor necrosis factor
8203,chloroquine,systemic lupus erythematosus,toll like receptor 9
8204,chloroquine,systemic lupus erythematosus,transmembrane protein 97
8205,hydroxychloroquine,systemic lupus erythematosus,toll like receptor 7
8206,hydroxychloroquine,systemic lupus erythematosus,toll like receptor 9
8207,hydroxychloroquine,systemic lupus erythematosus,transmembrane protein 97
8208,prednisone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
8209,prednisone,systemic lupus erythematosus,albumin
8210,betamethasone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
8211,cortisol,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
8212,cortisol,systemic lupus erythematosus,sex hormone binding globulin
8213,cortisol,systemic lupus erythematosus,serpin family a member 6
8214,triamcinolone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
8215,triamcinolone,systemic lupus erythematosus,serpin family a member 6
8216,dapsone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
8217,dapsone,systemic lupus erythematosus,n-acetyltransferase 2
8218,prednisolone,systemic lupus erythematosus,serpin family a member 6
8219,prednisolone,systemic lupus erythematosus,androgen receptor
8220,biotin,propionic acidemia,propionyl-coa carboxylase subunit alpha
8221,biotin,propionic acidemia,propionyl-coa carboxylase subunit beta
8222,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 33
8223,sunitinib,gastrointestinal stromal tumor,myosin light chain kinase family member 4
8224,sunitinib,gastrointestinal stromal tumor,"mer proto-oncogene, tyrosine kinase"
8225,sunitinib,gastrointestinal stromal tumor,death associated protein kinase 3
8226,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 17a
8227,sunitinib,gastrointestinal stromal tumor,cdc like kinase 4
8228,sunitinib,gastrointestinal stromal tumor,p21 (rac1) activated kinase 3
8229,sunitinib,gastrointestinal stromal tumor,cdc like kinase 2
8230,sunitinib,gastrointestinal stromal tumor,ribosomal protein s6 kinase a2
8231,sunitinib,gastrointestinal stromal tumor,cdc like kinase 1
8232,sunitinib,gastrointestinal stromal tumor,homeodomain interacting protein kinase 2
8233,sunitinib,gastrointestinal stromal tumor,ribosomal protein s6 kinase a5
8234,sunitinib,gastrointestinal stromal tumor,mitogen-activated protein kinase kinase kinase 19
8235,sunitinib,gastrointestinal stromal tumor,interleukin 1 receptor associated kinase 1
8236,sunitinib,gastrointestinal stromal tumor,bmp2 inducible kinase
8237,sunitinib,gastrointestinal stromal tumor,mitogen-activated protein kinase kinase kinase kinase 1
8238,sunitinib,gastrointestinal stromal tumor,dual specificity tyrosine phosphorylation regulated kinase 2
8239,sunitinib,gastrointestinal stromal tumor,checkpoint kinase 2
8240,sunitinib,gastrointestinal stromal tumor,myosin light chain kinase
8241,sunitinib,gastrointestinal stromal tumor,ret proto-oncogene
8242,sunitinib,gastrointestinal stromal tumor,phosphorylase kinase catalytic subunit gamma 2
8243,sunitinib,gastrointestinal stromal tumor,phosphorylase kinase catalytic subunit gamma 1
8244,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 4
8245,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 10
8246,sunitinib,gastrointestinal stromal tumor,axl receptor tyrosine kinase
8247,sunitinib,gastrointestinal stromal tumor,traf2 and nck interacting kinase
8248,sunitinib,gastrointestinal stromal tumor,myosin light chain kinase 3
8249,sunitinib,gastrointestinal stromal tumor,cyclin g associated kinase
8250,sunitinib,gastrointestinal stromal tumor,unc-51 like autophagy activating kinase 1
8251,sunitinib,gastrointestinal stromal tumor,casein kinase 1 delta
8252,sunitinib,gastrointestinal stromal tumor,delta like non-canonical notch ligand 1
8253,sunitinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
8254,sunitinib,gastrointestinal stromal tumor,homeodomain interacting protein kinase 1
8255,sunitinib,gastrointestinal stromal tumor,ap2 associated kinase 1
8256,sunitinib,gastrointestinal stromal tumor,misshapen like kinase 1
8257,sunitinib,gastrointestinal stromal tumor,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8258,sunitinib,gastrointestinal stromal tumor,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
8259,sunitinib,gastrointestinal stromal tumor,unc-51 like autophagy activating kinase 2
8260,sunitinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
8261,sunitinib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8262,imatinib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8263,imatinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
8264,imatinib,gastrointestinal stromal tumor,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
8265,imatinib,gastrointestinal stromal tumor,colony stimulating factor 1 receptor
8266,imatinib,gastrointestinal stromal tumor,solute carrier family 47 member 1
8267,imatinib,gastrointestinal stromal tumor,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8268,imatinib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
8269,imatinib,gastrointestinal stromal tumor,cdc like kinase 1
8270,imatinib,gastrointestinal stromal tumor,serine/threonine kinase 17a
8271,imatinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
8272,imatinib,gastrointestinal stromal tumor,interleukin 1 receptor associated kinase 1
8273,imatinib,gastrointestinal stromal tumor,"b-raf proto-oncogene, serine/threonine kinase"
8274,imatinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 3
8275,imatinib,gastrointestinal stromal tumor,cyclin g associated kinase
8276,imatinib,gastrointestinal stromal tumor,dead-box helicase 3 x-linked
8277,imatinib,gastrointestinal stromal tumor,cdc like kinase 4
8278,regorafenib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 4
8279,regorafenib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
8280,regorafenib,gastrointestinal stromal tumor,epoxide hydrolase 2
8281,regorafenib,gastrointestinal stromal tumor,"b-raf proto-oncogene, serine/threonine kinase"
8282,regorafenib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8283,regorafenib,gastrointestinal stromal tumor,ret proto-oncogene
8284,regorafenib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 1
8285,regorafenib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
8286,regorafenib,gastrointestinal stromal tumor,kinase insert domain receptor
8287,regorafenib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
8288,regorafenib,gastrointestinal stromal tumor,eph receptor a1
8289,regorafenib,gastrointestinal stromal tumor,cdc like kinase 1
8290,montelukast,allergic rhinitis,prostaglandin-endoperoxide synthase 1
8291,azelastine,allergic rhinitis,adrenoceptor alpha 1b
8292,azelastine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8293,azelastine,allergic rhinitis,adrenoceptor alpha 1a
8294,promazine,allergic rhinitis,adrenoceptor alpha 1a
8295,promazine,allergic rhinitis,adrenoceptor alpha 1b
8296,promazine,allergic rhinitis,cholinergic receptor muscarinic 5
8297,promazine,allergic rhinitis,adrenoceptor alpha 2a
8298,promazine,allergic rhinitis,5-hydroxytryptamine receptor 2a
8299,promazine,allergic rhinitis,dopamine receptor d2
8300,promazine,allergic rhinitis,cholinergic receptor muscarinic 1
8301,promazine,allergic rhinitis,adrenoceptor alpha 1d
8302,promazine,allergic rhinitis,cholinergic receptor muscarinic 4
8303,promazine,allergic rhinitis,histamine receptor h1
8304,promazine,allergic rhinitis,cholinergic receptor muscarinic 3
8305,promazine,allergic rhinitis,cholinergic receptor muscarinic 2
8306,mepyramine,allergic rhinitis,solute carrier family 22 member 5
8307,prednisone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8308,flunisolide,allergic rhinitis,serpin family a member 6
8309,hydrocodone,allergic rhinitis,opioid receptor mu 1
8310,fluticasone,allergic rhinitis,serpin family a member 6
8311,pseudoephedrine,allergic rhinitis,adrenoceptor alpha 2a
8312,pseudoephedrine,allergic rhinitis,solute carrier family 6 member 2
8313,pseudoephedrine,allergic rhinitis,adrenoceptor beta 2
8314,pseudoephedrine,allergic rhinitis,interleukin 2
8315,phenylephrine,allergic rhinitis,adrenoceptor alpha 2a
8316,cortisol,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8317,cortisol,allergic rhinitis,sex hormone binding globulin
8318,cortisol,allergic rhinitis,serpin family a member 6
8319,chlorpheniramine,allergic rhinitis,solute carrier family 6 member 2
8320,caffeine,allergic rhinitis,adenosine a2b receptor
8321,caffeine,allergic rhinitis,phosphodiesterase 4b
8322,caffeine,allergic rhinitis,adenosine a1 receptor
8323,caffeine,allergic rhinitis,adenosine a2a receptor
8324,caffeine,allergic rhinitis,adenosine a3 receptor
8325,clemastine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8326,clemastine,allergic rhinitis,adrenoceptor alpha 2a
8327,clemastine,allergic rhinitis,cholinergic receptor muscarinic 4
8328,clemastine,allergic rhinitis,transmembrane protein 97
8329,clemastine,allergic rhinitis,cholinergic receptor muscarinic 3
8330,clemastine,allergic rhinitis,cholinergic receptor muscarinic 5
8331,clemastine,allergic rhinitis,cholinergic receptor muscarinic 1
8332,clemastine,allergic rhinitis,cholinergic receptor muscarinic 2
8333,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 4
8334,brompheniramine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8335,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 2
8336,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 5
8337,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 3
8338,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 1
8339,mometasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8340,ephedrine,allergic rhinitis,solute carrier family 6 member 2
8341,ephedrine,allergic rhinitis,adrenoceptor beta 2
8342,hydroxyzine,allergic rhinitis,5-hydroxytryptamine receptor 2a
8343,hydroxyzine,allergic rhinitis,dopamine receptor d2
8344,fexofenadine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8345,dextromethorphan,allergic rhinitis,opioid receptor mu 1
8346,dextromethorphan,allergic rhinitis,solute carrier family 6 member 2
8347,beclometasone,allergic rhinitis,serpin family a member 6
8348,beclometasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8349,paracetamol,allergic rhinitis,transient receptor potential cation channel subfamily v member 1
8350,paracetamol,allergic rhinitis,sulfotransferase family 1a member 1
8351,paracetamol,allergic rhinitis,cannabinoid receptor 1
8352,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 3
8353,cyproheptadine,allergic rhinitis,5-hydroxytryptamine receptor 2a
8354,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 2
8355,cyproheptadine,allergic rhinitis,solute carrier family 6 member 2
8356,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 1
8357,cyproheptadine,allergic rhinitis,dopamine receptor d2
8358,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 5
8359,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 4
8360,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 1
8361,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 5
8362,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 2
8363,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 3
8364,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 4
8365,dexbrompheniramine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8366,dexbrompheniramine,allergic rhinitis,histamine receptor h1
8367,prednisolone,allergic rhinitis,serpin family a member 6
8368,astemizole,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8369,astemizole,allergic rhinitis,"major histocompatibility complex, class i, a"
8370,astemizole,allergic rhinitis,transmembrane protein 97
8371,codeine,allergic rhinitis,opioid receptor mu 1
8372,betamethasone,allergic rhinitis,prostaglandin-endoperoxide synthase 2
8373,betamethasone,allergic rhinitis,phospholipase a2 group ib
8374,doxylamine,allergic rhinitis,cholinergic receptor muscarinic 1
8375,loratadine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8376,triamcinolone,allergic rhinitis,prostaglandin-endoperoxide synthase 2
8377,triamcinolone,allergic rhinitis,serpin family a member 6
8378,ibuprofen,patent ductus arteriosus,c-x-c motif chemokine ligand 8
8379,ibuprofen,patent ductus arteriosus,albumin
8380,indomethacin,patent ductus arteriosus,c-x-c motif chemokine ligand 8
8381,indomethacin,patent ductus arteriosus,albumin
8382,indomethacin,patent ductus arteriosus,aldo-keto reductase family 1 member c3
8383,sulfasalazine,psoriatic arthritis,solute carrier family 46 member 1
8384,sulfasalazine,psoriatic arthritis,acetyl-coa acetyltransferase 1
8385,cortisol,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
8386,cortisol,psoriatic arthritis,sex hormone binding globulin
8387,cortisol,psoriatic arthritis,serpin family a member 6
8388,prednisolone,psoriatic arthritis,serpin family a member 6
8389,betamethasone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
8390,triamcinolone,psoriatic arthritis,serpin family a member 6
8391,tofacitinib,psoriatic arthritis,"fyn proto-oncogene, src family tyrosine kinase"
8392,tofacitinib,psoriatic arthritis,janus kinase 3
8393,tofacitinib,psoriatic arthritis,janus kinase 1
8394,tofacitinib,psoriatic arthritis,janus kinase 2
8395,leflunomide,psoriatic arthritis,dihydroorotate dehydrogenase (quinone)
8396,prednisone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
8397,imatinib,idiopathic hypereosinophilic syndrome,platelet derived growth factor receptor alpha
8398,acebutolol,anxiety,adrenoceptor beta 2
8399,acebutolol,anxiety,adrenoceptor beta 1
8400,alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8401,alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8402,alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8403,alprazolam,anxiety,bromodomain containing 4
8404,chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8405,chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8406,chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8407,clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8408,clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8409,clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8410,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8411,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8412,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8413,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8414,doxepin,anxiety,5-hydroxytryptamine receptor 2a
8415,doxepin,anxiety,solute carrier family 6 member 2
8416,doxepin,anxiety,histamine receptor h1
8417,doxepin,anxiety,dopamine receptor d2
8418,doxepin,anxiety,solute carrier family 6 member 4
8419,doxepin,anxiety,5-hydroxytryptamine receptor 1a
8420,trifluoperazine,anxiety,sigma non-opioid intracellular receptor 1
8421,trifluoperazine,anxiety,histamine receptor h1
8422,trifluoperazine,anxiety,5-hydroxytryptamine receptor 1a
8423,trifluoperazine,anxiety,5-hydroxytryptamine receptor 2a
8424,imipramine,anxiety,histamine receptor h1
8425,imipramine,anxiety,dopamine receptor d2
8426,imipramine,anxiety,5-hydroxytryptamine receptor 2a
8427,imipramine,anxiety,solute carrier family 6 member 2
8428,imipramine,anxiety,solute carrier family 6 member 4
8429,imipramine,anxiety,5-hydroxytryptamine receptor 1a
8430,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8431,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8432,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8433,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8434,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8435,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8436,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8437,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8438,methylphenobarbital,anxiety,glutamate ionotropic receptor kainate type subunit 2
8439,methylphenobarbital,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8440,methylphenobarbital,anxiety,cholinergic receptor nicotinic alpha 4 subunit
8441,clomipramine,anxiety,5-hydroxytryptamine receptor 2a
8442,clomipramine,anxiety,solute carrier family 6 member 2
8443,clomipramine,anxiety,solute carrier family 6 member 4
8444,clomipramine,anxiety,dopamine receptor d2
8445,clomipramine,anxiety,dopamine receptor d1
8446,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8447,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8448,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8449,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8450,desipramine,anxiety,adrenoceptor beta 2
8451,desipramine,anxiety,5-hydroxytryptamine receptor 1a
8452,desipramine,anxiety,adrenoceptor beta 1
8453,desipramine,anxiety,5-hydroxytryptamine receptor 2a
8454,desipramine,anxiety,dopamine receptor d2
8455,desipramine,anxiety,solute carrier family 6 member 4
8456,desipramine,anxiety,histamine receptor h1
8457,desipramine,anxiety,solute carrier family 6 member 2
8458,desipramine,anxiety,dopamine receptor d1
8459,imatinib,dermatofibrosarcoma protuberans,"kit proto-oncogene, receptor tyrosine kinase"
8460,imatinib,dermatofibrosarcoma protuberans,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8461,imatinib,dermatofibrosarcoma protuberans,discoidin domain receptor tyrosine kinase 1
8462,imatinib,dermatofibrosarcoma protuberans,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
8463,imatinib,dermatofibrosarcoma protuberans,solute carrier family 47 member 1
8464,imatinib,dermatofibrosarcoma protuberans,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8465,imatinib,dermatofibrosarcoma protuberans,platelet derived growth factor receptor beta
8466,imatinib,dermatofibrosarcoma protuberans,discoidin domain receptor tyrosine kinase 2
8467,imatinib,dermatofibrosarcoma protuberans,dead-box helicase 3 x-linked
8468,cephalotaxine,"chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein l3
8469,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",discoidin domain receptor tyrosine kinase 1
8470,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",platelet derived growth factor receptor alpha
8471,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 2, non-receptor tyrosine kinase"
8472,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 9
8473,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 19
8474,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","b-raf proto-oncogene, serine/threonine kinase"
8475,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",mitogen-activated protein kinase 14
8476,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
8477,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
8478,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",platelet derived growth factor receptor alpha
8479,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 2, non-receptor tyrosine kinase"
8480,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",eph receptor a5
8481,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",dead-box helicase 1
8482,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 19
8483,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",mitogen-activated protein kinase 14
8484,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 8
8485,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","b-raf proto-oncogene, serine/threonine kinase"
8486,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",receptor interacting serine/threonine kinase 3
8487,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",discoidin domain receptor tyrosine kinase 1
8488,hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",ribonucleotide reductase regulatory subunit m2
8489,hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 9
8490,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit gamma2
8491,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha3
8492,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha5
8493,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha6
8494,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha1
8495,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha2
8496,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit beta2
8497,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha4
8498,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit gamma2
8499,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit beta2
8500,biotin,biotinidase deficiency,holocarboxylase synthetase
8501,biotin,holocarboxylase synthetase deficiency,holocarboxylase synthetase
8502,methylprednisolone,mycosis fungoides,atp binding cassette subfamily b member 1
8503,triamcinolone,mycosis fungoides,serpin family a member 6
8504,prednisolone,mycosis fungoides,atp binding cassette subfamily b member 1
8505,prednisolone,mycosis fungoides,serpin family a member 6
8506,vincristine,mycosis fungoides,atp binding cassette subfamily b member 1
8507,vincristine,mycosis fungoides,tubulin beta 8 class viii
8508,vincristine,mycosis fungoides,tubulin beta 3 class iii
8509,vincristine,mycosis fungoides,tubulin beta class i
8510,vincristine,mycosis fungoides,tubulin beta 1 class vi
8511,vincristine,mycosis fungoides,tubulin beta 4a class iva
8512,vincristine,mycosis fungoides,tubulin beta 2a class iia
8513,vincristine,mycosis fungoides,tubulin beta 2b class iib
8514,vincristine,mycosis fungoides,tubulin beta 4b class ivb
8515,vincristine,mycosis fungoides,tubulin beta 6 class v
8516,cyclophosphamide,mycosis fungoides,atp binding cassette subfamily b member 1
8517,prednisone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
8518,prednisone,mycosis fungoides,atp binding cassette subfamily b member 1
8519,betamethasone,mycosis fungoides,atp binding cassette subfamily b member 1
8520,vinblastine,mycosis fungoides,tubulin beta 4a class iva
8521,vinblastine,mycosis fungoides,tubulin beta 1 class vi
8522,vinblastine,mycosis fungoides,tubulin beta 8 class viii
8523,vinblastine,mycosis fungoides,atp binding cassette subfamily b member 1
8524,vinblastine,mycosis fungoides,tubulin beta 2b class iib
8525,vinblastine,mycosis fungoides,tubulin beta 4b class ivb
8526,vinblastine,mycosis fungoides,tubulin beta 2a class iia
8527,vinblastine,mycosis fungoides,tubulin beta 3 class iii
8528,vinblastine,mycosis fungoides,tubulin beta 6 class v
8529,cortisol,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
8530,cortisol,mycosis fungoides,atp binding cassette subfamily b member 1
8531,cortisol,mycosis fungoides,sex hormone binding globulin
8532,cortisol,mycosis fungoides,serpin family a member 6
8533,ruxolitinib,primary myelofibrosis,mitogen-activated protein kinase kinase kinase 19
8534,ruxolitinib,primary myelofibrosis,death associated protein kinase 2
8535,ruxolitinib,primary myelofibrosis,janus kinase 1
8536,ruxolitinib,primary myelofibrosis,death associated protein kinase 3
8537,ruxolitinib,primary myelofibrosis,bmp2 inducible kinase
8538,ruxolitinib,primary myelofibrosis,doublecortin like kinase 3
8539,ruxolitinib,primary myelofibrosis,janus kinase 2
8540,ruxolitinib,primary myelofibrosis,serine/threonine kinase 16
8541,ruxolitinib,primary myelofibrosis,cyclin g associated kinase
8542,ruxolitinib,primary myelofibrosis,death associated protein kinase 1
8543,betamethasone,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8544,betamethasone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8545,panobinostat,plasma cell myeloma,histone deacetylase 6
8546,panobinostat,plasma cell myeloma,histone deacetylase 10
8547,panobinostat,plasma cell myeloma,histone deacetylase 11
8548,panobinostat,plasma cell myeloma,histone deacetylase 9
8549,panobinostat,plasma cell myeloma,histone deacetylase 7
8550,panobinostat,plasma cell myeloma,histone deacetylase 1
8551,panobinostat,plasma cell myeloma,histone deacetylase 2
8552,panobinostat,plasma cell myeloma,histone deacetylase 3
8553,panobinostat,plasma cell myeloma,histone deacetylase 4
8554,panobinostat,plasma cell myeloma,histone deacetylase 8
8555,panobinostat,plasma cell myeloma,histone deacetylase 5
8556,methylprednisolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8557,lenalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8558,lenalidomide,plasma cell myeloma,cereblon
8559,triamcinolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8560,triamcinolone,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8561,etoposide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8562,etoposide,plasma cell myeloma,dna topoisomerase ii alpha
8563,etoposide,plasma cell myeloma,atp binding cassette subfamily c member 1 (abcc1 blood group)
8564,etoposide,plasma cell myeloma,glutathione s-transferase theta 1
8565,vincristine,plasma cell myeloma,atp binding cassette subfamily c member 1 (abcc1 blood group)
8566,prednisone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8567,pomalidomide,plasma cell myeloma,cereblon
8568,prednisolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8569,bortezomib,plasma cell myeloma,proteasome 20s subunit alpha 1
8570,bortezomib,plasma cell myeloma,cathepsin g
8571,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 2
8572,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 8
8573,bortezomib,plasma cell myeloma,chymotrypsinogen b1
8574,thalidomide,plasma cell myeloma,tumor necrosis factor
8575,thalidomide,plasma cell myeloma,cereblon
8576,thalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8577,prednisolone,sjogren syndrome,serpin family a member 6
8578,cortisol,angioedema,sex hormone binding globulin
8579,cortisol,angioedema,serpin family a member 6
8580,prednisone,angioedema,nuclear receptor subfamily 3 group c member 1
8581,prednisone,angioedema,albumin
8582,prednisolone,angioedema,serpin family a member 6
8583,betamethasone,angioedema,nuclear receptor subfamily 3 group c member 1
8584,triamcinolone,angioedema,serpin family a member 6
8585,promazine,angioedema,5-hydroxytryptamine receptor 2a
8586,promazine,angioedema,dopamine receptor d2
8587,promazine,angioedema,histamine receptor h1
8588,vasopressin,hemophilia a,arginine vasopressin receptor 1b
8589,vasopressin,hemophilia a,arginine vasopressin receptor 1a
8590,vasopressin,hemophilia a,arginine vasopressin receptor 2
8591,desmopressin,hemophilia a,arginine vasopressin receptor 1a
8592,desmopressin,hemophilia a,arginine vasopressin receptor 1b
8593,ergocalciferol,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 2 subfamily r member 1
8594,ergocalciferol,x-linked dominant hypophosphatemic rickets,vitamin d receptor
8595,ergocalciferol,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 27 subfamily b member 1
8596,"1,25-dihydroxyvitamin d3",x-linked dominant hypophosphatemic rickets,vitamin d receptor
8597,l-citrulline,ornithine carbamoyltransferase deficiency,ornithine transcarbamylase
8598,finasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 2
8599,finasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 1
8600,tadalafil,benign prostatic hyperplasia,phosphodiesterase 5a
8601,tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
8602,prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
8603,prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
8604,prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
8605,doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
8606,prasugrel,cerebrovascular disorder,purinergic receptor p2y12
8607,prasugrel,cerebrovascular disorder,albumin
8608,caffeine,obesity disorder,cytochrome p450 family 1 subfamily b member 1
8609,caffeine,obesity disorder,cytochrome p450 family 2 subfamily e member 1
8610,caffeine,obesity disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"
8611,caffeine,obesity disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"
8612,caffeine,obesity disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"
8613,lorcaserin,obesity disorder,5-hydroxytryptamine receptor 2a
8614,lorcaserin,obesity disorder,solute carrier family 6 member 4
8615,sibutramine,obesity disorder,solute carrier family 6 member 3
8616,sibutramine,obesity disorder,solute carrier family 6 member 4
8617,sibutramine,obesity disorder,solute carrier family 6 member 2
8618,fenfluramine,obesity disorder,5-hydroxytryptamine receptor 2c
8619,fenfluramine,obesity disorder,5-hydroxytryptamine receptor 2a
8620,methamphetamine,obesity disorder,solute carrier family 6 member 2
8621,methamphetamine,obesity disorder,trace amine associated receptor 1
8622,methamphetamine,obesity disorder,solute carrier family 22 member 3
8623,methamphetamine,obesity disorder,solute carrier family 18 member a2
8624,methamphetamine,obesity disorder,solute carrier family 6 member 3
8625,methamphetamine,obesity disorder,solute carrier family 6 member 4
8626,bupropion,obesity disorder,solute carrier family 6 member 2
8627,bupropion,obesity disorder,solute carrier family 6 member 3
8628,bupropion,obesity disorder,cytochrome p450 family 2 subfamily e member 1
8629,bupropion,obesity disorder,adrenoceptor alpha 1a
8630,bupropion,obesity disorder,solute carrier family 6 member 4
8631,benzphetamine,obesity disorder,solute carrier family 18 member a2
8632,benzphetamine,obesity disorder,solute carrier family 6 member 3
8633,benzphetamine,obesity disorder,solute carrier family 6 member 2
8634,phentermine,obesity disorder,solute carrier family 6 member 4
8635,phentermine,obesity disorder,solute carrier family 6 member 3
8636,rimonabant,obesity disorder,cannabinoid receptor 2
8637,rimonabant,obesity disorder,cannabinoid receptor 1
8638,naltrexone,obesity disorder,opioid receptor mu 1
8639,naltrexone,obesity disorder,opioid receptor kappa 1
8640,naltrexone,obesity disorder,opioid receptor delta 1
8641,dexfenfluramine,obesity disorder,solute carrier family 6 member 4
8642,dexfenfluramine,obesity disorder,5-hydroxytryptamine receptor 2c
8643,dexfenfluramine,obesity disorder,cytochrome p450 family 2 subfamily e member 1
8644,phenmetrazine,obesity disorder,solute carrier family 6 member 3
8645,phenmetrazine,obesity disorder,solute carrier family 6 member 2
8646,amphetamine,obesity disorder,solute carrier family 22 member 3
8647,amphetamine,obesity disorder,solute carrier family 6 member 4
8648,amphetamine,obesity disorder,solute carrier family 6 member 2
8649,amphetamine,obesity disorder,dopamine receptor d2
8650,amphetamine,obesity disorder,solute carrier family 6 member 3
8651,secobarbital,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8652,zolpidem,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8653,zolpidem,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8654,choline,insomnia,adenosine a2a receptor
8655,eszopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8656,zaleplon,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8657,triazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8658,triazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8659,melatonin,insomnia,calreticulin
8660,nitrazepam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8661,nitrazepam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8662,midazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8663,midazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8664,pentobarbitone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8665,pentobarbitone,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8666,flurazepam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8667,flurazepam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8668,zopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8669,zopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8670,alprazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8671,alprazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8672,betamethasone,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
8673,betamethasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8674,cetirizine,"dermatitis, atopic",histamine receptor h1
8675,mometasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8676,doxepin,"dermatitis, atopic",histamine receptor h1
8677,doxepin,"dermatitis, atopic",histamine receptor h2
8678,clobetasol propionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8679,triamcinolone,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
8680,prednisone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8681,cortisol,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8682,l-glutamine,sickle cell anemia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
8683,hydroxyurea,sickle cell anemia,ribonucleotide reductase regulatory subunit m2
8684,prednisolone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8685,prednisolone,juvenile idiopathic arthritis,serpin family a member 6
8686,etodolac,juvenile idiopathic arthritis,dihydrofolate reductase
8687,methylprednisolone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8688,meloxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8689,salicylic acid,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8690,salicylic acid,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8691,salicylic acid,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8692,salicylic acid,juvenile idiopathic arthritis,high mobility group box 1
8693,naproxen,juvenile idiopathic arthritis,aldo-keto reductase family 1 member c3
8694,naproxen,juvenile idiopathic arthritis,dihydrofolate reductase
8695,celecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8696,chloroquine,juvenile idiopathic arthritis,tumor necrosis factor
8697,chloroquine,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8698,prednisone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
8699,prednisone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8700,betamethasone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8701,betamethasone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8702,tolmetin,juvenile idiopathic arthritis,c-x-c motif chemokine ligand 8
8703,triamcinolone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8704,triamcinolone,juvenile idiopathic arthritis,serpin family a member 6
8705,nabumetone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8706,nabumetone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8707,sulfasalazine,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8708,sulfasalazine,juvenile idiopathic arthritis,arachidonate 5-lipoxygenase
8709,sulfasalazine,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8710,sulfasalazine,juvenile idiopathic arthritis,solute carrier family 46 member 1
8711,rofecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8712,ibuprofen,juvenile idiopathic arthritis,c-x-c motif chemokine ligand 8
8713,ibuprofen,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8714,ibuprofen,juvenile idiopathic arthritis,dihydrofolate reductase
8715,piroxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8716,piroxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8717,spironolactone,acne,progesterone receptor
8718,spironolactone,acne,nuclear receptor subfamily 3 group c member 1
8719,spironolactone,acne,sex hormone binding globulin
8720,spironolactone,acne,androgen receptor
8721,spironolactone,acne,cytochrome p450 family 11 subfamily b member 1
8722,dapsone,acne,prostaglandin-endoperoxide synthase 2
8723,dapsone,acne,prostaglandin-endoperoxide synthase 1
8724,ethinylestradiol,acne,estrogen receptor 2
8725,ethinylestradiol,acne,sex hormone binding globulin
8726,estradiol valerate,acne,sex hormone binding globulin
8727,estradiol valerate,acne,androgen receptor
8728,azelaic acid,acne,tyrosinase
8729,drospirenone,acne,progesterone receptor
8730,drospirenone,acne,prostaglandin-endoperoxide synthase 2
8731,drospirenone,acne,androgen receptor
8732,tretinoin,acne,retinoid x receptor beta
8733,cortisol,acne,cytochrome p450 family 11 subfamily b member 1
8734,cortisol,acne,sex hormone binding globulin
8735,norethisterone,acne,sex hormone binding globulin
8736,norethisterone,acne,progesterone receptor
8737,minocycline,acne,interleukin 1 beta
8738,adapalene,acne,retinoid x receptor beta
8739,adapalene,acne,retinoic acid receptor beta
8740,adapalene,acne,retinoic acid receptor alpha
8741,adapalene,acne,retinoic acid receptor gamma
8742,levonorgestrel,acne,androgen receptor
8743,levonorgestrel,acne,progesterone receptor
8744,levonorgestrel,acne,sex hormone binding globulin
8745,levonorgestrel,acne,estrogen receptor 1
8746,norgestimate,acne,estrogen receptor 1
8747,norgestimate,acne,progesterone receptor
8748,estrone,acne,estrogen receptor 1
8749,estrone,acne,estrogen receptor 2
8750,estrone,acne,sex hormone binding globulin
8751,tretinoin,acute promyelocytic leukemia,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
8752,cytarabine,acute promyelocytic leukemia,"dna polymerase alpha 1, catalytic subunit"
8753,cytarabine,acute promyelocytic leukemia,"dna polymerase delta 1, catalytic subunit"
8754,cytarabine,acute promyelocytic leukemia,dna polymerase beta
8755,cytarabine,acute promyelocytic leukemia,"dna polymerase epsilon, catalytic subunit"
8756,tamibarotene,acute promyelocytic leukemia,retinoic acid receptor alpha
8757,tamibarotene,acute promyelocytic leukemia,retinoic acid receptor beta
8758,daunorubicin,acute promyelocytic leukemia,dna topoisomerase ii alpha
8759,lovastatin,hypoalphalipoproteinemia,3-hydroxy-3-methylglutaryl-coa reductase
8760,fenofibrate,hypoalphalipoproteinemia,peroxisome proliferator activated receptor alpha
8761,simvastatin,hypoalphalipoproteinemia,3-hydroxy-3-methylglutaryl-coa reductase
8762,gemfibrozil,hypoalphalipoproteinemia,peroxisome proliferator activated receptor alpha
8763,prednisolone,hypersensitivity pneumonitis,serpin family a member 6
8764,ceftriaxone,meningococcal meningitis,synuclein alpha
8765,acth,west syndrome,melanocortin 3 receptor
8766,vemurafenib,erdheim-chester disease,"b-raf proto-oncogene, serine/threonine kinase"
8767,vandetanib,thyroid gland carcinoma,ret proto-oncogene
8768,vandetanib,thyroid gland carcinoma,ste20 like kinase
8769,sorafenib,thyroid gland carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
8770,sorafenib,thyroid gland carcinoma,ret proto-oncogene
8771,sorafenib,thyroid gland carcinoma,ste20 like kinase
8772,triamcinolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8773,triamcinolone,chronic primary adrenal insufficiency,serpin family a member 6
8774,prednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8775,prednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8776,prednisolone,chronic primary adrenal insufficiency,serpin family a member 6
8777,prednisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8778,cortisol,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8779,cortisol,chronic primary adrenal insufficiency,sex hormone binding globulin
8780,cortisol,chronic primary adrenal insufficiency,serpin family a member 6
8781,cortisol,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8782,methylprednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8783,betamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8784,betamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8785,fludrocortisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8786,fludrocortisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8787,prednisolone,dermatitis herpetiformis,serpin family a member 6
8788,triamcinolone,dermatitis herpetiformis,serpin family a member 6
8789,prednisone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
8790,dapsone,dermatitis herpetiformis,myeloperoxidase
8791,cortisol,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
8792,cortisol,dermatitis herpetiformis,sex hormone binding globulin
8793,cortisol,dermatitis herpetiformis,serpin family a member 6
8794,betamethasone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
8795,imatinib,chronic eosinophilic leukemia,"kit proto-oncogene, receptor tyrosine kinase"
8796,imatinib,chronic eosinophilic leukemia,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8797,imatinib,chronic eosinophilic leukemia,discoidin domain receptor tyrosine kinase 1
8798,imatinib,chronic eosinophilic leukemia,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
8799,imatinib,chronic eosinophilic leukemia,solute carrier family 47 member 1
8800,imatinib,chronic eosinophilic leukemia,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8801,imatinib,chronic eosinophilic leukemia,platelet derived growth factor receptor beta
8802,imatinib,chronic eosinophilic leukemia,discoidin domain receptor tyrosine kinase 2
8803,imatinib,chronic eosinophilic leukemia,dead-box helicase 3 x-linked
8804,imatinib,myeloid neoplasm associated with pdgfra rearrangement,platelet derived growth factor receptor alpha
8805,cortisol,adrenogenital syndrome,cytochrome p450 family 11 subfamily b member 1
8806,nitric oxide,pulmonary arterial hypertension,guanylate cyclase 1 soluble subunit alpha 2
8807,pge1,pulmonary arterial hypertension,prostaglandin e receptor 1
8808,pge1,pulmonary arterial hypertension,prostaglandin e receptor 2
8809,pge1,pulmonary arterial hypertension,prostaglandin i2 receptor
8810,iloprost,pulmonary arterial hypertension,prostaglandin i2 receptor
8811,iloprost,pulmonary arterial hypertension,prostaglandin e receptor 1
8812,iloprost,pulmonary arterial hypertension,prostaglandin e receptor 4
8813,iloprost,pulmonary arterial hypertension,prostaglandin e receptor 2
8814,tadalafil,pulmonary arterial hypertension,phosphodiesterase 5a
8815,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 2
8816,nintedanib,interstitial lung disease,fibroblast growth factor receptor 3
8817,nintedanib,interstitial lung disease,kinase insert domain receptor
8818,nintedanib,interstitial lung disease,cdc like kinase 1
8819,nintedanib,interstitial lung disease,axl receptor tyrosine kinase
8820,nintedanib,interstitial lung disease,discoidin domain receptor tyrosine kinase 1
8821,nintedanib,interstitial lung disease,nuak family kinase 2
8822,nintedanib,interstitial lung disease,insulin receptor related receptor
8823,nintedanib,interstitial lung disease,fms related receptor tyrosine kinase 1
8824,nintedanib,interstitial lung disease,cyclin dependent kinase 16
8825,nintedanib,interstitial lung disease,serine/threonine kinase 16
8826,nintedanib,interstitial lung disease,rio kinase 1
8827,nintedanib,interstitial lung disease,"mer proto-oncogene, tyrosine kinase"
8828,nintedanib,interstitial lung disease,ste20 like kinase
8829,nintedanib,interstitial lung disease,platelet derived growth factor receptor beta
8830,nintedanib,interstitial lung disease,g protein-coupled receptor kinase 4
8831,nintedanib,interstitial lung disease,maternal embryonic leucine zipper kinase
8832,nintedanib,interstitial lung disease,cdc like kinase 4
8833,nintedanib,interstitial lung disease,serine/threonine kinase 11
8834,nintedanib,interstitial lung disease,srsf protein kinase 3
8835,nintedanib,interstitial lung disease,ttk protein kinase
8836,nintedanib,interstitial lung disease,platelet derived growth factor receptor alpha
8837,nintedanib,interstitial lung disease,serine/threonine kinase 4
8838,nintedanib,interstitial lung disease,protein kinase cgmp-dependent 1
8839,nintedanib,interstitial lung disease,bmp2 inducible kinase
8840,nintedanib,interstitial lung disease,pre-mrna processing factor kinase prp4k
8841,nintedanib,interstitial lung disease,p21 (rac1) activated kinase 2
8842,nintedanib,interstitial lung disease,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
8843,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 7
8844,nintedanib,interstitial lung disease,fibroblast growth factor receptor 1
8845,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 19
8846,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase 5
8847,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma2
8848,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit alpha1
8849,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta2
8850,nitrazepam,early myoclonic encephalopathy,sodium voltage-gated channel alpha subunit 1
8851,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta3
8852,clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit alpha1
8853,clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta2
8854,clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma2
8855,mexiletine,myotonic syndrome,sodium voltage-gated channel alpha subunit 4
8856,prednisolone,allergic bronchopulmonary aspergillosis,serpin family a member 6
8857,triamcinolone,diamond-blackfan anemia,serpin family a member 6
8858,cortisol,diamond-blackfan anemia,sex hormone binding globulin
8859,cortisol,diamond-blackfan anemia,serpin family a member 6
8860,prednisolone,diamond-blackfan anemia,serpin family a member 6
8861,prednisolone,diamond-blackfan anemia,androgen receptor
8862,prednisone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
8863,triamcinolone,chronic beryllium disease,serpin family a member 6
8864,cortisol,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
8865,cortisol,chronic beryllium disease,sex hormone binding globulin
8866,cortisol,chronic beryllium disease,serpin family a member 6
8867,prednisone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
8868,prednisolone,chronic beryllium disease,serpin family a member 6
8869,vandetanib,medullary thyroid gland carcinoma,ret proto-oncogene
8870,vandetanib,medullary thyroid gland carcinoma,kinase insert domain receptor
8871,vandetanib,medullary thyroid gland carcinoma,tek receptor tyrosine kinase
8872,vandetanib,medullary thyroid gland carcinoma,fms related receptor tyrosine kinase 3
8873,vandetanib,medullary thyroid gland carcinoma,axl receptor tyrosine kinase
8874,vandetanib,medullary thyroid gland carcinoma,"met proto-oncogene, receptor tyrosine kinase"
8875,vandetanib,medullary thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
8876,vandetanib,medullary thyroid gland carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
8877,cabozantinib,medullary thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
8878,lisuride,acromegaly,dopamine receptor d3
8879,lisuride,acromegaly,5-hydroxytryptamine receptor 2b
8880,lisuride,acromegaly,dopamine receptor d4
8881,lisuride,acromegaly,dopamine receptor d5
8882,bromocriptine,acromegaly,5-hydroxytryptamine receptor 6
8883,bromocriptine,acromegaly,dopamine receptor d4
8884,bromocriptine,acromegaly,5-hydroxytryptamine receptor 2b
8885,bromocriptine,acromegaly,dopamine receptor d5
8886,octreotide,acromegaly,somatostatin receptor 1
8887,octreotide,acromegaly,somatostatin receptor 3
8888,octreotide,acromegaly,somatostatin receptor 4
8889,octreotide,acromegaly,somatostatin receptor 5
8890,octreotide,acromegaly,somatostatin receptor 2
8891,nicotine,pellagra,cholinergic receptor nicotinic alpha 4 subunit
8892,nicotine,pellagra,cholinergic receptor nicotinic beta 2 subunit
8893,nicotine,pellagra,cholinergic receptor nicotinic alpha 2 subunit
8894,nicotine,pellagra,cholinergic receptor nicotinic beta 3 subunit
8895,nicotine,pellagra,cholinergic receptor nicotinic alpha 6 subunit
8896,ruxolitinib,myeloproliferative neoplasm,janus kinase 3
8897,ruxolitinib,myeloproliferative neoplasm,"kit proto-oncogene, receptor tyrosine kinase"
8898,ruxolitinib,myeloproliferative neoplasm,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8899,prednisolone,autoimmune hemolytic anemia,serpin family a member 6
8900,cortisol,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
8901,cortisol,autoimmune hemolytic anemia,sex hormone binding globulin
8902,cortisol,autoimmune hemolytic anemia,serpin family a member 6
8903,triamcinolone,autoimmune hemolytic anemia,serpin family a member 6
8904,prednisone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
8905,betamethasone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
8906,prednisolone,uveitis,serpin family a member 6
8907,fluorometholone,uveitis,serpin family a member 6
8908,triamcinolone,uveitis,serpin family a member 6
8909,cortisol,uveitis,sex hormone binding globulin
8910,cortisol,uveitis,serpin family a member 6
8911,cyclopentolate,uveitis,cholinergic receptor muscarinic 3
8912,cyclopentolate,uveitis,cholinergic receptor muscarinic 1
8913,azacitidine,chronic myelomonocytic leukemia,dna methyltransferase 3 alpha
8914,azacitidine,chronic myelomonocytic leukemia,dna methyltransferase 1
8915,azacitidine,chronic myelomonocytic leukemia,cytidine deaminase
8916,midostaurin,aggressive systemic mastocytosis,microtubule affinity regulating kinase 3
8917,midostaurin,aggressive systemic mastocytosis,protein kinase n1
8918,midostaurin,aggressive systemic mastocytosis,tank binding kinase 1
8919,midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 9
8920,midostaurin,aggressive systemic mastocytosis,calcium/calmodulin dependent protein kinase ii alpha
8921,midostaurin,aggressive systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
8922,midostaurin,aggressive systemic mastocytosis,serine/threonine kinase 4
8923,midostaurin,aggressive systemic mastocytosis,pre-mrna splicing tri-snrnp complex factor prpf4
8924,midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 11
8925,midostaurin,aggressive systemic mastocytosis,fms related receptor tyrosine kinase 3
8926,midostaurin,aggressive systemic mastocytosis,protein kinase n2
8927,midostaurin,aggressive systemic mastocytosis,tankyrase 2
8928,midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 19
8929,midostaurin,mast cell leukemia,microtubule affinity regulating kinase 3
8930,midostaurin,mast cell leukemia,protein kinase n1
8931,midostaurin,mast cell leukemia,tank binding kinase 1
8932,midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 9
8933,midostaurin,mast cell leukemia,calcium/calmodulin dependent protein kinase ii alpha
8934,midostaurin,mast cell leukemia,serine/threonine kinase 4
8935,midostaurin,mast cell leukemia,pre-mrna splicing tri-snrnp complex factor prpf4
8936,midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 11
8937,midostaurin,mast cell leukemia,protein kinase n2
8938,midostaurin,mast cell leukemia,tankyrase 2
8939,midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 19
8940,carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 4
8941,carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 5
8942,carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 9
8943,glibenclamide,neonatal diabetes mellitus,atp binding cassette subfamily c member 8
8944,glibenclamide,neonatal diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
8945,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 3
8946,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
8947,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8948,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 2
8949,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 8
8950,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
8951,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
8952,felbamate,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 2a
8953,felbamate,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 2b
8954,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
8955,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
8956,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 8
8957,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
8958,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 3
8959,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8960,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 10
8961,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 2
8962,phenobarbital,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
8963,phenobarbital,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
8964,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 3
8965,topiramate,lennox-gastaut syndrome,carbonic anhydrase 2
8966,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 4
8967,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 5
8968,topiramate,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8969,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
8970,topiramate,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
8971,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 3
8972,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
8973,topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8974,topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8975,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 1
8976,topiramate,lennox-gastaut syndrome,carbonic anhydrase 4
8977,topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8978,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 4
8979,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 1
8980,carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
8981,carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8982,carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
8983,clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8984,clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8985,clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8986,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8987,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8988,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
8989,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8990,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
8991,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8992,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8993,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
8994,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
8995,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
8996,primidone,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
8997,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
8998,primidone,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
8999,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
9000,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
9001,sapropterin,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,phenylalanine hydroxylase
9002,nizatidine,systemic mastocytosis,histamine receptor h2
9003,rabeprazole,systemic mastocytosis,atpase h+/k+ transporting subunit beta
9004,cimetidine,systemic mastocytosis,solute carrier family 47 member 1
9005,imatinib,systemic mastocytosis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
9006,imatinib,systemic mastocytosis,discoidin domain receptor tyrosine kinase 1
9007,imatinib,systemic mastocytosis,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
9008,imatinib,systemic mastocytosis,solute carrier family 47 member 1
9009,imatinib,systemic mastocytosis,"abl proto-oncogene 2, non-receptor tyrosine kinase"
9010,imatinib,systemic mastocytosis,platelet derived growth factor receptor beta
9011,imatinib,systemic mastocytosis,discoidin domain receptor tyrosine kinase 2
9012,imatinib,systemic mastocytosis,dead-box helicase 3 x-linked
9013,acth,stevens-johnson syndrome,melanocortin 3 receptor
9014,prednisolone,stevens-johnson syndrome,serpin family a member 6
9015,ezetimibe,homozygous familial hypercholesterolemia,atp binding cassette subfamily g member 8
9016,ezetimibe,homozygous familial hypercholesterolemia,atp binding cassette subfamily g member 5
9017,simvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
9018,methylprednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
9019,triamcinolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
9020,triamcinolone,congenital adrenal hyperplasia,serpin family a member 6
9021,prednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
9022,prednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
9023,prednisolone,congenital adrenal hyperplasia,serpin family a member 6
9024,betamethasone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
9025,betamethasone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
9026,cortisol,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
9027,cortisol,congenital adrenal hyperplasia,cytochrome p450 family 11 subfamily b member 1
9028,cortisol,congenital adrenal hyperplasia,sex hormone binding globulin
9029,cortisol,congenital adrenal hyperplasia,serpin family a member 6
9030,cortisol,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
9031,dantrolene,malignant hyperthermia of anesthesia,ryanodine receptor 1
9032,dantrolene,malignant hyperthermia of anesthesia,ryanodine receptor 3
9033,thalidomide,pyoderma gangrenosum,tumor necrosis factor
9034,thalidomide,pyoderma gangrenosum,nuclear factor kappa b subunit 1
9035,cytarabine,acute myeloid leukemia,"dna polymerase alpha 1, catalytic subunit"
9036,cytarabine,acute myeloid leukemia,"dna polymerase delta 1, catalytic subunit"
9037,cytarabine,acute myeloid leukemia,dna polymerase beta
9038,cytarabine,acute myeloid leukemia,"dna polymerase epsilon, catalytic subunit"
9039,daunorubicin,acute myeloid leukemia,dna topoisomerase ii beta
9040,daunorubicin,acute myeloid leukemia,dna topoisomerase ii alpha
9041,etoposide,acute myeloid leukemia,dna topoisomerase ii beta
9042,etoposide,acute myeloid leukemia,dna topoisomerase ii alpha
9043,fludarabine,acute myeloid leukemia,"dna polymerase alpha 1, catalytic subunit"
9044,mercaptopurine,acute myeloid leukemia,hypoxanthine phosphoribosyltransferase 1
9045,midostaurin,acute myeloid leukemia,microtubule affinity regulating kinase 3
9046,midostaurin,acute myeloid leukemia,protein kinase n1
9047,midostaurin,acute myeloid leukemia,tank binding kinase 1
9048,midostaurin,acute myeloid leukemia,death associated protein kinase 1
9049,midostaurin,acute myeloid leukemia,axl receptor tyrosine kinase
9050,midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 9
9051,midostaurin,acute myeloid leukemia,calcium/calmodulin dependent protein kinase ii alpha
9052,midostaurin,acute myeloid leukemia,"mer proto-oncogene, tyrosine kinase"
9053,midostaurin,acute myeloid leukemia,serine/threonine kinase 4
9054,midostaurin,acute myeloid leukemia,"pim-2 proto-oncogene, serine/threonine kinase"
9055,midostaurin,acute myeloid leukemia,pre-mrna splicing tri-snrnp complex factor prpf4
9056,midostaurin,acute myeloid leukemia,unc-51 like kinase 3
9057,midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 11
9058,midostaurin,acute myeloid leukemia,polo like kinase 4
9059,midostaurin,acute myeloid leukemia,protein kinase n2
9060,midostaurin,acute myeloid leukemia,neurotrophic receptor tyrosine kinase 3
9061,midostaurin,acute myeloid leukemia,cyclin g associated kinase
9062,midostaurin,acute myeloid leukemia,interleukin 1 receptor associated kinase 3
9063,midostaurin,acute myeloid leukemia,janus kinase 2
9064,midostaurin,acute myeloid leukemia,tankyrase 2
9065,midostaurin,acute myeloid leukemia,janus kinase 1
9066,midostaurin,acute myeloid leukemia,"met proto-oncogene, receptor tyrosine kinase"
9067,midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 19
9068,midostaurin,acute myeloid leukemia,ap2 associated kinase 1
9069,midostaurin,acute myeloid leukemia,colony stimulating factor 1 receptor
9070,venetoclax,acute myeloid leukemia,bcl2 apoptosis regulator
9071,venetoclax,acute myeloid leukemia,bcl2 like 2
9072,venetoclax,acute myeloid leukemia,bcl2 like 1
9073,mitoxantrone,acute myeloid leukemia,solute carrier family 47 member 2
9074,mitoxantrone,acute myeloid leukemia,solute carrier family 47 member 1
9075,quizartinib,acute myeloid leukemia,neurotrophic receptor tyrosine kinase 3
9076,quizartinib,acute myeloid leukemia,"kit proto-oncogene, receptor tyrosine kinase"
9077,quizartinib,acute myeloid leukemia,kinase insert domain receptor
9078,quizartinib,acute myeloid leukemia,fms related receptor tyrosine kinase 3
9079,quizartinib,acute myeloid leukemia,platelet derived growth factor receptor beta
9080,quizartinib,acute myeloid leukemia,platelet derived growth factor receptor alpha
9081,quizartinib,acute myeloid leukemia,myosin heavy chain 10
9082,quizartinib,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 19
9083,quizartinib,acute myeloid leukemia,colony stimulating factor 1 receptor
9084,thioguanine,acute myeloid leukemia,hypoxanthine phosphoribosyltransferase 1
9085,thioguanine,acute myeloid leukemia,inosine monophosphate dehydrogenase 2
9086,thioguanine,acute myeloid leukemia,inosine monophosphate dehydrogenase 1
9087,azacitidine,acute myeloid leukemia,dna methyltransferase 3 alpha
9088,azacitidine,acute myeloid leukemia,dna methyltransferase 1
9089,histamine,acute myeloid leukemia,histamine receptor h4
9090,histamine,acute myeloid leukemia,histamine receptor h1
9091,gilteritinib,acute myeloid leukemia,cyclin g associated kinase
9092,gilteritinib,acute myeloid leukemia,"ran, member ras oncogene family"
9093,gilteritinib,acute myeloid leukemia,solute carrier family 25 member 6
9094,gilteritinib,acute myeloid leukemia,"tu translation elongation factor, mitochondrial"
9095,gilteritinib,acute myeloid leukemia,24-dehydrocholesterol reductase
9096,gilteritinib,acute myeloid leukemia,interleukin 1 receptor associated kinase 3
9097,gilteritinib,acute myeloid leukemia,polo like kinase 4
9098,gilteritinib,acute myeloid leukemia,solute carrier family 25 member 5
9099,gilteritinib,acute myeloid leukemia,protein kinase c alpha
9100,gilteritinib,acute myeloid leukemia,acyl-coa synthetase long chain family member 5
9101,gilteritinib,acute myeloid leukemia,cytochrome c1
9102,gilteritinib,acute myeloid leukemia,fms related receptor tyrosine kinase 3
9103,gilteritinib,acute myeloid leukemia,unc-51 like kinase 3
9104,gilteritinib,acute myeloid leukemia,ap2 associated kinase 1
9105,gilteritinib,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 11
9106,gilteritinib,acute myeloid leukemia,platelet derived growth factor receptor beta
9107,vincristine,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
9108,vincristine,diffuse large b-cell lymphoma,atp binding cassette subfamily g member 2 (jr blood group)
9109,epirubicin,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
9110,etoposide,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
9111,etoposide,diffuse large b-cell lymphoma,atp binding cassette subfamily g member 2 (jr blood group)
9112,etoposide,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
9113,prednisone,diffuse large b-cell lymphoma,nuclear receptor subfamily 3 group c member 1
9114,prednisone,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
9115,lenalidomide,follicular lymphoma,cereblon
9116,teniposide,follicular lymphoma,dna topoisomerase ii alpha
9117,mitoxantrone,follicular lymphoma,dna topoisomerase ii alpha
9118,prednisone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
9119,cortisol,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
9120,betamethasone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
9121,prednisone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
9122,ivermectin,onchocerciasis,glycine receptor alpha 3
9123,thalidomide,poems syndrome,cereblon
9124,ibrutinib,marginal zone lymphoma,erb-b2 receptor tyrosine kinase 2
9125,cladribine,hairy cell leukemia,ribonucleotide reductase catalytic subunit m1
9126,vinblastine,gestational trophoblastic neoplasm,tubulin beta 4a class iva
9127,vinblastine,gestational trophoblastic neoplasm,tubulin beta 1 class vi
9128,vinblastine,gestational trophoblastic neoplasm,tubulin beta 8 class viii
9129,vinblastine,gestational trophoblastic neoplasm,atp binding cassette subfamily b member 1
9130,vinblastine,gestational trophoblastic neoplasm,tubulin beta 2b class iib
9131,vinblastine,gestational trophoblastic neoplasm,tubulin beta 4b class ivb
9132,vinblastine,gestational trophoblastic neoplasm,tubulin beta class i
9133,vinblastine,gestational trophoblastic neoplasm,tubulin beta 2a class iia
9134,vinblastine,gestational trophoblastic neoplasm,tubulin beta 3 class iii
9135,vinblastine,gestational trophoblastic neoplasm,tubulin beta 6 class v
9136,methyltestosterone,noonan syndrome,androgen receptor
9137,fluoxymesterone,noonan syndrome,androgen receptor
9138,tafamidis,amyloidosis,transthyretin
9139,prednisone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
9140,methylprednisolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
9141,triamcinolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
9142,triamcinolone,idiopathic acute eosinophilic pneumonia,serpin family a member 6
9143,prednisolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
9144,prednisolone,idiopathic acute eosinophilic pneumonia,serpin family a member 6
9145,cortisol,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
9146,cortisol,idiopathic acute eosinophilic pneumonia,sex hormone binding globulin
9147,cortisol,idiopathic acute eosinophilic pneumonia,serpin family a member 6
9148,betamethasone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
9149,prednisolone,sympathetic ophthalmia,serpin family a member 6
9150,triamcinolone,sympathetic ophthalmia,serpin family a member 6
9151,sapropterin,classic phenylketonuria,phenylalanine hydroxylase
9152,triamcinolone,sarcoidosis,serpin family a member 6
9153,cortisol,sarcoidosis,nuclear receptor subfamily 3 group c member 1
9154,cortisol,sarcoidosis,sex hormone binding globulin
9155,cortisol,sarcoidosis,serpin family a member 6
9156,prednisone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
9157,prednisolone,sarcoidosis,serpin family a member 6
9158,bosentan,scleroderma,endothelin receptor type a
9159,bosentan,scleroderma,endothelin receptor type b
9160,tafamidis,attrv122i amyloidosis,transthyretin
9161,prednisone,trichinellosis,nuclear receptor subfamily 3 group c member 1
9162,triamcinolone,trichinellosis,serpin family a member 6
9163,cortisol,trichinellosis,sex hormone binding globulin
9164,cortisol,trichinellosis,serpin family a member 6
9165,mometasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
9166,chloroquine,discoid lupus erythematosus,toll like receptor 9
9167,hydroxychloroquine,discoid lupus erythematosus,toll like receptor 7
9168,hydroxychloroquine,discoid lupus erythematosus,toll like receptor 9
9169,vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 1b
9170,vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 1a
9171,vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 2
9172,desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 1a
9173,desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 1b
9174,desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 2
9175,hydroxocobalamin,vitamin b12 deficiency,cubilin
9176,hydroxocobalamin,vitamin b12 deficiency,cobalamin binding intrinsic factor
9177,hydroxocobalamin,vitamin b12 deficiency,amnion associated transmembrane protein
9178,ciprofloxacin,escherichia coli infection,atp binding cassette subfamily b member 1
9179,oxaliplatin,malignant colon neoplasm,atp binding cassette subfamily g member 2 (jr blood group)
9180,oxaliplatin,malignant colon neoplasm,glutathione s-transferase pi 1
9181,oxaliplatin,malignant colon neoplasm,solute carrier family 22 member 1
9182,oxaliplatin,malignant colon neoplasm,nad(p)h quinone dehydrogenase 1
9183,oxaliplatin,malignant colon neoplasm,glutathione s-transferase mu 1
9184,oxaliplatin,malignant colon neoplasm,atpase copper transporting alpha
9185,trifluridine,malignant colon neoplasm,thymidylate synthetase
9186,trifluridine,malignant colon neoplasm,thymidine phosphorylase
9187,tipiracil,malignant colon neoplasm,thymidine phosphorylase
9188,5-fluorouracil,malignant colon neoplasm,atp binding cassette subfamily g member 2 (jr blood group)
9189,5-fluorouracil,malignant colon neoplasm,thymidine phosphorylase
9190,5-fluorouracil,malignant colon neoplasm,thymidylate synthetase
9191,5-fluorouracil,malignant colon neoplasm,methylenetetrahydrofolate reductase
9192,5-fluorouracil,malignant colon neoplasm,dihydropyrimidine dehydrogenase
9193,5-fluorouracil,malignant colon neoplasm,uridine monophosphate synthetase
9194,biperiden,parkinsonian disorder,cholinergic receptor muscarinic 2
9195,biperiden,parkinsonian disorder,cholinergic receptor muscarinic 4
9196,carbidopa,parkinsonian disorder,dopa decarboxylase
9197,procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 2
9198,procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 4
9199,procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 1
9200,pergolide,parkinsonian disorder,dopamine receptor d1
9201,pergolide,parkinsonian disorder,dopamine receptor d5
9202,pergolide,parkinsonian disorder,dopamine receptor d3
9203,pergolide,parkinsonian disorder,dopamine receptor d2
9204,pergolide,parkinsonian disorder,dopamine receptor d4
9205,methixene,parkinsonian disorder,cholinergic receptor muscarinic 4
9206,methixene,parkinsonian disorder,cholinergic receptor muscarinic 2
9207,methixene,parkinsonian disorder,cholinergic receptor muscarinic 1
9208,amantadine,parkinsonian disorder,dopa decarboxylase
9209,amantadine,parkinsonian disorder,monoamine oxidase b
9210,amantadine,parkinsonian disorder,sigma non-opioid intracellular receptor 1
9211,levodopa,parkinsonian disorder,dopa decarboxylase
9212,benzatropine,parkinsonian disorder,cholinergic receptor muscarinic 2
9213,orphenadrine,parkinsonian disorder,sodium voltage-gated channel alpha subunit 9
9214,orphenadrine,parkinsonian disorder,sodium voltage-gated channel alpha subunit 1
9215,orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 2
9216,orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 4
9217,orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 1
9218,methylphenidate,narcolepsy,solute carrier family 6 member 3
9219,methylphenidate,narcolepsy,solute carrier family 6 member 2
9220,dexamfetamine,narcolepsy,trace amine associated receptor 1
9221,amphetamine,narcolepsy,solute carrier family 6 member 2
9222,amphetamine,narcolepsy,solute carrier family 6 member 3
9223,imipramine,narcolepsy,5-hydroxytryptamine receptor 2a
9224,imipramine,narcolepsy,solute carrier family 6 member 3
9225,imipramine,narcolepsy,solute carrier family 6 member 2
9226,clomiphene,female infertility,cytochrome p450 family 19 subfamily a member 1
9227,clomiphene,female infertility,estrogen receptor 1
9228,caffeine,headache disorder,phosphodiesterase 4b
9229,haloperidol,headache disorder,histamine receptor h1
9230,haloperidol,headache disorder,adrenoceptor alpha 1a
9231,icosapent,hyperlipidemia,diacylglycerol o-acyltransferase 1
9232,lovastatin,hyperlipidemia,3-hydroxy-3-methylglutaryl-coa reductase
9233,nicotine,hyperlipidemia,cytochrome p450 family 19 subfamily a member 1
9234,ezetimibe,hyperlipidemia,atp binding cassette subfamily g member 8
9235,ezetimibe,hyperlipidemia,atp binding cassette subfamily g member 5
9236,nicotinic acid,hyperlipidemia,hydroxycarboxylic acid receptor 3
9237,bezafibrate,hyperlipidemia,3-hydroxy-3-methylglutaryl-coa reductase
9238,fenofibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
9239,estramustine,prostate neoplasm,cytochrome p450 family 3 subfamily a member 4
9240,estramustine,prostate neoplasm,estrogen receptor 1
9241,estramustine,prostate neoplasm,estrogen receptor 2
9242,flutamide,prostate neoplasm,cytochrome p450 family 1 subfamily b member 1
9243,flutamide,prostate neoplasm,cytochrome p450 family 1 subfamily a member 1
9244,flutamide,prostate neoplasm,cytochrome p450 family 2 subfamily c member 19
9245,flutamide,prostate neoplasm,cytochrome p450 family 3 subfamily a member 5
9246,flutamide,prostate neoplasm,androgen receptor
9247,flutamide,prostate neoplasm,aryl hydrocarbon receptor
9248,flutamide,prostate neoplasm,cytochrome p450 family 3 subfamily a member 4
9249,paclitaxel,neoplasm of esophagus,bcl2 apoptosis regulator
9250,paclitaxel,neoplasm of esophagus,cytochrome p450 family 19 subfamily a member 1
9251,paclitaxel,neoplasm of esophagus,atp binding cassette subfamily b member 1
9252,paclitaxel,neoplasm of esophagus,nuclear receptor subfamily 1 group i member 2
9253,clozapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9254,clozapine,manic bipolar affective disorder,dopamine receptor d1
9255,aripiprazole,manic bipolar affective disorder,dopamine receptor d5
9256,aripiprazole,manic bipolar affective disorder,dopamine receptor d1
9257,aripiprazole,manic bipolar affective disorder,solute carrier family 6 member 4
9258,aripiprazole,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9259,carbamazepine,manic bipolar affective disorder,solute carrier family 6 member 4
9260,risperidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9261,risperidone,manic bipolar affective disorder,dopamine receptor d1
9262,risperidone,manic bipolar affective disorder,tachykinin precursor 1
9263,risperidone,manic bipolar affective disorder,dopamine receptor d5
9264,risperidone,manic bipolar affective disorder,solute carrier family 6 member 4
9265,asenapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9266,asenapine,manic bipolar affective disorder,dopamine receptor d1
9267,asenapine,manic bipolar affective disorder,solute carrier family 6 member 4
9268,asenapine,manic bipolar affective disorder,tachykinin precursor 1
9269,paliperidone,manic bipolar affective disorder,dopamine receptor d1
9270,paliperidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9271,paliperidone,manic bipolar affective disorder,tachykinin precursor 1
9272,ziprasidone,manic bipolar affective disorder,dopamine receptor d1
9273,ziprasidone,manic bipolar affective disorder,dopamine receptor d5
9274,ziprasidone,manic bipolar affective disorder,solute carrier family 6 member 4
9275,ziprasidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9276,ziprasidone,manic bipolar affective disorder,tachykinin precursor 1
9277,olanzapine,manic bipolar affective disorder,dopamine receptor d1
9278,olanzapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9279,olanzapine,manic bipolar affective disorder,dopamine receptor d5
9280,promazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9281,promazine,manic bipolar affective disorder,dopamine receptor d1
9282,quetiapine,manic bipolar affective disorder,dopamine receptor d5
9283,quetiapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9284,quetiapine,manic bipolar affective disorder,dopamine receptor d1
9285,quetiapine,manic bipolar affective disorder,tachykinin precursor 1
9286,quetiapine,manic bipolar affective disorder,solute carrier family 6 member 4
9287,cariprazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9288,cariprazine,manic bipolar affective disorder,dopamine receptor d5
9289,cariprazine,manic bipolar affective disorder,dopamine receptor d1
9290,chlorpromazine,manic bipolar affective disorder,dopamine receptor d5
9291,chlorpromazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
9292,chlorpromazine,manic bipolar affective disorder,dopamine receptor d1
9293,chlorpromazine,manic bipolar affective disorder,solute carrier family 6 member 4
9294,doxepin,bipolar depression,5-hydroxytryptamine receptor 2a
9295,doxepin,bipolar depression,solute carrier family 6 member 4
9296,doxepin,bipolar depression,5-hydroxytryptamine receptor 1a
9297,primidone,bipolar depression,glutamate ionotropic receptor kainate type subunit 2
9298,sertraline,bipolar depression,solute carrier family 6 member 4
9299,sertraline,bipolar depression,monoamine oxidase a
9300,paroxetine,bipolar depression,tachykinin receptor 1
9301,paroxetine,bipolar depression,solute carrier family 6 member 4
9302,paroxetine,bipolar depression,5-hydroxytryptamine receptor 2a
9303,paroxetine,bipolar depression,5-hydroxytryptamine receptor 1a
9304,quetiapine,bipolar depression,dopamine receptor d5
9305,quetiapine,bipolar depression,5-hydroxytryptamine receptor 1a
9306,quetiapine,bipolar depression,5-hydroxytryptamine receptor 2a
9307,quetiapine,bipolar depression,dopamine receptor d1
9308,quetiapine,bipolar depression,tachykinin precursor 1
9309,quetiapine,bipolar depression,solute carrier family 6 member 4
9310,lurasidone,bipolar depression,5-hydroxytryptamine receptor 1a
9311,lurasidone,bipolar depression,5-hydroxytryptamine receptor 2a
9312,carbamazepine,bipolar depression,solute carrier family 6 member 4
9313,escitalopram,bipolar depression,solute carrier family 6 member 4
9314,phenobarbital,bipolar depression,glutamate ionotropic receptor kainate type subunit 2
9315,bupropion,bipolar depression,solute carrier family 6 member 4
9316,nefazodone,bipolar depression,5-hydroxytryptamine receptor 1a
9317,nefazodone,bipolar depression,5-hydroxytryptamine receptor 2a
9318,nefazodone,bipolar depression,solute carrier family 6 member 4
9319,citalopram,bipolar depression,solute carrier family 6 member 4
9320,risperidone,bipolar depression,5-hydroxytryptamine receptor 2a
9321,risperidone,bipolar depression,dopamine receptor d1
9322,risperidone,bipolar depression,5-hydroxytryptamine receptor 1a
9323,risperidone,bipolar depression,tachykinin precursor 1
9324,risperidone,bipolar depression,dopamine receptor d5
9325,risperidone,bipolar depression,solute carrier family 6 member 4
9326,fluvoxamine,bipolar depression,solute carrier family 6 member 4
9327,ziprasidone,bipolar depression,dopamine receptor d1
9328,ziprasidone,bipolar depression,dopamine receptor d5
9329,ziprasidone,bipolar depression,solute carrier family 6 member 4
9330,ziprasidone,bipolar depression,5-hydroxytryptamine receptor 2a
9331,ziprasidone,bipolar depression,5-hydroxytryptamine receptor 1a
9332,ziprasidone,bipolar depression,tachykinin precursor 1
9333,olanzapine,bipolar depression,5-hydroxytryptamine receptor 1a
9334,olanzapine,bipolar depression,dopamine receptor d1
9335,olanzapine,bipolar depression,5-hydroxytryptamine receptor 2a
9336,olanzapine,bipolar depression,dopamine receptor d5
9337,fluoxetine,bipolar depression,5-hydroxytryptamine receptor 2a
9338,fluoxetine,bipolar depression,solute carrier family 6 member 4
9339,paliperidone,bipolar depression,5-hydroxytryptamine receptor 1a
9340,paliperidone,bipolar depression,dopamine receptor d1
9341,paliperidone,bipolar depression,5-hydroxytryptamine receptor 2a
9342,paliperidone,bipolar depression,tachykinin precursor 1
9343,diazoxide,pancreatic insulinoma,atp binding cassette subfamily c member 8
9344,cimetidine,zollinger-ellison syndrome,solute carrier family 47 member 1
9345,rabeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9346,lansoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9347,nizatidine,zollinger-ellison syndrome,histamine receptor h2
9348,pantoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9349,famotidine,zollinger-ellison syndrome,solute carrier family 47 member 1
9350,esomeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9351,betamethasone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9352,prednisolone,polymyalgia rheumatica,serpin family a member 6
9353,methylprednisolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9354,triamcinolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9355,triamcinolone,polymyalgia rheumatica,serpin family a member 6
9356,prednisone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9357,ergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1b
9358,dihydroergotamine,cluster headache syndrome,adrenoceptor alpha 2a
9359,caffeine,cluster headache syndrome,phosphodiesterase 4b
9360,prednisone,serum sickness,nuclear receptor subfamily 3 group c member 1
9361,prednisone,serum sickness,albumin
9362,cortisol,serum sickness,nuclear receptor subfamily 3 group c member 1
9363,haloperidol,delirium,dopamine receptor d2
9364,haloperidol,delirium,dopamine receptor d3
9365,oxycodone,neuralgia,opioid receptor mu 1
9366,phenytoin,neuralgia,sodium voltage-gated channel alpha subunit 5
9367,phenytoin,neuralgia,sodium voltage-gated channel alpha subunit 9
9368,gabapentin,neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
9369,trimipramine,neuralgia,5-hydroxytryptamine receptor 2c
9370,naltrexone,neuralgia,opioid receptor mu 1
9371,desipramine,neuralgia,5-hydroxytryptamine receptor 2c
9372,carbamazepine,neuralgia,sodium voltage-gated channel alpha subunit 5
9373,carbamazepine,neuralgia,sodium voltage-gated channel alpha subunit 9
9374,amitriptyline,neuralgia,5-hydroxytryptamine receptor 2c
9375,amitriptyline,neuralgia,opioid receptor mu 1
9376,amitriptyline,neuralgia,neurotrophic receptor tyrosine kinase 1
9377,imipramine,neuralgia,5-hydroxytryptamine receptor 2c
9378,venlafaxine,neuralgia,5-hydroxytryptamine receptor 2c
9379,nortriptyline,neuralgia,5-hydroxytryptamine receptor 2c
9380,morphine,neuralgia,opioid receptor mu 1
9381,tramadol,neuralgia,opioid receptor mu 1
9382,tramadol,neuralgia,5-hydroxytryptamine receptor 2c
9383,lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 9
9384,lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 5
9385,lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 10
9386,ritonavir,covid-19,solute carrier family 47 member 1
9387,ibrutinib,waldenstrom macroglobulinemia,bmx non-receptor tyrosine kinase
9388,ibrutinib,waldenstrom macroglobulinemia,tec protein tyrosine kinase
9389,ibrutinib,waldenstrom macroglobulinemia,"blk proto-oncogene, src family tyrosine kinase"
9390,ibrutinib,waldenstrom macroglobulinemia,txk tyrosine kinase
9391,carmustine,malignant glioma,glutathione-disulfide reductase
9392,phenobarbital,hyperbilirubinemia,atp binding cassette subfamily c member 2
9393,phenobarbital,hyperbilirubinemia,atp binding cassette subfamily b member 11
9394,riboflavin,vitamin deficiency disorder,riboflavin kinase
9395,methylprednisolone,perennial allergic rhinitis,nuclear receptor subfamily 3 group c member 1
9396,gabapentin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
9397,pregabalin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
9398,calcifediol,vitamin d deficiency,vitamin d receptor
9399,"1,25-dihydroxyvitamin d3",vitamin d deficiency,vitamin d receptor
9400,ergocalciferol,vitamin d deficiency,vitamin d receptor
9401,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 2
9402,nintedanib,interstitial lung disease 2,dual specificity tyrosine phosphorylation regulated kinase 1b
9403,nintedanib,interstitial lung disease 2,fibroblast growth factor receptor 3
9404,nintedanib,interstitial lung disease 2,kinase insert domain receptor
9405,nintedanib,interstitial lung disease 2,cdc like kinase 1
9406,nintedanib,interstitial lung disease 2,doublecortin like kinase 1
9407,nintedanib,interstitial lung disease 2,axl receptor tyrosine kinase
9408,nintedanib,interstitial lung disease 2,txk tyrosine kinase
9409,nintedanib,interstitial lung disease 2,discoidin domain receptor tyrosine kinase 1
9410,nintedanib,interstitial lung disease 2,nuak family kinase 2
9411,nintedanib,interstitial lung disease 2,insulin receptor related receptor
9412,nintedanib,interstitial lung disease 2,fms related receptor tyrosine kinase 1
9413,nintedanib,interstitial lung disease 2,cyclin dependent kinase 16
9414,nintedanib,interstitial lung disease 2,serine/threonine kinase 16
9415,nintedanib,interstitial lung disease 2,rio kinase 1
9416,nintedanib,interstitial lung disease 2,"mer proto-oncogene, tyrosine kinase"
9417,nintedanib,interstitial lung disease 2,platelet derived growth factor receptor beta
9418,nintedanib,interstitial lung disease 2,g protein-coupled receptor kinase 4
9419,nintedanib,interstitial lung disease 2,maternal embryonic leucine zipper kinase
9420,nintedanib,interstitial lung disease 2,cdc like kinase 4
9421,nintedanib,interstitial lung disease 2,serine/threonine kinase 11
9422,nintedanib,interstitial lung disease 2,srsf protein kinase 3
9423,nintedanib,interstitial lung disease 2,ribosomal protein s6 kinase a2
9424,nintedanib,interstitial lung disease 2,ttk protein kinase
9425,nintedanib,interstitial lung disease 2,platelet derived growth factor receptor alpha
9426,nintedanib,interstitial lung disease 2,serine/threonine kinase 4
9427,nintedanib,interstitial lung disease 2,protein kinase cgmp-dependent 1
9428,nintedanib,interstitial lung disease 2,"hck proto-oncogene, src family tyrosine kinase"
9429,nintedanib,interstitial lung disease 2,bmp2 inducible kinase
9430,nintedanib,interstitial lung disease 2,ret proto-oncogene
9431,nintedanib,interstitial lung disease 2,eph receptor a3
9432,nintedanib,interstitial lung disease 2,pre-mrna processing factor kinase prp4k
9433,nintedanib,interstitial lung disease 2,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
9434,nintedanib,interstitial lung disease 2,unc-51 like autophagy activating kinase 1
9435,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 7
9436,nintedanib,interstitial lung disease 2,"yes proto-oncogene 1, src family tyrosine kinase"
9437,nintedanib,interstitial lung disease 2,fibroblast growth factor receptor 1
9438,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 19
9439,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase 5
9440,nintedanib,interstitial lung disease 2,activin a receptor type 1
9441,chlorpromazine,disruptive behavior disorder,dopamine receptor d4
9442,promazine,disruptive behavior disorder,dopamine receptor d4
9443,prednisone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
9444,cortisol,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
9445,methylprednisolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9446,betamethasone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9447,prednisone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9448,prednisolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9449,cortisol,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9450,clonazepam,absence epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
9451,rivaroxaban,embolism,coagulation factor x
9452,terbutaline,premature obstetric labor,adrenoceptor beta 2
9453,imatinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
9454,haloperidol,chronic schizophrenia,cytochrome p450 family 3 subfamily a member 4
9455,haloperidol,chronic schizophrenia,cholinergic receptor muscarinic 1
9456,mometasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
9457,cortisol,pruritus ani,nuclear receptor subfamily 3 group c member 1
9458,caffeine,vascular headaches,phosphodiesterase 4b
9459,dihydroergotamine,vascular headaches,adrenoceptor alpha 2a
9460,ergotamine,vascular headaches,5-hydroxytryptamine receptor 1b
9461,trospium chloride,urge incontinence,cholinergic receptor muscarinic 2
9462,trospium chloride,urge incontinence,cholinergic receptor muscarinic 1
9463,trospium chloride,urge incontinence,cholinergic receptor muscarinic 3
9464,darifenacin,urge incontinence,cholinergic receptor muscarinic 2
9465,darifenacin,urge incontinence,cholinergic receptor muscarinic 1
9466,tolterodine,urge incontinence,cholinergic receptor muscarinic 2
9467,tolterodine,urge incontinence,cholinergic receptor muscarinic 1
9468,drospirenone,premenstrual dysphoric disorder,nuclear receptor subfamily 3 group c member 2
9469,ethinylestradiol,premenstrual dysphoric disorder,estrogen receptor 2
9470,ivacaftor,pulmonary cystic fibrosis,cf transmembrane conductance regulator
9471,tafamidis,"familial amyloid neuropathy, portuguese type",transthyretin
9472,doxepin,severe major depression with psychotic features,5-hydroxytryptamine receptor 2a
9473,pralidoxime,poisoning of animals with phosphate salts,butyrylcholinesterase
9474,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4c
9475,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4a
9476,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4d
9477,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4b
